细胞株Cell Lines 16-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心

价　　格：¥19200
货　　号：Cell Line CV16
产　　地：北京

点击询问我要采购

竭诚为您服务！

BioVector NTCC典型培养物保藏中心: 联系人：Dr.Xu, Biovector NTCC Inc.; 电话：400-800-2947 工作QQ:1843439339 (微信同号); 邮件：Biovector@163.com; 手机：18901268599; 地址：北京; 已注册

详细信息
咨询记录(共0条)

细胞株Cell Lines

BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心

ID EM-3

AC CVCL_2033

SY EM3

DR BTO; BTO:0005905

DR CLO; CLO_0002923

DR CLDB; cl1165

DR Cosmic; 787492

DR Cosmic; 798662

DR Cosmic; 994179

DR Cosmic; 1026571

DR DSMZ; ACC-134

RX CelloPub=CLPUB00038;

RX PubMed=3332852;

RX PubMed=3856862;

RX PubMed=15843827;

CC Doubling time: ~40 hours (DSMZ).

ST Source(s): DSMZ; PubMed=25877200

ST Amelogenin: X

ST CSF1PO: 10,12

ST D13S317: 9,12

ST D16S539: 11,12

ST D5S818: 8,12

ST D7S820: 10

ST TH01: 9.3

ST TPOX: 8,12

ST vWA: 14,17

DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_1196 ! EM-2

SX Female

CA Cancer cell line

ID EM-C11

AC CVCL_V249

SY EMC11; C-G11; GM16133

DR CLO; CLO_0018831

DR Coriell; GM16133

RX PubMed=1518409;

RX PubMed=8187089;

OX NCBI_TaxID=10029; ! Cricetulus griseus

HI CVCL_D898 ! CHO-9

SX Female

CA Spontaneously immortalized cell line

ID EM-E6E7TERT-1

AC CVCL_4W29

RX PubMed=14633600;

CC Transfected with: HGNC; 11730; TERT.

CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_4W30 ! EM-E6E7TERT-2

SX Female

CA Transformed cell line

ID EM-E6E7TERT-2

AC CVCL_4W30

SY EM-E6/E7/hTERT-2

DR JCRB; JCRB1545

RX PubMed=14633600;

CC Transfected with: HGNC; 11730; TERT.

CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].

ST Source(s): JCRB

ST Amelogenin: X

ST CSF1PO: 12

ST D13S317: 8

ST D16S539: 11,12

ST D5S818: 12,13

ST D7S820: 11,12

ST TH01: 7,9

ST TPOX: 8,11

ST vWA: 16,20

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_4W29 ! EM-E6E7TERT-1

SX Female

CA Transformed cell line

ID EM-E6E7TERT-3

AC CVCL_4W31

RX PubMed=14633600;

CC Transfected with: HGNC; 11730; TERT.

CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID EM-G3

AC CVCL_5499

SY EMG3

RX PubMed=17063277;

RX PubMed=17366476;

DI NCIt; C4872; Breast carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID EM0001

AC CVCL_8W14

DR ECACC; 95110312

CC Part of: ECACC chromosomal abnormality collection.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Sex undetermined

CA Transformed cell line

ID EM2GEx a

AC CVCL_1G86

WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=31

CC Group: Fish cell line.

CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC031.

OX NCBI_TaxID=215346; ! Epinephelus merra

SX Sex undetermined

CA Spontaneously immortalized cell line

ID EM2HTr

AC CVCL_1G85

WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=30

CC Group: Fish cell line.

CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC030.

OX NCBI_TaxID=162300; ! Epinephelus malabaricus

SX Sex undetermined

CA Spontaneously immortalized cell line

ID EM3GEx

AC CVCL_1G87

WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=32

CC Group: Fish cell line.

CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC032.

OX NCBI_TaxID=215346; ! Epinephelus merra

SX Sex undetermined

CA Spontaneously immortalized cell line

ID EM4SpEx

AC CVCL_1G88

WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=33

CC Group: Fish cell line.

CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC033.

OX NCBI_TaxID=215346; ! Epinephelus merra

SX Sex undetermined

CA Spontaneously immortalized cell line

ID Ema

AC CVCL_L350

RX PubMed=23196801;

CC Doubling time: 26.6 hours (PubMed=23196801).

CC Breed/subspecies: English Springer Spaniel.

DI NCIt; C128121; Canine lymphoma

OX NCBI_TaxID=9615; ! Canis lupus familiaris

SX Female

CA Cancer cell line

ID EMC-BAC-1

AC CVCL_X486

DR Cosmic-CLP; 1503369

DR GDSC; 1503369

DR GEO; GSM1669763

RX PubMed=27397505;

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: DNA methylation analysis.

ST Source(s): Cosmic-CLP

ST Amelogenin: X,Y

ST CSF1PO: 11,12

ST D13S317: 11

ST D16S539: 10,12

ST D5S818: 10,12

ST D7S820: 10

ST TH01: 7

ST TPOX: 10

ST vWA: 15,16

DI NCIt; C2926; Non-small cell lung carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID EMC-BAC-2

AC CVCL_X487

DR Cosmic-CLP; 1503370

DR GDSC; 1503370

DR GEO; GSM1669764

RX PubMed=27397505;

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: DNA methylation analysis.

ST Source(s): Cosmic-CLP

ST Amelogenin: X

ST CSF1PO: 10,11

ST D13S317: 11,12

ST D16S539: 10,12

ST D5S818: 11,13

ST D7S820: 7,9

ST TH01: 6,9.3

ST TPOX: 8,11

ST vWA: 17

DI NCIt; C2926; Non-small cell lung carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID EMC100

AC CVCL_4W32

SY EPC-100; EPC100

DR JCRB; JCRB1538

RX PubMed=21155951;

CC Transfected with: HGNC; 11730; TERT.

CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].

ST Source(s): JCRB

ST Amelogenin: X

ST CSF1PO: 12

ST D13S317: 8

ST D16S539: 11,12

ST D5S818: 12,13

ST D7S820: 11,12

ST TH01: 7,9

ST TPOX: 8,11

ST vWA: 16,20

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_4W33 ! EMC214

SX Female

CA Transformed cell line

ID EMC214

AC CVCL_4W33

SY EPC-214

DR JCRB; JCRB1544

CC Transfected with: HGNC; 11730; TERT.

CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].

ST Source(s): JCRB

ST Amelogenin: X

ST CSF1PO: 12

ST D13S317: 8

ST D16S539: 11,12

ST D5S818: 12,13

ST D7S820: 11,12

ST TH01: 7,9

ST TPOX: 8,11

ST vWA: 16,20

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_4W32 ! EMC100

SX Female

CA Transformed cell line

ID EMJ

AC CVCL_E583

SY EMJH

DR dbMHC; 48778

DR ECACC; 86021103

DR IHW; IHW9097

DR IMGT/HLA; 10562

RX PubMed=8307784;

WW http://bioinformatics.hsanmartino.it/ecbr/cl97.html

CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID EML Cell Line, Clone 1

AC CVCL_9107

DR CLO; CLO_0002925

DR ATCC; CRL-11691

CC Breed/subspecies: C57BL/6 x DBA/2.

OX NCBI_TaxID=10090; ! Mus musculus

SX Male

CA Adult stem cell

ID EML-3C

AC CVCL_7190

SY EMBL3C

DR ATCC; CRL-2996

RX PubMed=19038510;

CC Discontinued: ATCC; CRL-2996; true.

CC Breed/subspecies: Portuguese Garrano.

OX NCBI_TaxID=9796; ! Equus caballus

SX Male

CA Spontaneously immortalized cell line

ID Emma-brain

AC CVCL_0C96

SY Emma-HSA; Emma; EFB

DR GEO; GSM1122236

RX PubMed=19461996;

RX PubMed=24582862;

WW https://www.kerafast.com/product/2263/canine-hemangiosarcoma-cell-line-efb

CC Doubling time: ~5-7 days (Kerafast).

CC Derived from metastatic site: Brain.

CC Breed/subspecies: Golden Retriever.

DI NCIt; C122783; Canine hemangiosarcoma

OX NCBI_TaxID=9615; ! Canis lupus familiaris

OI CVCL_5I29 ! Emma-spleen

SX Female

CA Cancer cell line

ID Emma-spleen

AC CVCL_5I29

SY EFS

DR GEO; GSM1122237

RX PubMed=24582862;

WW https://www.kerafast.com/product/2264/canine-hemangiosarcoma-cell-line-efs

CC Doubling time: ~3 days (Kerafast).

CC Breed/subspecies: Golden Retriever.

DI NCIt; C122783; Canine hemangiosarcoma

OX NCBI_TaxID=9615; ! Canis lupus familiaris

OI CVCL_0C96 ! Emma-brain

SX Female

CA Cancer cell line

ID EMT-1

AC CVCL_W832

RX DOI=10.1294/jes.11.75;

CC Breed/subspecies: Thoroughbred.

OX NCBI_TaxID=9796; ! Equus caballus

SX Female

CA Cancer cell line

ID EMT-2

AC CVCL_W833

RX DOI=10.1294/jes.11.75;

CC Breed/subspecies: Thoroughbred.

OX NCBI_TaxID=9796; ! Equus caballus

SX Male

CA Cancer cell line

ID EMT-3

AC CVCL_W834

RX DOI=10.1294/jes.11.75;

CC Breed/subspecies: Thoroughbred.

OX NCBI_TaxID=9796; ! Equus caballus

SX Female

CA Cancer cell line

ID EMT-6-1.1(1)

AC CVCL_4T81

DR ATCC; CRL-12184

RX Patent=US6013520;

CC Transfected with: UniProtKB; P27967; Barley nitrate reductase.

CC Breed/subspecies: BALB/cCRGL.

DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_1923 ! EMT6

SX Female

CA Cancer cell line

ID EMT-6-1.1(2)

AC CVCL_4T82

DR ATCC; CRL-12185

RX Patent=US6013520;

CC Transfected with: UniProtKB; P27967; Barley nitrate reductase.

CC Breed/subspecies: BALB/cCRGL.

DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_1923 ! EMT6

SX Female

CA Cancer cell line

ID EMT6

AC CVCL_1923

SY EMT-6; Experimental Mammary Tumour-6

DR BTO; BTO:0003329

DR CLO; CLO_0002926

DR ATCC; CRL-2755

DR ChEMBL-Cells; CHEMBL3307584

DR ChEMBL-Targets; CHEMBL614294

RX PubMed=4647494;

CC Breed/subspecies: BALB/cCRGL.

DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX NCBI_TaxID=10090; ! Mus musculus

SX Female

CA Cancer cell line

ID EMT6/AR1

AC CVCL_1924

SY EMT6/AR1.0; EMT6/AR 1.0

DR ECACC; 96042327

RX PubMed=1968761;

RX PubMed=2571735;

CC Doubling time: 12-15 hours (ECACC).

CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

CC Breed/subspecies: BALB/cCRGL.

DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_4173 ! EMT6/P

SX Female

CA Cancer cell line

ID EMT6/AR10.0

AC CVCL_1925

SY EMT6/AR 10.0

DR ECACC; 96042326

RX PubMed=2571735;

CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

CC Breed/subspecies: BALB/cCRGL.

DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_4173 ! EMT6/P

SX Female

CA Cancer cell line

ID EMT6/CPR

AC CVCL_4171

DR ECACC; 96042318

CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

CC Breed/subspecies: BALB/cCRGL.

DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_4173 ! EMT6/P

SX Female

CA Cancer cell line

ID EMT6/MTXR

AC CVCL_4172

SY EMT6/MR 1.0

DR ECACC; 96042322

RX PubMed=2571735;

CC Selected for resistance to: ChEBI; CHEBI:44185; Methotrexate (MTX).

CC Breed/subspecies: BALB/cCRGL.

DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_4173 ! EMT6/P

SX Female

CA Cancer cell line

ID EMT6/P

AC CVCL_4173

SY EMT6/Parent

DR ECACC; 96042344

RX PubMed=1968761;

RX PubMed=2571735;

CC Breed/subspecies: BALB/cCRGL.

DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_1923 ! EMT6

SX Female

CA Cancer cell line

ID EMT6/VCR/R

AC CVCL_4174

DR ECACC; 96042323

CC Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).

CC Breed/subspecies: BALB/cCRGL.

DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_4173 ! EMT6/P

SX Female

CA Cancer cell line

ID EMT6/VRP/R

AC CVCL_4175

SY EMT6/VRP

DR ECACC; 96042319

RX PubMed=1968761;

CC Selected for resistance to: ChEBI; CHEBI:9948; Verapamil (VPL).

CC Breed/subspecies: BALB/cCRGL.

DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_4173 ! EMT6/P

SX Female

CA Cancer cell line

ID EMTOKA

AC CVCL_E115

DR JCRB; JCRB1601

RX PubMed=8431860;

ST Source(s): JCRB

ST Amelogenin: X

ST CSF1PO: 10,11

ST D13S317: 11,13

ST D16S539: 9,12

ST D5S818: 9,11

ST D7S820: 10

ST TH01: 9

ST TPOX: 8,11

ST vWA: 17,18

DI NCIt; C42700; Uterine carcinosarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID EN

AC CVCL_2034

DR BioSample; SAMN03473481

DR CCLE; EN_ENDOMETRIUM

DR Cosmic; 1576453

DR Cosmic; 1995393

DR Cosmic; 2030463

DR Cosmic-CLP; 1240127

DR DSMZ; ACC-564

DR GDSC; 1240127

DR GEO; GSM887005

DR GEO; GSM888074

DR GEO; GSM1669765

DR TKG; TKG 0665

RX PubMed=12581894;

RX PubMed=22460905;

RX PubMed=27397505;

RX PubMed=28196595;

WW http://tcpaportal.org/mclp/

CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC Part of: MD Anderson Cell Lines Project.

CC Doubling time: ~50-80 hours (DSMZ).

CC Microsatellite instability: Instable (MSI-low) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: DNA methylation analysis.

CC Omics: Protein expression by reverse-phase protein arrays.

CC Omics: SNP array analysis.

CC Omics: Transcriptome analysis.

ST Source(s): Cosmic-CLP; DSMZ; TKG

ST Amelogenin: X

ST CSF1PO: 12,14

ST D13S317: 8,11

ST D16S539: 11.1,12 (DSMZ)

ST D16S539: 11,12 (Cosmic-CLP; TKG)

ST D5S818: 12,13

ST D7S820: 11

ST TH01: 6,9

ST TPOX: 8,11

ST vWA: 14,17

DI NCIt; C7558; Endometrial carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID En Son

AC CVCL_U774

SY EN SON

DR ATCC; CRL-1139

CC Discontinued: ATCC; CRL-1139; true.

DI NCIt; C2975; Cystic fibrosis

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Finite cell line

ID EN-1078D

AC CVCL_A423

SY EN1078D; En1078D

DR Cosmic; 1576454

RX PubMed=17894888;

RX PubMed=28196595;

WW http://tcpaportal.org/mclp/

CC Part of: MD Anderson Cell Lines Project.

CC Omics: Protein expression by reverse-phase protein arrays.

CC Derived from metastatic site: Ovary.

DI NCIt; C7558; Endometrial carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID EN-TRL-67T

AC CVCL_DH77

SY EN-TRL 67T; EN-TRL67T

RX PubMed=19222485;

DI NCIt; C7359; Endometrial adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID EN9F10

AC CVCL_J899

DR CLO; CLO_0002927

DR ATCC; CRL-2403

RX DOI=10.1080/09540109109354743;

CC Monoclonal antibody target: ChEBI; CHEBI:4822; Ergometrine (Ergonovine).

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_4032 ! P3X63Ag8.653

CA Hybridoma

ID ENA

AC CVCL_E584

DR dbMHC; 48779

DR IHW; IHW9260

DR IMGT/HLA; 10564

WW http://bioinformatics.hsanmartino.it/ecbr/cl260.html

CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Sex undetermined

CA Transformed cell line

ID EnCL-1

AC CVCL_F705

SY Endothelial Corpus Luteum-1

RX PubMed=21349168;

CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX NCBI_TaxID=9913; ! Bos taurus

SX Female

CA Transformed cell line

ID End1/E6E7

AC CVCL_3684

SY END1/E6E7

DR CLO; CLO_0002928

DR ATCC; CRL-2615

DR BioSample; SAMN03471694

RX PubMed=9314589;

CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].

ST Source(s): ATCC

ST Amelogenin: X

ST CSF1PO: 11,12

ST D13S317: 9,12

ST D16S539: 10,13

ST D5S818: 11,12

ST D7S820: 10

ST TH01: 6

ST TPOX: 8,11

ST vWA: 16,17

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID Endeavour-1

AC CVCL_6966

SY Endeavour 1; E1; POWHe001-A

DR CCRID; 3142C0001000000577

DR hPSCreg; POWHe001-A

DR ISCR; 763

RX Patent=US20070160974;

RX PubMed=18271699;

CC From: Prince of Wales Hospital; Australia.

CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC05-14.

CC Registration: International Depositary Authority, China Center for Type Culture Collection (CCTCC); C200602.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Embryonic stem cell

ID Endeavour-2

AC CVCL_9003

SY Endeavour 2; E2; POWHe002-A

DR hPSCreg; POWHe002-A

DR ISCR; 764

RX PubMed=20178001;

WW http://grants.nih.gov/stem_cells/registry/current.htm?id=388

CC From: Prince of Wales Hospital; Australia.

CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0073.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Embryonic stem cell

ID ENDO

AC CVCL_F551

SY TER281

DR IMGT/HLA; 10565

CC Part of: International Histocompatibility Workshop cell lines.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID Endo.4M

AC CVCL_1E64

WW http://axiogenesis.com/products/murine-endothelial-cells/endo-4m.html

CC From: Axiogenesis AG; Germany.

CC Transfected with: UniProtKB; P42212; GFP.

CC Breed/subspecies: 129S2/SvPas.

OX NCBI_TaxID=10090; ! Mus musculus

CA Finite cell line

ID EndoC-betaH1

AC CVCL_L909

SY EndoC-BH1

RX PubMed=21865645;

RX PubMed=21865653;

RX PubMed=25822155;

WW http://www.endocells.com/products-and-services/

CC Doubling time: 5 days (PubMed=21865645).

CC Transfected with: HGNC; 11730; TERT.

CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EndoC-betaH2

AC CVCL_IS71

SY EndoC-BH2

DR GEO; GSE48101

RX PubMed=24667639;

WW http://www.endocells.com/products-and-services/

CC Characteristics: The lentiviral vector insert containing the SV40 LT and hTERT can be excised by the Cre recombinase.

CC Characteristics: Following excision of immortalizing transgenes, cell proliferation sharply decreases and in parallel there is a massive enhancement of beta cell-specific features such as increased INS gene expression.

CC Doubling time: 5 to 7 days (PubMed=24667639).

CC Transfected with: HGNC; 11730; TERT.

CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC Omics: Transcriptome analysis.

OX NCBI_TaxID=9606; ! Homo sapiens

CA Conditionally immortalized cell line

ID EndoC-betaH3

AC CVCL_IS72

SY EndoC-BH3

WW http://www.endocells.com/products-and-services/

CC Characteristics: The lentiviral vector insert containing the SV40 LT and hTERT can be excised by the Cre recombinase upon addition of tamixofen.

CC Transfected with: HGNC; 11730; TERT.

CC Transfected with: Cre-ERT2; Cre recombinase fused with ligand-binding domaim of ESR mutated to only bind tamoxifen.

CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX NCBI_TaxID=9606; ! Homo sapiens

CA Conditionally immortalized cell line

ID Endor-CLS

AC CVCL_5740

DR CLS; 600173/NA

WW http://www.x-zell.co.th/product.php?productid=40086.

CC Discontinued: CLS; 600173; true.

OX NCBI_TaxID=9913; ! Bos taurus

CA Finite cell line

ID ENG-R

AC CVCL_0I69

DR CCLV; CCLV-RIE 0242

OX NCBI_TaxID=452646; ! Neovison vison

CA Spontaneously immortalized cell line

ID ENStem-A

AC CVCL_GS51

DR Millipore; SCC003

DR Millipore; SCR055

RX PubMed=24232252;

CC Discontinued: Millipore; SCC003; true.

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_9773 ! WA09

SX Female

CA Adult stem cell

ID ENU-T-1

AC CVCL_B397

SY ENU-T1; ENUT-1

RX PubMed=1339105;

RX PubMed=2575302;

CC Breed/subspecies: Sprague-Dawley.

DI NCIt; C60478; Rat nephroblastoma

OX NCBI_TaxID=10116; ! Rattus norvegicus

CA Cancer cell line

ID Envy

AC CVCL_9004

SY ENVY; MONUe001-A

DR hPSCreg; MONUe001-A

DR ISCR; 78

RX PubMed=15782217;

CC From: Monash University; Australia.

CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_7158 ! HES-3

SX Female

CA Embryonic stem cell

ID EO-2

AC CVCL_8349

SY Eel Ovary-2

RX DOI=10.3147/jsfp.16.129;

RX DOI=10.3147/jsfp.28.27;

CC Group: Fish cell line.

OX NCBI_TaxID=7937; ! Anguilla japonica

SX Sex undetermined

CA Spontaneously immortalized cell line

ID EOC 13.31

AC CVCL_5743

SY EOC-13.31; EOC 13

DR CLO; CLO_0002929

DR ATCC; CRL-2468

DR BCRC; 60490

RX PubMed=8550814;

RX PubMed=22651808;

CC Characteristics: CSF1 dependent.

CC Breed/subspecies: C3H/HeJ.

OX NCBI_TaxID=10090; ! Mus musculus

SX Female

CA Factor-dependent cell line

ID EOC 2

AC CVCL_5744

SY EOC-2; EOC2

DR CLO; CLO_0002930

DR ATCC; CRL-2467

RX PubMed=8550814;

RX PubMed=22651808;

CC Characteristics: CSF1 dependent.

CC Breed/subspecies: C3H/HeJ.

OX NCBI_TaxID=10090; ! Mus musculus

SX Female

CA Factor-dependent cell line

ID EOC 20

AC CVCL_5745

SY EOC-20; EOC20

DR CLO; CLO_0002931

DR ATCC; CRL-2469

RX PubMed=8550814;

RX PubMed=22651808;

CC Characteristics: CSF1 dependent.

CC Breed/subspecies: C3H/HeJ.

OX NCBI_TaxID=10090; ! Mus musculus

SX Female

CA Factor-dependent cell line

ID EOC 8

AC CVCL_K168

RX PubMed=8550814;

RX PubMed=22651808;

CC Characteristics: CSF1 dependent.

CC Breed/subspecies: C3H/HeJ.

OX NCBI_TaxID=10090; ! Mus musculus

SX Female

CA Factor-dependent cell line

ID EOC 9

AC CVCL_K169

RX PubMed=8550814;

RX PubMed=22651808;

CC Characteristics: CSF1 dependent.

CC Breed/subspecies: C3H/HeJ.

OX NCBI_TaxID=10090; ! Mus musculus

SX Female

CA Factor-dependent cell line

ID EoL-1

AC CVCL_0258

SY EOL-1; EOL1; EoL-1-cell; EoL-1 cell; AML-EOL-1

DR BTO; BTO:0002405

DR CLO; CLO_0002932

DR CLO; CLO_0002933

DR CLO; CLO_0050996

DR MCCL; MCC:0000149

DR CLDB; cl1166

DR BioSample; SAMN01821624

DR BioSample; SAMN03473158

DR CCLE; EOL1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR ChEMBL-Cells; CHEMBL3308381

DR ChEMBL-Targets; CHEMBL614489

DR Cosmic; 787428

DR Cosmic; 798671

DR Cosmic; 906856

DR Cosmic; 975246

DR Cosmic; 994180

DR Cosmic; 999731

DR Cosmic; 1012065

DR Cosmic; 1278780

DR Cosmic; 1623638

DR Cosmic; 2131562

DR Cosmic-CLP; 906856

DR DSMZ; ACC-386

DR ECACC; 94042252

DR GDSC; 906856

DR GEO; GSM887006

DR GEO; GSM888075

DR GEO; GSM1374475

DR GEO; GSM1669766

DR RCB; RCB0641

DR RCB; RCB3679

DR TKG; TKG 0476

RX PubMed=1477652;

RX PubMed=2415185;

RX PubMed=14630792;

RX PubMed=15843827;

RX PubMed=16408098;

RX PubMed=22460905;

RX PubMed=27397505;

CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC Doubling time: ~60 hours (DSMZ).

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: DNA methylation analysis.

CC Omics: SNP array analysis.

CC Omics: Transcriptome analysis.

ST Source(s): Cosmic-CLP; DSMZ; ECACC; PubMed=25877200; RCB; TKG

ST Amelogenin: X,Y

ST CSF1PO: 7,10

ST D13S317: 12,13

ST D16S539: 8,10

ST D18S51: 12,14

ST D21S11: 29

ST D3S1358: 16,17

ST D5S818: 11

ST D7S820: 10,13

ST D8S1179: 13

ST FGA: 24

ST Penta D: 7,11

ST Penta E: 5,7

ST TH01: 9.3

ST TPOX: 8

ST vWA: 16,17

DI NCIt; C4563; Chronic eosinophilic leukemia, not otherwise specified

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_S960 ! EoL-2

OI CVCL_4069 ! EoL-3

SX Male

CA Cancer cell line

ID EoL-2

AC CVCL_S960

RX PubMed=2415185;

DI NCIt; C4563; Chronic eosinophilic leukemia, not otherwise specified

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_0258 ! EoL-1

OI CVCL_4069 ! EoL-3

SX Male

CA Cancer cell line

ID EoL-3

AC CVCL_4069

DR CLO; CLO_0050997

DR BioSample; SAMN03472016

DR Cosmic; 2089673

DR RCB; RCB2142

DR TKG; TKG 0508

RX PubMed=2415185;

RX PubMed=23955599;

ST Source(s): RCB; TKG

ST Amelogenin: X

ST CSF1PO: 7,11

ST D13S317: 12,13

ST D16S539: 8,10

ST D5S818: 11

ST D7S820: 10,13

ST TH01: 9.3

ST TPOX: 8

ST vWA: 16,17

DI NCIt; C4563; Chronic eosinophilic leukemia, not otherwise specified

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_0258 ! EoL-1

OI CVCL_S960 ! EoL-2

SX Male

CA Cancer cell line

ID EOM-29

AC CVCL_6900

SY EOM29

DR Cosmic; 848326

RX PubMed=8621261;

DI NCIt; C7712; Uveal melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID EOM-3

AC CVCL_6901

SY EOM3

DR Cosmic; 848325

DR Cosmic; 899891

RX PubMed=8621261;

DI NCIt; C7712; Uveal melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID EOMA

AC CVCL_3507

DR BTO; BTO:0002685

DR CLO; CLO_0002934

DR ATCC; CRL-2586

DR BCRJ; 0079

DR JCRB; NIHS0318

RX PubMed=2166185;

WW http://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/eoma/eomacells.html

CC Discontinued: JCRB; NIHS0318; true.

CC Breed/subspecies: 129.

DI NCIt; C22931; Hemangioendothelioma of the mouse blood vessel, malignant

OX NCBI_TaxID=10090; ! Mus musculus

CA Cancer cell line

ID EOMA-GFP

AC CVCL_3508

DR CLO; CLO_0002935

DR ATCC; CRL-2587

CC Transfected with: UniProtKB; P42212; GFP.

CC Breed/subspecies: 129.

DI NCIt; C22931; Hemangioendothelioma of the mouse blood vessel, malignant

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_3507 ! EOMA

CA Cancer cell line

ID Eos-HL-60

AC CVCL_2892

DR CLO; CLO_0002936

DR CLDB; cl5062

DR ECACC; 96100920

DR GEO; GSM827454

ST Source(s): ECACC

ST Amelogenin: X

ST CSF1PO: 13,14

ST D13S317: 8,11

ST D16S539: 11

ST D5S818: 12

ST D7S820: 11,12

ST TH01: 8

ST TPOX: 8,11

ST vWA: 16,17

DI NCIt; C9154; Adult acute myeloid leukemia

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_0002 ! HL-60

SX Female

CA Cancer cell line

ID EP-1

AC CVCL_8350

RX DOI=10.1016/0044-8486(94)00394-4;

CC Group: Fish cell line.

OX NCBI_TaxID=7937; ! Anguilla japonica

SX Sex undetermined

CA Spontaneously immortalized cell line

ID Ep-16

AC CVCL_2894

SY Ep 16

DR CLO; CLO_0002937

DR CLO; CLO_0002938

DR CLDB; cl5187

DR ATCC; HB-155

DR IZSLER; BS Hy 43

OX NCBI_TaxID=10090; ! Mus musculus

CA Hybridoma

ID EP5

AC CVCL_CW57

SY EP-5

DR NCBI_Iran; H169

CC Monoclonal antibody target: UniProtKB; P02751; Human FN.

OX NCBI_TaxID=10090; ! Mus musculus

CA Hybridoma

ID EPa

AC CVCL_Z874

SY E Pa

RX PubMed=4810369;

RX PubMed=5759611;

RX PubMed=5777433;

RX PubMed=5777434;

CC Group: Insect cell line.

OX NCBI_TaxID=6978; ! Periplaneta americana

SX Sex undetermined

CA Spontaneously immortalized cell line

ID EPC

AC CVCL_4361

SY Epithelioma Papulosum Cyprini

DR CLO; CLO_0002940

DR CLDB; cl1167

DR CLDB; cl1168

DR ATCC; CRL-2872

DR BioSample; SAMN03152008

DR CCLV; CCLV-RIE 0173

DR ECACC; 93120820

DR IZSLER; BS CL 41

DR Wikidata; Q26882920

RX DOI=10.1016/S0769-2617(83)80060-4;

RX DOI=10.3147/jsfp.28.27;

RX PubMed=11673072;

RX PubMed=20143388;

WW https://de.wikipedia.org/wiki/EPC-Zellen

WW http://www.atcc.org/support/faqs/0e4bb/EPC%20ATCC%20CRL2872-1053.aspx

WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC Group: Fish cell line.

CC Problematic cell line: Misidentified. Originally deposited as a carp (Cyprinus carpio) cell line, is in fact a fathead minnow (Pimephales promelas) cell line.

CC Doubling time: ~36 hours (ATCC).

OX NCBI_TaxID=90988; ! Pimephales promelas

SX Sex undetermined

CA Spontaneously immortalized cell line

ID EPC-1

AC CVCL_4W34

DR JCRB; JCRB1536

CC Transfected with: HGNC; 11730; TERT.

CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].

ST Source(s): JCRB

ST Amelogenin: X

ST CSF1PO: 11,12

ST D13S317: 8,9

ST D16S539: 10,11

ST D5S818: 12,13

ST D7S820: 10,12

ST TH01: 6,7

ST TPOX: 8,11

ST vWA: 14

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID EPCtiHSP70

AC CVCL_6E02

RX PubMed=11869883;

CC Group: Fish cell line.

CC Problematic cell line: Misidentified. Parent cell line (EPC) was originally deposited as a carp (Cyprinus carpio) cell line, is in fact a fathead minnow (Pimephales promelas) cell line.

CC Transfected with: UniProtKB; P08659; Firefly luciferase.

CC Transfected with: UniProtKB; P42212; GFP.

OX NCBI_TaxID=90988; ! Pimephales promelas

HI CVCL_4361 ! EPC

SX Sex undetermined

CA Spontaneously immortalized cell line

ID EPG

AC CVCL_R841

SY Epithelioma Papulosum of Goldfish

RX DOI=10.1577/1548-8667(1993)005<0137:EACOSC>2.3.CO;2;

RX DOI=10.3147/jsfp.28.27;

CC Group: Fish cell line.

OX NCBI_TaxID=7957; ! Carassius auratus

SX Sex undetermined

CA Spontaneously immortalized cell line

ID EPG85-257DAU

AC CVCL_X177

SY 257DAU

RX PubMed=7773504;

RX PubMed=9180151;

CC Selected for resistance to: ChEBI; CHEBI:41977; Daunorubicin (Daunomycin).

DI NCIt; C4004; Gastric adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_X333 ! EPG85-257P

CA Cancer cell line

ID EPG85-257P

AC CVCL_X333

SY EPG85-257-P; EPG85-257/P; EPG85-257; 257P

RX PubMed=1975514;

RX PubMed=9180151;

RX PubMed=10949126;

RX PubMed=15812352;

RX PubMed=15875780;

CC Omics: Transcriptome analysis.

DI NCIt; C4004; Gastric adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID EPG85-257P-TR

AC CVCL_X178

RX PubMed=15812352;

DI NCIt; C4004; Gastric adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_X333 ! EPG85-257P

CA Cancer cell line

ID EPG85-257RDB

AC CVCL_X175

SY EPG85-257-RDB; EPG85-257/RDB; EPG85-257RDB/K3; EPG85-257P-RDB; 257RD

RX PubMed=10949126;

RX PubMed=15812352;

RX PubMed=15875780;

CC Selected for resistance to: ChEBI; CHEBI:41977; Daunorubicin (Daunomycin).

CC Omics: Transcriptome analysis.

DI NCIt; C4004; Gastric adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_X333 ! EPG85-257P

CA Cancer cell line

ID EPG85-257RDB-TR

AC CVCL_X179

RX PubMed=15812352;

CC Selected for resistance to: ChEBI; CHEBI:41977; Daunorubicin (Daunomycin).

DI NCIt; C4004; Gastric adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_X175 ! EPG85-257RDB

CA Cancer cell line

ID EPG85-257RNOV

AC CVCL_X176

SY EPG85-257-RNOV; EPG85-257RNOV/K3; EPG85-257/RNOV; EPG85-257 RNOV; EPG85-257RN; EPG85-257NOV; 257RN

RX PubMed=1975514;

RX PubMed=9180151;

RX PubMed=10949126;

RX PubMed=15812352;

RX PubMed=15875780;

CC Selected for resistance to: ChEBI; CHEBI:50729; Mitoxantrone.

CC Omics: Transcriptome analysis.

DI NCIt; C4004; Gastric adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_X333 ! EPG85-257P

CA Cancer cell line

ID EPG85-257RNOV-TR

AC CVCL_X180

RX PubMed=15812352;

CC Selected for resistance to: ChEBI; CHEBI:50729; Mitoxantrone.

DI NCIt; C4004; Gastric adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_X176 ! EPG85-257RNOV

CA Cancer cell line

ID EpH4

AC CVCL_0073

SY EPH4; Eph4; EpH-4

DR Lonza; 282

RX PubMed=7720705;

CC Breed/subspecies: BALB/c.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_S574 ! IM-Ep-1

SX Female

CA Spontaneously immortalized cell line

ID EpH4 1424

AC CVCL_S643

DR ATCC; CRL-3071

RX PubMed=12183438;

CC Transfected with: MGI; MGI:1346866; Map2k1 (constitutively activated form).

CC Breed/subspecies: BALB/c.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_S646 ! EpH4 betaMEKDD-116

SX Female

CA Cancer cell line

ID EpH4 1424.1

AC CVCL_S644

DR ATCC; CRL-3209

CC Transfected with: MGI; MGI:1346866; Map2k1 (constitutively activated form).

CC Breed/subspecies: BALB/c.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_S643 ! EpH4 1424

SX Female

CA Cancer cell line

ID EpH4 1424.2

AC CVCL_S645

DR ATCC; CRL-3210

CC Transfected with: MGI; MGI:1346866; Map2k1 (constitutively activated form).

CC Breed/subspecies: BALB/c.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_S643 ! EpH4 1424

SX Female

CA Cancer cell line

ID Eph4 A6

AC CVCL_DC66

SY Eph4-A6

DR ATCC; CRL-3058

RX PubMed=12150823;

CC Transfected with: RGD; 2561; Erbb2 (with E-661).

CC Transformant: Activated Erbb2/neu.

CC Breed/subspecies: BALB/c.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_0073 ! EpH4

SX Female

CA Transformed cell line

ID EpH4 betaMEKDD-116

AC CVCL_S646

SY EpH4 DD-116; B-MEKDD 116

DR ATCC; CRL-3069

RX PubMed=12183438;

CC Transfected with: MGI; MGI:1346866; Map2k1 (constitutively activated form).

CC Breed/subspecies: BALB/c.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_0073 ! EpH4

SX Female

CA Transformed cell line

ID EpH4 betaMEKDD-47

AC CVCL_S647

SY EpH4 DD-47; B-MEKDD 47

RX PubMed=12183438;

CC Transfected with: MGI; MGI:1346866; Map2k1 (constitutively activated form).

CC Breed/subspecies: BALB/c.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_0073 ! EpH4

SX Female

CA Transformed cell line

ID EpH4-Be1a

AC CVCL_S575

SY Be1a

RX PubMed=9661050;

CC Breed/subspecies: BALB/c.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_0073 ! EpH4

SX Female

CA Spontaneously immortalized cell line

ID EpH4-Be4a

AC CVCL_S576

SY Be4a

RX PubMed=9661050;

CC Breed/subspecies: BALB/c.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_0073 ! EpH4

SX Female

CA Spontaneously immortalized cell line

ID EpH4-Ev

AC CVCL_S648

SY Eph4-Empty vector

DR ATCC; CRL-3063

CC Transfected with: UniProtKB; P13249; S.alboniger pac.

CC Breed/subspecies: BALB/c.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_0073 ! EpH4

SX Female

CA Spontaneously immortalized cell line

ID EpH4-H1B

AC CVCL_S577

SY H1B

RX PubMed=9661050;

CC Breed/subspecies: BALB/c.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_0073 ! EpH4

SX Female

CA Spontaneously immortalized cell line

ID EpH4-I3G2

AC CVCL_S578

SY I3G2

RX PubMed=9661050;

CC Breed/subspecies: BALB/c.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_0073 ! EpH4

SX Female

CA Spontaneously immortalized cell line

ID EpH4-J3B1

AC CVCL_S579

SY J3B1

RX PubMed=9661050;

CC Breed/subspecies: BALB/c.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_0073 ! EpH4

SX Female

CA Spontaneously immortalized cell line

ID EpH4-K3A3

AC CVCL_S580

SY K3A3

RX PubMed=9661050;

CC Breed/subspecies: BALB/c.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_0073 ! EpH4

SX Female

CA Spontaneously immortalized cell line

ID EPI

AC CVCL_F741

DR CLO; CLO_0002941

DR CLDB; cl1169

RX PubMed=1540965;

CC Breed/subspecies: Fischer 344.

DI NCIt; C64011; Adenocarcinoma of the rat mammary gland

OX NCBI_TaxID=10116; ! Rattus norvegicus

OI CVCL_0P18 ! R3230AC clone H

OI CVCL_0P19 ! R3230AC clone I

OI CVCL_0P20 ! R3230AC clone L

SX Female

CA Cancer cell line

ID Epi-544

AC CVCL_N843

SY Epi544

DR GEO; GSM1632454

DR GEO; GSM1632455

DR GEO; GSM1632458

DR GEO; GSM1632459

RX PubMed=21357725;

RX PubMed=26365879;

CC Doubling time: ~48 hours (PubMed=21357725).

CC Omics: Deep RNAseq analysis.

DI NCIt; C3714; Epithelioid sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID epiHFF1-B1

AC CVCL_DQ54

SY epiHFF1_iPS_B1

RX PubMed=27345787;

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_3285 ! HFF-1

SX Male

CA Induced pluripotent stem cell

ID epiHUVEC

AC CVCL_9S75

RX PubMed=26987922;

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Induced pluripotent stem cell

ID EpiSC-5

AC CVCL_Y499

SY EpiSC5

DR ENCODE; ENCBS177ENC

DR GEO; GSM450280

WW http://genome.ucsc.edu/ENCODE/protocols/cell/mouse/EpiSC-5_Gilbert_protocol.pdf

CC Part of: ENCODE project mouse cell lines.

OX NCBI_TaxID=10090; ! Mus musculus

SX Male

CA Adult stem cell

ID EpiSC-7

AC CVCL_Y500

SY EpiSC7

DR ENCODE; ENCBS178ENC

DR GEO; GSM450281

WW http://genome.ucsc.edu/ENCODE/protocols/cell/mouse/EpiSC-7_Gilbert_protocol.pdf

CC Part of: ENCODE project mouse cell lines.

OX NCBI_TaxID=10090; ! Mus musculus

SX Male

CA Adult stem cell

ID EPLC-272H

AC CVCL_1197

DR CLO; CLO_0002942

DR EFO; EFO_0006573

DR BioSample; SAMN03473099

DR CCLE; EPLC272H_LUNG

DR ChEMBL-Cells; CHEMBL3308104

DR ChEMBL-Targets; CHEMBL1075443

DR Cosmic; 753556

DR Cosmic; 1995394

DR Cosmic-CLP; 753556

DR DSMZ; ACC-383

DR GDSC; 753556

DR GEO; GSM784228

DR GEO; GSM827194

DR GEO; GSM887007

DR GEO; GSM888076

DR GEO; GSM1669767

RX PubMed=22460905;

RX PubMed=25485619;

RX PubMed=27397505;

CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC Doubling time: ~60 hours (DSMZ).

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: Deep RNAseq analysis.

CC Omics: DNA methylation analysis.

CC Omics: SNP array analysis.

CC Omics: Transcriptome analysis.

ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200

ST Amelogenin: X

ST CSF1PO: 13

ST D13S317: 12,13

ST D16S539: 11,12

ST D18S51: 15

ST D21S11: 31.2

ST D3S1358: 15

ST D5S818: 13

ST D7S820: 8,9

ST D8S1179: 12

ST FGA: 20

ST Penta D: 12

ST Penta E: 11,12

ST TH01: 7,9.3

ST TPOX: 8

ST vWA: 18

DI NCIt; C45544; Lung mucoepidermoid carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID EPLC-32M1

AC CVCL_8193

SY EPLC 32M1; EPLC3-2M1; EPLC32M1

DR ATCC; CRL-2182

DR BioSample; SAMN03151690

DR BioSample; SAMN03472559

RX PubMed=2438285;

RX PubMed=2840315;

RX PubMed=10508494;

RX PubMed=20143388;

WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=10508494, PubMed=20143388).

CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

CC Discontinued: ATCC; CRL-2182; true.

ST Source(s): ATCC

ST Amelogenin: X

ST CSF1PO: 9,10

ST D13S317: 13.3,14.3

ST D16S539: 9,10

ST D5S818: 11,12

ST D7S820: 8,12

ST TH01: 7

ST TPOX: 8,12,13

ST vWA: 17,18

DI NCIt; C4029; Cervical adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_0030 ! HeLa

SX Female

CA Cancer cell line

ID EPLC-65H

AC CVCL_8194

SY EPLC 65H; EPLC-65

DR BioSample; SAMN03151691

RX PubMed=2438285;

RX PubMed=2840315;

RX PubMed=10508494;

RX PubMed=20143388;

WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=10508494, PubMed=20143388).

CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI NCIt; C4029; Cervical adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_0030 ! HeLa

SX Female

CA Cancer cell line

ID EpN1.10

AC CVCL_AV26

RX PubMed=20167219;

CC Group: Insect cell line.

OX NCBI_TaxID=65032; ! Epiphyas postvittana

SX Sex undetermined

CA Spontaneously immortalized cell line

ID EPNT-5

AC CVCL_4622

DR CLO; CLO_0002943

DR CLDB; cl1170

DR CLDB; cl1171

RX PubMed=560733;

RX PubMed=6269518;

WW http://www.rccc.cytspb.rssi.ru/ecellbank/animal/aepnt-5.htm

CC Breed/subspecies: C57BL/6.

OX NCBI_TaxID=10090; ! Mus musculus

CA Cancer cell line

ID EPP85-181P

AC CVCL_X181

SY EPP85-181-P; EPP85-181; 181P

RX PubMed=10949126;

RX PubMed=12136248;

DI NCIt; C8294; Pancreatic adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID EPP85-181RDB

AC CVCL_X182

SY EPP85-181-RDB; EPP85-181RDB/K3; 181RD

RX PubMed=10949126;

RX PubMed=12136248;

CC Selected for resistance to: ChEBI; CHEBI:41977; Daunorubicin (Daunomycin).

DI NCIt; C8294; Pancreatic adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_X181 ! EPP85-181P

CA Cancer cell line

ID EPP85-181RNOV

AC CVCL_X183

SY EPP85-181-RNOV; EPP85-181RNOV/K2; 181RN

RX PubMed=10949126;

RX PubMed=12136248;

CC Selected for resistance to: ChEBI; CHEBI:50729; Mitoxantrone.

DI NCIt; C8294; Pancreatic adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_X181 ! EPP85-181P

CA Cancer cell line

ID EPYP-1

AC CVCL_D574

SY EPYP1

RX PubMed=8687134;

RX PubMed=8900919;

CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC Breed/subspecies: Copenhagen.

OX NCBI_TaxID=10116; ! Rattus norvegicus

SX Male

CA Transformed cell line

ID EPYP-2

AC CVCL_0J53

SY EPYP2

RX PubMed=8687134;

CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC Breed/subspecies: Copenhagen.

OX NCBI_TaxID=10116; ! Rattus norvegicus

SX Male

CA Transformed cell line

ID EPYP-3

AC CVCL_0J54

SY EPYP3

RX PubMed=8687134;

CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC Breed/subspecies: Copenhagen.

OX NCBI_TaxID=10116; ! Rattus norvegicus

SX Male

CA Transformed cell line

ID EqS02a

AC CVCL_9W05

RX PubMed=18191170;

CC Characteristics: Infected by BPV-1.

OX NCBI_TaxID=9796; ! Equus caballus

CA Cancer cell line

ID EqS04b

AC CVCL_9W06

RX PubMed=18191170;

CC Characteristics: Infected by BPV-1.

OX NCBI_TaxID=9796; ! Equus caballus

CA Cancer cell line

ID EqT8888

AC CVCL_7191

RX PubMed=1604800;

OX NCBI_TaxID=9796; ! Equus caballus

SX Female

CA Cancer cell line

ID ER-1

AC CVCL_L896

DR BTO; BTO:0004815

RX PubMed=1618698;

RX PubMed=8276719;

CC Breed/subspecies: Spontaneously hypertensive rat (SHR).

DI NCIt; C64011; Adenocarcinoma of the rat mammary gland

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_6B46 ! c-SST-2 clone 4

SX Female

CA Cancer cell line

ID ER-Cal-27

AC CVCL_EI26

DR GEO; GSM1519077

DR GEO; GSM1519078

DR GEO; GSM1519079

RX PubMed=25888065;

CC Selected for resistance to: ChEBI; CHEBI:114785; Erlotinib.

CC Omics: Transcriptome analysis.

DI NCIt; C4648; Tongue squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_1107 ! CAL-27

SX Male

CA Cancer cell line

ID ER-Fadu

AC CVCL_EI27

DR GEO; GSM1524313

DR GEO; GSM1524314

DR GEO; GSM1524315

RX PubMed=25888065;

CC Selected for resistance to: ChEBI; CHEBI:114785; Erlotinib.

CC Omics: Transcriptome analysis.

DI NCIt; C4043; Hypopharyngeal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_1218 ! FaDu

SX Male

CA Cancer cell line

ID ER-SCC-25

AC CVCL_EI28

DR GEO; GSM1519071

DR GEO; GSM1519072

DR GEO; GSM1519073

RX PubMed=25888065;

CC Selected for resistance to: ChEBI; CHEBI:114785; Erlotinib.

CC Omics: Transcriptome analysis.

DI NCIt; C4648; Tongue squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_1682 ! SCC-25

SX Male

CA Cancer cell line

ID ER-SQ20B

AC CVCL_EI29

DR GEO; GSM1524319

DR GEO; GSM1524320

DR GEO; GSM1524321

RX PubMed=25888065;

CC Selected for resistance to: ChEBI; CHEBI:114785; Erlotinib.

CC Omics: Transcriptome analysis.

DI NCIt; C4044; Laryngeal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_7138 ! SQ-20B

SX Sex undetermined

CA Cancer cell line

ID ER4.7G11

AC CVCL_J179

SY ER4.7G.11; 7G11

DR CLO; CLO_0002944

DR ATCC; HB-11642

RX Patent=US6719972;

CC Monoclonal antibody target: UniProtKB; P16410; Human CTLA4/CD152.

OX NCBI_TaxID=10090; ! Mus musculus

CA Hybridoma

ID ER5.3D8

AC CVCL_DD27

SY 3D8; CTLA4.3

DR ATCC; HB-11641

RX Patent=US6719972;

CC Monoclonal antibody target: UniProtKB; P16410; Human CTLA4/CD152.

CC Discontinued: ATCC; HB-11641; probable.

OX NCBI_TaxID=10090; ! Mus musculus

CA Hybridoma

ID ER5.4D3

AC CVCL_DD28

SY 4D3; CTLA4.1

DR ATCC; HB-11645

RX Patent=US6719972;

CC Monoclonal antibody target: UniProtKB; P16410; Human CTLA4/CD152.

CC Discontinued: ATCC; HB-11645; probable.

OX NCBI_TaxID=10090; ! Mus musculus

CA Hybridoma

ID ERA-1

AC CVCL_9005

SY ERA1; ULBe001-A

DR hPSCreg; ULBe001-A

DR ISCR; 1563

RX PubMed=19549452;

CC From: Universite Libre de Bruxelles; Brussels; Belgium.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Embryonic stem cell

ID ERA-2

AC CVCL_9006

SY ERA2; ULBe002-A

DR hPSCreg; ULBe002-A

DR ISCR; 1564

RX PubMed=19549452;

CC From: Universite Libre de Bruxelles; Brussels; Belgium.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Embryonic stem cell

ID ERA-3

AC CVCL_9007

SY ERA3; ULBe003-A

DR hPSCreg; ULBe003-A

DR ISCR; 1565

RX PubMed=19549452;

CC From: Universite Libre de Bruxelles; Brussels; Belgium.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Embryonic stem cell

ID ERAMUC-1

AC CVCL_9008

SY ERAMUC1; ULBe004-A

DR hPSCreg; ULBe004-A

DR ISCR; 1566

RX PubMed=19549452;

CC From: Universite Libre de Bruxelles; Brussels; Belgium.

DI NCIt; C2975; Cystic fibrosis

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Embryonic stem cell

ID ERAMUC-2

AC CVCL_9009

SY ERAMUC2; ULBe005-A

DR hPSCreg; ULBe005-A

DR ISCR; 1567

RX PubMed=19549452;

CC From: Universite Libre de Bruxelles; Brussels; Belgium.

DI NCIt; C2975; Cystic fibrosis

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Embryonic stem cell

ID EREB2-5

AC CVCL_W845

SY EREB2.5; ER/EB2-5

RX PubMed=7828599;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EREp

AC CVCL_4520

SY EREP

DR CLO; CLO_0002945

DR CLDB; cl1172

DR ATCC; CRL-6498

DR IZSLER; BS CL 112

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6498; true.

OX NCBI_TaxID=9986; ! Oryctolagus cuniculus

CA Finite cell line

ID Ericka

AC CVCL_6F57

RX PubMed=1690682;

RX PubMed=16702430;

CC Group: Non-human primate cell line.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9598; ! Pan troglodytes

SX Female

CA Transformed cell line

ID ERpP

AC CVCL_L897

DR BTO; BTO:0004816

RX PubMed=8276719;

RX PubMed=9568647;

CC Breed/subspecies: Spontaneously hypertensive rat (SHR).

DI NCIt; C64011; Adenocarcinoma of the rat mammary gland

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_L896 ! ER-1

SX Female

CA Cancer cell line

ID ery ED3 SiPSA

AC CVCL_X730

WW http://harvard.eagle-i.net/i/00000147-c606-6633-6889-6c3880000000

CC From: Harvard University; Boston; USA.

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_X731 ! ery ED4 SiPSA

SX Female

CA Induced pluripotent stem cell

ID ery ED4 SiPSA

AC CVCL_X731

WW http://harvard.eagle-i.net/i/00000147-c608-1ebd-6889-6c3880000000

CC From: Harvard University; Boston; USA.

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_X730 ! ery ED3 SiPSA

SX Female

CA Induced pluripotent stem cell

ID ERY-1

AC CVCL_9492

RX PubMed=15475075;

DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID Es Ho

AC CVCL_U775

DR ATCC; CRL-1274

CC Discontinued: ATCC; CRL-1274; true.

DI NCIt; C125701; Ehlers-Danlos syndrome, type VII

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Finite cell line

ID Es Ke

AC CVCL_F120

DR ATCC; CRL-1299

DR ATCC; CRL-1409

CC Discontinued: ATCC; CRL-1299; true.

CC Discontinued: ATCC; CRL-1409; true.

DI NCIt; C125699; Ehlers-Danlos syndrome, type IV

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Finite cell line

ID ES Tet-On/Ngn3

AC CVCL_EG65

SY ES (Tet-On/Ngn3)

DR BCGO; BCGO_0000108

RX PubMed=17932425;

CC Transfected with: MGI; MGI:893591; Neurog3.

CC Breed/subspecies: 129P2/OlaHsd-Hprt<b-m3>.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_C315 ! HM-1 ES

SX Male

CA Embryonic stem cell

ID ES-1-OT

AC CVCL_5122

SY ES-10T

DR Cosmic; 801762

DR Cosmic; 1078365

DR Cosmic; 1381109

DR GEO; GSM393028

DR IGRhCellID; ES1OT%20GEO

RX PubMed=1792900;

RX PubMed=7591257;

RX PubMed=8221663;

DI NCIt; C4817; Ewing sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID ES-2

AC CVCL_3509

SY ES2

DR BTO; BTO:0004424

DR CLO; CLO_0002947

DR EFO; EFO_0002177

DR ATCC; CRL-1978

DR BCRC; 60067

DR BCRJ; 0080

DR BioSample; SAMN03472439

DR CCLE; ES2_OVARY

DR CCRID; 3111C0001CCC000371

DR CCRID; 3131C0001000700111

DR CGH-DB; 323-2

DR Cosmic; 844353

DR Cosmic; 897429

DR Cosmic; 1044235

DR Cosmic; 1102814

DR Cosmic; 1113277

DR Cosmic; 1139225

DR Cosmic; 1223312

DR Cosmic; 1305327

DR Cosmic; 1312191

DR Cosmic; 1328071

DR Cosmic; 1450145

DR Cosmic; 1708382

DR Cosmic; 1709256

DR Cosmic; 1995396

DR Cosmic; 2074240

DR Cosmic-CLP; 1240128

DR GDSC; 1240128

DR GEO; GSM95455

DR GEO; GSM313713

DR GEO; GSM659376

DR GEO; GSM784563

DR GEO; GSM887008

DR GEO; GSM888077

DR GEO; GSM1001491

DR GEO; GSM1176276

DR GEO; GSM1669769

DR IGRhCellID; ES2

DR PRIDE; PXD000901

RX PubMed=1717140;

RX PubMed=12960427;

RX PubMed=16382445;

RX PubMed=17671176;

RX PubMed=18560578;

RX PubMed=22328975;

RX PubMed=22460905;

RX PubMed=23415752;

RX PubMed=23839242;

RX PubMed=24023729;

RX PubMed=25230021;

RX PubMed=25485619;

RX PubMed=27397505;

RX PubMed=28196595;

WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/e/cell-lines-detail-457.html

WW http://tcpaportal.org/mclp/

CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC Part of: MD Anderson Cell Lines Project.

CC Part of: OCCP ovarian cancer cell line panel.

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: Deep RNAseq analysis.

CC Omics: DNA methylation analysis.

CC Omics: Protein expression by reverse-phase protein arrays.

CC Omics: Secretome proteome analysis.

CC Omics: SNP array analysis.

CC Omics: Transcriptome analysis.

ST Source(s): ATCC; Cosmic-CLP; PubMed=25230021; PubMed=25877200

ST Amelogenin: X

ST CSF1PO: 10,15

ST D13S317: 11

ST D16S539: 11,13

ST D18S51: 13,15

ST D21S11: 32.2 (PubMed=25230021)

ST D21S11: 32.2,33.2 (PubMed=25877200)

ST D3S1358: 15,18

ST D5S818: 11,13

ST D7S820: 11

ST D8S1179: 14

ST FGA: 21

ST Penta D: 8,13

ST Penta E: 13,16

ST TH01: 9.3

ST TPOX: 8,12

ST vWA: 16,17

DI NCIt; C40078; Ovarian clear cell adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID ES-2/T80

AC CVCL_CZ94

SY ES-2 T80; ES-2T80

DR GEO; GSM95464

RX PubMed=16382445;

CC Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).

DI NCIt; C40078; Ovarian clear cell adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_3509 ! ES-2

SX Female

CA Cancer cell line

ID ES-2/TxT50

AC CVCL_CZ95

SY ES-2 TxT50; ES-2TxT50

DR GEO; GSM95429

RX PubMed=16382445;

CC Selected for resistance to: ChEBI; CHEBI:4672; Docetaxel anhydrous (Taxotere).

DI NCIt; C40078; Ovarian clear cell adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_3509 ! ES-2

SX Female

CA Cancer cell line

ID ES-2R

AC CVCL_M715

RX PubMed=1717140;

CC Selected for resistance to: ChEBI; CHEBI:41576; 3'-deamino-3'-(3-cyanomorpholin-4-yl)doxorubicin (Cyanomorpholinoadriamycin; MRA-CN).

DI NCIt; C40078; Ovarian clear cell adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_3509 ! ES-2

SX Female

CA Cancer cell line

ID ES-5838

AC CVCL_6255

SY 5838 Ewing's; 5838; #5838

DR Cosmic; 1079353

DR Lonza; 628

RX PubMed=327080;

RX PubMed=2620246;

RX PubMed=3004699;

RX PubMed=3390826;

RX PubMed=6750238;

CC Derived from metastatic site: Pleural effusion.

DI NCIt; C4817; Ewing sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID ES-76

AC CVCL_C079

SY EVMSe001-A

DR hPSCreg; EVMSe001-A

CC From: Eastern Virginia Medical School; Norfolk; USA.

OX NCBI_TaxID=9606; ! Homo sapiens

CA Embryonic stem cell

ID ES-78-1

AC CVCL_C080

SY EVMSe002-A

DR hPSCreg; EVMSe002-A

CC From: Eastern Virginia Medical School; Norfolk; USA.

OX NCBI_TaxID=9606; ! Homo sapiens

CA Embryonic stem cell

ID ES-78-2

AC CVCL_C081

SY EVMSe003-A

DR hPSCreg; EVMSe003-A

CC From: Eastern Virginia Medical School; Norfolk; USA.

OX NCBI_TaxID=9606; ! Homo sapiens

CA Embryonic stem cell

ID ES-8040 20-2

AC CVCL_F750

DR CLO; CLO_0050777

DR RCB; RCB1847

RX PubMed=1946997;

CC Breed/subspecies: C3H/He.

DI NCIt; C21895; Mouse erythroid leukemia

OX NCBI_TaxID=10090; ! Mus musculus

SX Male

CA Cancer cell line

ID ES-8047 2-1

AC CVCL_F751

DR CLO; CLO_0050778

DR RCB; RCB1848

RX PubMed=1946997;

CC Breed/subspecies: C3H/He.

DI NCIt; C21895; Mouse erythroid leukemia

OX NCBI_TaxID=10090; ! Mus musculus

SX Male

CA Cancer cell line

ID ES-C57BL/6

AC CVCL_5746

SY Line 693; #693

DR CLO; CLO_0002948

DR ATCC; SCRC-1002

RX PubMed=11730008;

CC Breed/subspecies: C57BL/6.

OX NCBI_TaxID=10090; ! Mus musculus

SX Male

CA Embryonic stem cell

ID ES-D3

AC CVCL_4378

SY ES D3; D3; D3 ES; D3_ES

DR BTO; BTO:0001582

DR CLO; CLO_0002949

DR CLO; CLO_0002950

DR EFO; EFO_0005910

DR ATCC; CRL-1934

DR ATCC; CRL-11632

DR BCRC; 60205

DR CCRID; 3131C0001000300018

DR CCRID; 3131C0001000300019

DR ENCODE; ENCBS029ENC

DR GEO; GSM450273

DR GEO; GSM450278

DR GEO; GSM450279

DR GEO; GSM450282

DR GEO; GSM450285

DR PRIDE; PXD000589

DR TOKU-E; 3545

RX PubMed=3897439;

RX PubMed=9353641;

RX PubMed=14705957;

RX PubMed=25894527;

WW http://www.atcc.org/support/faqs/ddf06/ATCC%20CRL1934%20vs%20ATCC%20CRL11632-693.aspx

WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/d/cell-lines-detail-148.html

WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/e/cell-lines-detail-265.html

CC Part of: ENCODE project mouse cell lines.

CC Omics: Cell surface proteome.

CC Breed/subspecies: 129S2/SvPas.

OX NCBI_TaxID=10090; ! Mus musculus

SX Male

CA Embryonic stem cell

ID ES-D3 GL

AC CVCL_5747

DR CLO; CLO_0002951

DR ATCC; SCRC-1003

DR BCRC; 60469

CC Discontinued: ATCC; SCRC-1003; true.

CC Breed/subspecies: 129S2/SvPas.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_4378 ! ES-D3

SX Male

CA Embryonic stem cell

ID ES-E14

AC CVCL_C320

SY E14; E-14; ES (E14)

DR BTO; BTO:0005136

DR EFO; EFO_0007075

DR BioSamples; SAMEA2155660

DR ENCODE; ENCBS033ENC

DR ENCODE; ENCBS042ENC

DR ENCODE; ENCBS043ENC

DR ENCODE; ENCBS054SMP

DR ENCODE; ENCBS324NLT

DR GEO; GSM344759

DR GEO; GSM344760

DR GEO; GSM397410

DR GEO; GSM397411

DR GEO; GSM413111

DR GEO; GSM413112

DR GEO; GSM413113

DR GEO; GSM413117

DR GEO; GSM413118

DR GEO; GSM413119

DR GEO; GSM413123

DR GEO; GSM413124

DR GEO; GSM413125

DR GEO; GSM413129

DR GEO; GSM413130

DR GEO; GSM413131

DR GEO; GSM413135

DR GEO; GSM413136

DR GEO; GSM413137

DR GEO; GSM413141

DR GEO; GSM413142

DR GEO; GSM413143

DR GEO; GSM413147

DR GEO; GSM413148

DR GEO; GSM413149

DR GEO; GSM413153

DR GEO; GSM413154

DR GEO; GSM413155

DR GEO; GSM1000126

DR GEO; GSM1000125

DR GEO; GSM1000121

DR GEO; GSM1000124

DR GEO; GSM1000123

DR GEO; GSM1014154

RX PubMed=3821905;

RX PubMed=19581487;

RX PubMed=23850244;

RX PubMed=26484140;

WW http://genome.ucsc.edu/ENCODE/protocols/cell/mouse/ES-E14_Stam_protocol.pdf

CC Part of: ENCODE project mouse cell lines.

CC Omics: DNA methylation analysis.

CC Omics: Genome sequenced.

CC Omics: H3K27me3 ChIP-seq epigenome analysis.

CC Omics: H3K36me3 ChIP-seq epigenome analysis.

CC Omics: H3K4me3 ChIP-seq epigenome analysis.

CC Omics: H3K9me2 ChIP-seq epigenome analysis.

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129/Ola.

OX NCBI_TaxID=10090; ! Mus musculus

SX Male

CA Embryonic stem cell

ID ES-E14TG2a

AC CVCL_9108

SY E14TG2a; E14tg2a

DR CLO; CLO_0002952

DR EFO; EFO_0006275

DR ATCC; CRL-1821

DR BCRC; 60206

DR ECACC; 08021401

DR PRIDE; PXD000589

DR RCB; AES0135

DR TOKU-E; 1158

RX PubMed=3821905;

RX PubMed=25894527;

WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/e/cell-lines-detail-571.html

CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).

CC Omics: Cell surface proteome.

CC Breed/subspecies: 129/Ola.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_C320 ! ES-E14

SX Male

CA Embryonic stem cell

ID ES-E14TG2a.4

AC CVCL_Y481

SY E14TG2a.4; E14Tg2a.4; E14Tg2a.IV

DR ENCODE; ENCBS171HGC

DR ENCODE; ENCBS705LKU

WW https://www.mmrrc.org/catalog/cellLineSDS.php?mmrrc_id=15890

CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).

CC Breed/subspecies: 129/Ola.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_9108 ! ES-E14TG2a

SX Male

CA Embryonic stem cell

ID ES-OMC-MN

AC CVCL_5242

RX PubMed=9143739;

RX PubMed=10929770;

RX PubMed=16557275;

WW http://www.cells-talk.com/index.php/page/copelibrary?key=ES-OMC-MN

CC Doubling time: 68.5 hours, at 90th passage (PubMed=9143739).

DI NCIt; C3714; Epithelioid sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID ES-R1

AC CVCL_2167

SY R1; R1 ES; R-1

DR BTO; BTO:0004500

DR CLO; CLO_0008697

DR EFO; EFO_0002076

DR ATCC; SCRC-1011

DR ChEMBL-Cells; CHEMBL3307379

DR ChEMBL-Targets; CHEMBL614383

DR ECACC; 07072001

DR ENCODE; ENCBS388DNV

DR PRIDE; PRD000194

DR PRIDE; PXD000589

RX PubMed=8378314;

RX PubMed=9353641;

RX PubMed=20512790;

RX PubMed=25894527;

WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/r/cell-lines-detail-521.html

CC Omics: Cell surface proteome.

CC Omics: Deep proteome analysis.

CC Discontinued: ATCC; SCRC-1011; probable.

CC Breed/subspecies: 129X1/SvJ x 129S1/Sv-Oca2+Tyr+KitlSl-J.

OX NCBI_TaxID=10090; ! Mus musculus

SX Male

CA Embryonic stem cell

ID ES-R1 CAG-S-hCOUP-TFI

AC CVCL_BW90

RX PubMed=20382891;

WW https://www.nursa.org/nursa/reagents/cellLine.jsf?doi=10.1621/RQEXOC2BJV

CC Characteristics: The transfected construct consist of a ubiquitous CAGGS (hybrid chicken beta actin and cytomegalovirus) promoter, a loxP-STOP-loxP (LSL) cassette, and the Myc-FLAG-tagged NR/CoR cDNA followed by a polyadenylation signal. The contruct is silent and the transfected gene can be conditionally overexpressed after cre recombinase mediated activation.

CC Transfected with: HGNC; 7975; NR2F1.

CC Breed/subspecies: 129X1/SvJ x 129S1/Sv-Oca2+Tyr+KitlSl-J.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2167 ! ES-R1

SX Male

CA Embryonic stem cell

ID ES-R1 CAG-S-hERalpha

AC CVCL_BW91

RX PubMed=20382891;

WW https://www.nursa.org/nursa/reagents/cellLine.jsf?doi=10.1621/82JR1QYCBV

CC Transfected with: HGNC; 3467; ESR1.

CC Breed/subspecies: 129X1/SvJ x 129S1/Sv-Oca2+Tyr+KitlSl-J.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2167 ! ES-R1

SX Male

CA Embryonic stem cell

ID ES-R1 CAG-S-hERRalpha

AC CVCL_BW92

RX PubMed=20382891;

WW https://www.nursa.org/nursa/reagents/cellLine.jsf?doi=10.1621/4N3X5DWGI3

CC Transfected with: HGNC; 3471; ESRRA.

CC Breed/subspecies: 129X1/SvJ x 129S1/Sv-Oca2+Tyr+KitlSl-J.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2167 ! ES-R1

SX Male

CA Embryonic stem cell

ID ES-R1 CAG-S-hPPARgamma2

AC CVCL_BW93

RX PubMed=20382891;

CC Transfected with: HGNC; 9236; PPARG.

CC Breed/subspecies: 129X1/SvJ x 129S1/Sv-Oca2+Tyr+KitlSl-J.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2167 ! ES-R1

SX Male

CA Embryonic stem cell

ID ES-R1 CAG-S-hRXRalpha

AC CVCL_BW94

RX PubMed=20382891;

CC Transfected with: HGNC; 10477; RXRA.

CC Breed/subspecies: 129X1/SvJ x 129S1/Sv-Oca2+Tyr+KitlSl-J.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2167 ! ES-R1

SX Male

CA Embryonic stem cell

ID ES-R1 CAG-S-hSRC-1

AC CVCL_BW95

RX PubMed=20382891;

CC Transfected with: HGNC; 7668; NCOA1.

CC Breed/subspecies: 129X1/SvJ x 129S1/Sv-Oca2+Tyr+KitlSl-J.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2167 ! ES-R1

SX Male

CA Embryonic stem cell

ID ES-R1 CAG-S-hSRC-2

AC CVCL_BW96

RX PubMed=20382891;

WW https://www.nursa.org/nursa/reagents/cellLine.jsf?doi=10.1621/B7O7PAMCCC

CC Transfected with: HGNC; 7669; NCOA2.

CC Breed/subspecies: 129X1/SvJ x 129S1/Sv-Oca2+Tyr+KitlSl-J.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2167 ! ES-R1

SX Male

CA Embryonic stem cell

ID ES-R1 CAG-S-mPPARalpha

AC CVCL_BW97

RX PubMed=20382891;

WW https://www.nursa.org/nursa/reagents/cellLine.jsf?doi=10.1621/BZFRSZYLIW

CC Transfected with: MGI; MGI:104740; Ppara.

CC Breed/subspecies: 129X1/SvJ x 129S1/Sv-Oca2+Tyr+KitlSl-J.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2167 ! ES-R1

SX Male

CA Embryonic stem cell

ID ES-R1/7AC5/EYFP

AC CVCL_6767

SY 7AC5/EYFP; ES-R1-EYFP 7AC5/EYFP

DR CLO; CLO_0001489

DR ATCC; SCRC-1033

DR ECACC; 07072003

RX PubMed=10951501;

CC Transfected with: UniProtKB; P42212; EYFP (modified GFP at L-46, 64-LG-65, L-68, A-72, T-153, A-163, G-175, Y-203 and L-231).

CC Breed/subspecies: 129X1/SvJ x 129S1/Sv-Oca2+Tyr+KitlSl-J.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2167 ! ES-R1

SX Male

CA Embryonic stem cell

ID ES-R1/B5/EGFP

AC CVCL_AR60

SY B5/EGFP; ES-R1-EGFP B5/EGFP

DR ECACC; 07072007

RX PubMed=9867352;

RX PubMed=10951501;

CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC Breed/subspecies: 129X1/SvJ x 129S1/Sv-Oca2+Tyr+KitlSl-J.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2167 ! ES-R1

SX Male

CA Embryonic stem cell

ID ES-R1/CK6/ECFP

AC CVCL_AR61

SY ES-R1-ECFP CK6/ECFP

DR ECACC; 07072004

CC Transfected with: UniProtKB; Q66PV6; CFP.

CC Breed/subspecies: 129X1/SvJ x 129S1/Sv-Oca2+Tyr+KitlSl-J.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2167 ! ES-R1

SX Male

CA Embryonic stem cell

ID ES-R1/CK8/ECFP

AC CVCL_AR62

SY ES-R1-ECFP CK8/ECFP

DR ECACC; 07072005

CC Transfected with: UniProtKB; Q66PV6; CFP.

CC Breed/subspecies: 129X1/SvJ x 129S1/Sv-Oca2+Tyr+KitlSl-J.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2167 ! ES-R1

SX Male

CA Embryonic stem cell

ID ES-R1/D4/XEGFP

AC CVCL_AR63

SY ES-R1-EGFP D4/XEGFP

DR ECACC; 07072006

CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC Breed/subspecies: 129X1/SvJ x 129S1/Sv-Oca2+Tyr+KitlSl-J.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2167 ! ES-R1

SX Male

CA Embryonic stem cell

ID ES-R1/E

AC CVCL_6516

SY R1/E

DR CLO; CLO_0008700

DR ATCC; SCRC-1036

DR CCRID; 3131C0001001100015

CC Breed/subspecies: 129X1/SvJ x 129S1/Sv-Oca2+Tyr+KitlSl-J.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2167 ! ES-R1

SX Male

CA Embryonic stem cell

ID ES-R1/YC5/EYFP

AC CVCL_AR64

SY YC5/EYFP; ES-R1-EYFP YC5/EYFP

DR ECACC; 07072002

RX PubMed=10951501;

CC Transfected with: UniProtKB; P42212; EYFP (modified GFP at L-46, 64-LG-65, L-68, A-72, T-153, A-163, G-175, Y-203 and L-231).

CC Breed/subspecies: 129X1/SvJ x 129S1/Sv-Oca2+Tyr+KitlSl-J.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2167 ! ES-R1

SX Male

CA Embryonic stem cell

ID ES[10]

AC CVCL_C767

SY ES-10; ES10; ESe025-A

DR BioSamples; SAMEA7780168

DR hPSCreg; ESe025-A

DR ISCR; 1335

RX PubMed=20177997;

WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/ES-10.pdf

CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Embryonic stem cell

ID ES[11EM]

AC CVCL_C768

SY ES-11EM; ES11-EM; ESe026-A

DR hPSCreg; ESe026-A

DR ISCR; 2209

CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.

DI NCIt; C5183; Hereditary multiple exostoses

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Embryonic stem cell

ID ES[2]

AC CVCL_C769

SY ES-2; ES2; ESe009-A

DR BioSamples; SAMEA104012537

DR hPSCreg; ESe009-A

DR ISCR; 1336

RX PubMed=20177997;

CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Embryonic stem cell

ID ES[3]

AC CVCL_C770

SY ES-3; ES3; ESe010-A

DR BioSamples; SAMEA104012539

DR hPSCreg; ESe010-A

DR ISCR; 1337

RX PubMed=20177997;

CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Embryonic stem cell

ID ES[4]

AC CVCL_C771

SY ES-4; ES4; ESe014-A

DR BioSamples; SAMEA7778668

DR hPSCreg; ESe014-A

DR ISCR; 1338

RX PubMed=20177997;

CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Embryonic stem cell

ID ES[5]

AC CVCL_C772

SY ES-5; ES5; ESe016-A

DR hPSCreg; ESe016-A

DR ISCR; 1339

RX PubMed=20177997;

CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Embryonic stem cell

ID ES[6]

AC CVCL_C773

SY ES-6; ES6; ESe015-A

DR hPSCreg; ESe015-A

DR ISCR; 1340

RX PubMed=20177997;

CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Embryonic stem cell

ID ES[7]

AC CVCL_C774

SY ES-7; ES7; ESe022-A

DR hPSCreg; ESe022-A

DR ISCR; 1341

RX PubMed=20177997;

CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Embryonic stem cell

ID ES[8]

AC CVCL_C775

SY ES-8; ES8; ESe023-A

DR hPSCreg; ESe023-A

DR ISCR; 1342

RX PubMed=20177997;

CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Embryonic stem cell

ID ES[9]

AC CVCL_C776

SY ES-9; ES9; ESe024-A

DR hPSCreg; ESe024-A

DR ISCR; 1343

RX PubMed=20177997;

CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tet4932441K18Rik(9)]

AC CVCL_H859

DR GEO; GSM778036

DR GEO; GSM778037

DR GEO; GSM778038

DR GEO; GSM778039

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=4932441K18Rik

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetAes(24)]

AC CVCL_H795

SY AG23197

DR Coriell; AG23197

DR GEO; GSM364239

DR GEO; GSM364240

DR GEO; GSM364241

DR GEO; GSM364242

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Aes

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetAff1(9)]

AC CVCL_H860

DR GEO; GSM777812

DR GEO; GSM777813

DR GEO; GSM777814

DR GEO; GSM777815

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Aff1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetAnkrd22(9)]

AC CVCL_H861

SY AG23563

DR Coriell; AG23563

DR GEO; GSM777816

DR GEO; GSM777817

DR GEO; GSM777818

DR GEO; GSM777819

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Ankrd22

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetArnt2(26)]

AC CVCL_H862

DR GEO; GSM777820

DR GEO; GSM777821

DR GEO; GSM777822

DR GEO; GSM777823

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Arnt2

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetAscl1(12)]

AC CVCL_H796

SY AG23178

DR Coriell; AG23178

DR GEO; GSM364346

DR GEO; GSM364347

DR GEO; GSM364348

DR GEO; GSM364349

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Ascl1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetAscl2(21)]

AC CVCL_H797

SY AG23168

DR Coriell; AG23168

DR GEO; GSM364329

DR GEO; GSM364330

DR GEO; GSM364331

DR GEO; GSM364332

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Ascl2

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetAsh2l(6)]

AC CVCL_H863

SY AG23568

DR Coriell; AG23568

DR GEO; GSM777824

DR GEO; GSM777825

DR GEO; GSM777826

DR GEO; GSM777827

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Ash2l

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetAtf3(5)]

AC CVCL_H798

SY AG23171

DR Coriell; AG23171

DR GEO; GSM364209

DR GEO; GSM364210

DR GEO; GSM364211

DR GEO; GSM364212

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Atf3

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetAtxn1(20)]

AC CVCL_H864

DR GEO; GSM777828

DR GEO; GSM777829

DR GEO; GSM777830

DR GEO; GSM777831

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Atxn1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetBatf3(35)]

AC CVCL_H865

SY AG23512

DR Coriell; AG23512

DR GEO; GSM777832

DR GEO; GSM777833

DR GEO; GSM777834

DR GEO; GSM777835

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Batf3

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetBcl6(32)]

AC CVCL_H866

SY AG23582

DR Coriell; AG23582

DR GEO; GSM777836

DR GEO; GSM777837

DR GEO; GSM777838

DR GEO; GSM777839

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Bcl6

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetCbx8(9)]

AC CVCL_H801

SY AG23200

DR Coriell; AG23200

DR GEO; GSM364231

DR GEO; GSM364232

DR GEO; GSM364233

DR GEO; GSM364234

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Cbx8

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetCdx2(6)]

AC CVCL_H802

SY AG23174

DR Coriell; AG23174

DR GEO; GSM364205

DR GEO; GSM364370

DR GEO; GSM364371

DR GEO; GSM364372

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Cdx2

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetCdyl(12)]

AC CVCL_H867

SY AG23538

DR Coriell; AG23538

DR GEO; GSM777840

DR GEO; GSM777841

DR GEO; GSM777842

DR GEO; GSM777843

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Cdyl

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetCdyl2(24)]

AC CVCL_H868

SY AG23546

DR Coriell; AG23546

DR GEO; GSM777844

DR GEO; GSM777845

DR GEO; GSM777846

DR GEO; GSM777847

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Cdyl2

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetChes1(2)]

AC CVCL_H869

SY AG23533

DR Coriell; AG23533

DR GEO; GSM777848

DR GEO; GSM777849

DR GEO; GSM777850

DR GEO; GSM777851

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Ches1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetControl(13)]

AC CVCL_H811

SY AG23205

DR Coriell; AG23205

DR GEO; GSM364262

DR GEO; GSM364375

DR GEO; GSM364376

DR GEO; GSM364377

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Control

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetCtbp2(23)]

AC CVCL_H870

DR GEO; GSM766433

DR GEO; GSM766434

DR GEO; GSM766435

DR GEO; GSM766436

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Ctbp2

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetCtnnb1(20)]

AC CVCL_H812

SY AG23202

DR Coriell; AG23202

DR GEO; GSM364193

DR GEO; GSM364194

DR GEO; GSM364195

DR GEO; GSM364196

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Ctnnb1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetDedd2(23)]

AC CVCL_H871

DR GEO; GSM777852

DR GEO; GSM777853

DR GEO; GSM777854

DR GEO; GSM777855

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Dedd2

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetDlx3(3)]

AC CVCL_H813

SY AG23173

DR Coriell; AG23173

DR GEO; GSM364317

DR GEO; GSM364318

DR GEO; GSM364319

DR GEO; GSM364320

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Dlx3

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetDmrt1(21)]

AC CVCL_H872

SY AG23561

DR Coriell; AG23561

DR GEO; GSM777856

DR GEO; GSM777857

DR GEO; GSM777858

DR GEO; GSM777859

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Dmrt1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetDnmt3b(22)]

AC CVCL_H814

SY AG23203

DR Coriell; AG23203

DR GEO; GSM364357

DR GEO; GSM364358

DR GEO; GSM364359

DR GEO; GSM364360

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Dnmt3b

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetDppa3(7)]

AC CVCL_H873

SY AG23549

DR Coriell; AG23549

DR GEO; GSM777860

DR GEO; GSM777861

DR GEO; GSM777862

DR GEO; GSM777863

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Dppa3

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetDppa5(7)]

AC CVCL_H815

SY AG23219

DR Coriell; AG23219

DR GEO; GSM364235

DR GEO; GSM364236

DR GEO; GSM364237

DR GEO; GSM364238

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Dppa5a

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetEed(36)]

AC CVCL_H816

DR GEO; GSM364217

DR GEO; GSM364218

DR GEO; GSM364219

DR GEO; GSM364220

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Eed

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetElf1(21)]

AC CVCL_H817

SY AG23176

DR Coriell; AG23176

DR GEO; GSM364367

DR GEO; GSM364400

DR GEO; GSM364401

DR GEO; GSM364402

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Elf1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetElf5(18)]

AC CVCL_H874

DR GEO; GSM777864

DR GEO; GSM777865

DR GEO; GSM777866

DR GEO; GSM777867

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Elf5

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetEll2(38)]

AC CVCL_H875

SY AG23557

DR Coriell; AG23557

DR GEO; GSM777868

DR GEO; GSM777869

DR GEO; GSM777870

DR GEO; GSM777871

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Ell2

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetEomes(35)]

AC CVCL_H818

SY AG23201

DR Coriell; AG23201

DR GEO; GSM364269

DR GEO; GSM364270

DR GEO; GSM364271

DR GEO; GSM364272

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Eomes

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetEsx1(16)]

AC CVCL_H819

SY AG23175

DR Coriell; AG23175

DR GEO; GSM364227

DR GEO; GSM364228

DR GEO; GSM364229

DR GEO; GSM364230

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Esx1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetEts1(6)]

AC CVCL_H876

SY AG23559

DR Coriell; AG23559

DR GEO; GSM777872

DR GEO; GSM777873

DR GEO; GSM777874

DR GEO; GSM777875

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Ets1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetEtv1(15)]

AC CVCL_H877

SY AG23535

DR Coriell; AG23535

DR GEO; GSM777876

DR GEO; GSM777877

DR GEO; GSM777878

DR GEO; GSM777879

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Etv1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetEtv3(15)]

AC CVCL_H820

SY AG23199

DR Coriell; AG23199

DR GEO; GSM364333

DR GEO; GSM364334

DR GEO; GSM364335

DR GEO; GSM364336

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Etv3

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetEtv5(24)]

AC CVCL_H878

DR GEO; GSM766420

DR GEO; GSM766421

DR GEO; GSM766422

DR GEO; GSM766423

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Etv5

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetFbxo15(14)]

AC CVCL_H879

SY AG23539

DR Coriell; AG23539

DR GEO; GSM777880

DR GEO; GSM777881

DR GEO; GSM777882

DR GEO; GSM777883

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Fbxo15

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetFem1b(6)]

AC CVCL_H821

DR GEO; GSM364297

DR GEO; GSM364298

DR GEO; GSM364299

DR GEO; GSM364300

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Fem1b

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetFgfbp1(2)]

AC CVCL_H880

SY AG23586

DR Coriell; AG23586

DR GEO; GSM777884

DR GEO; GSM777885

DR GEO; GSM777886

DR GEO; GSM777887

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Fgfbp1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetFhl2(7)]

AC CVCL_H881

DR GEO; GSM777888

DR GEO; GSM777889

DR GEO; GSM777890

DR GEO; GSM777891

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Fhl2

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetFosl2(1)]

AC CVCL_H882

SY AG23545

DR Coriell; AG23545

DR GEO; GSM777892

DR GEO; GSM777893

DR GEO; GSM777894

DR GEO; GSM777895

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Fosl2

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetFoxa1(36)]

AC CVCL_H883

DR GEO; GSM777896

DR GEO; GSM777897

DR GEO; GSM777898

DR GEO; GSM777899

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Foxa1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetFoxc1(18)]

AC CVCL_H884

DR GEO; GSM777900

DR GEO; GSM777901

DR GEO; GSM777902

DR GEO; GSM777903

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Foxc1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetFoxg1(8)]

AC CVCL_H885

SY AG23525

DR Coriell; AG23525

DR GEO; GSM777904

DR GEO; GSM777905

DR GEO; GSM777906

DR GEO; GSM777907

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Foxg1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetFoxj2(6)]

AC CVCL_H822

SY AG23217

DR Coriell; AG23217

DR GEO; GSM364321

DR GEO; GSM364322

DR GEO; GSM364323

DR GEO; GSM364324

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Foxj2

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetFoxl2(15)]

AC CVCL_H886

SY AG23514

DR Coriell; AG23514

DR GEO; GSM777908

DR GEO; GSM777909

DR GEO; GSM777910

DR GEO; GSM777911

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Foxl2

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetFoxp3(12)]

AC CVCL_H887

DR GEO; GSM777912

DR GEO; GSM777913

DR GEO; GSM777914

DR GEO; GSM777915

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Foxp3

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetGadd45a(6)]

AC CVCL_H823

SY AG23218

DR Coriell; AG23218

DR GEO; GSM364281

DR GEO; GSM364282

DR GEO; GSM364283

DR GEO; GSM364284

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Gadd45a

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetGata2(7)]

AC CVCL_H888

SY AG23519

DR Coriell; AG23519

DR GEO; GSM777916

DR GEO; GSM777917

DR GEO; GSM777918

DR GEO; GSM777919

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Gata2

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetGata3(14)]

AC CVCL_H824

SY AG23181

DR Coriell; AG23181

DR GEO; GSM364309

DR GEO; GSM364310

DR GEO; GSM364311

DR GEO; GSM364312

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Gata3

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetGbx2(8)]

AC CVCL_H889

SY AG23558

DR Coriell; AG23558

DR GEO; GSM777920

DR GEO; GSM777921

DR GEO; GSM777922

DR GEO; GSM777923

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Gbx2

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetGrhl2(22)]

AC CVCL_H890

DR GEO; GSM777924

DR GEO; GSM777925

DR GEO; GSM777926

DR GEO; GSM777927

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Grhl2

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetHesx1(8)]

AC CVCL_H891

SY AG23516

DR Coriell; AG23516

DR GEO; GSM777928

DR GEO; GSM777929

DR GEO; GSM777930

DR GEO; GSM777931

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Hesx1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetHmga2(18)]

AC CVCL_H892

SY AG23571

DR Coriell; AG23571

DR GEO; GSM777932

DR GEO; GSM777933

DR GEO; GSM777934

DR GEO; GSM777935

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Hmga2

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetHnf4a(1)]

AC CVCL_H893

SY AG23520

DR Coriell; AG23520

DR GEO; GSM777936

DR GEO; GSM777937

DR GEO; GSM777938

DR GEO; GSM777939

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Hnf4a

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetHoxa2(12)]

AC CVCL_H894

SY AG23534

DR Coriell; AG23534

DR GEO; GSM777940

DR GEO; GSM777941

DR GEO; GSM777942

DR GEO; GSM777943

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Hoxa2

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetHoxa9(19)]

AC CVCL_H895

SY AG23532

DR Coriell; AG23532

DR GEO; GSM777944

DR GEO; GSM777945

DR GEO; GSM777946

DR GEO; GSM777947

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Hoxa9

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetHsf2bp(10)]

AC CVCL_H896

DR GEO; GSM777948

DR GEO; GSM777949

DR GEO; GSM777950

DR GEO; GSM777951

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Hsf2bp

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetId1(1)]

AC CVCL_H825

SY AG23206

DR Coriell; AG23206

DR GEO; GSM364366

DR GEO; GSM364397

DR GEO; GSM364398

DR GEO; GSM364399

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Id1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetId3(18)]

AC CVCL_H897

DR GEO; GSM777952

DR GEO; GSM777953

DR GEO; GSM777954

DR GEO; GSM777955

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Id3

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetInppl1(21)]

AC CVCL_H898

DR GEO; GSM777956

DR GEO; GSM777957

DR GEO; GSM777958

DR GEO; GSM777959

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Inppl1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetIrf2(7)]

AC CVCL_H899

SY AG23560

DR Coriell; AG23560

DR GEO; GSM777960

DR GEO; GSM777961

DR GEO; GSM777962

DR GEO; GSM777963

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Irf2

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetJarid1a(21)]

AC CVCL_H900

DR GEO; GSM777964

DR GEO; GSM777965

DR GEO; GSM777966

DR GEO; GSM777967

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Jarid1a

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetJarid2(37)]

AC CVCL_H901

DR GEO; GSM766425

DR GEO; GSM766426

DR GEO; GSM766427

DR GEO; GSM766428

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Jarid2

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetJmjd2c(14)]

AC CVCL_H902

DR GEO; GSM766429

DR GEO; GSM766430

DR GEO; GSM766431

DR GEO; GSM766432

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Jmjd2c

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetJun(4)]

AC CVCL_H903

SY AG23526

DR Coriell; AG23526

DR GEO; GSM777968

DR GEO; GSM777969

DR GEO; GSM777970

DR GEO; GSM777971

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Jun

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetKlf3(11)]

AC CVCL_H904

DR GEO; GSM777972

DR GEO; GSM777973

DR GEO; GSM777974

DR GEO; GSM777975

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Klf3

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetKlf4(16)]

AC CVCL_H826

SY AG23193

DR Coriell; AG23193

DR GEO; GSM364263

DR GEO; GSM364264

DR GEO; GSM364392

DR GEO; GSM364393

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Klf4

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetKlf9(23)]

AC CVCL_H905

SY AG23562

DR Coriell; AG23562

DR GEO; GSM777976

DR GEO; GSM777977

DR GEO; GSM777978

DR GEO; GSM777979

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Klf9

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetLass2(12)]

AC CVCL_H906

SY AG23565

DR Coriell; AG23565

DR GEO; GSM777980

DR GEO; GSM777981

DR GEO; GSM777982

DR GEO; GSM777983

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Lass2

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetLhx2(13)]

AC CVCL_H907

SY AG23523

DR Coriell; AG23523

DR GEO; GSM777984

DR GEO; GSM777985

DR GEO; GSM777986

DR GEO; GSM777987

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Lhx2

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetMbd3(12)]

AC CVCL_H908

SY AG23536

DR Coriell; AG23536

DR GEO; GSM777988

DR GEO; GSM777989

DR GEO; GSM777990

DR GEO; GSM777991

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Mbd3

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetMef2c(5)]

AC CVCL_H827

SY AG23180

DR Coriell; AG23180

DR GEO; GSM364277

DR GEO; GSM364278

DR GEO; GSM364279

DR GEO; GSM364280

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Mef2c

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetMeis2(40)]

AC CVCL_H909

SY AG23522

DR Coriell; AG23522

DR GEO; GSM777992

DR GEO; GSM777993

DR GEO; GSM777994

DR GEO; GSM777995

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Meis2

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetMettl5(15)]

AC CVCL_H910

DR GEO; GSM766437

DR GEO; GSM766438

DR GEO; GSM766439

DR GEO; GSM766440

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Mettl5

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetMkrn1(15)]

AC CVCL_H911

SY AG23552

DR Coriell; AG23552

DR GEO; GSM777996

DR GEO; GSM777997

DR GEO; GSM777998

DR GEO; GSM777999

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Mkrn1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetMsc(24)]

AC CVCL_H828

DR GEO; GSM364203

DR GEO; GSM364204

DR GEO; GSM364385

DR GEO; GSM364386

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Msc

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetMybl2(6)]

AC CVCL_H829

SY AG23212

DR Coriell; AG23212

DR GEO; GSM364206

DR GEO; GSM364387

DR GEO; GSM364388

DR GEO; GSM364389

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Mybl2

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetMyc(16)]

AC CVCL_H830

SY AG23204

DR Coriell; AG23204

DR GEO; GSM364213

DR GEO; GSM364214

DR GEO; GSM364215

DR GEO; GSM364216

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Myc

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetMycn(44)]

AC CVCL_H831

SY AG23207

DR Coriell; AG23207

DR GEO; GSM364221

DR GEO; GSM364222

DR GEO; GSM364223

DR GEO; GSM364406

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Mycn

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetMyod1(14)]

AC CVCL_H832

SY AG23183

DR Coriell; AG23183

DR GEO; GSM364289

DR GEO; GSM364290

DR GEO; GSM364291

DR GEO; GSM364292

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Myod1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetNanog(24)]

AC CVCL_H833

SY AG23194

DR Coriell; AG23194

DR GEO; GSM364361

DR GEO; GSM364362

DR GEO; GSM364363

DR GEO; GSM364364

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Nanog

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetNkx2-5(12)]

AC CVCL_H912

SY AG23527

DR Coriell; AG23527

DR GEO; GSM778000

DR GEO; GSM778001

DR GEO; GSM778002

DR GEO; GSM778003

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Nkx2-5

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetNr0b1(15)]

AC CVCL_H834

SY AG23187

DR Coriell; AG23187

DR GEO; GSM364202

DR GEO; GSM364378

DR GEO; GSM364379

DR GEO; GSM364380

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Nr0b1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetNr2f1(14)]

AC CVCL_H913

DR GEO; GSM778004

DR GEO; GSM778005

DR GEO; GSM778006

DR GEO; GSM778007

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Nr2f1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetNr2f2(5)]

AC CVCL_H835

SY AG23167

DR Coriell; AG23167

DR GEO; GSM364313

DR GEO; GSM364314

DR GEO; GSM364315

DR GEO; GSM364316

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Nr2f2

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetNr5a2(7)]

AC CVCL_H836

SY AG23188

DR Coriell; AG23188

DR GEO; GSM364207

DR GEO; GSM364208

DR GEO; GSM364390

DR GEO; GSM364391

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Nr5a2

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetNrip1(20)]

AC CVCL_H837

SY AG23170

DR Coriell; AG23170

DR GEO; GSM364305

DR GEO; GSM364306

DR GEO; GSM364307

DR GEO; GSM364308

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Nrip1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetNsbp1(6)]

AC CVCL_H914

SY AG23515

DR Coriell; AG23515

DR GEO; GSM778008

DR GEO; GSM778009

DR GEO; GSM778010

DR GEO; GSM778011

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Nsbp1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetNupr1(17)]

AC CVCL_H915

SY AG23564

DR Coriell; AG23564

DR GEO; GSM778012

DR GEO; GSM778013

DR GEO; GSM778014

DR GEO; GSM778015

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Nupr1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetOstf1(15)]

AC CVCL_H916

DR GEO; GSM778016

DR GEO; GSM778017

DR GEO; GSM778018

DR GEO; GSM778019

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Ostf1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetOtx1(6)]

AC CVCL_H917

SY AG23524

DR Coriell; AG23524

DR GEO; GSM778020

DR GEO; GSM778021

DR GEO; GSM778022

DR GEO; GSM778023

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Otx1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetOtx2(15)]

AC CVCL_H838

SY AG23179

DR Coriell; AG23179

DR GEO; GSM364265

DR GEO; GSM364266

DR GEO; GSM364267

DR GEO; GSM364268

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Otx2

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetPdlim1(15)]

AC CVCL_H918

SY AG23541

DR Coriell; AG23541

DR GEO; GSM778024

DR GEO; GSM778025

DR GEO; GSM778026

DR GEO; GSM778027

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Pdlim1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetPou5f1(18)]

AC CVCL_H839

SY AG23191

DR Coriell; AG23191

DR GEO; GSM364251

DR GEO; GSM364252

DR GEO; GSM364253

DR GEO; GSM364254

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Pou5f1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetPrickle1(11)]

AC CVCL_H919

DR GEO; GSM778028

DR GEO; GSM778029

DR GEO; GSM778030

DR GEO; GSM778031

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Prickle1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetRest(19)]

AC CVCL_H920

SY AG23576

DR Coriell; AG23576

DR GEO; GSM778032

DR GEO; GSM778033

DR GEO; GSM778034

DR GEO; GSM778035

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Rest

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetRhox6(24)]

AC CVCL_H840

DR GEO; GSM364354

DR GEO; GSM364355

DR GEO; GSM364356

DR GEO; GSM364408

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Rhox6

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetRxra(2)]

AC CVCL_H841

SY AG23236

DR Coriell; AG23236

DR GEO; GSM364350

DR GEO; GSM364351

DR GEO; GSM364352

DR GEO; GSM364353

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Rxra

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetSall4(17)]

AC CVCL_H842

SY AG23189

DR Coriell; AG23189

DR GEO; GSM364381

DR GEO; GSM364382

DR GEO; GSM364383

DR GEO; GSM364384

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Sall4

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetSap30(12)]

AC CVCL_H921

SY AG23537

DR Coriell; AG23537

DR GEO; GSM778040

DR GEO; GSM778041

DR GEO; GSM778042

DR GEO; GSM778043

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Sap30

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetSfpi1(10)]

AC CVCL_H843

SY AG23213

DR Coriell; AG23213

DR GEO; GSM364365

DR GEO; GSM364394

DR GEO; GSM364395

DR GEO; GSM364396

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Sfpi1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetSfrs6(2)]

AC CVCL_H922

SY AG23556

DR Coriell; AG23556

DR GEO; GSM778044

DR GEO; GSM778045

DR GEO; GSM778046

DR GEO; GSM778047

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Sfrs6

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetSirt3(19)]

AC CVCL_H923

SY AG23528

DR Coriell; AG23528

DR GEO; GSM778048

DR GEO; GSM778049

DR GEO; GSM778050

DR GEO; GSM778051

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Sirt3

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetSix1(15)]

AC CVCL_H924

SY AG23550

DR Coriell; AG23550

DR GEO; GSM778052

DR GEO; GSM778053

DR GEO; GSM778054

DR GEO; GSM778055

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Six1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetSmad1(5)]

AC CVCL_H844

SY AG23196

DR Coriell; AG23196

DR GEO; GSM364273

DR GEO; GSM364274

DR GEO; GSM364275

DR GEO; GSM364276

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Smad1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetSmad4(14)]

AC CVCL_H845

DR GEO; GSM364325

DR GEO; GSM364326

DR GEO; GSM364327

DR GEO; GSM364328

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Smad4

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetSmad6(9)]

AC CVCL_H925

SY AG23530

DR Coriell; AG23530

DR GEO; GSM778056

DR GEO; GSM778057

DR GEO; GSM778058

DR GEO; GSM778059

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Smad6

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetSmad7(3)]

AC CVCL_H846

SY AG23195

DR Coriell; AG23195

DR GEO; GSM364338

DR GEO; GSM364339

DR GEO; GSM364340

DR GEO; GSM364341

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Smad7

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetSox11(2)]

AC CVCL_H926

DR GEO; GSM778060

DR GEO; GSM778061

DR GEO; GSM778062

DR GEO; GSM778063

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Sox11

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetSox15(10)]

AC CVCL_H927

DR GEO; GSM778064

DR GEO; GSM778065

DR GEO; GSM778066

DR GEO; GSM778067

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Sox15

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetSox2(3)]

AC CVCL_H847

SY AG23190

DR Coriell; AG23190

DR GEO; GSM364255

DR GEO; GSM364256

DR GEO; GSM364257

DR GEO; GSM364258

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Sox2

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetSox7(32)]

AC CVCL_H928

SY AG23544

DR Coriell; AG23544

DR GEO; GSM778068

DR GEO; GSM778069

DR GEO; GSM778070

DR GEO; GSM778071

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Sox7

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetSox9(13)]

AC CVCL_H848

SY AG23177

DR Coriell; AG23177

DR GEO; GSM364285

DR GEO; GSM364286

DR GEO; GSM364287

DR GEO; GSM364288

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Sox9

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetStat3(15)]

AC CVCL_H849

DR GEO; GSM364243

DR GEO; GSM364244

DR GEO; GSM364245

DR GEO; GSM364246

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Stat3

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetStra13(12)]

AC CVCL_H929

DR GEO; GSM778072

DR GEO; GSM778073

DR GEO; GSM778074

DR GEO; GSM778075

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Stra13

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetSub1(12)]

AC CVCL_H930

DR GEO; GSM778076

DR GEO; GSM778077

DR GEO; GSM778078

DR GEO; GSM778079

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Sub1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetSuz12(9)]

AC CVCL_H850

SY AG23208

DR Coriell; AG23208

DR GEO; GSM364224

DR GEO; GSM364225

DR GEO; GSM364226

DR GEO; GSM364407

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Suz12

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetT(21)]

AC CVCL_H851

SY AG23215

DR Coriell; AG23215

DR GEO; GSM364247

DR GEO; GSM364248

DR GEO; GSM364249

DR GEO; GSM364250

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=T

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetTbx3(15)]

AC CVCL_H931

SY AG23594

DR Coriell; AG23594

DR GEO; GSM766441

DR GEO; GSM766442

DR GEO; GSM766424

DR GEO; GSM766443

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Tbx3

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetTbx5(2)]

AC CVCL_H932

SY AG23521

DR Coriell; AG23521

DR GEO; GSM778080

DR GEO; GSM778081

DR GEO; GSM778082

DR GEO; GSM778083

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Tbx5

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetTcea2]

AC CVCL_DN42

SY AG23185

DR Coriell; AG23185

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Tcea2

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetTcea3(22)]

AC CVCL_H852

DR GEO; GSM364197

DR GEO; GSM364198

DR GEO; GSM364199

DR GEO; GSM364200

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Tcea3

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetTcf3(7)]

AC CVCL_H853

SY AG23192

DR Coriell; AG23192

DR GEO; GSM364368

DR GEO; GSM364403

DR GEO; GSM364404

DR GEO; GSM364405

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Tcf3

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetTcf4(9)]

AC CVCL_H854

SY AG23172

DR Coriell; AG23172

DR GEO; GSM364293

DR GEO; GSM364294

DR GEO; GSM364295

DR GEO; GSM364296

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Tcf4

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetTcfap2c(18)]

AC CVCL_H933

SY AG23567

DR Coriell; AG23567

DR GEO; GSM778084

DR GEO; GSM778085

DR GEO; GSM778086

DR GEO; GSM778087

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Tcfap2c

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetTcfcp2l1(6)]

AC CVCL_H934

SY AG23551

DR Coriell; AG23551

DR GEO; GSM778088

DR GEO; GSM778089

DR GEO; GSM778090

DR GEO; GSM778091

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Tcfcp2l1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetTcl1(6)]

AC CVCL_H935

DR GEO; GSM766416

DR GEO; GSM766417

DR GEO; GSM766418

DR GEO; GSM766419

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Tcl1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetTgif1(8)]

AC CVCL_H936

SY AG23572

DR Coriell; AG23572

DR GEO; GSM778092

DR GEO; GSM778093

DR GEO; GSM778094

DR GEO; GSM778095

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Tgif1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetTgm2(14)]

AC CVCL_H937

SY AG23570

DR Coriell; AG23570

DR GEO; GSM778096

DR GEO; GSM778097

DR GEO; GSM778098

DR GEO; GSM778099

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Tgm2

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetTrpv2(9)]

AC CVCL_H938

SY AG23529

DR Coriell; AG23529

DR GEO; GSM778100

DR GEO; GSM778101

DR GEO; GSM778102

DR GEO; GSM778103

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Trpv2

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetTuba1a(12)]

AC CVCL_H855

SY AG23210

DR Coriell; AG23210

DR GEO; GSM364201

DR GEO; GSM364373

DR GEO; GSM364374

DR GEO; GSM364409

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Tuba1a

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetUgp2(20)]

AC CVCL_H939

SY AG23540

DR Coriell; AG23540

DR GEO; GSM778104

DR GEO; GSM778105

DR GEO; GSM778106

DR GEO; GSM778107

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Ugp2

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):Utf1]

AC CVCL_DN43

SY AG23596

DR Coriell; AG23596

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Utf1

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetWhsc2(18)]

AC CVCL_H856

SY AG23209

DR Coriell; AG23209

DR GEO; GSM364259

DR GEO; GSM364260

DR GEO; GSM364261

DR GEO; GSM364369

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Whsc2

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetZfand3(6)]

AC CVCL_H857

SY AG23198

DR Coriell; AG23198

DR GEO; GSM364301

DR GEO; GSM364302

DR GEO; GSM364303

DR GEO; GSM364304

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Zfand3

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetZfp57(22)]

AC CVCL_H940

SY AG23573

DR Coriell; AG23573

DR GEO; GSM778108

DR GEO; GSM778109

DR GEO; GSM778110

DR GEO; GSM778111

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Zfp57

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetZic1(6)]

AC CVCL_H941

DR GEO; GSM778112

DR GEO; GSM778113

DR GEO; GSM778114

DR GEO; GSM778115

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Zic1

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetZmat4(15)]

AC CVCL_H942

SY AG23531

DR Coriell; AG23531

DR GEO; GSM778116

DR GEO; GSM778117

DR GEO; GSM778118

DR GEO; GSM778119

RX PubMed=22355682;

WW http://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Zmat4

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES[MC1R(20):tetZscan4c(5)]

AC CVCL_H858

SY AG23166

DR Coriell; AG23166

DR GEO; GSM364342

DR GEO; GSM364343

DR GEO; GSM364344

DR GEO; GSM364345

RX PubMed=19796622;

WW http://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Zscan4c

CC Omics: Transcriptome analysis.

CC Breed/subspecies: 129S6/SvEvTac.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_H810 ! MC1

SX Male

CA Embryonic stem cell

ID ES020488

AC CVCL_N844

RX PubMed=7685133;

CC Doubling time: ~60 hours (PubMed=7685133).

DI NCIt; C3714; Epithelioid sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID ES1

AC CVCL_1198

SY ES-1

DR ChEMBL-Cells; CHEMBL3308820

DR ChEMBL-Targets; CHEMBL2366146

DR Cosmic; 684053

DR Cosmic; 949158

DR Cosmic; 2228222

DR Cosmic-CLP; 949158

DR GDSC; 949158

DR GEO; GSM1669768

DR GEO; GSM1676361

DR GEO; GSM1701628

RX PubMed=25010205;

RX PubMed=26351324;

RX PubMed=27397505;

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: Deep RNAseq analysis.

CC Omics: DNA methylation analysis.

ST Source(s): Cosmic-CLP

ST Amelogenin: X

ST CSF1PO: 10

ST D13S317: 9,11

ST D16S539: 11

ST D5S818: 11

ST D7S820: 9,12

ST TH01: 9.3,10

ST TPOX: 10

ST vWA: 16,19

DI NCIt; C4817; Ewing sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID ES2

AC CVCL_AX39

SY ES-2

DR Cosmic; 684054

DR Cosmic; 2228223

DR GEO; GSM1676356

DR GEO; GSM1701686

RX PubMed=26351324;

DI NCIt; C4817; Ewing sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ES3

AC CVCL_1199

SY ES-3

DR ChEMBL-Cells; CHEMBL3308150

DR ChEMBL-Targets; CHEMBL2366135

DR Cosmic; 684055

DR Cosmic-CLP; 684055

DR GDSC; 684055

DR GEO; GSM1669770

DR GEO; GSM1676368

DR GEO; GSM1701629

RX PubMed=26351324;

RX PubMed=27397505;

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: DNA methylation analysis.

ST Source(s): Cosmic-CLP

ST Amelogenin: X,Y

ST CSF1PO: 10,11

ST D13S317: 9

ST D16S539: 12,13

ST D5S818: 11,12

ST D7S820: 9,11

ST TH01: 7,9.3

ST TPOX: 8,12

ST vWA: 14,20

DI NCIt; C4817; Ewing sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID ES4

AC CVCL_1200

SY ES-4

DR ChEMBL-Cells; CHEMBL3308151

DR ChEMBL-Targets; CHEMBL2366118

DR Cosmic; 684056

DR Cosmic; 949156

DR Cosmic; 2228224

DR Cosmic-CLP; 949156

DR GDSC; 949156

DR GEO; GSM1669771

DR GEO; GSM1676340

DR GEO; GSM1676369

DR GEO; GSM1701630

DR GEO; GSM1701671

DR GEO; GSM1701698

RX PubMed=25010205;

RX PubMed=26351324;

RX PubMed=27397505;

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: Deep RNAseq analysis.

CC Omics: DNA methylation analysis.

ST Source(s): Cosmic-CLP

ST Amelogenin: X,Y

ST CSF1PO: 11

ST D13S317: 11,12

ST D16S539: 9

ST D5S818: 11,12

ST D7S820: 11,12

ST TH01: 6,7

ST TPOX: 8,10

ST vWA: 16,17

DI NCIt; C4817; Ewing sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID ES5

AC CVCL_1201

DR ChEMBL-Cells; CHEMBL3308517

DR ChEMBL-Targets; CHEMBL2366312

DR Cosmic; 684057

DR Cosmic-CLP; 684057

DR GDSC; 684057

DR GEO; GSM1669772

RX PubMed=27397505;

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: DNA methylation analysis.

ST Source(s): Cosmic-CLP

ST Amelogenin: X,Y

ST CSF1PO: 11,13

ST D13S317: 12,14

ST D16S539: 11,12

ST D5S818: 13

ST D7S820: 9,11

ST TH01: 7

ST TPOX: 8

ST vWA: 15,16

DI NCIt; C4817; Ewing sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID ES5.2D8

AC CVCL_DD29

DR ATCC; HB-11374

RX Patent=US5883223;

CC Monoclonal antibody target: UniProtKB; P16410; Human CTLA4/CD152.

CC Discontinued: ATCC; HB-11374; probable.

OX NCBI_TaxID=10090; ! Mus musculus

CA Hybridoma

ID ES5.3D6

AC CVCL_DD30

SY 3D6; CTLA4.2

DR ATCC; HB-11644

RX Patent=US6719972;

CC Monoclonal antibody target: UniProtKB; P16410; Human CTLA4/CD152.

CC Discontinued: ATCC; HB-11644; probable.

OX NCBI_TaxID=10090; ! Mus musculus

CA Hybridoma

ID ES5.4E3

AC CVCL_DD31

SY 4E3; CTLA4.4

DR ATCC; HB-11643

RX Patent=US6719972;

CC Monoclonal antibody target: UniProtKB; P16410; Human CTLA4/CD152.

CC Discontinued: ATCC; HB-11643; probable.

OX NCBI_TaxID=10090; ! Mus musculus

CA Hybridoma

ID ES6

AC CVCL_1202

SY ES-6

DR ChEMBL-Cells; CHEMBL3308152

DR ChEMBL-Targets; CHEMBL2366373

DR Cosmic; 684058

DR Cosmic; 949157

DR Cosmic; 2228225

DR Cosmic-CLP; 949157

DR GDSC; 949157

DR GEO; GSM1669773

DR GEO; GSM1676357

DR GEO; GSM1701687

RX PubMed=25010205;

RX PubMed=26351324;

RX PubMed=27397505;

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: Deep RNAseq analysis.

CC Omics: DNA methylation analysis.

ST Source(s): Cosmic-CLP

ST Amelogenin: X,Y

ST CSF1PO: 12

ST D13S317: 11,13

ST D16S539: 12

ST D5S818: 11,13

ST D7S820: 11,12

ST TH01: 7

ST TPOX: 8,9

ST vWA: 15

DI NCIt; C4817; Ewing sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID ES7

AC CVCL_1203

SY ES-7

DR ChEMBL-Cells; CHEMBL3308821

DR ChEMBL-Targets; CHEMBL2366297

DR Cosmic; 684059

DR Cosmic; 1995398

DR Cosmic; 2228226

DR Cosmic-CLP; 684059

DR GDSC; 684059

DR GEO; GSM1669774

DR GEO; GSM1676296

DR GEO; GSM1701631

RX PubMed=25010205;

RX PubMed=26351324;

RX PubMed=27397505;

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: Deep RNAseq analysis.

CC Omics: DNA methylation analysis.

ST Source(s): Cosmic-CLP

ST Amelogenin: X

ST CSF1PO: 12,14

ST D13S317: 8,11

ST D16S539: 11,12

ST D5S818: 11

ST D7S820: 10

ST TH01: 7

ST TPOX: 8,11

ST vWA: 14,17

DI NCIt; C4817; Ewing sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID ES8

AC CVCL_1204

SY ES-8

DR ChEMBL-Cells; CHEMBL3308153

DR ChEMBL-Targets; CHEMBL2366069

DR Cosmic; 684060

DR Cosmic; 949155

DR Cosmic; 1995399

DR Cosmic; 2060799

DR Cosmic; 2228227

DR Cosmic-CLP; 949155

DR GDSC; 949155

DR GEO; GSM1669775

DR GEO; GSM1676297

DR GEO; GSM1701632

RX PubMed=25010205;

RX PubMed=26351324;

RX PubMed=27397505;

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: Deep RNAseq analysis.

CC Omics: DNA methylation analysis.

ST Source(s): Cosmic-CLP

ST Amelogenin: X,Y

ST CSF1PO: 10,13

ST D13S317: 13

ST D16S539: 11

ST D5S818: 12,13

ST D7S820: 7,12

ST TH01: 6,9.3

ST TPOX: 8,9

ST vWA: 16,17

DI NCIt; C4817; Ewing sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID Esa-1

AC CVCL_J512

DR ATCC; HTB-83

RX PubMed=833871;

CC Discontinued: ATCC; HTB-83; true.

DI NCIt; C4817; Ewing sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID ESC 98B01

AC CVCL_GT24

DR BCRC; SC81023

CC Breed/subspecies: C57BL/6.

OX NCBI_TaxID=10090; ! Mus musculus

CA Embryonic stem cell

ID ESC-410

AC CVCL_E310

RX PubMed=20819098;

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID ESC/LCM1T

AC CVCL_Y279

DR CGH-DB; 211-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM10T-N

AC CVCL_Y209

DR CGH-DB; 220-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM11T-N

AC CVCL_Y210

DR CGH-DB; 221-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM12T-N

AC CVCL_Y211

DR CGH-DB; 222-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM14T-N

AC CVCL_Y212

DR CGH-DB; 223-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM15T-N

AC CVCL_Y213

DR CGH-DB; 224-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM16T-N

AC CVCL_Y214

DR CGH-DB; 225-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM17T-N

AC CVCL_Y215

DR CGH-DB; 226-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM18T

AC CVCL_Y216

DR CGH-DB; 227-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM2T-N

AC CVCL_Y217

DR CGH-DB; 212-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM20T-N

AC CVCL_Y218

DR CGH-DB; 228-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM21T-N

AC CVCL_Y219

DR CGH-DB; 229-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM22T-N

AC CVCL_Y220

DR CGH-DB; 230-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM23T

AC CVCL_Y221

DR CGH-DB; 231-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM24T-N

AC CVCL_Y222

DR CGH-DB; 232-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM25T-N

AC CVCL_Y223

DR CGH-DB; 233-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM26T-N

AC CVCL_Y224

DR CGH-DB; 234-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM27T-N

AC CVCL_Y225

DR CGH-DB; 235-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM29T-N

AC CVCL_Y226

DR CGH-DB; 236-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM3T-N

AC CVCL_Y227

DR CGH-DB; 213-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM31T-N

AC CVCL_Y228

DR CGH-DB; 237-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM32T-N

AC CVCL_Y229

DR CGH-DB; 238-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM33T

AC CVCL_Y230

DR CGH-DB; 239-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM34T-N

AC CVCL_Y231

DR CGH-DB; 240-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM35T-N

AC CVCL_Y232

DR CGH-DB; 241-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM36T

AC CVCL_Y233

DR CGH-DB; 242-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM37T-N

AC CVCL_Y234

DR CGH-DB; 243-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM38T-N

AC CVCL_Y235

DR CGH-DB; 244-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM39T-N

AC CVCL_Y236

DR CGH-DB; 245-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM4T-N

AC CVCL_Y237

DR CGH-DB; 214-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM40T

AC CVCL_Y238

DR CGH-DB; 246-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM41T-N

AC CVCL_Y239

DR CGH-DB; 247-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM42T-N

AC CVCL_Y240

DR CGH-DB; 248-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM43T-N

AC CVCL_Y241

DR CGH-DB; 249-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM44T-N

AC CVCL_Y242

DR CGH-DB; 250-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM45T-N

AC CVCL_Y243

DR CGH-DB; 251-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM46T-N

AC CVCL_Y244

DR CGH-DB; 252-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM47T-N

AC CVCL_Y245

DR CGH-DB; 253-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM48T-N

AC CVCL_Y246

DR CGH-DB; 254-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM49T-N

AC CVCL_Y247

DR CGH-DB; 255-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM5T

AC CVCL_Y248

DR CGH-DB; 215-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM50T-N

AC CVCL_Y249

DR CGH-DB; 256-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM51T-N

AC CVCL_Y250

DR CGH-DB; 257-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM52T-N

AC CVCL_Y251

DR CGH-DB; 258-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM53T-N

AC CVCL_Y252

DR CGH-DB; 259-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM54T-N

AC CVCL_Y253

DR CGH-DB; 260-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM55T-N

AC CVCL_Y254

DR CGH-DB; 261-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM56T-N

AC CVCL_Y255

DR CGH-DB; 262-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM57T-N

AC CVCL_Y256

DR CGH-DB; 263-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM58T-N

AC CVCL_Y257

DR CGH-DB; 264-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM59T-N

AC CVCL_Y258

DR CGH-DB; 265-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM6T

AC CVCL_Y259

DR CGH-DB; 216-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM60T-N

AC CVCL_Y260

DR CGH-DB; 266-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM61T-N

AC CVCL_Y261

DR CGH-DB; 267-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM62T-N

AC CVCL_Y262

DR CGH-DB; 268-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM66T-N

AC CVCL_Y263

DR CGH-DB; 269-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM67T-N

AC CVCL_Y264

DR CGH-DB; 270-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM69T-N

AC CVCL_Y265

DR CGH-DB; 271-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM7T

AC CVCL_Y266

DR CGH-DB; 217-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM70T-N

AC CVCL_Y267

DR CGH-DB; 272-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM71T-N

AC CVCL_Y268

DR CGH-DB; 273-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM8T-N

AC CVCL_Y269

DR CGH-DB; 218-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESC/LCM9T-N

AC CVCL_Y270

DR CGH-DB; 219-1

DI NCIt; C4024; Esophageal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID ESCC-DR

AC CVCL_R804

RX PubMed=17352229;

CC Breed/subspecies: Wistar.

DI NCIt; C63892; Squamous cell carcinoma of the rat esophagus

OX NCBI_TaxID=10116; ! Rattus norvegicus

SX Male

CA Cancer cell line

ID ESF 158

AC CVCL_C257

DR ATCC; SCRC-1016

OX NCBI_TaxID=10090; ! Mus musculus

CA Embryonic stem cell

ID ESI-013

AC CVCL_B852

SY SSCCe001-A

DR hPSCreg; SSCCe001-A

RX PubMed=18371388;

CC From: ESI BIO - BioTime, Inc. (ES Cell International).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Embryonic stem cell

ID ESI-014

AC CVCL_B853

SY SSCCe002-A

DR hPSCreg; SSCCe002-A

DR ISCR; 79

RX PubMed=18371388;

WW http://grants.nih.gov/stem_cells/registry/current.htm?id=465

CC Group: Clinical grade hESC cell line.

CC From: ESI BIO - BioTime, Inc. (ES Cell International).

CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0092.

CC Miscellaneous: Sibling to ESI-017 (CVCL_B854).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Embryonic stem cell

ID ESI-017

AC CVCL_B854

SY ESI017; SSCCe003-A

DR hPSCreg; SSCCe003-A

DR ISCR; 80

RX PubMed=18371388;

RX PubMed=20177998;

RX PubMed=22265736;

WW http://www.esibio.com/products/product-category/cell-lines/esi-017-human-embryonic-stem-cell-line-46-xx/

WW http://grants.nih.gov/stem_cells/registry/current.htm?id=466

CC Group: Clinical grade hESC cell line.

CC From: ESI BIO - BioTime, Inc. (ES Cell International).

CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0093.

CC Omics: CNV analysis.

CC Omics: Genome sequenced.

CC Omics: SNP array analysis.

CC Miscellaneous: Sibling to ESI-014 (CVCL_B853).

ST Source(s): ESI_BIO

ST Amelogenin: X

ST CSF1PO: 11,12

ST D13S317: 11

ST D16S539: 10,11

ST D18S51: 13,16

ST D21S11: 30,33.2

ST D3S1358: 16,18

ST D5S818: 12

ST D7S820: 8,12

ST D8S1179: 12,14

ST FGA: 22

ST Penta D: 13,14

ST Penta E: 7,14

ST TH01: 6,7

ST TPOX: 8,11

ST vWA: 14,16

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Embryonic stem cell

ID ESI-027

AC CVCL_B855

SY SSCCe006-A

DR hPSCreg; SSCCe006-A

RX PubMed=18371388;

CC From: ESI BIO - BioTime, Inc. (ES Cell International).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Embryonic stem cell

ID ESI-035

AC CVCL_B856

SY ESI035; SSCCe007-A

DR hPSCreg; SSCCe007-A

DR ISCR; 81

RX PubMed=18371388;

RX PubMed=20177998;

RX PubMed=22265736;

WW http://www.esibio.com/products/product-category/cell-lines/esi-035-human-embryonic-stem-cell-line-46-xx/

WW http://grants.nih.gov/stem_cells/registry/current.htm?id=485

CC Group: Clinical grade hESC cell line.

CC From: ESI BIO - BioTime, Inc. (ES Cell International).

CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0129.

CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-01.

CC Omics: CNV analysis.

CC Omics: Genome sequenced.

CC Omics: SNP array analysis.

ST Source(s): ESI_BIO

ST Amelogenin: X

ST CSF1PO: 12

ST D13S317: 11,12

ST D16S539: 12

ST D18S51: 14,17

ST D21S11: 28

ST D3S1358: 15,16

ST D5S818: 11,12

ST D7S820: 11

ST D8S1179: 13

ST FGA: 21,23

ST Penta D: 9,12

ST Penta E: 11,14

ST TH01: 7,8

ST TPOX: 8,11

ST vWA: 16

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Embryonic stem cell

ID ESI-049

AC CVCL_B857

SY ESI049; SSCCe004-A

DR hPSCreg; SSCCe004-A

DR ISCR; 82

RX PubMed=18371388;

RX PubMed=20177998;

RX PubMed=22265736;

WW http://www.esibio.com/products/product-category/cell-lines/esi-049-human-embryonic-stem-cell-line-46-xy/

WW http://grants.nih.gov/stem_cells/registry/current.htm?id=486

CC Group: Clinical grade hESC cell line.

CC From: ESI BIO - BioTime, Inc. (ES Cell International).

CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0130.

CC Omics: CNV analysis.

CC Omics: Genome sequenced.

CC Omics: SNP array analysis.

ST Source(s): ESI_BIO

ST Amelogenin: X,Y

ST CSF1PO: 10,12

ST D13S317: 12,13

ST D16S539: 9,11

ST D18S51: 10,13

ST D21S11: 29,31

ST D3S1358: 15,16

ST D5S818: 11,12

ST D7S820: 11,13

ST D8S1179: 14,15

ST FGA: 18,20

ST Penta D: 11,15

ST Penta E: 15,18

ST TH01: 9

ST TPOX: 8,11

ST vWA: 17,19

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Embryonic stem cell

ID ESI-051

AC CVCL_B858

SY ESI051; SSCCe005-A

DR hPSCreg; SSCCe005-A

DR ISCR; 83

RX PubMed=18371388;

RX PubMed=22265736;

WW http://www.esibio.com/products/product-category/cell-lines/esi-051-human-embryonic-stem-cell-line-46-xx/

WW http://grants.nih.gov/stem_cells/registry/current.htm?id=487

CC Group: Clinical grade hESC cell line.

CC From: ESI BIO - BioTime, Inc. (ES Cell International).

CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0131.

CC Omics: CNV analysis.

CC Omics: Genome sequenced.

CC Omics: SNP array analysis.

CC Miscellaneous: Sibling to ESI-053 (CVCL_B859).

ST Source(s): ESI_BIO

ST Amelogenin: X

ST CSF1PO: 10,11

ST D13S317: 12

ST D16S539: 11

ST D18S51: 18

ST D21S11: 24.2,31.2

ST D3S1358: 14,16

ST D5S818: 12,13

ST D7S820: 11

ST D8S1179: 10,13

ST FGA: 20,22.2

ST Penta D: 9,11

ST Penta E: 5,17

ST TH01: 6,7

ST TPOX: 8,11

ST vWA: 15,18

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Embryonic stem cell

ID ESI-053

AC CVCL_B859

SY ESI053; SSCCe008-A

DR hPSCreg; SSCCe008-A

DR ISCR; 84

RX PubMed=18371388;

RX PubMed=20177998;

RX PubMed=22265736;

WW http://www.esibio.com/products/product-category/cell-lines/esi-053-human-embryonic-stem-cell-line-46-xx/

WW http://grants.nih.gov/stem_cells/registry/current.htm?id=488

CC Group: Clinical grade hESC cell line.

CC From: ESI BIO - BioTime, Inc. (ES Cell International).

CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0132.

CC Omics: CNV analysis.

CC Omics: Genome sequenced.

CC Omics: SNP array analysis.

CC Miscellaneous: Sibling to ESI-051 (CVCL_B858).

ST Source(s): ESI_BIO

ST Amelogenin: X

ST CSF1PO: 10

ST D13S317: 9,12

ST D16S539: 11

ST D18S51: 16,18

ST D21S11: 30,31.2

ST D3S1358: 16

ST D5S818: 11,12

ST D7S820: 11

ST D8S1179: 10,14

ST FGA: 24

ST Penta D: 9,11

ST Penta E: 11,15

ST TH01: 6,7

ST TPOX: 8,11

ST vWA: 13,16

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Embryonic stem cell

ID ESK-4

AC CVCL_3685

DR CLO; CLO_0002953

DR CLDB; cl1174

DR CLDB; cl1175

DR ATCC; CL-184

DR BCRC; 60202

DR ECACC; 93120821

DR IZSLER; BS CL 42

RX Patent=US4070453;

RX PubMed=19508353;

OX NCBI_TaxID=9823; ! Sus scrofa

SX Female

CA Finite cell line

ID ESKOL

AC CVCL_B398

SY Eskol

DR Cosmic; 1809510

DR GEO; GSM1374476

RX PubMed=1895754;

RX PubMed=11060441;

RX PubMed=11755467;

RX PubMed=22653958;

CC Problematic cell line: Possibly misidentified. It is not certain that this cell line originate from a hairy cell leukemia (PubMed=22653958).

CC Omics: Transcriptome analysis.

DI NCIt; C7402; Hairy cell leukemia

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID ESO-26

AC CVCL_2035

SY ESO26

DR BioSample; SAMN03473393

DR Cosmic; 1599336

DR Cosmic-CLP; 1503366

DR DSMZ; ACC-708

DR ECACC; 11012009

DR GDSC; 1503366

DR GEO; GSM1669776

RX PubMed=20075370;

RX PubMed=23795680;

CC Doubling time: ~35-50 hours (DSMZ).

CC Microsatellite instability: Instable (MSI-low) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: DNA methylation analysis.

ST Source(s): Cosmic-CLP; DSMZ; ECACC

ST Amelogenin: X,Y

ST CSF1PO: 9,10

ST D13S317: 9,11

ST D16S539: 9

ST D5S818: 12

ST D7S820: 11

ST TH01: 9

ST TPOX: 7,9

ST vWA: 14,18

DI NCIt; C4025; Esophageal adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID ESO-51

AC CVCL_2036

SY ESO51

DR BioSample; SAMN03473444

DR Cosmic; 1599338

DR Cosmic-CLP; 1503367

DR DSMZ; ACC-694

DR ECACC; 11012010

DR GDSC; 1503367

DR GEO; GSM1669777

RX PubMed=20075370;

RX PubMed=23795680;

RX PubMed=27397505;

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: DNA methylation analysis.

ST Source(s): Cosmic-CLP; DSMZ; ECACC

ST Amelogenin: X,Y (Cosmic-CLP)

ST Amelogenin: X (DSMZ; ECACC)

ST CSF1PO: 10

ST D13S317: 11

ST D16S539: 13

ST D5S818: 11

ST D7S820: 8 (Cosmic-CLP; DSMZ)

ST D7S820: 8.2 (ECACC)

ST TH01: 9

ST TPOX: 8

ST vWA: 14,15

DI NCIt; C4025; Esophageal adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID ESP-1

AC CVCL_8351

SY ESP1

DR BioSample; SAMN03151692

RX PubMed=1246601;

RX PubMed=6451928;

RX PubMed=20143388;

WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601, PubMed=6451928, PubMed=20143388).

CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI NCIt; C4029; Cervical adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_0030 ! HeLa

SX Female

CA Cancer cell line

ID ESS-1

AC CVCL_1205

SY ESS1

DR CLO; CLO_0002954

DR BioSample; SAMN03473556

DR CCLE; ESS1_ENDOMETRIUM

DR ChEMBL-Cells; CHEMBL3308384

DR ChEMBL-Targets; CHEMBL1075444

DR Cosmic; 907000

DR Cosmic; 1105622

DR Cosmic; 1576456

DR Cosmic-CLP; 907000

DR DSMZ; ACC-461

DR GDSC; 907000

DR GEO; GSM887009

DR GEO; GSM888078

DR GEO; GSM1669778

DR Lonza; 1422

RX PubMed=9663606;

RX PubMed=22460905;

RX PubMed=27397505;

RX PubMed=28196595;

WW http://tcpaportal.org/mclp/

CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC Part of: MD Anderson Cell Lines Project.

CC Doubling time: ~120 hours (DSMZ).

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: DNA methylation analysis.

CC Omics: Protein expression by reverse-phase protein arrays.

CC Omics: SNP array analysis.

CC Omics: Transcriptome analysis.

ST Source(s): Cosmic-CLP; DSMZ

ST Amelogenin: X

ST CSF1PO: 10,14

ST D13S317: 8,12

ST D16S539: 12,13

ST D5S818: 10,12

ST D7S820: 9,11

ST TH01: 7,9

ST TPOX: 8

ST vWA: 16,17

DI NCIt; C8973; Endometrioid stromal sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID ESSA1

AC CVCL_6E07

SY Embryonic Stem-like cell Sparus Aurata 1

RX PubMed=22903186;

CC Group: Fish cell line.

OX NCBI_TaxID=8175; ! Sparus aurata

SX Sex undetermined

CA Embryonic stem cell

ID ESSA2

AC CVCL_6E08

SY Embryonic Stem-like cell Sparus Aurata 2

RX DOI=10.1111/j.1439-0426.2010.01411.x;

CC Group: Fish cell line.

OX NCBI_TaxID=8175; ! Sparus aurata

SX Sex undetermined

CA Embryonic stem cell

ID Esther

AC CVCL_X932

SY NK8b; NK-8; NK 8

RX PubMed=4174339;

RX PubMed=4178827;

RX PubMed=4320167;

RX PubMed=5786183;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID ETC

AC CVCL_F272

DR BCRJ; 0081

OX NCBI_TaxID=9685; ! Felis catus

SX Sex undetermined

CA Undefined cell line type

ID ETCC001

AC CVCL_6G18

SY ETCC-001

RX PubMed=25264427;

DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Finite cell line

ID ETCC006

AC CVCL_6G19

SY ETCC-006

DR DSMZ; ACC-790

RX PubMed=25264427;

CC Doubling time: ~2-4 days (DSMZ).

CC Transfected with: HGNC; 11730; TERT.

ST Source(s): DSMZ

ST Amelogenin: X

ST CSF1PO: 12,13

ST D13S317: 9,10

ST D16S539: 11

ST D5S818: 10,12

ST D7S820: 11,12

ST TH01: 7,9

ST TPOX: 8,11

ST vWA: 16

DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_6G18 ! ETCC001

SX Female

CA Telomerase immortalized cell line

ID ETCC007

AC CVCL_6G20

SY ETCC-007

DR DSMZ; ACC-791

RX PubMed=25264427;

CC Doubling time: ~40 hours (DSMZ).

CC Transfected with: HGNC; 11730; TERT.

ST Source(s): DSMZ

ST Amelogenin: X

ST CSF1PO: 12,13

ST D13S317: 9,10

ST D16S539: 11

ST D5S818: 10,12

ST D7S820: 11,12

ST TH01: 7,9

ST TPOX: 8,11

ST vWA: 16

DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_6G18 ! ETCC001

SX Female

CA Telomerase immortalized cell line

ID ETCC008

AC CVCL_6G21

SY ETCC 008

DR DSMZ; ACC-792

RX PubMed=25264427;

CC Doubling time: ~24 hours (DSMZ).

CC Transfected with: HGNC; 11730; TERT.

ST Source(s): DSMZ

ST Amelogenin: X

ST CSF1PO: 12,13

ST D13S317: 9,10

ST D16S539: 11

ST D5S818: 10,12

ST D7S820: 11,12

ST TH01: 7,9

ST TPOX: 8,11

ST vWA: 16

DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_6G18 ! ETCC001

SX Female

CA Telomerase immortalized cell line

ID ETCC010

AC CVCL_6G22

SY ETCC-010

DR DSMZ; ACC-793

RX PubMed=25264427;

CC Doubling time: ~30 hours (DSMZ).

CC Transfected with: HGNC; 11730; TERT.

ST Source(s): DSMZ

ST Amelogenin: X

ST CSF1PO: 12,13

ST D13S317: 9,10

ST D16S539: 11

ST D5S818: 10,12

ST D7S820: 11,12

ST TH01: 7,9

ST TPOX: 8,11

ST vWA: 16

DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_6G18 ! ETCC001

SX Female

CA Telomerase immortalized cell line

ID ETCC011

AC CVCL_6G23

SY ETCC-011

DR DSMZ; ACC-797

RX PubMed=25264427;

CC Doubling time: ~2-4 days (DSMZ).

CC Transfected with: HGNC; 11730; TERT.

DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_6G18 ! ETCC001

SX Female

CA Telomerase immortalized cell line

ID ETCC016

AC CVCL_Y086

SY ETCC-016

DR DSMZ; ACC-798

RX PubMed=25126481;

CC Characteristics: Has 4 copies of EGFR.

CC Doubling time: 24 hours (PubMed=25126481); ~50 hours (DSMZ).

CC Derived from metastatic site: Pleural effusion.

ST Source(s): DSMZ

ST Amelogenin: X

ST CSF1PO: 10,12

ST D13S317: 10

ST D16S539: 12

ST D5S818: 11,12

ST D7S820: 9,12

ST TH01: 9

ST TPOX: 8,11

ST vWA: 17,19

DI NCIt; C3512; Lung adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID ETK-1

AC CVCL_1206

SY ETK1

DR BioSample; SAMN03151925

DR ChEMBL-Cells; CHEMBL3308831

DR ChEMBL-Targets; CHEMBL2366116

DR Cosmic; 906861

DR Cosmic-CLP; 906861

DR GDSC; 906861

DR GEO; GSM1669779

DR RCB; RCB1289

RX CelloPub=CLPUB00275;

RX PubMed=10761710;

RX PubMed=16643607;

RX PubMed=20143388;

RX PubMed=27397505;

WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC Problematic cell line: Contaminated. Shown to be a SSP-25 derivative (PubMed=16643607, PubMed=20143388).

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: DNA methylation analysis.

CC Discontinued: RCB; RCB1289; true.

ST Source(s): Cosmic-CLP

ST Amelogenin: X

ST CSF1PO: 12

ST D13S317: 12

ST D16S539: 10,12

ST D5S818: 10

ST D7S820: 11

ST TH01: 7

ST TPOX: 8

ST vWA: 14,17

DI NCIt; C35417; Intrahepatic cholangiocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_4902 ! SSP-25

SX Female

CA Cancer cell line

ID ETN-1

AC CVCL_7954

SY ETN1

DR Cosmic; 1576455

RX PubMed=2732002;

RX PubMed=28196595;

WW http://tcpaportal.org/mclp/

CC Part of: MD Anderson Cell Lines Project.

CC Omics: Protein expression by reverse-phase protein arrays.

DI NCIt; C7558; Endometrial carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID Etv2-Venus-KI

AC CVCL_1Q68

DR RCB; AES0176

RX PubMed=21911838;

CC Breed/subspecies: 129/Sv.

OX NCBI_TaxID=10090; ! Mus musculus

SX Male

CA Embryonic stem cell

ID Etv2-Venus-KO

AC CVCL_1Q69

DR RCB; AES0177

RX PubMed=21911838;

OX NCBI_TaxID=10090; ! Mus musculus

SX Male

CA Embryonic stem cell

ID Eu Ken

AC CVCL_U691

SY EuKen

DR ATCC; CRL-1108

CC Discontinued: ATCC; CRL-1108; true.

DI NCIt; C72070; Systemic scleroderma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Finite cell line

ID EU-1

AC CVCL_8857

SY 855; Line 855; Emory University-1

DR BioSample; SAMN03151904

RX PubMed=7888679;

RX PubMed=8152261;

RX PubMed=9108419;

RX PubMed=12592342;

RX PubMed=20143388;

WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC Problematic cell line: Contaminated. Shown to be a Reh derivative (PubMed=12592342, PubMed=20143388).

ST Source(s): COG

ST Amelogenin: X

ST CSF1PO: 11,12

ST D13S317: 11,13

ST D16S539: 8,9,10

ST D18S51: 10,14

ST D19S433: 12,13

ST D21S11: 28,30,31

ST D2S1338: 20,22

ST D3S1358: 17,18

ST D5S818: 11,13

ST D7S820: 9,12,13

ST D8S1179: 13,15

ST FGA: 22,23

ST TH01: 7

ST TPOX: 8

ST vWA: 14,15

DI NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_1650 ! Reh

SX Female

CA Cancer cell line

ID EU-12

AC CVCL_8858

SY EU12; Emory University-12

RX PubMed=9108419;

RX PubMed=12393550;

DI NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID EU-13

AC CVCL_8859

SY Emory University-13

RX PubMed=9108419;

DI NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID EU-4

AC CVCL_8862

SY 870; Line 870 Emory University-4

RX PubMed=7888679;

RX PubMed=9108419;

DI NCIt; C9160; Childhood acute myeloid leukemia

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID EU-5

AC CVCL_8863

SY 916; Line 916 Emory University-5

RX PubMed=7888679;

RX PubMed=9108419;

DI NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID EU-6

AC CVCL_8864

SY 920; Line 920 Emory University-6

RX PubMed=7888679;

RX PubMed=9108419;

ST Source(s): COG

ST Amelogenin: X

ST CSF1PO: 10,11

ST D13S317: 8,14

ST D16S539: 9,12

ST D18S51: 12,13,16

ST D19S433: 12,14

ST D21S11: 27,29

ST D2S1338: 17,24,25

ST D3S1358: 17

ST D5S818: 11,12

ST D7S820: 9

ST D8S1179: 12,13

ST FGA: 22,24

ST TH01: 8,9.3

ST TPOX: 8

ST vWA: 17,18

DI NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID EU-7

AC CVCL_8865

SY 91-17 Emory University-7

DR BioSample; SAMN03151619

RX PubMed=7888679;

RX PubMed=9108419;

RX PubMed=12592342;

RX PubMed=20143388;

WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC Problematic cell line: Contaminated. Shown to be a CCRF-CEM derivative (PubMed=12592342, PubMed=20143388).

DI NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_0207 ! CCRF-CEM

SX Female

CA Cancer cell line

ID EU-8

AC CVCL_8866

SY 91-06 Emory University-8

RX PubMed=7888679;

RX PubMed=9108419;

DI NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID EU-9

AC CVCL_8867

SY 93-10; Emory University-9

RX PubMed=7888679;

RX PubMed=9108419;

DI NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID EU93-2

AC CVCL_DR53

RX PubMed=7494598;

CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

OX NCBI_TaxID=10116; ! Rattus norvegicus

OI CVCL_DR54 ! EU93-3

CA Transformed cell line

ID EU93-3

AC CVCL_DR54

RX PubMed=7494598;

CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

OX NCBI_TaxID=10116; ! Rattus norvegicus

OI CVCL_DR53 ! EU93-2

CA Transformed cell line

ID EUE

AC CVCL_7262

DR BTO; BTO:0000430

DR BioSample; SAMN03151693

RX PubMed=13580596;

RX PubMed=6451928;

RX PubMed=20143388;

WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=6451928, PubMed=20143388).

CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI NCIt; C4029; Cervical adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_0030 ! HeLa

SX Female

CA Cancer cell line

ID EUFA001

AC CVCL_G051

SY 92VU001

RX PubMed=7662964;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125704; Fanconi anemia, complementation group C

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA006

AC CVCL_G052

SY 92VU006

RX PubMed=7662964;

RX PubMed=10094191;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125702; Fanconi anemia, complementation group A

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA007

AC CVCL_AK50

SY EUFA 007

RX PubMed=9713825;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125702; Fanconi anemia, complementation group A

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA043

AC CVCL_AK51

RX PubMed=10094191;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125702; Fanconi anemia, complementation group A

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA056

AC CVCL_G053

SY 92VU056

RX PubMed=7662964;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125702; Fanconi anemia, complementation group A

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA121

AC CVCL_G040

SY EUFA121L; GM16757

DR CLO; CLO_0018433

DR Coriell; GM16757

RX PubMed=11001585;

RX PubMed=12065746;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125707; Fanconi anemia, complementation group F

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID EUFA123

AC CVCL_G054

SY 93VU123

RX PubMed=7662964;

RX PubMed=10094191;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125702; Fanconi anemia, complementation group A

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA127

AC CVCL_AK52

RX PubMed=10094191;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125702; Fanconi anemia, complementation group A

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA130

AC CVCL_G055

SY 93VU130

RX PubMed=7662964;

RX PubMed=9713825;

RX PubMed=11001585;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125709; Fanconi anemia, complementation group E

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID EUFA1333

AC CVCL_GR84

RX PubMed=14630800;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C129027; Fanconi anemia, complementation group J

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA134

AC CVCL_G056

SY 93VU134

RX PubMed=7662964;

RX PubMed=10094191;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125702; Fanconi anemia, complementation group A

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA139

AC CVCL_AK53

RX PubMed=10094191;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125702; Fanconi anemia, complementation group A

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA143

AC CVCL_G057

SY EUFA143B

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125708; Fanconi anemia, complementation group G

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA158

AC CVCL_G058

SY 93VU158

RX PubMed=7662964;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125704; Fanconi anemia, complementation group C

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA166

AC CVCL_G059

SY 93VU166

RX PubMed=7662964;

RX PubMed=10468606;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125704; Fanconi anemia, complementation group C

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA186

AC CVCL_AK54

RX PubMed=10094191;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125702; Fanconi anemia, complementation group A

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA202

AC CVCL_G060

SY 93VU202

RX PubMed=7662964;

RX PubMed=10468606;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125706; Fanconi anemia, complementation group D2

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA223

AC CVCL_AK55

RX PubMed=12955722;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125702; Fanconi anemia, complementation group A

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA232

AC CVCL_AK56

RX PubMed=12955722;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125702; Fanconi anemia, complementation group A

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA245

AC CVCL_AK57

RX PubMed=10094191;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125702; Fanconi anemia, complementation group A

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA255

AC CVCL_AK58

RX PubMed=10094191;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125702; Fanconi anemia, complementation group A

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA262

AC CVCL_AK59

RX PubMed=12955722;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125702; Fanconi anemia, complementation group A

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA263

AC CVCL_AK60

RX PubMed=12955722;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125702; Fanconi anemia, complementation group A

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA268

AC CVCL_G062

RX PubMed=10468606;

RX PubMed=12955722;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125702; Fanconi anemia, complementation group A

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA275

AC CVCL_G061

SY EUFA 275

RX PubMed=9713825;

RX PubMed=10094191;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125702; Fanconi anemia, complementation group A

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA316

AC CVCL_G063

RX PubMed=10468606;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125708; Fanconi anemia, complementation group G

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA337

AC CVCL_AK61

RX PubMed=12955722;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125702; Fanconi anemia, complementation group A

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA349

AC CVCL_G064

RX PubMed=10468606;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125708; Fanconi anemia, complementation group G

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA353

AC CVCL_G065

RX PubMed=10094191;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125702; Fanconi anemia, complementation group A

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA388

AC CVCL_AK62

RX PubMed=12955722;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125702; Fanconi anemia, complementation group A

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA409

AC CVCL_G066

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125709; Fanconi anemia, complementation group E

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA410

AC CVCL_G067

RX PubMed=10468606;

RX PubMed=11001585;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125709; Fanconi anemia, complementation group E

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA423F

AC CVCL_AK16

SY EUFA423

RX PubMed=12065746;

RX PubMed=22152194;

CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

DI NCIt; C125705; Fanconi anemia, complementation group D1

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_G068 ! EUFA423L

CA Transformed cell line

ID EUFA423L

AC CVCL_G068

SY EUFA423

RX PubMed=10468606;

RX PubMed=12065746;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125705; Fanconi anemia, complementation group D1

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_AK16 ! EUFA423F

CA Transformed cell line

ID EUFA418

AC CVCL_AK63

RX PubMed=10094191;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125702; Fanconi anemia, complementation group A

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA426

AC CVCL_G069

RX PubMed=10094191;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125702; Fanconi anemia, complementation group A

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA444

AC CVCL_G070

SY EUFA 444

RX PubMed=9713825;

RX PubMed=10094191;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125702; Fanconi anemia, complementation group A

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA445

AC CVCL_AK64

SY EUFA 445

RX PubMed=9713825;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125702; Fanconi anemia, complementation group A

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA471

AC CVCL_AK65

SY EUFA 471

RX PubMed=9713825;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125702; Fanconi anemia, complementation group A

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA483

AC CVCL_AK66

RX PubMed=10094191;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125702; Fanconi anemia, complementation group A

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA507

AC CVCL_AK67

RX PubMed=10094191;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125702; Fanconi anemia, complementation group A

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA528

AC CVCL_G071

SY EUFA 528

RX PubMed=10094191;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125702; Fanconi anemia, complementation group A

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA543

AC CVCL_GR85

DR TOKU-E; 4017

RX PubMed=14630800;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C129027; Fanconi anemia, complementation group J

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA586

AC CVCL_AK68

RX PubMed=10094191;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125702; Fanconi anemia, complementation group A

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA592

AC CVCL_GR86

DR TOKU-E; 4011

RX PubMed=14630800;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C129026; Fanconi anemia, complementation group I

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA598

AC CVCL_G072

RX PubMed=10094191;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125702; Fanconi anemia, complementation group A

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA622

AC CVCL_G073

RX PubMed=10468606;

RX PubMed=11001585;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125709; Fanconi anemia, complementation group E

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA689

AC CVCL_G074

RX PubMed=10094191;

RX PubMed=10468606;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125702; Fanconi anemia, complementation group A

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA696

AC CVCL_GR87

DR TOKU-E; 4014

RX PubMed=14630800;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C129027; Fanconi anemia, complementation group J

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA704

AC CVCL_G075

RX PubMed=10094191;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125702; Fanconi anemia, complementation group A

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA763

AC CVCL_AK69

RX PubMed=10094191;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C125702; Fanconi anemia, complementation group A

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA816

AC CVCL_GR88

DR TOKU-E; 4012

RX PubMed=14630800;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C129026; Fanconi anemia, complementation group I

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EUFA961

AC CVCL_GR89

DR TOKU-E; 4013

RX PubMed=14630800;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C129026; Fanconi anemia, complementation group I

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID Ev248

AC CVCL_DD91

SY EV248; EV-248

DR ATCC; HB-8565

RX Patent=US4695538;

OX NCBI_TaxID=9606; ! Homo sapiens

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2155 ! P3/NS1/1-Ag4.1

CA Hybridoma

ID EVA,LW

AC CVCL_E585

SY EVA, LW

DR dbMHC; 48780

DR IHW; IHW9119

DR IMGT/HLA; 11664

RX PubMed=8307784;

WW http://bioinformatics.hsanmartino.it/ecbr/cl119.html

CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Sex undetermined

CA Transformed cell line

ID EVA,SP

AC CVCL_E586

SY EVA, SP

DR dbMHC; 48781

DR ECACC; 94082234

DR IHW; IHW9135

DR IMGT/HLA; 11678

RX PubMed=8307784;

WW http://bioinformatics.hsanmartino.it/ecbr/cl135.html

CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC Discontinued: ECACC; 94082234; probable.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Sex undetermined

CA Transformed cell line

ID EVLB3

AC CVCL_W816

SY Endothelial Venous Line clone B3

RX PubMed=10691096;

CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EVLC2

AC CVCL_8687

SY Endothelial Venous Line clone C2

DR BioSample; SAMN03151993

RX PubMed=10691096;

RX PubMed=11407081;

RX PubMed=12453433;

RX PubMed=20143388;

WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC Problematic cell line: Contaminated. Unknown origin but not an umbilical vein endothelium cell line (PubMed=12453433, PubMed=20143388).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Sex undetermined

CA Undefined cell line type

ID EVLK1

AC CVCL_W817

SY Endothelial Venous Line clone K1

RX PubMed=10691096;

CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID EVLK2

AC CVCL_W818

SY Endothelial Venous Line clone K2

RX PubMed=10691096;

CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID Evsa-E

AC CVCL_5G37

SY Evsa E; EVSa-E

RX PubMed=212193;

RX PubMed=1000504;

RX PubMed=1000506;

CC Derived from metastatic site: Ascites.

DI NCIt; C4872; Breast carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_1207 ! Evsa-T

SX Female

CA Cancer cell line

ID Evsa-T

AC CVCL_1207

SY EVSA-T; EVSa-T; Evsa T; EVSAT; EvsaT

DR CLO; CLO_0002955

DR EFO; EFO_0006574

DR BioSample; SAMN03472910

DR BioSample; SAMN03473598

DR CCLE; EVSAT_BREAST

DR ChEMBL-Cells; CHEMBL3307361

DR ChEMBL-Targets; CHEMBL614295

DR Cosmic; 906862

DR Cosmic; 944298

DR Cosmic; 997931

DR Cosmic; 1046926

DR Cosmic; 1287906

DR Cosmic; 1289388

DR Cosmic; 2165020

DR Cosmic-CLP; 906862

DR DSMZ; ACC-433

DR GDSC; 906862

DR GEO; GSM344366

DR GEO; GSM344416

DR GEO; GSM783964

DR GEO; GSM843500

DR GEO; GSM843501

DR GEO; GSM847317

DR GEO; GSM847471

DR GEO; GSM1374477

DR GEO; GSM1661978

DR GEO; GSM1669780

DR TOKU-E; 4049

RX PubMed=212193;

RX PubMed=1000504;

RX PubMed=1000505;

RX PubMed=3702420;

RX PubMed=9570382;

RX PubMed=23601657;

RX PubMed=25485619;

RX PubMed=27397505;

RX PubMed=28196595;

WW http://tcpaportal.org/mclp/

CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC Part of: MD Anderson Cell Lines Project.

CC Doubling time: ~50 hours (DSMZ).

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: Deep RNAseq analysis.

CC Omics: DNA methylation analysis.

CC Omics: miRNA expression profiling.

CC Omics: Protein expression by reverse-phase protein arrays.

CC Omics: SNP array analysis.

CC Omics: Transcriptome analysis.

CC Derived from metastatic site: Ascites.

ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200

ST Amelogenin: X

ST CSF1PO: 11,12

ST D13S317: 11,12 (Cosmic-CLP; DSMZ)

ST D13S317: 12 (PubMed=25877200)

ST D16S539: 9

ST D18S51: 12,17

ST D21S11: 30,31.2

ST D3S1358: 14,17

ST D5S818: 12,13

ST D7S820: 10,12

ST D8S1179: 16

ST FGA: 21,24,25

ST Penta D: 12,14

ST Penta E: 12,16

ST TH01: 6

ST TPOX: 8

ST vWA: 15,16

DI NCIt; C4872; Breast carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_5G37 ! Evsa-E

SX Female

CA Cancer cell line

ID EW 7476

AC CVCL_EQ72

SY EW7476

DR GDSC; 1290801

DI NCIt; C9145; Osteosarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID EW-1

AC CVCL_1208

SY EW1; IARC-EW1; IARC-EW-1; IARC-EW 1

DR ChEMBL-Cells; CHEMBL3308164

DR ChEMBL-Targets; CHEMBL2366364

DR Cosmic; 684061

DR Cosmic; 949163

DR Cosmic; 2250470

DR Cosmic; 2301552

DR Cosmic-CLP; 949163

DR GDSC; 949163

DR GEO; GSM1669781

RX PubMed=6713356;

RX PubMed=25223734;

RX PubMed=27397505;

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: DNA methylation analysis.

CC Derived from metastatic site: Pleural effusion.

ST Source(s): Cosmic-CLP

ST Amelogenin: X,Y

ST CSF1PO: 11

ST D13S317: 13,14

ST D16S539: 12

ST D5S818: 11,15

ST D7S820: 11,12

ST TH01: 6,9.3

ST TPOX: 8,11

ST vWA: 19

DI NCIt; C4817; Ewing sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_3446 ! EW-2

SX Male

CA Cancer cell line

ID EW-11

AC CVCL_1209

SY EW11; IARC-EW11; IARC-EW-11; IARC-EW 11

DR ChEMBL-Cells; CHEMBL3308193

DR ChEMBL-Targets; CHEMBL2366223

DR Cosmic; 684062

DR Cosmic; 965554

DR Cosmic; 1084592

DR Cosmic-CLP; 684062

DR GDSC; 684062

DR GEO; GSM1669782

RX PubMed=6713356;

RX PubMed=27397505;

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: DNA methylation analysis.

CC Derived from metastatic site: Mediastinal lymph node.

ST Source(s): Cosmic-CLP

ST Amelogenin: X

ST CSF1PO: 11,13

ST D13S317: 11,12

ST D16S539: 12

ST D5S818: 12

ST D7S820: 10,11

ST TH01: 9.3

ST TPOX: 8,9

ST vWA: 15,19

DI NCIt; C4817; Ewing sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID EW-12

AC CVCL_1210

SY EW12; IARC-EW12; IARC-EW-12; IARC-EW 12

DR ChEMBL-Cells; CHEMBL3308528

DR ChEMBL-Targets; CHEMBL2366255

DR Cosmic; 684063

DR Cosmic; 949162

DR Cosmic-CLP; 949162

DR GDSC; 949162

DR GEO; GSM1669783

RX PubMed=27397505;

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: DNA methylation analysis.

ST Source(s): Cosmic-CLP

ST Amelogenin: X

ST CSF1PO: 12

ST D13S317: 11

ST D16S539: 12

ST D5S818: 12

ST D7S820: 10

ST TH01: 9

ST TPOX: 8

ST vWA: 15,20

DI NCIt; C4817; Ewing sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID EW-13

AC CVCL_1211

SY EW13; IARC-EW13; IARC-EW-13; IARC-EW 13

DR ChEMBL-Cells; CHEMBL3308194

DR ChEMBL-Targets; CHEMBL2366124

DR Cosmic; 684064

DR Cosmic; 949166

DR Cosmic-CLP; 949166

DR GDSC; 949166

DR GEO; GSM1669784

RX PubMed=27397505;

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: DNA methylation analysis.

ST Source(s): Cosmic-CLP

ST Amelogenin: X,Y

ST CSF1PO: 10

ST D13S317: 10,11

ST D16S539: 13

ST D5S818: 12

ST D7S820: 8,10

ST TH01: 7,9

ST TPOX: 8

ST vWA: 18

DI NCIt; C4817; Ewing sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID EW-16

AC CVCL_1212

SY EW16; IARC-EW16; IARC-EW-16; IARC-EW 16

DR ChEMBL-Cells; CHEMBL3308195

DR ChEMBL-Targets; CHEMBL2366358

DR Cosmic; 684065

DR Cosmic; 949165

DR Cosmic; 1995401

DR Cosmic; 2250472

DR Cosmic-CLP; 949165

DR GDSC; 949165

DR GEO; GSM1669785

RX PubMed=25223734;

RX PubMed=27397505;

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: DNA methylation analysis.

ST Source(s): Cosmic-CLP

ST Amelogenin: X,Y

ST CSF1PO: 12,13

ST D13S317: 12,14

ST D16S539: 13

ST D5S818: 11,12

ST D7S820: 9,10

ST TH01: 9,9.3

ST TPOX: 8,9

ST vWA: 17,19

DI NCIt; C4817; Ewing sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID EW-17

AC CVCL_3445

SY EW17; IARC-EW17; IARC-EW-17; IARC-EW 17

DR Cosmic; 1084593

DI NCIt; C4817; Ewing sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID EW-18

AC CVCL_1213

SY EW18; IARC-EW-18

DR ChEMBL-Cells; CHEMBL3308832

DR ChEMBL-Targets; CHEMBL2366097

DR Cosmic; 684066

DR Cosmic; 949164

DR Cosmic; 1081697

DR Cosmic; 2250476

DR Cosmic-CLP; 949164

DR GDSC; 949164

DR GEO; GSM1669786

RX PubMed=25223734;

RX PubMed=27397505;

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: DNA methylation analysis.

ST Source(s): Cosmic-CLP

ST Amelogenin: X

ST CSF1PO: 10,12

ST D13S317: 10,13

ST D16S539: 11,12

ST D5S818: 11,12

ST D7S820: 7,12

ST TH01: 9.3

ST TPOX: 8,11

ST vWA: 16,17

DI NCIt; C4817; Ewing sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID EW-19

AC CVCL_A463

SY EW19; IARC-EW-19

DR Cosmic; 684067

DI NCIt; C4817; Ewing sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID EW-2

AC CVCL_3446

SY EW2; IARC-EW2; IARC-EW-2; IARC-EW 2

DR Cosmic; 1388895

DR Cosmic; 2228228

RX PubMed=6713356;

RX PubMed=25010205;

CC Derived from metastatic site: Peripheral blood.

DI NCIt; C4817; Ewing sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_1208 ! EW-1

SX Male

CA Cancer cell line

ID EW-22

AC CVCL_1214

SY EW22; IARC-EW-22

DR ChEMBL-Cells; CHEMBL3308196

DR ChEMBL-Targets; CHEMBL2366162

DR Cosmic; 684068

DR Cosmic; 949167

DR Cosmic; 2250461

DR Cosmic-CLP; 949167

DR GDSC; 949167

DR GEO; GSM1669787

RX PubMed=25223734;

RX PubMed=27397505;

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: DNA methylation analysis.

ST Source(s): Cosmic-CLP

ST Amelogenin: X

ST CSF1PO: 11

ST D13S317: 12

ST D16S539: 13

ST D5S818: 11

ST D7S820: 10,11

ST TH01: 6

ST TPOX: 9,11

ST vWA: 17

DI NCIt; C4817; Ewing sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID EW-23

AC CVCL_EI71

DR Cosmic; 2250462

RX PubMed=25223734;

CC From: Delattre O.; Institut Curie; Paris; France.

DI NCIt; C4817; Ewing sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID EW-24

AC CVCL_1215

SY EW24; IARC-EW-24

DR ChEMBL-Cells; CHEMBL3308197

DR ChEMBL-Targets; CHEMBL2366206

DR Cosmic; 684069

DR Cosmic; 949168

DR Cosmic; 1995404

DR Cosmic-CLP; 949168

DR GDSC; 949168

DR GEO; GSM1669788

RX PubMed=27397505;

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: DNA methylation analysis.

ST Source(s): Cosmic-CLP

ST Amelogenin: X

ST CSF1PO: 11,12

ST D13S317: 14

ST D16S539: 11

ST D5S818: 12

ST D7S820: 12,13

ST TH01: 6,9.3

ST TPOX: 10,12

ST vWA: 15,16

DI NCIt; C4817; Ewing sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID EW-3

AC CVCL_1216

SY EW3; IARC-EW3; IARC-EW-3; IARC-EW 3

DR ChEMBL-Cells; CHEMBL3308521

DR ChEMBL-Targets; CHEMBL2366307

DR Cosmic; 684070

DR Cosmic; 949161

DR Cosmic; 1995405

DR Cosmic; 2250460

DR Cosmic-CLP; 949161

DR GDSC; 949161

DR GEO; GSM510005

DR GEO; GSM1669789

RX PubMed=6713356;

RX PubMed=16631476;

RX PubMed=25223734;

RX PubMed=27397505;

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: DNA methylation analysis.

CC Derived from metastatic site: Pleural effusion.

ST Source(s): Cosmic-CLP

ST Amelogenin: X,Y

ST CSF1PO: 11,12

ST D13S317: 12

ST D16S539: 11,12

ST D5S818: 12

ST D7S820: 8,11

ST TH01: 9.3,10

ST TPOX: 8,9

ST vWA: 15,16

DI NCIt; C4817; Ewing sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID EW-7

AC CVCL_1217

SY EW7; IARC-EW7; IARC-EW-7; IARC-EW 7

DR ChEMBL-Cells; CHEMBL3308165

DR ChEMBL-Targets; CHEMBL2366112

DR Cosmic; 684071

DR Cosmic; 949160

DR Cosmic; 2250471

DR Cosmic-CLP; 949160

DR GDSC; 949160

DR GEO; GSM1669790

RX PubMed=6713356;

RX PubMed=16631476;

RX PubMed=25223734;

RX PubMed=27397505;

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: DNA methylation analysis.

CC Derived from metastatic site: Pleural effusion.

ST Source(s): Cosmic-CLP

ST Amelogenin: X

ST CSF1PO: 12

ST D13S317: 8

ST D16S539: 12

ST D5S818: 10,13

ST D7S820: 9

ST TH01: 6

ST TPOX: 8,9

ST vWA: 16,18

DI NCIt; C4817; Ewing sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID EW-8

AC CVCL_V618

SY EW8

DR CCLE; EW8_BONE

DR Cosmic; 2294583

DR Cosmic; 2228229

DR GEO; GSM1676298

DR GEO; GSM1701633

RX PubMed=25010205;

RX PubMed=25984343;

RX PubMed=26351324;

CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC Doubling time: 30 hours (PubMed=25984343).

CC Omics: Deep RNAseq analysis.

CC Omics: shRNA library screening.

DI NCIt; C4817; Ewing sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID EW36

AC CVCL_W742

SY Ew36; EW-36; EW 36

DR Cosmic; 931104

RX PubMed=1325212;

RX PubMed=2052620;

RX PubMed=3080238;

RX PubMed=6243721;

RX PubMed=6243722;

RX PubMed=6265077;

RX PubMed=6286763;

RX PubMed=7757991;

RX PubMed=8515068;

RX PubMed=9473234;

RX PubMed=9973220;

CC Characteristics: EBV-negative.

DI NCIt; C3457; B-cell non-Hodgkin lymphoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID EWS-502

AC CVCL_S740

SY EWS502

DR CCLE; EWS502_BONE

DR Cosmic; 2294584

RX PubMed=16766266;

RX PubMed=25984343;

CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC Doubling time: 46 hours (PubMed=25984343).

CC Omics: shRNA library screening.

DI NCIt; C4817; Ewing sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID EWS-834

AC CVCL_AW95

SY EWS834

DR Cosmic; 2294585

CC From: Fletcher J.A.; Department of Pathology; Brigham and Women's Hospital; Harvard Medical School; Boston; USA.

DI NCIt; C4817; Ewing sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID EWS-925

AC CVCL_M142

RX PubMed=11504746;

DI NCIt; C4817; Ewing sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID eWT-1323-2

AC CVCL_0G83

DR SKIP; SKIP000538

RX PubMed=24321451;

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_0G84 ! eWT-1323-4

SX Female

CA Induced pluripotent stem cell

ID eWT-1323-4

AC CVCL_0G84

DR SKIP; SKIP000539

RX PubMed=24321451;

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_0G83 ! eWT-1323-2

SX Female

CA Induced pluripotent stem cell

ID eWT-BJ2

AC CVCL_0G85

DR SKIP; SKIP000540

RX PubMed=24321451;

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_3653 ! BJ [Human fibroblast]

SX Male

CA Induced pluripotent stem cell

ID eWT-BJ4

AC CVCL_0G86

DR SKIP; SKIP000541

RX PubMed=24321451;

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_3653 ! BJ [Human fibroblast]

SX Male

CA Induced pluripotent stem cell

ID Ex-3LL

AC CVCL_5748

DR JCRB; JCRB1349

RX PubMed=10408901;

CC Breed/subspecies: C57BL/6.

DI NCIt; C21769; Malignant tumors of the mouse pulmonary system

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_5653 ! 3LL

CA Cancer cell line

ID EX5.3D10

AC CVCL_DD32

DR ATCC; HB-11373

RX Patent=US5883223;

CC Monoclonal antibody target: UniProtKB; P10747; Human CD28.

CC Discontinued: ATCC; HB-11373; probable.

OX NCBI_TaxID=10090; ! Mus musculus

CA Hybridoma

ID Expi293F

AC CVCL_D615

WW http://www.thermofisher.com/order/catalog/product/A14527

CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_6642 ! HEK293-F

SX Female

CA Transformed cell line

ID ExpiCHO-S

AC CVCL_5J31

WW http://www.thermofisher.com/order/catalog/product/A29127

OX NCBI_TaxID=10029; ! Cricetulus griseus

HI CVCL_7183 ! CHO-S

SX Female

CA Spontaneously immortalized cell line

ID Ezem-BL

AC CVCL_7192

SY Ezem

RX PubMed=9882297;

RX PubMed=16051863;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID EZQ-3 iPSC

AC CVCL_GP79

RX PubMed=27558610;

DI NCIt; C3362; Schizophrenia

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Induced pluripotent stem cell

ID EZQ-4 iPSC

AC CVCL_GP80

RX PubMed=27558610;

DI NCIt; C3362; Schizophrenia

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Induced pluripotent stem cell

ID EZQ-9 iPSC

AC CVCL_GP81

RX PubMed=27558610;

DI NCIt; C3362; Schizophrenia

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Induced pluripotent stem cell

ID EZZ (TOU II-4)

AC CVCL_2781

SY EZZ; TOU II-4

DR CLO; CLO_0002956

DR CLDB; cl1177

DR ECACC; 93093003

RX PubMed=6438434;

RX PubMed=6817143;

WW http://www.imgt.org/IMGTrepertoire/LocusGenes/locus/human/IGH/Hu_IGHcellines.html

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID F C3H

AC CVCL_HA23

DR BCRJ; 0082

CC Breed/subspecies: C3H/HeJ.

OX NCBI_TaxID=10090; ! Mus musculus

CA Finite cell line

ID F-137

AC CVCL_1Q45

SY F 137; F137

RX PubMed=1180485;

RX PubMed=4736620;

RX PubMed=18623934;

CC Problematic cell line: Contaminated. Shown to be a Jiyoye derivative (PubMed=4736620).

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_1317 ! Jiyoye

SX Male

CA Cancer cell line

ID F-3

AC CVCL_CW34

SY F 3

DR ATCC; HB-8217

RX Patent=US4678747;

RX Patent=US5168043;

CC Discontinued: ATCC; HB-8217; probable.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2155 ! P3/NS1/1-Ag4.1

CA Hybridoma

ID F-36E

AC CVCL_7227

SY F36E; F-36EGM; F-36-EGM; F36EGM

DR CLO; CLO_0051545

DR BioSample; SAMN03472229

DR Cosmic; 787429

DR Cosmic; 919126

DR Cosmic; 1281312

DR RCB; RCB0776

RX PubMed=1834251;

ST Source(s): RCB

ST Amelogenin: X,Y

ST CSF1PO: 9

ST D13S317: 10

ST D16S539: 10,12

ST D5S818: 9,13

ST D7S820: 9,11

ST TH01: 8,9

ST TPOX: 9,11

ST vWA: 14,16

DI NCIt; C3247; Myelodysplastic syndrome

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_2037 ! F-36P

SX Male

CA Cancer cell line

ID F-36P

AC CVCL_2037

SY F36P

DR CLO; CLO_0051549

DR BioSample; SAMN03472228

DR BioSample; SAMN03473531

DR CCLE; F36P_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR Cosmic; 975247

DR Cosmic; 1012066

DR Cosmic; 1465955

DR Cosmic; 2089665

DR Cosmic; 2306204

DR DSMZ; ACC-543

DR ECACC; 99072808

DR GEO; GSM482505

DR GEO; GSM887010

DR GEO; GSM888079

DR GEO; GSM1374478

DR Lonza; 262

DR RCB; RCB0775

DR TOKU-E; 4108

RX PubMed=1834251;

RX PubMed=16408098;

RX PubMed=22460905;

RX PubMed=23955599;

RX PubMed=25984343;

WW http://www.cells-talk.com/index.php/page/copelibrary?key=F-36P

WW http://www.addexbio.com/productdetail?pid=4881

CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC Doubling time: 55 hours (PubMed=25984343); ~24-36 hours (DSMZ).

CC Omics: shRNA library screening.

CC Omics: SNP array analysis.

CC Omics: Transcriptome analysis.

ST Source(s): AddexBio; DSMZ; ECACC; RCB

ST Amelogenin: X,Y

ST CSF1PO: 9

ST D13S317: 10

ST D16S539: 10,12

ST D5S818: 13

ST D7S820: 9,11

ST TH01: 8 (AddexBio; ECACC; RCB)

ST TH01: 8,9 (DSMZ)

ST TPOX: 9,11

ST vWA: 14,16

DI NCIt; C3247; Myelodysplastic syndrome

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID F-502

AC CVCL_DG17

DR GEO; GSM114610

RX PubMed=16966431;

DI NCIt; C3058; Glioblastoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID F.M.

AC CVCL_S456

DR ATCC; CRL-6169

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6169; true.

OX NCBI_TaxID=61378; ! Felis margarita

SX Sex undetermined

CA Finite cell line

ID F.thy 62891

AC CVCL_6394

DR CLO; CLO_0002957

DR ATCC; CRL-10936

DR BioSample; SAMN03471324

RX Patent=US5283354;

RX Patent=US5621090;

CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

ST Source(s): ATCC

ST Amelogenin: X

ST CSF1PO: 7,13

ST D13S317: 12,14

ST D16S539: 10,11

ST D5S818: 12

ST D7S820: 9,11

ST TH01: 6

ST TPOX: 8,9

ST vWA: 16

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID F1-3G8-1

AC CVCL_J226

DR CLO; CLO_0002966

DR ATCC; HB-192

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_3411 ! P3X63Ag8

CA Hybridoma

ID F1-652

AC CVCL_2038

SY F1.652

DR CLO; CLO_0002961

DR CLO; CLO_0002967

DR ATCC; CRL-2039

DR DSMZ; ACC-309

CC Doubling time: ~30-36 hours (DSMZ).

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_4032 ! P3X63Ag8.653

CA Hybridoma

ID F1-73

AC CVCL_N340

DR ATCC; CRL-7922

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-7922; true.

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_3605 ! T1-73

CA Finite cell line

ID F1-F

AC CVCL_2G59

RX PubMed=7989764;

RX PubMed=11046045;

CC Breed/subspecies: BALB/c.

OX NCBI_TaxID=10090; ! Mus musculus

CA Spontaneously immortalized cell line

ID F10-150

AC CVCL_M394

DR ECACC; 91060552

CC Monoclonal antibody target: UniProtKB; Q4QWZ3; Sheep ITGAL/CD11a.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2199 ! Sp2/0-Ag14

CA Hybridoma

ID F10-150.58

AC CVCL_M395

DR ECACC; 93100509

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2199 ! Sp2/0-Ag14

CA Hybridoma

ID F10-89-4

AC CVCL_M396

DR ECACC; 89062101

DR NCBI_Iran; H119

CC Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2155 ! P3/NS1/1-Ag4.1

CA Hybridoma

ID F11

AC CVCL_H605

SY F-11

DR CLO; CLO_0002962

DR CLDB; cl1188

DR ECACC; 08062601

RX PubMed=3858835;

WW https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&id=266798&lvl=3

OX NCBI_TaxID=10090; ! Mus musculus

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_2132 ! N18TG2

CA Hybrid cell line

ID F111

AC CVCL_6C52

SY F-111; F 111

RX PubMed=50281;

RX PubMed=2463382;

RX PubMed=8455944;

CC Breed/subspecies: Fischer 344.

OX NCBI_TaxID=10116; ! Rattus norvegicus

CA Spontaneously immortalized cell line

ID F1121L

AC CVCL_U092

RX PubMed=16651449;

DI NCIt; C3512; Lung adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID F119

AC CVCL_J278

DR JCRB; JCRB1324

RX PubMed=15671532;

CC Monoclonal antibody target: UniProtKB; Q96RD9; Human FCRL5/CD307e.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2199 ! Sp2/0-Ag14

CA Hybridoma

ID F11G

AC CVCL_J237

DR TKG; TKG 0315

RX PubMed=1878337;

CC Monoclonal antibody target: UniProtKB; P01027; Mouse C3.

OX NCBI_TaxID=10090; ! Mus musculus

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_3411 ! P3X63Ag8

CA Hybridoma

ID F12

AC CVCL_M045

DR ECACC; 92032412

RX PubMed=2272497;

CC Monoclonal antibody target: UniProtKB; Q06304; Aeromonas sobria asa1 (aerolysin/hemolysin).

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2199 ! Sp2/0-Ag14

CA Hybridoma

ID F12-1

AC CVCL_C628

DR ISCR; 277

RX PubMed=18849973;

CC From: Harvard University; Boston; USA.

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_C629 ! F12-3

OI CVCL_C630 ! F12-4

OI CVCL_C631 ! F12-5

OI CVCL_C632 ! F12-6

OI CVCL_C633 ! F12-8

OI CVCL_C634 ! F124-5

OI CVCL_C635 ! F124-10

OI CVCL_C636 ! F124B-3

OI CVCL_C637 ! F124B-4

SX Male

CA Induced pluripotent stem cell

ID F12-3

AC CVCL_C629

DR ISCR; 276

RX PubMed=18849973;

CC From: Harvard University; Boston; USA.

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_C628 ! F12-1

OI CVCL_C630 ! F12-4

OI CVCL_C631 ! F12-5

OI CVCL_C632 ! F12-6

OI CVCL_C633 ! F12-8

OI CVCL_C634 ! F124-5

OI CVCL_C635 ! F124-10

OI CVCL_C636 ! F124B-3

OI CVCL_C637 ! F124B-4

SX Male

CA Induced pluripotent stem cell

ID F12-4

AC CVCL_C630

DR ISCR; 275

RX PubMed=18849973;

CC From: Harvard University; Boston; USA.

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_C628 ! F12-1

OI CVCL_C629 ! F12-3

OI CVCL_C631 ! F12-5

OI CVCL_C632 ! F12-6

OI CVCL_C633 ! F12-8

OI CVCL_C634 ! F124-5

OI CVCL_C635 ! F124-10

OI CVCL_C636 ! F124B-3

OI CVCL_C637 ! F124B-4

SX Male

CA Induced pluripotent stem cell

ID F12-5

AC CVCL_C631

DR ISCR; 230

RX PubMed=18849973;

CC From: Harvard University; Boston; USA.

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_C628 ! F12-1

OI CVCL_C629 ! F12-3

OI CVCL_C630 ! F12-4

OI CVCL_C632 ! F12-6

OI CVCL_C633 ! F12-8

OI CVCL_C634 ! F124-5

OI CVCL_C635 ! F124-10

OI CVCL_C636 ! F124B-3

OI CVCL_C637 ! F124B-4

SX Male

CA Induced pluripotent stem cell

ID F12-6

AC CVCL_C632

DR ISCR; 274

RX PubMed=18849973;

CC From: Harvard University; Boston; USA.

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_C628 ! F12-1

OI CVCL_C629 ! F12-3

OI CVCL_C630 ! F12-4

OI CVCL_C631 ! F12-5

OI CVCL_C633 ! F12-8

OI CVCL_C634 ! F124-5

OI CVCL_C635 ! F124-10

OI CVCL_C636 ! F124B-3

OI CVCL_C637 ! F124B-4

SX Male

CA Induced pluripotent stem cell

ID F12-8

AC CVCL_C633

DR ISCR; 273

RX PubMed=18849973;

CC From: Harvard University; Boston; USA.

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_C628 ! F12-1

OI CVCL_C629 ! F12-3

OI CVCL_C630 ! F12-4

OI CVCL_C631 ! F12-5

OI CVCL_C632 ! F12-6

OI CVCL_C634 ! F124-5

OI CVCL_C635 ! F124-10

OI CVCL_C636 ! F124B-3

OI CVCL_C637 ! F124B-4

SX Male

CA Induced pluripotent stem cell

ID F124-10

AC CVCL_C635

DR ISCR; 271

RX PubMed=18849973;

CC From: Harvard University; Boston; USA.

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_C628 ! F12-1

OI CVCL_C629 ! F12-3

OI CVCL_C630 ! F12-4

OI CVCL_C631 ! F12-5

OI CVCL_C632 ! F12-6

OI CVCL_C633 ! F12-8

OI CVCL_C634 ! F124-5

OI CVCL_C636 ! F124B-3

OI CVCL_C637 ! F124B-4

SX Male

CA Induced pluripotent stem cell

ID F124-5

AC CVCL_C634

DR ISCR; 272

RX PubMed=18849973;

CC From: Harvard University; Boston; USA.

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_C628 ! F12-1

OI CVCL_C629 ! F12-3

OI CVCL_C630 ! F12-4

OI CVCL_C631 ! F12-5

OI CVCL_C632 ! F12-6

OI CVCL_C633 ! F12-8

OI CVCL_C635 ! F124-10

OI CVCL_C636 ! F124B-3

OI CVCL_C637 ! F124B-4

SX Male

CA Induced pluripotent stem cell

ID F124B-3

AC CVCL_C636

DR ISCR; 270

RX PubMed=18849973;

CC From: Harvard University; Boston; USA.

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_C628 ! F12-1

OI CVCL_C629 ! F12-3

OI CVCL_C630 ! F12-4

OI CVCL_C631 ! F12-5

OI CVCL_C632 ! F12-6

OI CVCL_C633 ! F12-8

OI CVCL_C634 ! F124-5

OI CVCL_C635 ! F124-10

OI CVCL_C637 ! F124B-4

SX Male

CA Induced pluripotent stem cell

ID F124B-4

AC CVCL_C637

DR ISCR; 269

RX PubMed=18849973;

CC From: Harvard University; Boston; USA.

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_C628 ! F12-1

OI CVCL_C629 ! F12-3

OI CVCL_C630 ! F12-4

OI CVCL_C631 ! F12-5

OI CVCL_C632 ! F12-6

OI CVCL_C633 ! F12-8

OI CVCL_C634 ! F124-5

OI CVCL_C635 ! F124-10

OI CVCL_C636 ! F124B-3

SX Male

CA Induced pluripotent stem cell

ID F15-42-1-5

AC CVCL_M397

DR ECACC; 89062107

CC Monoclonal antibody target: UniProtKB; P04216; Human THY1/CD90.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2155 ! P3/NS1/1-Ag4.1

CA Hybridoma

ID F16-4-4-11

AC CVCL_M398

DR ECACC; 89062109

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2155 ! P3/NS1/1-Ag4.1

CA Hybridoma

ID F17-23-2

AC CVCL_M399

DR ECACC; 89062110

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2155 ! P3/NS1/1-Ag4.1

CA Hybridoma

ID F1706

AC CVCL_6C53

SY F-1706; F 1706

RX PubMed=50281;

CC Breed/subspecies: Fischer 344.

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_6C52 ! F111

CA Spontaneously immortalized cell line

ID F18 AF1

AC CVCL_G648

SY F18

DR CLO; CLO_0002969

DR ATCC; HB-8208

RX Patent=US4504586;

CC Monoclonal antibody target: UniProtKB; P09603; Human CSF1.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2199 ! Sp2/0-Ag14

CA Hybridoma

ID F19

AC CVCL_K209

DR CLO; CLO_0002970

DR ATCC; CRL-2733

DR ATCC; HB-8269

RX Patent=US5059523;

OX NCBI_TaxID=10090; ! Mus musculus

CA Hybridoma

ID F1A3-23

AC CVCL_G649

SY A3

DR CLO; CLO_0002971

DR ATCC; HB-8207

RX Patent=US4504586;

CC Monoclonal antibody target: UniProtKB; P09603; Human CSF1.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2199 ! Sp2/0-Ag14

CA Hybridoma

ID F1B

AC CVCL_6318

SY F 1 B; F1B(N)

DR CLO; CLO_0002964

DR ATCC; CRL-6168

RX PubMed=5066602;

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

OX NCBI_TaxID=9685; ! Felis catus

SX Female

CA Cancer cell line

ID F2.4A3

AC CVCL_A039

RX PubMed=7514905;

CC Problematic cell line: Possibly contaminated. May originate from SK-HEP-1 as 4 other cell lines from the same paper (PubMed=7514905) have been shown to be contaminated.

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_A038 ! FEC.2

CA Finite cell line

ID F2.4E5

AC CVCL_A040

SY F2-4E5

DR BioSample; SAMN03151917

RX PubMed=7514905;

RX PubMed=10508494;

RX PubMed=20143388;

WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC Problematic cell line: Contaminated. Shown to be a SK-HEP-1 derivative (PubMed=10508494, PubMed=20143388).

CC Characteristics: Has lost chromosome Y.

CC Derived from metastatic site: Ascites.

DI NCIt; C3099; Hepatocellular carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_0525 ! SK-HEP-1

SX Male

CA Cancer cell line

ID F2.5B6

AC CVCL_A041

SY F2-5B6

DR BioSample; SAMN03151918

RX PubMed=7514905;

RX PubMed=10508494;

RX PubMed=20143388;

WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC Problematic cell line: Contaminated. Shown to be a SK-HEP-1 derivative (PubMed=10508494, PubMed=20143388).

CC Characteristics: Has lost chromosome Y.

CC Derived from metastatic site: Ascites.

DI NCIt; C3099; Hepatocellular carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_0525 ! SK-HEP-1

SX Male

CA Cancer cell line

ID F21-1D3G7C8

AC CVCL_G650

DR CLO; CLO_0002973

DR ATCC; HB-9463

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2199 ! Sp2/0-Ag14

CA Hybridoma

ID F23

AC CVCL_N322

SY F.sub.23

DR ATCC; HB-8231

RX Patent=US4713352;

RX Patent=US4935344;

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2155 ! P3/NS1/1-Ag4.1

CA Hybridoma

ID F23.1

AC CVCL_D665

DR BCRJ; 0083

OX NCBI_TaxID=10116; ! Rattus norvegicus

CA Hybridoma

ID F23.2

AC CVCL_D666

DR BCRJ; 0084

OX NCBI_TaxID=10116; ! Rattus norvegicus

CA Hybridoma

ID F24

AC CVCL_K210

DR CLO; CLO_0002974

DR ATCC; HB-9257

RX Patent=US5059523;

OX NCBI_TaxID=10090; ! Mus musculus

CA Hybridoma

ID F2408

AC CVCL_8352

SY F 2408

DR IFO; IFO50015

CC Breed/subspecies: Fischer 344.

OX NCBI_TaxID=10116; ! Rattus norvegicus

CA Spontaneously immortalized cell line

ID F2408 EBNA2 cl-14

AC CVCL_E943

SY F2408-E2 Cl.14

DR JCRB; JCRB0143.5

DR JCRB; NIHS0223.5

RX PubMed=7556601;

CC Transfected with: UniProtKB; P12978; EBV EBNA2.

CC Discontinued: JCRB; NIHS0223.5; true.

CC Breed/subspecies: Fischer 344.

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_8352 ! F2408

CA Transformed cell line

ID F2408 EBNA2 cl-16

AC CVCL_E944

SY F2408-E2 Cl.16

DR JCRB; JCRB0143.2

DR JCRB; NIHS0223.2

RX PubMed=7556601;

CC Transfected with: UniProtKB; P12978; EBV EBNA2.

CC Discontinued: JCRB; NIHS0223.2; true.

CC Breed/subspecies: Fischer 344.

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_8352 ! F2408

CA Transformed cell line

ID F2408 EBNA2 cl-18

AC CVCL_E945

SY F2408-E2 Cl.18

DR JCRB; JCRB0143.3

DR JCRB; NIHS0223.3

RX PubMed=7556601;

CC Transfected with: UniProtKB; P12978; EBV EBNA2.

CC Discontinued: JCRB; NIHS0223.3; true.

CC Breed/subspecies: Fischer 344.

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_8352 ! F2408

CA Transformed cell line

ID F2408 EBNA2 cl-23

AC CVCL_E946

SY F2408-E2 Cl.23

DR JCRB; JCRB0143.6

DR JCRB; NIHS0223.6

RX PubMed=7556601;

CC Transfected with: UniProtKB; P12978; EBV EBNA2.

CC Discontinued: JCRB; NIHS0223.6; true.

CC Breed/subspecies: Fischer 344.

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_8352 ! F2408

CA Transformed cell line

ID F2408 EBNA2 cl-24

AC CVCL_E947

SY F2408-E2 Cl.24

DR JCRB; JCRB0143.4

DR JCRB; NIHS0223.4

RX PubMed=7556601;

CC Transfected with: UniProtKB; P12978; EBV EBNA2.

CC Discontinued: JCRB; NIHS0223.4; true.

CC Breed/subspecies: Fischer 344.

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_8352 ! F2408

CA Transformed cell line

ID F2408 EBNA2 cl-28

AC CVCL_E948

SY F2408-E2 Cl.28

DR JCRB; JCRB0143.7

DR JCRB; NIHS0223.7

RX PubMed=7556601;

CC Transfected with: UniProtKB; P12978; EBV EBNA2.

CC Discontinued: JCRB; NIHS0223.7; true.

CC Breed/subspecies: Fischer 344.

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_8352 ! F2408

CA Transformed cell line

ID F2408 EBNA2 cl-9

AC CVCL_E949

SY F2408-E2 Cl.9

DR JCRB; JCRB0143.1

DR JCRB; NIHS0223.1

RX PubMed=7556601;

CC Transfected with: UniProtKB; P12978; EBV EBNA2.

CC Discontinued: JCRB; NIHS0223.1; true.

CC Breed/subspecies: Fischer 344.

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_8352 ! F2408

CA Transformed cell line

ID F2408 pZipNeo

AC CVCL_E950

DR JCRB; JCRB0143.0

DR JCRB; NIHS0223.0

RX PubMed=7556601;

CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC Discontinued: JCRB; NIHS0223.0; true.

CC Breed/subspecies: Fischer 344.

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_8352 ! F2408

CA Transformed cell line

ID F2408-B812

AC CVCL_E951

SY B812

DR IFO; IFO50099

RX PubMed=6829165;

WW http://cellbank.nibiohn.go.jp//legacy/sheet/att00070.htm

CC Breed/subspecies: Fischer 344.

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_L072 ! F2408-No.7

CA Spontaneously immortalized cell line

ID F2408-B993

AC CVCL_E952

DR IFO; IFO50100

WW http://cellbank.nibiohn.go.jp//legacy/sheet/att00070.htm

CC Breed/subspecies: Fischer 344.

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_L072 ! F2408-No.7

CA Spontaneously immortalized cell line

ID F2408-No.20

AC CVCL_L070

DR IFO; IFO50101

CC Breed/subspecies: Fischer 344.

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_8352 ! F2408

CA Spontaneously immortalized cell line

ID F2408-No.3

AC CVCL_L071

DR IFO; IFO50098

CC Breed/subspecies: Fischer 344.

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_8352 ! F2408

CA Spontaneously immortalized cell line

ID F2408-No.7

AC CVCL_L072

DR IFO; IFO50102

RX PubMed=6829165;

CC Breed/subspecies: Fischer 344.

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_8352 ! F2408

CA Spontaneously immortalized cell line

ID F25 [Cat erythroleukemia]

AC CVCL_6387

DR CLO; CLO_0002975

DR ATCC; CRL-6566

DR NCBI_Iran; C593

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

OX NCBI_TaxID=9685; ! Felis catus

SX Female

CA Cancer cell line

ID F25 [Mouse hybridoma]

AC CVCL_J279

DR JCRB; JCRB1323

RX PubMed=15671532;

CC Monoclonal antibody target: UniProtKB; Q96RD9; Human FCRL5/CD307e.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2199 ! Sp2/0-Ag14

CA Hybridoma

ID F25.2

AC CVCL_J950

DR ATCC; HB-8109

RX Patent=US4522918;

RX PubMed=6789331;

CC Discontinued: ATCC; HB-8109; probable.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2155 ! P3/NS1/1-Ag4.1

CA Hybridoma

ID F255A4

AC CVCL_8688

DR BioSample; SAMN03151694

RX PubMed=6451928;

RX PubMed=20143388;

WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=6451928, PubMed=20143388).

CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI NCIt; C4029; Cervical adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_0030 ! HeLa

SX Female

CA Cancer cell line

ID F2C03

AC CVCL_EQ51

RX PubMed=20569274;

CC Characteristics: Cell line expressing non-mutated MECP2 allele.

CC Omics: Transcriptome analysis.

DI NCIt; C75488; Rett syndrome

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_EQ52 ! F2C14

SX Female

CA Finite cell line

ID F2C14

AC CVCL_EQ52

RX PubMed=20569274;

CC Characteristics: Cell line expressing mutated MECP2 allele.

CC Omics: Transcriptome analysis.

DI NCIt; C75488; Rett syndrome

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_EQ51 ! F2C03

SX Female

CA Finite cell line

ID F3-20-7

AC CVCL_T985

DR ECACC; 89062112

CC Discontinued: ECACC; 89062112; probable.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2155 ! P3/NS1/1-Ag4.1

CA Hybridoma

ID F3-87-8-1

AC CVCL_T976

DR ECACC; 89062108

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2155 ! P3/NS1/1-Ag4.1

CA Hybridoma

ID F31

AC CVCL_N323

SY F.sub.31

DR ATCC; HB-8548

RX Patent=US4713352;

CC Discontinued: ATCC; HB-8548; probable.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2155 ! P3/NS1/1-Ag4.1

CA Hybridoma

ID F32 VIII C4

AC CVCL_L512

SY F-32 VIII C4

DR CLO; CLO_0002977

DR ATCC; CRL-1653

RX PubMed=6376344;

CC Monoclonal antibody target: UniProtKB; F1S379; Pig REN1.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2199 ! Sp2/0-Ag14

CA Hybridoma

ID F344-Tg.EC4011

AC CVCL_5F85

RX PubMed=23437152;

CC Breed/subspecies: Fischer 344.

OX NCBI_TaxID=10116; ! Rattus norvegicus

SX Male

CA Embryonic stem cell

ID F3B6

AC CVCL_8953

DR CLO; CLO_0002978

DR ATCC; HB-8785

DR NCBI_Iran; C197

RX Patent=US4677070;

CC Group: Hybridoma fusion partner cell line.

CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).

OX NCBI_TaxID=9606; ! Homo sapiens

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2155 ! P3/NS1/1-Ag4.1

CA Hybrid cell line

ID F3C15

AC CVCL_EQ53

RX PubMed=20569274;

CC Characteristics: Cell line expressing mutated MECP2 allele.

CC Omics: Transcriptome analysis.

DI NCIt; C75488; Rett syndrome

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_EQ54 ! F3C18

SX Female

CA Finite cell line

ID F3C18

AC CVCL_EQ54

RX PubMed=20569274;

CC Characteristics: Cell line expressing non-mutated MECP2 allele.

CC Omics: Transcriptome analysis.

DI NCIt; C75488; Rett syndrome

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_EQ53 ! F3C15

SX Female

CA Finite cell line

ID F3II

AC CVCL_E119

RX PubMed=8691844;

CC Breed/subspecies: DBA.

DI NCIt; C21790; Mouse melanoma

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_4512 ! Clone M-3

SX Male

CA Cancer cell line

ID F4/4.K6

AC CVCL_4606

DR CLO; CLO_0002979

DR CLDB; cl1194

DR DSMZ; ACC-52

RX PubMed=2785556;

CC Characteristics: IL4 dependent.

CC Discontinued: DSMZ; ACC-52; true.

CC Breed/subspecies: C57BL/10.

OX NCBI_TaxID=10090; ! Mus musculus

CA Factor-dependent cell line

ID F4/80

AC CVCL_7263

DR CLO; CLO_0002980

DR ATCC; HB-198

DR CCRID; 3131C0001000600045

OX NCBI_TaxID=10090; ! Mus musculus

OX NCBI_TaxID=10116; ! Rattus norvegicus

CA Hybridoma

ID F4/B8

AC CVCL_9R59

SY B8

RX PubMed=1057176;

RX PubMed=4514957;

CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).

CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).

CC Breed/subspecies: DBA/2.

DI NCIt; C21895; Mouse erythroid leukemia

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_9R58 ! FSD1/F4

CA Cancer cell line

ID F4/B8/3

AC CVCL_6368

SY B8/3

DR JCRB; JCRB0238

CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).

CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).

CC Breed/subspecies: DBA/2.

DI NCIt; C21895; Mouse erythroid leukemia

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_9R59 ! F4/B8

CA Cancer cell line

ID F422

AC CVCL_J510

SY F-422

RX PubMed=2822586;

OX NCBI_TaxID=9685; ! Felis catus

CA Cancer cell line

ID F435

AC CVCL_5A31

RX PubMed=19906157;

RX PubMed=25887056;

CC Transfected with: HGNC; 3546; F8 (construct called N8 with 20-769 and 1657-2351).

CC Omics: Genome sequenced.

OX NCBI_TaxID=10029; ! Cricetulus griseus

HI CVCL_1977 ! CHO-DXB11

SX Female

CA Spontaneously immortalized cell line

ID F4374

AC CVCL_6F46

RX PubMed=12441130;

RX PubMed=15322275;

OX NCBI_TaxID=9888; ! Muntiacus muntjak

SX Female

CA Finite cell line

ID F4374 hTERT

AC CVCL_6F50

SY OF4374 hTERT

RX PubMed=12441130;

RX PubMed=15322275;

CC Transfected with: HGNC; 11730; TERT.

OX NCBI_TaxID=9888; ! Muntiacus muntjak

HI CVCL_6F49 ! OF4374

SX Female

CA Telomerase immortalized cell line

ID F45J

AC CVCL_L513

SY 45J

DR CLO; CLO_0002981

DR ATCC; HB-9740

RX Patent=US5091512;

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2155 ! P3/NS1/1-Ag4.1

CA Hybridoma

ID F4869

AC CVCL_6F47

RX PubMed=12441130;

RX PubMed=15322275;

OX NCBI_TaxID=9888; ! Muntiacus muntjak

SX Male

CA Finite cell line

ID F4869 hTERT

AC CVCL_6F48

RX PubMed=15322275;

OX NCBI_TaxID=9888; ! Muntiacus muntjak

HI CVCL_6F47 ! F4869

SX Male

CA Telomerase immortalized cell line

ID F4C1

AC CVCL_IV56

RX PubMed=178673;

CC Doubling time: 48 hours (PubMed=178673).

CC Breed/subspecies: Fischer 344.

DI NCIt; C132194; Rat pituitary gland neoplasm

OX NCBI_TaxID=10116; ! Rattus norvegicus

OI CVCL_H712 ! MtT/E

OI CVCL_H713 ! MtT/S

OI CVCL_H714 ! MtT/Se

OI CVCL_H715 ! MtT/SM

SX Female

CA Cancer cell line

ID F4N

AC CVCL_4176

SY F4N (MEL); F4N(MEL); F4N MEL; MEL-F4N

DR CLO; CLO_0002982

DR ECACC; 96121718

RX PubMed=1057176;

CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).

CC Breed/subspecies: DBA/2.

DI NCIt; C21895; Mouse erythroid leukemia

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_9R58 ! FSD1/F4

CA Cancer cell line

ID F4N-S

AC CVCL_4344

SY F4N-Sofia; F4N (Sofia); F4N-S MEL; F4N clone Sofia

CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).

CC Breed/subspecies: DBA/2.

DI NCIt; C21895; Mouse erythroid leukemia

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_4176 ! F4N

CA Cancer cell line

ID F5

AC CVCL_V616

DR BTO; BTO:0004530

DR CCLE; F5_CENTRAL_NERVOUS_SYSTEM

RX PubMed=25984343;

CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC Doubling time: 46 hours (PubMed=25984343).

DI NCIt; C3230; Meningioma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID F5-5.F1

AC CVCL_4177

SY F5-5.fl

DR CLO; CLO_0050783

DR ECACC; 99072803

DR RCB; RCB0560

RX PubMed=1071084;

CC Breed/subspecies: DDD.

DI NCIt; C21604; Mouse leukemia

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_4312 ! T-3-Cl-2

SX Male

CA Cancer cell line

ID F5-A-1/22.8.13

AC CVCL_L514

DR CLO; CLO_0002984

DR ATCC; HB-8051

RX Patent=US4446122;

CC Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_4032 ! P3X63Ag8.653

CA Hybridoma

ID F56

AC CVCL_J280

DR JCRB; JCRB1189

RX PubMed=15671532;

CC Monoclonal antibody target: UniProtKB; Q96RD9; Human FCRL5/CD307e.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2199 ! Sp2/0-Ag14

CA Hybridoma

ID F64.5

AC CVCL_J951

RX PubMed=6789331;

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2155 ! P3/NS1/1-Ag4.1

CA Hybridoma

ID F6B3

AC CVCL_4Y23

SY SR-C3H/St glioma

DR JCRB; JCRB1571

RX CelloPub=CLPUB00270;

CC Breed/subspecies: C3H/St.

OX NCBI_TaxID=10090; ! Mus musculus

CA Cancer cell line

ID F6C01

AC CVCL_EQ55

RX PubMed=20569274;

CC Characteristics: Cell line expressing non-mutated MECP2 allele.

CC Omics: Transcriptome analysis.

DI NCIt; C75488; Rett syndrome

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_EQ56 ! F6C04

SX Female

CA Finite cell line

ID F6C04

AC CVCL_EQ56

RX PubMed=20569274;

CC Characteristics: Cell line expressing mutated MECP2 allele.

CC Omics: Transcriptome analysis.

DI NCIt; C75488; Rett syndrome

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_EQ55 ! F6C01

SX Female

CA Finite cell line

ID F8

AC CVCL_6388

DR CLO; CLO_0002986

DR ATCC; CRL-6074

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6074; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Sex undetermined

CA Undefined cell line type

ID F8-11-13

AC CVCL_T977

DR ECACC; 89062102

DR NCBI_Iran; H122

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2155 ! P3/NS1/1-Ag4.1

CA Hybridoma

ID F81

AC CVCL_9259

SY F-81; FK81

DR CCRID; 3131C0001000400013

DR KCB; KCB 2006104YJ

RX PubMed=24525403;

WW http://www.rccc.cytspb.rssi.ru/ecellbank/animal/af-81.htm

OX NCBI_TaxID=9685; ! Felis catus

HI CVCL_7216 ! Clone 81

SX Female

CA Transformed cell line

ID F9

AC CVCL_0259

DR BTO; BTO:0000095

DR CLO; CLO_0002988

DR CLO; CLO_0050537

DR CLO; CLO_0050539

DR EFO; EFO_0002053

DR MCCL; MCC:0000150

DR CLDB; cl1198

DR CLDB; cl1199

DR CLDB; cl1200

DR CLDB; cl1201

DR CLDB; cl4950

DR ATCC; CRL-1720

DR CCRID; 3111C0001CCC000276

DR CCRID; 3131C0001000800004

DR ChEMBL-Cells; CHEMBL3307489

DR ChEMBL-Targets; CHEMBL614296

DR CLS; 400174/p811_F9

DR DSMZ; ACC-112

DR ECACC; 85061803

DR ICLC; ATL99006

DR JCRB; JCRB0721

DR KCLB; 21720

DR Lonza; 261

DR RCB; RCB1555

DR RCB; RCB2643

DR TKG; TKG 0519

DR TOKU-E; 1176

RX PubMed=61803;

RX PubMed=214238;

RX PubMed=6479493;

WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/f/cell-lines-detail-206.html

CC Doubling time: ~24 hours (DSMZ).

CC Breed/subspecies: 129/Sv.

DI NCIt; C129859; Mouse teratocarcinoma

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_5572 ! OTT6050

SX Male

CA Cancer cell line

ID F9-41

AC CVCL_8300

DR JCRB; JCRB0001

CC Breed/subspecies: 129/Sv.

DI NCIt; C129859; Mouse teratocarcinoma

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_0259 ! F9

SX Male

CA Cancer cell line

ID F9/LM(1+10)

AC CVCL_T372

DR CLO; CLO_0050535

DR RCB; RCB2315

RX PubMed=16314080;

CC Transfected with: MGI; MGI:105382; Lama5.

CC Breed/subspecies: 129/Sv.

DI NCIt; C129859; Mouse teratocarcinoma

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_0259 ! F9

SX Male

CA Cancer cell line

ID F9/LM10

AC CVCL_T373

DR CLO; CLO_0050534

DR RCB; RCB2314

RX PubMed=16314080;

CC Transfected with: MGI; MGI:105382; Lama5.

CC Breed/subspecies: 129/Sv.

DI NCIt; C129859; Mouse teratocarcinoma

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_0259 ! F9

SX Male

CA Cancer cell line

ID F98

AC CVCL_3510

DR CLO; CLO_0002992

DR ATCC; CRL-2397

DR BCRJ; 0085

RX PubMed=7435138;

RX PubMed=19381449;

CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).

CC Breed/subspecies: Fischer 344.

DI NCIt; C64069; Rat malignant glioma

OX NCBI_TaxID=10116; ! Rattus norvegicus

SX Female

CA Cancer cell line

ID F98 EGFR

AC CVCL_B047

SY F98(EGFR)

DR ATCC; CRL-2948

RX PubMed=12036929;

CC Transfected with: HGNC; 3236; EGFR.

CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).

CC Breed/subspecies: Fischer 344.

DI NCIt; C64069; Rat malignant glioma

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_3510 ! F98

SX Female

CA Cancer cell line

ID F98npEGFRvIII

AC CVCL_B048

DR ATCC; CRL-2949

CC Transfected with: HGNC; 3236; EGFR (truncated extracellular mutant).

CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).

CC Breed/subspecies: Fischer 344.

DI NCIt; C64069; Rat malignant glioma

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_3510 ! F98

SX Female

CA Cancer cell line

ID FA18JTO

AC CVCL_2895

DR BioSample; SAMN03470923

DR JCRB; JCRB0315

ST Source(s): JCRB; PubMed=25877200

ST Amelogenin: X,Y

ST CSF1PO: 10,14

ST D13S317: 8,10

ST D16S539: 11

ST D18S51: 14,16

ST D19S433: 13,14

ST D21S11: 30

ST D2S1338: 17,18

ST D3S1358: 15,17

ST D5S818: 11,13

ST D7S820: 11

ST D8S1179: 13,16

ST FGA: 21,22

ST Penta D: 11,13

ST Penta E: 8,11

ST TH01: 6,9

ST TPOX: 11

ST vWA: 16,18

DI NCIt; C125702; Fanconi anemia, complementation group A

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Finite cell line

ID FA18JTO hTERT

AC CVCL_D253

DR JCRB; JCRB3007

DR JCRB; KURB1389

CC Transfected with: HGNC; 11730; TERT.

ST Source(s): JCRB

ST Amelogenin: X,Y

ST CSF1PO: 10,14

ST D13S317: 8,10

ST D16S539: 11

ST D5S818: 11,13

ST D7S820: 11

ST TH01: 6,9

ST TPOX: 11

ST vWA: 16,18

DI NCIt; C125702; Fanconi anemia, complementation group A

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_2895 ! FA18JTO

SX Male

CA Telomerase immortalized cell line

ID FA20P

AC CVCL_J286

DR BioSample; SAMN03472406

DR JCRB; JCRB3010

DR JCRB; KURB1390

ST Source(s): JCRB

ST Amelogenin: X,Y

ST CSF1PO: 12,13

ST D13S317: 7,11

ST D16S539: 11

ST D5S818: 10,12

ST D7S820: 11,12

ST TH01: 9,10

ST TPOX: 8,9

ST vWA: 16,17

DI NCIt; C125702; Fanconi anemia, complementation group A

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Finite cell line

ID Fa2N-4

AC CVCL_0267

SY Fa2N4

DR MCCL; MCC:0000158

DR ATCC; PTA-5566

RX PubMed=14722322;

RX PubMed=18332078;

CC Discontinued: ATCC; PTA-5566; true.

OX NCBI_TaxID=9606; ! Homo sapiens

CA Transformed cell line

ID Fa32

AC CVCL_0268

DR MCCL; MCC:0000159

CC Breed/subspecies: AxC.

DI NCIt; C60416; Rat hepatocellular carcinoma

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_4775 ! Faza 967

SX Male

CA Cancer cell line

ID FA34

AC CVCL_IU78

DR Cosmic; 2559131

RX PubMed=25653542;

CC Doubling time: ~34 hours (PubMed=25653542).

CC Derived from metastatic site: Pleural effusion.

DI NCIt; C3512; Lung adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID FA44

AC CVCL_IU79

DR Cosmic; 2559132

RX PubMed=25653542;

CC Doubling time: ~22 hours (PubMed=25653542).

CC Derived from metastatic site: Pleural effusion.

DI NCIt; C3512; Lung adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FA49

AC CVCL_IU80

DR Cosmic; 2559133

RX PubMed=25653542;

CC Doubling time: ~22 hours (PubMed=25653542).

CC Derived from metastatic site: Pleural effusion.

DI NCIt; C3512; Lung adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FA6

AC CVCL_4034

SY FA-6

DR EFO; EFO_0006392

DR Cosmic; 710855

RX PubMed=11169959;

RX PubMed=11787853;

WW http://www.pawefish.path.cam.ac.uk/PancCellLineDescriptions/FA6.html

DI NCIt; C8294; Pancreatic adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID FA98

AC CVCL_IU81

DR Cosmic; 2559134

RX PubMed=25653542;

CC Doubling time: ~22 hours (PubMed=25653542).

CC Derived from metastatic site: Pleural effusion.

DI NCIt; C3512; Lung adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FA9JTO

AC CVCL_2896

DR BioSample; SAMN03470919

DR JCRB; JCRB0314

ST Source(s): JCRB; PubMed=25877200

ST Amelogenin: X,Y

ST CSF1PO: 11,12

ST D13S317: 9,12

ST D16S539: 9,11

ST D18S51: 13,16

ST D19S433: 14,16.2

ST D21S11: 29

ST D2S1338: 23,24

ST D3S1358: 16,18

ST D5S818: 12

ST D7S820: 11

ST D8S1179: 10

ST FGA: 23,24

ST Penta D: 9,12

ST Penta E: 14,16

ST TH01: 9

ST TPOX: 8,11

ST vWA: 14

DI NCIt; C125708; Fanconi anemia, complementation group G

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Finite cell line

ID FA9JTO hTERT-1

AC CVCL_D254

DR JCRB; JCRB3006

DR JCRB; KURB1463

CC Transfected with: HGNC; 11730; TERT.

ST Source(s): JCRB

ST Amelogenin: X,Y

ST CSF1PO: 11,12

ST D13S317: 9,12

ST D16S539: 9,11

ST D5S818: 12

ST D7S820: 11

ST TH01: 9

ST TPOX: 8,11

ST vWA: 14

DI NCIt; C125708; Fanconi anemia, complementation group G

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_2896 ! FA9JTO

SX Male

CA Telomerase immortalized cell line

ID FA9JTOTERT

AC CVCL_2897

DR JCRB; JCRB1060

DR JCRB; NIHS0310

CC Transfected with: HGNC; 11730; TERT.

CC Discontinued: JCRB; NIHS0310; true.

ST Source(s): JCRB

ST Amelogenin: X,Y

ST CSF1PO: 11,12

ST D13S317: 9,12

ST D16S539: 9,11

ST D5S818: 12

ST D7S820: 11

ST TH01: 9

ST TPOX: 8,11

ST vWA: 14

DI NCIt; C125708; Fanconi anemia, complementation group G

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_2896 ! FA9JTO

SX Male

CA Telomerase immortalized cell line

ID FAA-HTC1

AC CVCL_E111

DR BTO; BTO:0005827

DR JCRB; JCRB0249

RX CelloPub=CLPUB00281;

RX PubMed=1295697;

CC Transformant: ChEBI; CHEBI:17356; 2-acetamidofluorene (2AAF).

CC Breed/subspecies: Fischer 344/DuCrj.

DI NCIt; C60416; Rat hepatocellular carcinoma

OX NCBI_TaxID=10116; ! Rattus norvegicus

SX Male

CA Cancer cell line

ID FaDu

AC CVCL_1218

SY FADU

DR BTO; BTO:0003233

DR CLO; CLO_0002993

DR EFO; EFO_0002178

DR ATCC; HTB-43

DR BCRC; 60214

DR BCRJ; 0301

DR BioSample; SAMN03471972

DR CCLE; FADU_UPPER_AERODIGESTIVE_TRACT

DR CCRID; 3131C0001000700132

DR ChEMBL-Cells; CHEMBL3307943

DR ChEMBL-Targets; CHEMBL612250

DR Cosmic; 686975

DR Cosmic; 906863

DR Cosmic; 921832

DR Cosmic; 1006466

DR Cosmic; 1017792

DR Cosmic; 1122668

DR Cosmic; 1339914

DR Cosmic; 1530736

DR Cosmic; 1752764

DR Cosmic; 2301587

DR Cosmic-CLP; 906863

DR DSMZ; ACC-784

DR GDSC; 906863

DR GEO; GSM482707

DR GEO; GSM482708

DR GEO; GSM482709

DR GEO; GSM482710

DR GEO; GSM887011

DR GEO; GSM888080

DR GEO; GSM1374479

DR GEO; GSM1374480

DR GEO; GSM1524310

DR GEO; GSM1524311

DR GEO; GSM1524312

DR GEO; GSM1669791

DR IGRhCellID; FaDu

DR KCLB; 30043

DR PRIDE; PXD002486

RX DOI=10.1016/B978-0-12-333530-2.50007-1;

RX PubMed=327080;

RX PubMed=833871;

RX PubMed=2990217;

RX PubMed=3138611;

RX PubMed=4332311;

RX PubMed=6935474;

RX PubMed=7459858;

RX PubMed=21833476;

RX PubMed=21868764;

RX PubMed=22460905;

RX PubMed=25485619;

RX PubMed=25888065;

RX PubMed=27397505;

RX PubMed=28196595;

WW http://tcpaportal.org/mclp/

CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC Part of: KuDOS 95 cell line panel.

CC Part of: MD Anderson Cell Lines Project.

CC Doubling time: ~30 hours (DSMZ).

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: Deep RNAseq analysis.

CC Omics: DNA methylation analysis.

CC Omics: Protein expression by reverse-phase protein arrays.

CC Omics: SNP array analysis.

CC Omics: Transcriptome analysis.

ST Source(s): ATCC; Cosmic-CLP; DSMZ; KCLB; PubMed=21868764; PubMed=25877200

ST Amelogenin: Not_detected (ATCC; Cosmic-CLP; DSMZ; PubMed=21868764; PubMed=25877200)

ST Amelogenin: X (KCLB)

ST CSF1PO: 12

ST D13S317: 8,9

ST D16S539: 11 (ATCC; Cosmic-CLP; PubMed=21868764; PubMed=25877200)

ST D16S539: 11,12 (DSMZ)

ST D18S51: 16

ST D21S11: 31.2

ST D3S1358: 17,18

ST D5S818: 12

ST D7S820: 11,12

ST D8S1179: 13

ST FGA: 25

ST Penta D: 11

ST Penta E: 17,19

ST TH01: 8

ST TPOX: 11

ST vWA: 15,17,18 (ATCC; DSMZ)

ST vWA: 15,17 (Cosmic-CLP; KCLB; PubMed=21868764; PubMed=25877200)

DI NCIt; C4043; Hypopharyngeal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FaDu/T

AC CVCL_EG58

SY FaDu/T-200

RX PubMed=21833476;

CC Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).

DI NCIt; C4043; Hypopharyngeal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_1218 ! FaDu

SX Male

CA Cancer cell line

ID FAK-/-

AC CVCL_8954

DR CLO; CLO_0002994

DR ATCC; CRL-2644

RX PubMed=7566154;

CC Knockout cell: Method=KO mouse; MGI; MGI:95481; Ptk2.

OX NCBI_TaxID=10090; ! Mus musculus

CA Spontaneously immortalized cell line

ID FAK+/+

AC CVCL_8955

DR CLO; CLO_0002995

DR ATCC; CRL-2645

RX PubMed=7566154;

OX NCBI_TaxID=10090; ! Mus musculus

CA Spontaneously immortalized cell line

ID FAL3

AC CVCL_F946

DR BioSample; SAMN03471954

DR RCB; RCB2284

DR TKG; TKG 0564

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC Discontinued: RCB; RCB2284; true.

ST Source(s): RCB; TKG

ST Amelogenin: X,Y

ST CSF1PO: 12,13

ST D13S317: 11

ST D16S539: 10

ST D5S818: 10

ST D7S820: 11

ST TH01: 9

ST TPOX: 8,9

ST vWA: 14,17

DI NCIt; C62505; Fanconi anemia

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID Fall-3

AC CVCL_CW07

DR ATCC; SCRC-1009

RX PubMed=2056275;

CC Discontinued: ATCC; SCRC-1009; true.

OX NCBI_TaxID=10090; ! Mus musculus

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_4032 ! P3X63Ag8.653

CA Hybridoma

ID FAMPAC

AC CVCL_5749

SY Fampac; PA-CLS-13; PA-CLS 13

DR CLS; 300309/p578_FAMPAC

RX PubMed=15112280;

RX PubMed=22753594;

ST Source(s): CLS

ST Amelogenin: X

ST CSF1PO: 10

ST D13S317: 8

ST D16S539: 14

ST D18S51: 15

ST D21S11: 32.2

ST D3S1358: 16,17

ST D5S818: 10,11

ST D7S820: 11

ST Penta D: 11

ST Penta E: 12,13

ST vWA: 15

DI NCIt; C9120; Pancreatic ductal adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID FAMPAC-A

AC CVCL_5750

SY PA-CLS-13A; PA-CLS 13A

DR CLS; 300310/p573_FAMPAC-A

ST Source(s): CLS

ST Amelogenin: X

ST CSF1PO: 10

ST D13S317: 8

ST D16S539: 14

ST D18S51: 15

ST D21S11: 32.2

ST D3S1358: 16,17

ST D5S818: 10,11

ST D7S820: 11

ST D8S1179: 10,12

ST FGA: 22

ST Penta D: 11

ST Penta E: 12,13

ST TH01: 9

ST TPOX: 8

ST vWA: 15

DI NCIt; C9120; Pancreatic ductal adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_5749 ! FAMPAC

SX Female

CA Cancer cell line

ID Fang-8

AC CVCL_6G29

RX PubMed=265551;

RX PubMed=6244232;

CC Derived from metastatic site: Intra-abdominal.

DI NCIt; C9325; Adrenal cortex carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID Fao

AC CVCL_0269

SY FaO; FAO; FAO-1

DR BTO; BTO:0001517

DR CLO; CLO_0002996

DR MCCL; MCC:0000160

DR CLDB; cl1206

DR CLDB; cl4908

DR ECACC; 89042701

DR ICLC; ATL99001

DR Lonza; 260

RX PubMed=4157008;

CC Breed/subspecies: AxC.

DI NCIt; C60416; Rat hepatocellular carcinoma

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_4775 ! Faza 967

SX Male

CA Cancer cell line

ID Faof1C2

AC CVCL_4722

SY C2

DR CLO; CLO_0002105

DR CLDB; cl559

DR ECACC; 94101906

RX PubMed=4157008;

CC Breed/subspecies: AxC.

DI NCIt; C60416; Rat hepatocellular carcinoma

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_0269 ! Fao

SX Male

CA Cancer cell line

ID Farage

AC CVCL_3302

SY FARAGE; Farage OL; Farage Original Line

DR CLO; CLO_0002997

DR EFO; EFO_0006393

DR ATCC; CRL-2630

DR BioSample; SAMN03471757

DR Cosmic; 1295510

DR Cosmic; 1517602

DR Cosmic; 1541919

DR Cosmic; 1945180

DR Cosmic; 2022591

DR Cosmic; 2276315

DR Cosmic-CLP; 1297449

DR GDSC; 1297449

DR GEO; GSM380125

DR GEO; GSM552429

DR GEO; GSM907525

DR GEO; GSM1374481

DR GEO; GSM1669792

DR IGRhCellID; Farage

RX DOI=10.3109/10428199209053591;

RX PubMed=9172815;

RX PubMed=19278952;

RX PubMed=19358282;

RX PubMed=23292937;

RX PubMed=25485619;

RX PubMed=27397505;

RX PubMed=28196595;

WW http://tcpaportal.org/mclp/

CC Part of: MD Anderson Cell Lines Project.

CC Microsatellite instability: Instable (MSI-low) (Sanger).

CC Omics: Array-based CGH.

CC Omics: CNV analysis.

CC Omics: Deep exome analysis.

CC Omics: Deep RNAseq analysis.

CC Omics: DNA methylation analysis.

CC Omics: miRNA expression profiling.

CC Omics: Protein expression by reverse-phase protein arrays.

CC Omics: SNP array analysis.

CC Omics: Transcriptome analysis.

CC Derived from metastatic site: Lymph node.

ST Source(s): ATCC; Cosmic-CLP

ST Amelogenin: X

ST CSF1PO: 11,12

ST D13S317: 11,13

ST D16S539: 11,12

ST D5S818: 12

ST D7S820: 12

ST TH01: 8,9

ST TPOX: 9

ST vWA: 14,15

DI NCIt; C8851; Diffuse large B-cell lymphoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID Farage 10.6.1

AC CVCL_J602

SY 10.6.1

RX PubMed=11378582;

CC Derived from metastatic site: Lymph node.

DI NCIt; C8851; Diffuse large B-cell lymphoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_3302 ! Farage

SX Female

CA Cancer cell line

ID Faraz-ICR

AC CVCL_IU69

RX PubMed=28215484;

CC Doubling time: 35 hours (PubMed=28215484).

CC Omics: Array-based CGH.

DI NCIt; C7977; Pancreatic acinar cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID FAT 7

AC CVCL_3511

DR CLO; CLO_0002998

DR ATCC; CRL-2109

RX PubMed=8148052;

CC Breed/subspecies: Fischer 344.

DI NCIt; C60511; Rat squamous cell carcinoma

OX NCBI_TaxID=10116; ! Rattus norvegicus

SX Male

CA Cancer cell line

ID Faza 967

AC CVCL_4775

SY FAZA 967; Faza967; FAZA; Faza

DR BTO; BTO:0001189

RX PubMed=4157008;

CC Breed/subspecies: AxC.

DI NCIt; C60416; Rat hepatocellular carcinoma

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_5125 ! Fu5-5

SX Male

CA Cancer cell line

ID Faza 967 clone 2

AC CVCL_S739

SY Faza 967clone2

DR ChEMBL-Cells; CHEMBL3308588

DR ChEMBL-Targets; CHEMBL614495

RX PubMed=2431944;

RX PubMed=6617662;

CC Selected for resistance to: ChEBI; CHEBI:41879; Dexamethasone.

CC Breed/subspecies: AxC.

DI NCIt; C60416; Rat hepatocellular carcinoma

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_S742 ! DEX-Faza 967

SX Male

CA Cancer cell line

ID FB-1

AC CVCL_A603

SY FB1

DR BTO; BTO:0005162

DR Cosmic; 849975

DR Cosmic; 891252

DR Cosmic; 1162840

DR Cosmic; 1507374

DR Cosmic; 1533550

DR Cosmic; 1536127

DR Cosmic; 1889005

DR Cosmic; 2319856

RX PubMed=9398720;

DI NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID FB-2

AC CVCL_9917

SY FB2

DR BioSample; SAMN03151972

DR Cosmic; 1084278

RX PubMed=11807785;

RX PubMed=17725429;

RX PubMed=19087340;

RX PubMed=20143388;

WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC Problematic cell line: Contaminated. Shown to be a TPC-1 derivative (PubMed=19087340, PubMed=20143388).

DI NCIt; C4035; Thyroid gland papillary carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_6298 ! TPC-1

SX Female

CA Cancer cell line

ID FB0001

AC CVCL_8W15

DR ECACC; 94091617

CC Part of: ECACC chromosomal abnormality collection.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FB2

AC CVCL_G688

DR CLO; CLO_0002999

DR ATCC; CRL-1891

DR KCLB; 21891

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_6971 ! FOX-NY

CA Hybridoma

ID FB2.Bm

AC CVCL_S346

DR ATCC; CRL-6032

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6032; true.

OX NCBI_TaxID=9913; ! Bos taurus

OI CVCL_4178 ! FB2.K

OI CVCL_4179 ! FB2.Ln

OI CVCL_4180 ! FB2.Sp

OI CVCL_4181 ! FB2.Thy

SX Female

CA Finite cell line

ID FB2.K

AC CVCL_4178

DR CLO; CLO_0003000

DR ATCC; CRL-6033

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

OX NCBI_TaxID=9913; ! Bos taurus

OI CVCL_S346 ! FB2.Bm

OI CVCL_4179 ! FB2.Ln

OI CVCL_4180 ! FB2.Sp

OI CVCL_4181 ! FB2.Thy

SX Female

CA Finite cell line

ID FB2.Ln

AC CVCL_4179

DR CLO; CLO_0003001

DR ATCC; CRL-6034

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6034; true.

OX NCBI_TaxID=9913; ! Bos taurus

OI CVCL_S346 ! FB2.Bm

OI CVCL_4178 ! FB2.K

OI CVCL_4180 ! FB2.Sp

OI CVCL_4181 ! FB2.Thy

SX Female

CA Finite cell line

ID FB2.Sp

AC CVCL_4180

DR CLO; CLO_0003002

DR CLDB; cl1207

DR ATCC; CRL-6035

DR ECACC; 90031908

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6035; true.

CC Discontinued: ECACC; 90031908; probable.

OX NCBI_TaxID=9913; ! Bos taurus

OI CVCL_S346 ! FB2.Bm

OI CVCL_4178 ! FB2.K

OI CVCL_4179 ! FB2.Ln

OI CVCL_4181 ! FB2.Thy

SX Female

CA Finite cell line

ID FB2.Thy

AC CVCL_4181

SY FB2.Sp/Thy

DR CLO; CLO_0003003

DR ATCC; CRL-6036

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6036; true.

OX NCBI_TaxID=9913; ! Bos taurus

OI CVCL_S346 ! FB2.Bm

OI CVCL_4178 ! FB2.K

OI CVCL_4179 ! FB2.Ln

OI CVCL_4180 ! FB2.Sp

SX Female

CA Finite cell line

ID FB3.Bm

AC CVCL_N501

DR ATCC; CRL-6037

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6037; true.

OX NCBI_TaxID=9913; ! Bos taurus

OI CVCL_4182 ! FB3.Ln

OI CVCL_4183 ! FB3.Thy

SX Male

CA Finite cell line

ID FB3.Ln

AC CVCL_4182

DR CLO; CLO_0003004

DR ATCC; CRL-6038

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6038; true.

OX NCBI_TaxID=9913; ! Bos taurus

OI CVCL_N501 ! FB3.Bm

OI CVCL_4183 ! FB3.Thy

SX Male

CA Finite cell line

ID FB3.Thy

AC CVCL_4183

SY FB3.Sp/Thy

DR CLO; CLO_0003005

DR ATCC; CRL-6039

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

OX NCBI_TaxID=9913; ! Bos taurus

OI CVCL_N501 ! FB3.Bm

OI CVCL_4182 ! FB3.Ln

SX Male

CA Finite cell line

ID FB4.Bm

AC CVCL_N502

DR ATCC; CRL-6040

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6040; true.

OX NCBI_TaxID=9913; ! Bos taurus

OI CVCL_4184 ! FB4.Ln

OI CVCL_4185 ! FB4.Sp/Thy

SX Female

CA Finite cell line

ID FB4.Ln

AC CVCL_4184

DR CLO; CLO_0003006

DR ATCC; CRL-6041

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6041; true.

OX NCBI_TaxID=9913; ! Bos taurus

OI CVCL_N502 ! FB4.Bm

OI CVCL_4185 ! FB4.Sp/Thy

SX Female

CA Finite cell line

ID FB4.Sp/Thy

AC CVCL_4185

DR CLO; CLO_0003007

DR ATCC; CRL-6042

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6042; true.

OX NCBI_TaxID=9913; ! Bos taurus

OI CVCL_N502 ! FB4.Bm

OI CVCL_4184 ! FB4.Ln

SX Female

CA Finite cell line

ID FB5.Bm

AC CVCL_4186

DR CLO; CLO_0003008

DR ATCC; CRL-6043

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

OX NCBI_TaxID=9913; ! Bos taurus

OI CVCL_4187 ! FB5.Ln

SX Male

CA Finite cell line

ID FB5.Ln

AC CVCL_4187

DR CLO; CLO_0003009

DR ATCC; CRL-6044

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6044; true.

OX NCBI_TaxID=9913; ! Bos taurus

OI CVCL_4186 ! FB5.Bm

SX Male

CA Finite cell line

ID FB8H3

AC CVCL_B399

SY Mab8H3

DR CLO; CLO_0003010

DR ATCC; CRL-2402

RX DOI=10.1021/jf00045a043;

CC Monoclonal antibody target: ChEBI; CHEBI:38221; Fumonisin B1.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_4032 ! P3X63Ag8.653

CA Hybridoma

ID FBBC-1

AC CVCL_F709

SY Fetal Bovine Brain Cell line-1

RX PubMed=19032985;

CC Doubling time: ~24 hours (PubMed=19032985).

CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].

OX NCBI_TaxID=9913; ! Bos taurus

CA Transformed cell line

ID FbEM-1

AC CVCL_0Q76

RX PubMed=9286736;

RX PubMed=10956554;

DI NCIt; C3014; Endometriosis

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Spontaneously immortalized cell line

ID FBHE

AC CVCL_2898

SY Fetal Bovine Heart Endothelial

DR CLO; CLO_0003011

DR CLDB; cl1208

DR CLDB; cl1209

DR ATCC; CRL-1395

DR ECACC; 87043002

DR IFO; IFO50154

DR IZSLER; BS CL 113

DR IZSLER; BS CL 212

WW http://www.cells-talk.com/index.php/page/copelibrary?key=CRL%201395

WW http://www.cells-talk.com/index.php/page/copelibrary?key=FBHE

CC Discontinued: ECACC; 87043002; probable.

CC Discontinued: IZSLER; BS CL 113; probable.

OX NCBI_TaxID=9913; ! Bos taurus

CA Finite cell line

ID FBL-3

AC CVCL_0J68

SY FBL3

RX PubMed=185295;

RX PubMed=564410;

RX PubMed=4867923;

CC Breed/subspecies: C57BL/6.

DI NCIt; C21604; Mouse leukemia

OX NCBI_TaxID=10090; ! Mus musculus

CA Cancer cell line

ID FBL-J5

AC CVCL_9253

SY FBL-J 5; Fetal Bovine Lung from cow J 5

DR CLO; CLO_0003012

DR CLDB; cl1210

RX PubMed=4372838;

CC Breed/subspecies: Jersey.

OX NCBI_TaxID=9913; ! Bos taurus

SX Female

CA Spontaneously immortalized cell line

ID FBM-17

AC CVCL_X195

SY Fetal Bovine Macrophage-17

RX PubMed=8593321;

CC Doubling time: 48 hours (PubMed=8593321).

OX NCBI_TaxID=9913; ! Bos taurus

CA Spontaneously immortalized cell line

ID FBT

AC CVCL_J446

SY Foetal Bovine Turbinate

DR CLO; CLO_0003013

DR CLDB; cl1211

DR CLDB; cl1212

OX NCBI_TaxID=9913; ! Bos taurus

CA Undefined cell line type

ID Fbx15^(Beta geo/Beta geo)ES

AC CVCL_T794

SY Fbx15 Beta geo/Beta geo ES

DR RCB; AES0120

DR RCB; RCB2661

RX PubMed=12665572;

CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.

CC Knockout cell: Method=Homologous recombination; MGI; MGI:1354755; Fbxo15.

CC Discontinued: RCB; RCB2661; true.

CC Breed/subspecies: 129S4/SvJae.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_T793 ! RF8

SX Male

CA Embryonic stem cell

ID FC0002

AC CVCL_8W16

DR ECACC; 95082301

CC Part of: ECACC chromosomal abnormality collection.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FC0003

AC CVCL_8W17

DR ECACC; 96082002

CC Part of: ECACC chromosomal abnormality collection.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FC0004

AC CVCL_8W18

DR ECACC; 96082301

CC Part of: ECACC chromosomal abnormality collection.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FC0005

AC CVCL_8W19

DR ECACC; 96082302

CC Part of: ECACC chromosomal abnormality collection.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FC0006

AC CVCL_8W20

DR ECACC; 96091307

CC Part of: ECACC chromosomal abnormality collection.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FC0007

AC CVCL_8W21

DR ECACC; 97102213

CC Part of: ECACC chromosomal abnormality collection.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C35710; Allgrove syndrome

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FC018

AC CVCL_B349

SY CEBe001-A

DR hPSCreg; CEBe001-A

DR ISCR; 85

RX PubMed=15153613;

CC From: Cellectis/Cellartis.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Sex ambiguous

CA Embryonic stem cell

ID FC100.Ln

AC CVCL_4926

DR CLO; CLO_0003016

DR ATCC; CRL-6117

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6117; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_4927 ! FC100.Sp

OI CVCL_4928 ! FC100.T

SX Male

CA Finite cell line

ID FC100.Sp

AC CVCL_4927

DR CLO; CLO_0003017

DR ATCC; CRL-6116

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6116; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_4926 ! FC100.Ln

OI CVCL_4928 ! FC100.T

SX Male

CA Finite cell line

ID FC100.T

AC CVCL_4928

DR CLO; CLO_0003018

DR ATCC; CRL-6115

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6115; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_4926 ! FC100.Ln

OI CVCL_4927 ! FC100.Sp

SX Male

CA Cancer cell line

ID FC101

AC CVCL_4929

DR CLO; CLO_0003019

DR ATCC; CRL-6118

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6118; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Sex undetermined

CA Finite cell line

ID FC102

AC CVCL_4930

DR CLO; CLO_0003020

DR ATCC; CRL-6119

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6119; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Sex undetermined

CA Finite cell line

ID FC103.En

AC CVCL_S220

SY FC103.Cn

DR ATCC; CRL-6151

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6151; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Female

CA Finite cell line

ID FC104.We

AC CVCL_4931

SY Fc104WE

DR CLO; CLO_0003021

DR ATCC; CRL-6152

RX PubMed=6500159;

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6152; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Sex undetermined

CA Finite cell line

ID FC105.We

AC CVCL_N500

DR ATCC; CRL-6153

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6153; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Sex undetermined

CA Finite cell line

ID FC106.We

AC CVCL_4932

DR CLO; CLO_0003022

DR ATCC; CRL-6154

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6154; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Sex undetermined

CA Finite cell line

ID FC107.We

AC CVCL_4933

DR CLO; CLO_0003023

DR ATCC; CRL-6155

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6155; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Sex undetermined

CA Finite cell line

ID FC108.We

AC CVCL_4934

DR CLO; CLO_0003024

DR ATCC; CRL-6156

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6156; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Sex undetermined

CA Finite cell line

ID FC109.We

AC CVCL_4935

DR CLO; CLO_0003025

DR ATCC; CRL-6157

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6157; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Sex undetermined

CA Finite cell line

ID FC11.BM

AC CVCL_4936

DR CLO; CLO_0003026

DR ATCC; CRL-6088

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6088; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_S209 ! FC11th

SX Female

CA Cancer cell line

ID FC11th

AC CVCL_S209

DR ATCC; CRL-6089

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6089; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_4936 ! FC11.BM

SX Female

CA Cancer cell line

ID FC110.We

AC CVCL_4937

DR CLO; CLO_0003027

DR ATCC; CRL-6158

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6158; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Sex undetermined

CA Finite cell line

ID FC112

AC CVCL_4938

DR CLO; CLO_0003028

DR ATCC; CRL-6120

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6120; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Sex undetermined

CA Finite cell line

ID FC113

AC CVCL_4939

DR CLO; CLO_0003029

DR ATCC; CRL-6121

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6121; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Sex undetermined

CA Finite cell line

ID FC114A.Int

AC CVCL_S221

DR ATCC; CRL-6159

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6159; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_S222 ! FC114A.Tr

OI CVCL_S223 ! FC114B.Int

OI CVCL_S224 ! FC114C.Int

OI CVCL_S225 ! FC114C.Tr

OI CVCL_S226 ! FC114D.Int

OI CVCL_S227 ! FC114D.Tr

OI CVCL_S228 ! FC114E.Int

OI CVCL_4940 ! FC114E.Tr

SX Male

CA Finite cell line

ID FC114A.Tr

AC CVCL_S222

DR ATCC; CRL-6160

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6160; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_S221 ! FC114A.Int

OI CVCL_S223 ! FC114B.Int

OI CVCL_S224 ! FC114C.Int

OI CVCL_S225 ! FC114C.Tr

OI CVCL_S226 ! FC114D.Int

OI CVCL_S227 ! FC114D.Tr

OI CVCL_S228 ! FC114E.Int

OI CVCL_4940 ! FC114E.Tr

SX Male

CA Finite cell line

ID FC114B.Int

AC CVCL_S223

DR ATCC; CRL-6161

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6161; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_S221 ! FC114A.Int

OI CVCL_S222 ! FC114A.Tr

OI CVCL_S224 ! FC114C.Int

OI CVCL_S225 ! FC114C.Tr

OI CVCL_S226 ! FC114D.Int

OI CVCL_S227 ! FC114D.Tr

OI CVCL_S228 ! FC114E.Int

OI CVCL_4940 ! FC114E.Tr

SX Male

CA Finite cell line

ID FC114C.Int

AC CVCL_S224

DR ATCC; CRL-6162

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6162; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_S221 ! FC114A.Int

OI CVCL_S222 ! FC114A.Tr

OI CVCL_S223 ! FC114B.Int

OI CVCL_S225 ! FC114C.Tr

OI CVCL_S226 ! FC114D.Int

OI CVCL_S227 ! FC114D.Tr

OI CVCL_S228 ! FC114E.Int

OI CVCL_4940 ! FC114E.Tr

SX Male

CA Finite cell line

ID FC114C.Tr

AC CVCL_S225

DR ATCC; CRL-6163

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6163; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_S221 ! FC114A.Int

OI CVCL_S222 ! FC114A.Tr

OI CVCL_S223 ! FC114B.Int

OI CVCL_S224 ! FC114C.Int

OI CVCL_S226 ! FC114D.Int

OI CVCL_S227 ! FC114D.Tr

OI CVCL_S228 ! FC114E.Int

OI CVCL_4940 ! FC114E.Tr

SX Male

CA Finite cell line

ID FC114D.Int

AC CVCL_S226

DR ATCC; CRL-6164

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6164; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_S221 ! FC114A.Int

OI CVCL_S222 ! FC114A.Tr

OI CVCL_S223 ! FC114B.Int

OI CVCL_S224 ! FC114C.Int

OI CVCL_S225 ! FC114C.Tr

OI CVCL_S227 ! FC114D.Tr

OI CVCL_S228 ! FC114E.Int

OI CVCL_4940 ! FC114E.Tr

SX Male

CA Finite cell line

ID FC114D.Tr

AC CVCL_S227

DR ATCC; CRL-6165

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6165; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_S221 ! FC114A.Int

OI CVCL_S222 ! FC114A.Tr

OI CVCL_S223 ! FC114B.Int

OI CVCL_S224 ! FC114C.Int

OI CVCL_S225 ! FC114C.Tr

OI CVCL_S226 ! FC114D.Int

OI CVCL_S228 ! FC114E.Int

OI CVCL_4940 ! FC114E.Tr

SX Male

CA Finite cell line

ID FC114E.Int

AC CVCL_S228

DR ATCC; CRL-6166

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6166; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_S221 ! FC114A.Int

OI CVCL_S222 ! FC114A.Tr

OI CVCL_S223 ! FC114B.Int

OI CVCL_S224 ! FC114C.Int

OI CVCL_S225 ! FC114C.Tr

OI CVCL_S226 ! FC114D.Int

OI CVCL_S227 ! FC114D.Tr

OI CVCL_4940 ! FC114E.Tr

SX Male

CA Finite cell line

ID FC114E.Tr

AC CVCL_4940

DR CLO; CLO_0003030

DR ATCC; CRL-6167

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_S221 ! FC114A.Int

OI CVCL_S222 ! FC114A.Tr

OI CVCL_S223 ! FC114B.Int

OI CVCL_S224 ! FC114C.Int

OI CVCL_S225 ! FC114C.Tr

OI CVCL_S226 ! FC114D.Int

OI CVCL_S227 ! FC114D.Tr

OI CVCL_S228 ! FC114E.Int

SX Male

CA Finite cell line

ID FC115.K

AC CVCL_4941

DR CLO; CLO_0003031

DR ATCC; CRL-6122

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6122; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Sex undetermined

CA Finite cell line

ID FC116.Sk

AC CVCL_S190

DR ATCC; CRL-6123

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6123; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Female

CA Finite cell line

ID FC118

AC CVCL_4942

DR CLO; CLO_0003032

DR ATCC; CRL-6124

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6124; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Sex undetermined

CA Finite cell line

ID FC119

AC CVCL_4943

DR CLO; CLO_0003033

DR ATCC; CRL-6125

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6125; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Sex undetermined

CA Finite cell line

ID FC16.Sp

AC CVCL_4944

DR CLO; CLO_0003034

DR ATCC; CRL-6174

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6174; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_6415 ! LFC16.Ln

SX Female

CA Cancer cell line

ID FC2.K

AC CVCL_4188

SY Fc2K

DR CLO; CLO_0003035

DR ATCC; CRL-6126

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_4189 ! FC2.Lu

SX Male

CA Finite cell line

ID FC2.Lu

AC CVCL_4189

SY Fc2Lu; Fc 2 Lu

DR CLO; CLO_0003014

DR CLO; CLO_0003036

DR CLO; CLO_0003038

DR CLDB; cl1213

DR CLDB; cl1214

DR ATCC; CCL-217

DR ATCC; CRL-6569

DR ECACC; 90112712

DR IZSLER; BS CL 43

RX PubMed=7065527;

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6569; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_4188 ! FC2.K

SX Male

CA Finite cell line

ID FC25.T

AC CVCL_N527

SY FC25T

DR ATCC; CRL-6090

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6090; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Male

CA Cancer cell line

ID FC26

AC CVCL_S208

DR ATCC; CRL-6091

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6091; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Sex undetermined

CA Finite cell line

ID FC28.Lu

AC CVCL_4190

SY Fc28Lu

DR CLO; CLO_0003037

DR ATCC; CRL-6130

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6130; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_S193 ! FC28.Sp/Thy

SX Sex undetermined

CA Finite cell line

ID FC28.Sp/Thy

AC CVCL_S193

DR ATCC; CRL-6131

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6131; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_4190 ! FC28.Lu

SX Sex undetermined

CA Finite cell line

ID FC3.K

AC CVCL_S191

DR ATCC; CRL-6128

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6128; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_S192 ! FC3.Lu

OI CVCL_4191 ! FC3.Tg

OI CVCL_S217 ! FC3.Thy

SX Female

CA Finite cell line

ID FC3.Lu

AC CVCL_S192

DR ATCC; CRL-6129

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6129; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_S191 ! FC3.K

OI CVCL_4191 ! FC3.Tg

OI CVCL_S217 ! FC3.Thy

SX Female

CA Finite cell line

ID FC3.Tg

AC CVCL_4191

SY Fc3Tg; Fc 3 Tg

DR CLO; CLO_0003015

DR CLO; CLO_0003039

DR CLDB; cl1215

DR CLDB; cl1216

DR ATCC; CCL-176

DR ATCC; CRL-6570

DR ECACC; 90073002

DR IZSLER; BS CL 44

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Characteristics: Can undergo 50 PDL.

CC Discontinued: ATCC; CRL-6570; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_S191 ! FC3.K

OI CVCL_S192 ! FC3.Lu

OI CVCL_S217 ! FC3.Thy

SX Female

CA Finite cell line

ID FC3.Thy

AC CVCL_S217

SY FC0003 Thm; Fc3Th

DR ATCC; CRL-6075

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6075; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_S191 ! FC3.K

OI CVCL_S192 ! FC3.Lu

OI CVCL_4191 ! FC3.Tg

SX Female

CA Finite cell line

ID FC36.22

AC CVCL_8195

DR NIH-ARP; 3194-41

RX PubMed=8525373;

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_8165 ! 67-1

CA Transformed cell line

ID FC4.14F8

AC CVCL_AR45

DR ECACC; 93100516

OX NCBI_TaxID=10090; ! Mus musculus

CA Hybridoma

ID FC4.K

AC CVCL_K170

SY FC4

DR ATCC; CRL-6076

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6076; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Female

CA Finite cell line

ID FC42.Bm

AC CVCL_S207

DR ATCC; CRL-6092

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6092; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Sex undetermined

CA Finite cell line

ID FC43

AC CVCL_S206

DR ATCC; CRL-6093

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6093; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Sex undetermined

CA Finite cell line

ID FC47

AC CVCL_4945

DR CLO; CLO_0003040

DR ATCC; CRL-6094

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

OX NCBI_TaxID=9685; ! Felis catus

SX Sex undetermined

CA Finite cell line

ID FC5.Bm

AC CVCL_S216

DR ATCC; CRL-6077

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6077; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_4946 ! FC5.K

OI CVCL_S215 ! FC5.Sp

OI CVCL_S214 ! FC5.Thy

SX Male

CA Finite cell line

ID FC5.K

AC CVCL_4946

DR CLO; CLO_0003041

DR ATCC; CRL-6078

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6078; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_S216 ! FC5.Bm

OI CVCL_S215 ! FC5.Sp

OI CVCL_S214 ! FC5.Thy

SX Male

CA Finite cell line

ID FC5.Sp

AC CVCL_S215

DR ATCC; CRL-6079

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6079; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_S216 ! FC5.Bm

OI CVCL_4946 ! FC5.K

OI CVCL_S214 ! FC5.Thy

SX Male

CA Finite cell line

ID FC5.Thy

AC CVCL_S214

DR ATCC; CRL-6080

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6080; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_S216 ! FC5.Bm

OI CVCL_4946 ! FC5.K

OI CVCL_S215 ! FC5.Sp

SX Male

CA Finite cell line

ID FC54.Sp

AC CVCL_S194

DR ATCC; CRL-6095

DR ATCC; CRL-6132

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6095; true.

CC Discontinued: ATCC; CRL-6132; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_S195 ! FC54.Thy

SX Female

CA Finite cell line

ID FC54.Thy

AC CVCL_S195

DR ATCC; CRL-6133

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6133; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_S194 ! FC54.Sp

SX Female

CA Finite cell line

ID FC55.Sp

AC CVCL_S204

DR ATCC; CRL-6096

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6096; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Male

CA Cancer cell line

ID FC56.Thy

AC CVCL_4192

SY Fc56Thy

DR CLO; CLO_0003042

DR ATCC; CRL-6134

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6134; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Male

CA Finite cell line

ID FC57.Sp

AC CVCL_S196

DR ATCC; CRL-6135

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6135; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_4193 ! FC57.Thy

SX Male

CA Finite cell line

ID FC57.Thy

AC CVCL_4193

SY Fc57Thy

DR CLO; CLO_0003043

DR ATCC; CRL-6136

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6136; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_S196 ! FC57.Sp

SX Male

CA Finite cell line

ID FC58.Thy

AC CVCL_4194

SY Fc58Thy

DR CLO; CLO_0003044

DR ATCC; CRL-6137

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6137; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Female

CA Finite cell line

ID FC59.Sp

AC CVCL_S197

DR ATCC; CRL-6138

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6138; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_4195 ! FC59.Thy

SX Male

CA Finite cell line

ID FC59.Thy

AC CVCL_4195

SY Fc59Thy

DR CLO; CLO_0003045

DR ATCC; CRL-6139

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6139; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_S197 ! FC59.Sp

SX Male

CA Finite cell line

ID FC6.Bm

AC CVCL_4196

SY Fc6Bm

DR CLO; CLO_0003046

DR ATCC; CRL-6081

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6081; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_4197 ! FC6.K

OI CVCL_S213 ! FC6.Sp

OI CVCL_S212 ! FC6.Thm

SX Male

CA Finite cell line

ID FC6.K

AC CVCL_4197

SY Fc6K

DR CLO; CLO_0003047

DR ATCC; CRL-6082

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6082; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_4196 ! FC6.Bm

OI CVCL_S213 ! FC6.Sp

OI CVCL_S212 ! FC6.Thm

SX Male

CA Finite cell line

ID FC6.Sp

AC CVCL_S213

DR ATCC; CRL-6083

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6083; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_4196 ! FC6.Bm

OI CVCL_4197 ! FC6.K

OI CVCL_S212 ! FC6.Thm

SX Male

CA Finite cell line

ID FC6.Thm

AC CVCL_S212

DR ATCC; CRL-6085

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6085; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_4196 ! FC6.Bm

OI CVCL_4197 ! FC6.K

OI CVCL_S213 ! FC6.Sp

SX Male

CA Finite cell line

ID FC60(A).Cvx

AC CVCL_S203

DR ATCC; CRL-6097

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6097; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_4947 ! FC60(A).We

OI CVCL_4948 ! FC60(B).We

SX Female

CA Finite cell line

ID FC60(A).We

AC CVCL_4947

AS CVCL_4949

SY FC60A.We

DR CLO; CLO_0003048

DR CLO; CLO_0003050

DR ATCC; CRL-6140

DR ATCC; CRL-6571

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6140; true.

CC Discontinued: ATCC; CRL-6571; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_S203 ! FC60(A).Cvx

OI CVCL_4948 ! FC60(B).We

SX Female

CA Finite cell line

ID FC60(B).We

AC CVCL_4948

AS CVCL_4950

SY FC60B.We

DR CLO; CLO_0003049

DR CLO; CLO_0003051

DR ATCC; CRL-6098

DR ATCC; CRL-6141

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6098; true.

CC Discontinued: ATCC; CRL-6141; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_S203 ! FC60(A).Cvx

OI CVCL_4947 ! FC60(A).We

SX Female

CA Finite cell line

ID FC61

AC CVCL_4951

DR CLO; CLO_0003052

DR ATCC; CRL-6099

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6099; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Sex undetermined

CA Finite cell line

ID FC63.Br

AC CVCL_S198

DR ATCC; CRL-6142

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6142; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_4952 ! FC63.Res

SX Sex undetermined

CA Finite cell line

ID FC63.Res

AC CVCL_4952

DR CLO; CLO_0003053

DR ATCC; CRL-6143

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6143; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_S198 ! FC63.Br

SX Sex undetermined

CA Finite cell line

ID FC65.T

AC CVCL_S200

SY FC65T

DR ATCC; CRL-6084

DR ATCC; CRL-6100

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6084; true.

CC Discontinued: ATCC; CRL-6100; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Sex undetermined

CA Cancer cell line

ID FC69

AC CVCL_S189

DR ATCC; CRL-6101

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6101; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Sex undetermined

CA Finite cell line

ID FC70.We

AC CVCL_4953

DR CLO; CLO_0003054

DR ATCC; CRL-6102

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6102; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Sex undetermined

CA Finite cell line

ID FC71A.We

AC CVCL_4954

DR CLO; CLO_0003055

DR ATCC; CRL-6145

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6145; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_S199 ! FC71B.Sg

SX Sex undetermined

CA Finite cell line

ID FC71B.Sg

AC CVCL_S199

DR ATCC; CRL-6144

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6144; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_4954 ! FC71A.We

SX Sex undetermined

CA Finite cell line

ID FC72A.Br

AC CVCL_S201

DR ATCC; CRL-6146

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6146; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_S202 ! FC72B.Br

OI CVCL_S218 ! FC72C.Br

OI CVCL_S219 ! FC72D.Br

SX Sex undetermined

CA Finite cell line

ID FC72B.Br

AC CVCL_S202

SY FC72B.Ns

DR ATCC; CRL-6147

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6147; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_S201 ! FC72A.Br

OI CVCL_S218 ! FC72C.Br

OI CVCL_S219 ! FC72D.Br

SX Sex undetermined

CA Finite cell line

ID FC72C.Br

AC CVCL_S218

DR ATCC; CRL-6148

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6148; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_S201 ! FC72A.Br

OI CVCL_S202 ! FC72B.Br

OI CVCL_S219 ! FC72D.Br

SX Sex undetermined

CA Finite cell line

ID FC72D.Br

AC CVCL_S219

DR ATCC; CRL-6149

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6149; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_S201 ! FC72A.Br

OI CVCL_S202 ! FC72B.Br

OI CVCL_S218 ! FC72C.Br

SX Sex undetermined

CA Finite cell line

ID FC74

AC CVCL_S188

DR ATCC; CRL-6104

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6104; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Female

CA Finite cell line

ID FC77.T

AC CVCL_4955

DR CLO; CLO_0003056

DR ATCC; CRL-6105

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

OX NCBI_TaxID=9685; ! Felis catus

SX Male

CA Cancer cell line

ID FC79.We

AC CVCL_4956

DR CLO; CLO_0003057

DR ATCC; CRL-6106

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6106; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Sex undetermined

CA Finite cell line

ID FC8

AC CVCL_S211

DR ATCC; CRL-6086

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6086; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Sex undetermined

CA Finite cell line

ID FC81.Sp

AC CVCL_4957

DR CLO; CLO_0003058

DR ATCC; CRL-6107

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6107; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_4958 ! FC81.T

OI CVCL_4959 ! FC81.Thy

SX Female

CA Finite cell line

ID FC81.T

AC CVCL_4958

DR CLO; CLO_0003059

DR ATCC; CRL-6108

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6108; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_4957 ! FC81.Sp

OI CVCL_4959 ! FC81.Thy

SX Female

CA Cancer cell line

ID FC81.Thy

AC CVCL_4959

DR CLO; CLO_0003060

DR ATCC; CRL-6109

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6109; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_4957 ! FC81.Sp

OI CVCL_4958 ! FC81.T

SX Female

CA Finite cell line

ID FC83.Bm

AC CVCL_N669

DR ATCC; CRL-6111

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6111; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_4960 ! FC83.Res

OI CVCL_4961 ! FC83.Sp

OI CVCL_N670 ! FC83.Thy

SX Male

CA Finite cell line

ID FC83.Res

AC CVCL_4960

DR CLO; CLO_0003061

DR ATCC; CRL-6567

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_N669 ! FC83.Bm

OI CVCL_4961 ! FC83.Sp

OI CVCL_N670 ! FC83.Thy

SX Male

CA Cancer cell line

ID FC83.Sp

AC CVCL_4961

DR CLO; CLO_0003062

DR ATCC; CRL-6110

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6110; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_N669 ! FC83.Bm

OI CVCL_4960 ! FC83.Res

OI CVCL_N670 ! FC83.Thy

SX Male

CA Cancer cell line

ID FC83.Thy

AC CVCL_N670

DR ATCC; CRL-6112

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6112; true.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_N669 ! FC83.Bm

OI CVCL_4960 ! FC83.Res

OI CVCL_4961 ! FC83.Sp

SX Male

CA Undefined cell line type

ID FC87.Sk

AC CVCL_4962

DR CLO; CLO_0003064

DR ATCC; CRL-6150

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6150; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Sex undetermined

CA Finite cell line

ID FC94.T

AC CVCL_4963

DR CLO; CLO_0003065

DR ATCC; CRL-6113

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6113; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Female

CA Cancer cell line

ID FC95.Thy

AC CVCL_4964

DR CLO; CLO_0003066

DR ATCC; CRL-6114

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6114; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Female

CA Finite cell line

ID FC9WF

AC CVCL_S210

SY Fc9WF

DR ATCC; CRL-6087

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6087; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Sex undetermined

CA Finite cell line

ID FCCM-2

AC CVCL_X045

SY FCCM2

RX PubMed=8385463;

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FCCM-9

AC CVCL_F730

SY FCCM9

RX PubMed=8385463;

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FCI-P1p

AC CVCL_DH00

DR GEO; GSM1001417

DR GEO; GSM1001454

RX PubMed=26080861;

CC Omics: Transcriptome analysis.

DI NCIt; C7550; Ovarian serous adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID FCI-P2p

AC CVCL_DH01

DR GEO; GSM1001435

RX PubMed=26080861;

CC Omics: Transcriptome analysis.

ST Source(s): PubMed=26080861

ST Amelogenin: X

ST CSF1PO: 10,13

ST D13S317: 10

ST D16S539: 12

ST D5S818: 11

ST D7S820: 9,10

ST TH01: 6,9

ST TPOX: 11

ST vWA: 14,17

DI NCIt; C7550; Ovarian serous adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID FCK

AC CVCL_DB45

SY Felis Catus Kidney

DR ATCC; CRL-6568

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6568; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Female

CA Finite cell line

ID FCNCBS1

AC CVCL_C752

SY NC01; TIFRe001-A

DR hPSCreg; TIFRe001-A

WW http://www.cellnet.org/007_news/viewnews.php?nid=80

CC From: Tata Institute of Fundamental Research; India.

OX NCBI_TaxID=9606; ! Homo sapiens

CA Embryonic stem cell

ID FCNCBS2

AC CVCL_C753

SY NC02; TIFRe002-A

DR hPSCreg; TIFRe002-A

WW http://www.cellnet.org/007_news/viewnews.php?nid=80

CC From: Tata Institute of Fundamental Research; India.

OX NCBI_TaxID=9606; ! Homo sapiens

CA Embryonic stem cell

ID FCNCBS3

AC CVCL_C754

SY NC03; TIFRe003-A

DR hPSCreg; TIFRe003-A

WW http://www.cellnet.org/007_news/viewnews.php?nid=80

CC From: Tata Institute of Fundamental Research; India.

OX NCBI_TaxID=9606; ! Homo sapiens

CA Embryonic stem cell

ID FCP-S1M

AC CVCL_L884

DR CLO; CLO_0050681

DR BioSample; SAMN03472232

DR RCB; RCB0783

ST Source(s): RCB

ST Amelogenin: X,Y

ST CSF1PO: 11,12

ST D13S317: 8,11

ST D16S539: 9,10

ST D5S818: 11,13

ST D7S820: 11,12

ST TH01: 7

ST TPOX: 8,11

ST vWA: 18,19

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Finite cell line

ID FCP-S2H

AC CVCL_L885

DR CLO; CLO_0050682

DR BioSample; SAMN03472233

DR RCB; RCB0784

ST Source(s): RCB

ST Amelogenin: X

ST CSF1PO: 9,10

ST D13S317: 8,10

ST D16S539: 9,10

ST D5S818: 11

ST D7S820: 11

ST TH01: 7,9

ST TPOX: 11

ST vWA: 17,18

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Finite cell line

ID FCP-S3H

AC CVCL_L886

DR CLO; CLO_0050683

DR BioSample; SAMN03472234

DR RCB; RCB0785

ST Source(s): RCB

ST Amelogenin: X

ST CSF1PO: 9,10

ST D13S317: 8,12

ST D16S539: 9,10

ST D5S818: 10,11

ST D7S820: 11,12

ST TH01: 7

ST TPOX: 8,9

ST vWA: 17,18

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Finite cell line

ID FCP-S4H

AC CVCL_L887

DR CLO; CLO_0050684

DR BioSample; SAMN03472235

DR RCB; RCB0786

ST Source(s): RCB

ST Amelogenin: X

ST CSF1PO: 12

ST D13S317: 8

ST D16S539: 9,10

ST D5S818: 10,12

ST D7S820: 11

ST TH01: 7,9

ST TPOX: 8

ST vWA: 17,18

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Finite cell line

ID FCP-S5H

AC CVCL_L888

DR CLO; CLO_0050685

DR BioSample; SAMN03472236

DR RCB; RCB0787

ST Source(s): RCB

ST Amelogenin: X

ST CSF1PO: 10,11

ST D13S317: 10,12

ST D16S539: 9,13

ST D5S818: 11,13

ST D7S820: 8,10

ST TH01: 7

ST TPOX: 8,11

ST vWA: 14,16

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Finite cell line

ID FCP-S6H

AC CVCL_L889

DR CLO; CLO_0050686

DR BioSample; SAMN03472237

DR RCB; RCB0788

ST Source(s): RCB

ST Amelogenin: X

ST CSF1PO: 10,12

ST D13S317: 8,10

ST D16S539: 10

ST D5S818: 11,12

ST D7S820: 11,12

ST TH01: 7,9

ST TPOX: 8,12

ST vWA: 18,19

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Finite cell line

ID FCR-HS02

AC CVCL_IU61

RX PubMed=28178429;

CC Doubling time: 56.5 hours (PubMed=28178429).

CC Breed/subspecies: Flat-Coated Retriever.

DI NCIt; C128125; Canine histiocytic sarcoma

OX NCBI_TaxID=9615; ! Canis lupus familiaris

SX Male

CA Cancer cell line

ID Fcwf-4

AC CVCL_6389

SY Fcwf

DR CLO; CLO_0003069

DR ATCC; CRL-2787

DR BCRJ; 0334

OX NCBI_TaxID=9685; ! Felis catus

CA Spontaneously immortalized cell line

ID FD-LSC-1

AC CVCL_S891

RX PubMed=24001612;

DI NCIt; C4044; Laryngeal squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FD441.8

AC CVCL_9174

DR CLO; CLO_0003070

DR ATCC; TIB-213

OX NCBI_TaxID=10090; ! Mus musculus

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_2199 ! Sp2/0-Ag14

CA Hybridoma

ID FDC-1

AC CVCL_0F06

DR ATCC; CRL-2729

DR BioSample; SAMN03471779

RX PubMed=1375241;

RX PubMed=7608535;

CC Discontinued: ATCC; CRL-2729; true.

ST Source(s): ATCC

ST Amelogenin: X,Y

ST CSF1PO: 10,12

ST D13S317: 10,12

ST D16S539: 9,12

ST D5S818: 13

ST D7S820: 11,12

ST TH01: 8,9.3

ST TPOX: 8

ST vWA: 15,19

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Finite cell line

ID FDC-P1

AC CVCL_2039

SY FDCP-1; FDCP1; Factor Dependent Continuous-Paterson 1; Factor Dependent Cell-Paterson 1

DR BTO; BTO:0000595

DR CLO; CLO_0003072

DR CLO; CLO_0003073

DR ATCC; CRL-12103

DR BCRJ; 0086

DR CCRID; 3111C0001CCC000007

DR DSMZ; ACC-368

DR Lonza; 759

DR Wikidata; Q27653134

RX PubMed=2656885;

RX PubMed=6968334;

WW http://www.cells-talk.com/index.php/page/copelibrary?key=FDCP1

CC Characteristics: IL3 dependent.

CC Doubling time: ~30-40 hours (DSMZ).

CC Caution: According to PubMed=6968334 originate from DBA/2 mice but in the original deposit document for DSMZ ACC-268 it is said to originate from C57BL/6 x DBA/2 (B6D2F1) (personal communication of MacLeod R.A.F.).

CC Breed/subspecies: DBA/2.

OX NCBI_TaxID=10090; ! Mus musculus

CA Factor-dependent cell line

ID FDC-P2

AC CVCL_5284

SY FDCP-2; FDCP2; Factor Dependent Continuous-Paterson 2; Factor Dependent Cell-Paterson 2; AD-3

DR BCRJ; 0037

RX PubMed=2497280;

RX PubMed=2656885;

RX PubMed=3079807;

RX PubMed=3089920;

RX PubMed=6968334;

WW http://www.cells-talk.com/index.php/page/copelibrary?key=FDCP2

CC Characteristics: IL3 dependent.

CC Breed/subspecies: DBA/2.

OX NCBI_TaxID=10090; ! Mus musculus

CA Factor-dependent cell line

ID FDC-P3

AC CVCL_H543

SY FDCP-3; FDCP3; Factor Dependent Continuous-Paterson 3

RX PubMed=6968334;

CC Characteristics: IL3 dependent.

CC Breed/subspecies: C57BL/6 x DBA/2.

OX NCBI_TaxID=10090; ! Mus musculus

CA Factor-dependent cell line

ID FDCP-Mix cl.A4

AC CVCL_2040

SY FDCP-mix; FDCPmix; FDCP MIX A4; FDPC-mix A4; FDCPmixA4

DR BTO; BTO:0000446

DR CLO; CLO_0003074

DR DSMZ; ACC-401

DR Lonza; 721

RX PubMed=3091439;

WW http://www.cells-talk.com/index.php/page/copelibrary?key=FDCPmix

CC Characteristics: IL3 dependent.

CC Doubling time: ~70-80 hours (DSMZ).

CC Breed/subspecies: C57BL/6 x DBA/2.

OX NCBI_TaxID=10090; ! Mus musculus

CA Factor-dependent cell line

ID FDCW2

AC CVCL_0260

SY FDCP1-WEHI2; FDC2

DR MCCL; MCC:0000151

DR TOKU-E; 3701

RX PubMed=9345037;

CC Characteristics: IL3 dependent.

CC Breed/subspecies: DBA/2.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2039 ! FDC-P1

CA Factor-dependent cell line

ID Fe Bos

AC CVCL_3303

DR CLO; CLO_0003075

DR ATCC; CRL-1177

DI NCIt; C125697; Ehlers-Danlos syndrome, type II

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Finite cell line

ID Fe Sin

AC CVCL_U776

SY Fesin

DR ATCC; CRL-1106

CC Discontinued: ATCC; CRL-1106; true.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Finite cell line

ID FE-8

AC CVCL_GS30

SY FE8

DR TOKU-E; 3546

RX PubMed=3125552;

RX PubMed=3533793;

CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).

CC Transfected with: HGNC; 5173; HRAS (with V-12).

CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).

CC Breed/subspecies: Fischer 344.

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_4086 ! 208F

CA Transformed cell line

ID FE-PD

AC CVCL_H614

SY FEPD; FePD

DR BTO; BTO:0005005

DR ChEMBL-Cells; CHEMBL3307722

DR ChEMBL-Targets; CHEMBL614866

DR Cosmic; 1086362

DR Cosmic; 2013354

DR Cosmic; 2024370

DR Cosmic; 2402467

DR GEO; GSM1217152

RX PubMed=8035614;

RX PubMed=15356658;

RX PubMed=16596703;

DI NCIt; C3720; Anaplastic large cell lymphoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID FE0001

AC CVCL_8W22

DR ECACC; 94100312

CC Part of: ECACC chromosomal abnormality collection.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C74988; Holoprosencephaly

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FE0002

AC CVCL_8W23

DR ECACC; 94110944

CC Part of: ECACC chromosomal abnormality collection.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C99105; VACTERL association

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FE0003

AC CVCL_8W24

DR ECACC; 94120857

CC Part of: ECACC chromosomal abnormality collection.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C2989; DiGeorge syndrome

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FE0005

AC CVCL_8W25

DR ECACC; 95011615

CC Part of: ECACC chromosomal abnormality collection.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FE0008

AC CVCL_8W26

DR ECACC; 95033056

CC Part of: ECACC chromosomal abnormality collection.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FE0010

AC CVCL_8W27

DR ECACC; 95042117

CC Part of: ECACC chromosomal abnormality collection.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FE0015

AC CVCL_8W28

DR ECACC; 95090703

CC Part of: ECACC chromosomal abnormality collection.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FE0024

AC CVCL_8W29

DR ECACC; 96030619

CC Part of: ECACC chromosomal abnormality collection.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FE0030

AC CVCL_8W30

DR ECACC; 96091906

CC Part of: ECACC chromosomal abnormality collection.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FE0033

AC CVCL_8W31

DR ECACC; 97012316

CC Part of: ECACC chromosomal abnormality collection.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FE0035

AC CVCL_8W32

DR ECACC; 97012318

CC Part of: ECACC chromosomal abnormality collection.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FE0036

AC CVCL_8W33

DR ECACC; 97040401

CC Part of: ECACC chromosomal abnormality collection.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FE0037

AC CVCL_8W34

DR ECACC; 97040402

CC Part of: ECACC chromosomal abnormality collection.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FE0042

AC CVCL_8W35

DR ECACC; 98051805

CC Part of: ECACC chromosomal abnormality collection.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FE0043

AC CVCL_8W36

DR ECACC; 98051806

CC Part of: ECACC chromosomal abnormality collection.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FE0046

AC CVCL_8W37

DR ECACC; 98090704

CC Part of: ECACC chromosomal abnormality collection.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C102979; Congenital hydronephrosis

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FEA4 + PFSC/C1

AC CVCL_4198

DR CLO; CLO_0003077

DR CLDB; cl1220

DR ECACC; 90031402

OX NCBI_TaxID=9685; ! Felis catus

CA Transformed cell line

ID FEC

AC CVCL_R875

SY Flounder Embryonic Cell line

RX CelloPub=CLPUB00053;

RX PubMed=15521323;

CC Group: Fish cell line.

OX NCBI_TaxID=8255; ! Paralichthys olivaceus

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FEC.2

AC CVCL_A038

RX PubMed=7514905;

OX NCBI_TaxID=9606; ! Homo sapiens

CA Finite cell line

ID FEK

AC CVCL_D697

SY Fetal Equine Kidney

DR BCRJ; 0088

CC Discontinued: BCRJ; 0088; probable.

OX NCBI_TaxID=9796; ! Equus caballus

CA Finite cell line

ID FEL

AC CVCL_4199

DR CLO; CLO_0003078

DR CLDB; cl1221

DR ECACC; 89020802

RX PubMed=4043531;

OX NCBI_TaxID=9986; ! Oryctolagus cuniculus

CA Finite cell line

ID FeLV-3281

AC CVCL_4521

SY FeLV 3281; FeLV3281

DR CLO; CLO_0003079

DR CLO; CLO_0003080

DR CLDB; cl1222

DR ATCC; CRL-9116

DR IZSLER; BS TCL 86

OX NCBI_TaxID=9685; ! Felis catus

SX Sex undetermined

CA Cancer cell line

ID FELV3281-AD

AC CVCL_8689

DR CLO; CLO_0050153

DR RCB; RCB2610

OX NCBI_TaxID=9685; ! Felis catus

HI CVCL_4521 ! FeLV-3281

SX Sex undetermined

CA Cancer cell line

ID FEMX-I

AC CVCL_A011

SY FEMX-1; FEMX

DR Cosmic; 922391

RX PubMed=3390834;

RX PubMed=7806588;

RX PubMed=18359977;

CC Derived from metastatic site: Lymph node.

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID FEMX-I/SUPERctr

AC CVCL_HA93

DR GEO; GSM329155

DR GEO; GSM329195

RX PubMed=18802032;

CC Characteristics: Control cell for FEMX-I/SUPER733 (CVCL_HA94).

CC Derived from metastatic site: Lymph node.

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_A011 ! FEMX-I

SX Female

CA Cancer cell line

ID FEMX-I/SUPER733

AC CVCL_HA94

DR GEO; GSM329201

DR GEO; GSM329202

RX PubMed=18802032;

CC Knockout cell: Method=shRNA knockdown; HGNC; 9454; PROM1.

CC Derived from metastatic site: Lymph node.

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_A011 ! FEMX-I

SX Female

CA Cancer cell line

ID FEMX-V

AC CVCL_HA92

RX PubMed=7806588;

RX PubMed=18359977;

CC Characteristics: Cell line with no metastatic potential.

CC Derived from metastatic site: Lymph node.

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_A011 ! FEMX-I

SX Female

CA Cancer cell line

ID Fen

AC CVCL_W773

SY FEN

RX PubMed=7534804;

RX PubMed=8512807;

RX PubMed=12127398;

DI NCIt; C4912; Bladder carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID Fen Cl 3.7

AC CVCL_W774

SY Fen cl.3.7

RX PubMed=11180296;

DI NCIt; C4912; Bladder carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_W773 ! Fen

CA Cancer cell line

ID FER

AC CVCL_4200

DR CLO; CLO_0003081

DR CLDB; cl1223

DR ECACC; 90031401

OX NCBI_TaxID=9685; ! Felis catus

CA Spontaneously immortalized cell line

ID Fer Ray

AC CVCL_H577

DR CLO; CLO_0003082

DR CLDB; cl1224

DR ATCC; CRL-1156

CC Discontinued: ATCC; CRL-1156; true.

DI NCIt; C34568; Ehlers-Danlos syndrome

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Finite cell line

ID FES 21

AC CVCL_B132

SY FES21; UHe001-A

DR hPSCreg; UHe001-A

DR ISCR; 1568

DR IGRhCellID; FES21%20p51-2

RX PubMed=16895598;

RX PubMed=17572666;

CC From: University of Helsinki; Helsinki; Finland.

CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-19.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Embryonic stem cell

ID FES 22

AC CVCL_B133

SY FES22; UHe002-A

DR hPSCreg; UHe002-A

DR IGRhCellID; FES22%20p41-2

DR ISCR; 1569

RX PubMed=16895598;

RX PubMed=17572666;

CC From: University of Helsinki; Helsinki; Finland.

CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-19.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Embryonic stem cell

ID FES 29

AC CVCL_B134

SY FES29; UHe003-A

DR hPSCreg; UHe003-A

DR IGRhCellID; FES29%20p37-2

DR ISCR; 1570

RX PubMed=16895598;

RX PubMed=17572666;

CC From: University of Helsinki; Helsinki; Finland.

CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-19.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Embryonic stem cell

ID FES 30

AC CVCL_B135

SY FES30; UHe004-A

DR hPSCreg; UHe004-A

DR ISCR; 1571

RX PubMed=16895598;

RX PubMed=17572666;

CC From: University of Helsinki; Helsinki; Finland.

CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-19.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Embryonic stem cell

ID FES 61

AC CVCL_B136

SY FES61; UHe005-A

DR hPSCreg; UHe005-A

DR IGRhCellID; FES61%20p48-2

DR ISCR; 1572

RX PubMed=16895598;

CC From: University of Helsinki; Helsinki; Finland.

CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-19.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Embryonic stem cell

ID FES 75

AC CVCL_B137

SY FES75; UHe006-A

DR hPSCreg; UHe006-A

DR IGRhCellID; FES75%20p19-2

DR ISCR; 1573

CC From: University of Helsinki; Helsinki; Finland.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Embryonic stem cell

ID FET

AC CVCL_A604

SY HCT-FET

DR Cosmic; 711265

DR Cosmic; 887232

DR Cosmic; 1131684

DR GEO; GSM1448154

RX PubMed=3349466;

RX PubMed=6437669;

RX PubMed=7761852;

RX PubMed=7329817;

RX PubMed=8895552;

RX PubMed=9000147;

RX PubMed=9000572;

RX PubMed=11526487;

RX PubMed=17363507;

RX PubMed=25926053;

CC Microsatellite instability: Stable (MSS) (PubMed=9000147; PubMed=25926053).

CC Omics: Transcriptome analysis.

DI NCIt; C4910; Colon carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FeT-1C

AC CVCL_3686

DR CLO; CLO_0003083

DR ATCC; CRL-11968

RX Patent=US5846825;

OX NCBI_TaxID=9685; ! Felis catus

CA Spontaneously immortalized cell line

ID FeT-1M

AC CVCL_M765

SY FIV-Fet1M

DR ATCC; CRL-10775

RX Patent=US5275813;

CC Discontinued: ATCC; CRL-10775; probable.

OX NCBI_TaxID=9685; ! Felis catus

HI CVCL_3686 ! FeT-1C

CA Spontaneously immortalized cell line

ID FeT-2D

AC CVCL_M766

DR ATCC; CRL-10774

RX Patent=US5275813;

CC Discontinued: ATCC; CRL-10774; probable.

OX NCBI_TaxID=9685; ! Felis catus

CA Spontaneously immortalized cell line

ID FeT-J

AC CVCL_3687

SY FeTJ-1

DR CLO; CLO_0003084

DR ATCC; CRL-11967

RX Patent=US5846825;

RX PubMed=18366545;

OX NCBI_TaxID=9685; ! Felis catus

HI CVCL_3686 ! FeT-1C

CA Spontaneously immortalized cell line

ID FetMSC

AC CVCL_6F27

RX PubMed=22567895;

RX PubMed=25697001;

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_6F28 ! M-FetMSC

SX Male

CA Adult stem cell

ID FF

AC CVCL_U308

DR ATCC; CRL-1479

CC Discontinued: ATCC; CRL-1479; true.

OX NCBI_TaxID=10036; ! Mesocricetus auratus

HI CVCL_2711 ! RPMI-1846

CA Cancer cell line

ID FF-11

AC CVCL_R897

SY Flounder Fin-11

RX DOI=10.3147/jsfp.26.69;

CC Group: Fish cell line.

OX NCBI_TaxID=8255; ! Paralichthys olivaceus

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FF101

AC CVCL_8562

DR JCRB; JCRB1040

DR JCRB; NIHS0323

RX PubMed=2702652;

CC Discontinued: JCRB; NIHS0323; true.

CC Breed/subspecies: Donryu.

DI NCIt; C60416; Rat hepatocellular carcinoma

OX NCBI_TaxID=10116; ! Rattus norvegicus

CA Cancer cell line

ID FF452-3

AC CVCL_IU56

SY FF452 clone 3

RX PubMed=6276755;

RX PubMed=6294333;

RX PubMed=6302703;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_2676 ! P3HR-1

SX Male

CA Cancer cell line

ID FFPRI-SpIm-2AM

AC CVCL_Z546

DR NISES; SK0031

RX CelloPub=CLPUB00196;

WW http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275022

CC Group: Insect cell line.

OX NCBI_TaxID=1578839; ! Lemyra imparilis

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FFPRI-SpIm-2AM-IPL

AC CVCL_Z547

WW http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275053

CC Group: Insect cell line.

OX NCBI_TaxID=1578839; ! Lemyra imparilis

HI CVCL_Z546 ! FFPRI-SpIm-2AM

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FFPRI-SpIm-2AM-SF

AC CVCL_Z548

WW http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275052

CC Group: Insect cell line.

OX NCBI_TaxID=1578839; ! Lemyra imparilis

HI CVCL_Z546 ! FFPRI-SpIm-2AM

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FFN

AC CVCL_R898

SY Flounder FiN

RX PubMed=14710758;

CC Group: Fish cell line.

OX NCBI_TaxID=8255; ! Paralichthys olivaceus

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FG

AC CVCL_IP73

SY Flounder Gill

RX DOI=10.1007/s10661-010-1533-1;

CC Group: Fish cell line.

OX NCBI_TaxID=8255; ! Paralichthys olivaceus

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FG-2

AC CVCL_N514

SY FG-Met-2; FG-Met2; FG2

DR ChEMBL-Cells; CHEMBL3307953

DR ChEMBL-Targets; CHEMBL612407

DR Cosmic; 922253

RX PubMed=3815343;

CC Derived from metastatic site: Celiac axis lymph node.

DI NCIt; C5721; Pancreatic adenosquamous carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_8196 ! COLO 357/FG

SX Female

CA Cancer cell line

ID FG-9307

AC CVCL_8197

SY Flounder Gill-9307

RX DOI=10.1016/S0044-8486(97)00070-7;

RX DOI=10.1577/1548-8454(2003)065<0044:SNTOTG>2.0.CO;2;

CC Group: Fish cell line.

OX NCBI_TaxID=8255; ! Paralichthys olivaceus

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FGC4

AC CVCL_0261

SY FGC-4

DR CLO; CLO_0003093

DR MCCL; MCC:0000152

DR CLDB; cl1234

DR ECACC; 94101904

RX PubMed=2128461;

WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/f/cell-lines-detail-600.html

CC Transfected with: UniProtKB; P0A9M5; E.coli gpt.

CC Breed/subspecies: AxC.

DI NCIt; C60416; Rat hepatocellular carcinoma

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_0269 ! Fao

CA Cancer cell line

ID fGS/OSS

AC CVCL_1B45

SY Female germ-line Stem/Ovarian Somatic Sheath

DR EFO; EFO_0005745

DR DGRC; 191

DR ENCODE; ENCBS091DQU

DR GEO; GSM915680

RX PubMed=17056713;

RX PubMed=24434506;

CC Group: Insect cell line.

CC Characteristics: Co-culture of ovarian germline stem cells (GSCs) and somatic sheath cells.

OX NCBI_TaxID=7227; ! Drosophila melanogaster

SX Female

CA Spontaneously immortalized cell line

ID FGH

AC CVCL_F273

DR BCRJ; 0089

ST Source(s): BCRJ

ST Amelogenin: X

ST CSF1PO: 10,12

ST D13S317: 12

ST D16S539: 9,11

ST D5S818: 10,11

ST D7S820: 10,11

ST TH01: 7,9

ST TPOX: 8,11

ST vWA: 17,18

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Finite cell line

ID FH fl/fl

AC CVCL_HG00

DR Ximbio; 153291

RX PubMed=21849978;

CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC Breed/subspecies: 129S6/SvEvTac x C57BL/6Ncr.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_E222 ! G4

SX Male

CA Transformed cell line

ID FH-/- CL 1

AC CVCL_HG01

DR Ximbio; 153289

RX PubMed=21849978;

CC Knockout cell: Method=Cre/loxP; MGI:95530; Fh1.

CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC Breed/subspecies: 129S6/SvEvTac x C57BL/6Ncr.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_HG00 ! FH fl/fl

SX Male

CA Transformed cell line

ID FH-/- CL 19

AC CVCL_HG02

DR Ximbio; 153290

RX PubMed=21849978;

CC Knockout cell: Method=Cre/loxP; MGI:95530; Fh1.

CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC Breed/subspecies: 129S6/SvEvTac x C57BL/6Ncr.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_HG00 ! FH fl/fl

SX Male

CA Transformed cell line

ID FH-BNB

AC CVCL_F700

RX PubMed=22672995;

CC Transfected with: HGNC; 11730; TERT.

CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Conditionally immortalized cell line

ID FH01

AC CVCL_E587

SY FH1

DR dbMHC; 48782

DR IHW; IHW9373

DR IMGT/HLA; 13543

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FH02

AC CVCL_E588

SY FH2

DR dbMHC; 48793

DR IHW; IHW9374

DR IMGT/HLA; 25984

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FH03

AC CVCL_E589

SY FH3

DR dbMHC; 48804

DR IHW; IHW9375

DR IMGT/HLA; 25985

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FH04

AC CVCL_E590

SY FH4

DR dbMHC; 48814

DR IHW; IHW9376

DR IMGT/HLA; 13541

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FH05

AC CVCL_E591

SY FH5; TER145

DR dbMHC; 48825

DR IHW; IHW9377

DR IMGT/HLA; 17341

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FH06

AC CVCL_E592

SY FH6

DR dbMHC; 48836

DR IHW; IHW9380

DR IMGT/HLA; 17350

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FH07

AC CVCL_E593

SY FH7; TER317; TER391

DR dbMHC; 48847

DR IHW; IHW9381

DR IMGT/HLA; 25990

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FH08

AC CVCL_E594

SY FH8

DR dbMHC; 48857

DR IHW; IHW9382

DR IMGT/HLA; 17342

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FH09

AC CVCL_E595

SY FH9; TER333; TER377; TER476

DR dbMHC; 48858

DR IHW; IHW9383

DR IMGT/HLA; 25992

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FH10

AC CVCL_E596

DR dbMHC; 48783

DR IHW; IHW9384

DR IMGT/HLA; 25993

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FH11

AC CVCL_E597

SY TER142; TER203

DR dbMHC; 48784

DR IHW; IHW9385

DR IMGT/HLA; 25994

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FH12

AC CVCL_E598

DR dbMHC; 48785

DR IHW; IHW9386

DR IMGT/HLA; 25995

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FH13

AC CVCL_E599

SY ws148

DR dbMHC; 48786

DR IHW; IHW9387

DR IMGT/HLA; 13295

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FH14

AC CVCL_E600

DR dbMHC; 48787

DR IHW; IHW9388

DR IMGT/HLA; 25996

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FH15

AC CVCL_E601

DR dbMHC; 48788

DR IHW; IHW9389

DR IMGT/HLA; 20677

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FH16

AC CVCL_E602

DR dbMHC; 48789

DR IHW; IHW9390

DR IMGT/HLA; 25997

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FH17

AC CVCL_E603

DR dbMHC; 48790

DR IHW; IHW9391

DR IMGT/HLA; 25998

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FH18

AC CVCL_E604

DR dbMHC; 48791

DR IHW; IHW9398

DR IMGT/HLA; 26002

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FH19

AC CVCL_E605

DR dbMHC; 48792

DR IHW; IHW9400

DR IMGT/HLA; 26004

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Sex undetermined

CA Transformed cell line

ID FH20

AC CVCL_E606

DR dbMHC; 48794

DR IHW; IHW9402

DR IMGT/HLA; 26006

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FH21

AC CVCL_E607

DR dbMHC; 48795

DR IHW; IHW9403

DR IMGT/HLA; 26007

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FH22

AC CVCL_E608

DR dbMHC; 48796

DR IHW; IHW9404

DR IMGT/HLA; 26008

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FH23

AC CVCL_E609

DR dbMHC; 48797

DR IHW; IHW9405

DR IMGT/HLA; 26009

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FH24

AC CVCL_E610

DR dbMHC; 48798

DR IHW; IHW9406

DR IMGT/HLA; 26010

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FH25

AC CVCL_E611

DR dbMHC; 48799

DR IHW; IHW9407

DR IMGT/HLA; 26011

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FH26

AC CVCL_E612

DR dbMHC; 48800

DR IHW; IHW9408

DR IMGT/HLA; 26012

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Sex undetermined

CA Transformed cell line

ID FH27

AC CVCL_E613

DR dbMHC; 48801

DR IHW; IHW9409

DR IMGT/HLA; 26013

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FH28

AC CVCL_E614

DR dbMHC; 48802

DR IHW; IHW9410

DR IMGT/HLA; 26014

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FH29

AC CVCL_E615

DR dbMHC; 48803

DR IHW; IHW9411

DR IMGT/HLA; 26015

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FH30

AC CVCL_E616

DR dbMHC; 48805

DR IHW; IHW9412

DR IMGT/HLA; 26016

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Sex undetermined

CA Transformed cell line

ID FH31

AC CVCL_E617

DR dbMHC; 48806

DR IHW; IHW9413

DR IMGT/HLA; 26017

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FH32

AC CVCL_E618

DR dbMHC; 48807

DR IHW; IHW9414

DR IMGT/HLA; 26018

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Sex undetermined

CA Transformed cell line

ID FH33

AC CVCL_F541

DR IMGT/HLA; 12668

CC Part of: International Histocompatibility Workshop cell lines.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FH34

AC CVCL_E619

DR dbMHC; 48808

DR IHW; IHW9415

DR IMGT/HLA; 26019

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FH35

AC CVCL_E620

DR dbMHC; 48809

DR IHW; IHW9416

DR IMGT/HLA; 26020

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FH36

AC CVCL_E621

DR dbMHC; 48810

DR IHW; IHW9423

DR IMGT/HLA; 26026

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FH37

AC CVCL_E622

DR dbMHC; 48811

DR IHW; IHW9424

DR IMGT/HLA; 26027

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FH38

AC CVCL_E623

SY FH 38; SH38

DR dbMHC; 48812

DR IHW; IHW9426

DR IMGT/HLA; 12641

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FH39

AC CVCL_E624

SY TER373; TER472

DR dbMHC; 48813

DR IHW; IHW9427

DR IMGT/HLA; 26029

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FH40

AC CVCL_E625

DR dbMHC; 48815

DR IHW; IHW9428

DR IMGT/HLA; 26030

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Sex undetermined

CA Transformed cell line

ID FH41

AC CVCL_E626

SY FH 41; R.G; RG; TER323; TER414

DR dbMHC; 48816

DR IHW; IHW9429

DR IMGT/HLA; 11285

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FH42

AC CVCL_E627

SY TER383

DR dbMHC; 48817

DR IHW; IHW9430

DR IMGT/HLA; 26031

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FH43

AC CVCL_E628

DR dbMHC; 48818

DR IHW; IHW9431

DR IMGT/HLA; 26032

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FH44

AC CVCL_E629

SY TER334; TER384; TER467

DR dbMHC; 48819

DR IHW; IHW9432

DR IMGT/HLA; 26033

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FH45

AC CVCL_E630

SY TER339; TER390

DR dbMHC; 48820

DR IHW; IHW9433

DR IMGT/HLA; 26034

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FH46

AC CVCL_E631

DR dbMHC; 48821

DR IHW; IHW9434

DR IMGT/HLA; 26035

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FH47

AC CVCL_E632

DR dbMHC; 48822

DR IHW; IHW9435

DR IMGT/HLA; 26036

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FH48

AC CVCL_E633

SY TER222; TER299

DR dbMHC; 48823

DR IHW; IHW9436

DR IMGT/HLA; 12966

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FH49

AC CVCL_E634

DR dbMHC; 48824

DR IHW; IHW9437

DR IMGT/HLA; 26037

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FH50

AC CVCL_E635

DR dbMHC; 48826

DR IHW; IHW9438

DR IMGT/HLA; 12967

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FH51

AC CVCL_E636

DR dbMHC; 48827

DR IHW; IHW9439

DR IMGT/HLA; 26038

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Sex undetermined

CA Transformed cell line

ID FH52

AC CVCL_E637

DR dbMHC; 48828

DR IHW; IHW9440

DR IMGT/HLA; 26039

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FH53

AC CVCL_E638

DR dbMHC; 48829

DR IHW; IHW9441

DR IMGT/HLA; 26040

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Sex undetermined

CA Transformed cell line

ID FH54

AC CVCL_E639

DR dbMHC; 48830

DR IHW; IHW9442

DR IMGT/HLA; 26041

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FH55

AC CVCL_E640

DR dbMHC; 48831

DR IHW; IHW9443

DR IMGT/HLA; 26042

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Sex undetermined

CA Transformed cell line

ID FH56

AC CVCL_E641

DR dbMHC; 48832

DR IHW; IHW9444

DR IMGT/HLA; 26043

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FH57

AC CVCL_E642

DR dbMHC; 48833

DR IHW; IHW9445

DR IMGT/HLA; 26044

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Sex undetermined

CA Transformed cell line

ID FH58

AC CVCL_E643

DR dbMHC; 48834

DR IHW; IHW9446

DR IMGT/HLA; 26045

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Sex undetermined

CA Transformed cell line

ID FH59

AC CVCL_E644

DR dbMHC; 48835

DR IHW; IHW9447

DR IMGT/HLA; 12743

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FH60

AC CVCL_E645

SY FH 60

DR dbMHC; 48837

DR IHW; IHW9448

DR IMGT/HLA; 12753

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FH61

AC CVCL_E646

DR dbMHC; 48838

DR IHW; IHW9449

DR IMGT/HLA; 26046

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Sex undetermined

CA Transformed cell line

ID FH62

AC CVCL_E647

DR dbMHC; 48839

DR IHW; IHW9450

DR IMGT/HLA; 26047

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Sex undetermined

CA Transformed cell line

ID FH63

AC CVCL_E648

DR dbMHC; 48840

DR IHW; IHW9451

DR IMGT/HLA; 26048

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Sex undetermined

CA Transformed cell line

ID FH64

AC CVCL_E649

DR dbMHC; 48841

DR IHW; IHW9452

DR IMGT/HLA; 26049

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Sex undetermined

CA Transformed cell line

ID FH65

AC CVCL_E650

DR dbMHC; 48842

DR IHW; IHW9453

DR IMGT/HLA; 26050

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FH66

AC CVCL_E651

SY FH 66

DR dbMHC; 48843

DR IHW; IHW9454

DR IMGT/HLA; 12745

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FH67

AC CVCL_E652

SY FH 67; TER213; TER311

DR dbMHC; 48844

DR IHW; IHW9455

DR IMGT/HLA; 12746

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FH68

AC CVCL_E653

DR dbMHC; 48845

DR IHW; IHW9456

DR IMGT/HLA; 26051

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Sex undetermined

CA Transformed cell line

ID FH69

AC CVCL_E654

DR dbMHC; 48846

DR IHW; IHW9457

DR IMGT/HLA; 26052

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Sex undetermined

CA Transformed cell line

ID FH70EY

AC CVCL_E655

DR dbMHC; 48848

DR IHW; IHW9458

DR IMGT/HLA; 26053

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FH71

AC CVCL_E656

SY TER462

DR dbMHC; 48849

DR IHW; IHW9460

DR IMGT/HLA; 20647

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Sex undetermined

CA Transformed cell line

ID FH72

AC CVCL_E657

DR dbMHC; 48850

DR IHW; IHW9461

DR IMGT/HLA; 26055

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Sex undetermined

CA Transformed cell line

ID FH73

AC CVCL_G558

DR dbMHC; 48851

DR IHW; IHW9462

DR IMGT/HLA; 13328

CC Part of: International Histocompatibility Workshop cell lines.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Sex undetermined

CA Transformed cell line

ID FH74

AC CVCL_E658

DR dbMHC; 48852

DR IHW; IHW9463

DR IMGT/HLA; 26056

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Sex undetermined

CA Transformed cell line

ID FH75

AC CVCL_E659

DR dbMHC; 48853

DR IHW; IHW9464

DR IMGT/HLA; 26057

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Sex undetermined

CA Transformed cell line

ID FH76

AC CVCL_E660

DR dbMHC; 48854

DR IHW; IHW9466

DR IMGT/HLA; 26059

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FH77

AC CVCL_E661

DR dbMHC; 48855

DR IHW; IHW9467

DR IMGT/HLA; 26060

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FH78

AC CVCL_E662

DR dbMHC; 48856

DR IHW; IHW9468

DR IMGT/HLA; 26061

CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FHC

AC CVCL_3688

SY Fetal Human Colon

DR BTO; BTO:0003808

DR CLO; CLO_0003236

DR ATCC; CRL-1831

DR BioSample; SAMN03471253

DR ChEMBL-Cells; CHEMBL3308603

DR ChEMBL-Targets; CHEMBL614654

DR GEO; GSM1448155

RX PubMed=6519668;

RX PubMed=20193843;

CC Characteristics: Forms solid tumors after transplantation into SCID mice.

CC Characteristics: Is hypotriploid, has >20 copies of the 8q23~8q24.3 region containing MYC. Has TP53 pArg273His.

CC Omics: Transcriptome analysis.

ST Source(s): ATCC

ST Amelogenin: X,Y

ST CSF1PO: 11,12

ST D13S317: 12,13

ST D16S539: 9,11

ST D5S818: 12,13

ST D7S820: 8,12

ST TH01: 6,9.3

ST TPOX: 8,11

ST vWA: 16

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Spontaneously immortalized cell line

ID FHC1-hiPSC1

AC CVCL_C415

SY FHC.1.H.iPSC.1

DR RSCB; RSCB0046

CC From: Royan Institute; Theran; Iran.

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_C416 ! FHC1-hiPSC2

OI CVCL_C417 ! FHC1-hiPSC3

OI CVCL_C418 ! FHC1-hiPSC4

OI CVCL_C419 ! FHC1-hiPSC5

OI CVCL_C420 ! FHC1-hiPSC6

OI CVCL_C421 ! FHC1-hiPSC7

OI CVCL_C422 ! FHC1-hiPSC8

OI CVCL_C423 ! FHC1-hiPSC9

SX Female

CA Induced pluripotent stem cell

ID FHC1-hiPSC2

AC CVCL_C416

SY FHC.1.H.iPSC.2

DR RSCB; RSCB0047

CC From: Royan Institute; Theran; Iran.

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_C415 ! FHC1-hiPSC1

OI CVCL_C417 ! FHC1-hiPSC3

OI CVCL_C418 ! FHC1-hiPSC4

OI CVCL_C419 ! FHC1-hiPSC5

OI CVCL_C420 ! FHC1-hiPSC6

OI CVCL_C421 ! FHC1-hiPSC7

OI CVCL_C422 ! FHC1-hiPSC8

OI CVCL_C423 ! FHC1-hiPSC9

SX Female

CA Induced pluripotent stem cell

ID FHC1-hiPSC3

AC CVCL_C417

SY FHC.1.H.iPSC.3; RIi003-A

DR hPSCreg; RIi003-A

DR RSCB; RSCB0048

CC From: Royan Institute; Theran; Iran.

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_C415 ! FHC1-hiPSC1

OI CVCL_C416 ! FHC1-hiPSC2

OI CVCL_C418 ! FHC1-hiPSC4

OI CVCL_C419 ! FHC1-hiPSC5

OI CVCL_C420 ! FHC1-hiPSC6

OI CVCL_C421 ! FHC1-hiPSC7

OI CVCL_C422 ! FHC1-hiPSC8

OI CVCL_C423 ! FHC1-hiPSC9

SX Female

CA Induced pluripotent stem cell

ID FHC1-hiPSC4

AC CVCL_C418

SY FHC.1.H.iPSC.4

DR RSCB; RSCB0050

CC From: Royan Institute; Theran; Iran.

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_C415 ! FHC1-hiPSC1

OI CVCL_C416 ! FHC1-hiPSC2

OI CVCL_C417 ! FHC1-hiPSC3

OI CVCL_C419 ! FHC1-hiPSC5

OI CVCL_C420 ! FHC1-hiPSC6

OI CVCL_C421 ! FHC1-hiPSC7

OI CVCL_C422 ! FHC1-hiPSC8

OI CVCL_C423 ! FHC1-hiPSC9

SX Female

CA Induced pluripotent stem cell

ID FHC1-hiPSC5

AC CVCL_C419

SY FHC.1.H.iPSC.5

DR RSCB; RSCB0051

CC From: Royan Institute; Theran; Iran.

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_C415 ! FHC1-hiPSC1

OI CVCL_C416 ! FHC1-hiPSC2

OI CVCL_C417 ! FHC1-hiPSC3

OI CVCL_C418 ! FHC1-hiPSC4

OI CVCL_C420 ! FHC1-hiPSC6

OI CVCL_C421 ! FHC1-hiPSC7

OI CVCL_C422 ! FHC1-hiPSC8

OI CVCL_C423 ! FHC1-hiPSC9

SX Female

CA Induced pluripotent stem cell

ID FHC1-hiPSC6

AC CVCL_C420

SY FHC.1.H.iPSC.6

DR RSCB; RSCB0052

CC From: Royan Institute; Theran; Iran.

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_C415 ! FHC1-hiPSC1

OI CVCL_C416 ! FHC1-hiPSC2

OI CVCL_C417 ! FHC1-hiPSC3

OI CVCL_C418 ! FHC1-hiPSC4

OI CVCL_C419 ! FHC1-hiPSC5

OI CVCL_C421 ! FHC1-hiPSC7

OI CVCL_C422 ! FHC1-hiPSC8

OI CVCL_C423 ! FHC1-hiPSC9

SX Female

CA Induced pluripotent stem cell

ID FHC1-hiPSC7

AC CVCL_C421

SY FHC.1.H.iPSC.7

DR RSCB; RSCB0053

CC From: Royan Institute; Theran; Iran.

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_C415 ! FHC1-hiPSC1

OI CVCL_C416 ! FHC1-hiPSC2

OI CVCL_C417 ! FHC1-hiPSC3

OI CVCL_C418 ! FHC1-hiPSC4

OI CVCL_C419 ! FHC1-hiPSC5

OI CVCL_C420 ! FHC1-hiPSC6

OI CVCL_C422 ! FHC1-hiPSC8

OI CVCL_C423 ! FHC1-hiPSC9

SX Female

CA Induced pluripotent stem cell

ID FHC1-hiPSC8

AC CVCL_C422

SY FHC.1.H.iPSC.8

DR RSCB; RSCB0065

CC From: Royan Institute; Theran; Iran.

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_C415 ! FHC1-hiPSC1

OI CVCL_C416 ! FHC1-hiPSC2

OI CVCL_C417 ! FHC1-hiPSC3

OI CVCL_C418 ! FHC1-hiPSC4

OI CVCL_C419 ! FHC1-hiPSC5

OI CVCL_C420 ! FHC1-hiPSC6

OI CVCL_C421 ! FHC1-hiPSC7

OI CVCL_C423 ! FHC1-hiPSC9

SX Female

CA Induced pluripotent stem cell

ID FHC1-hiPSC9

AC CVCL_C423

SY FHC.1.H.iPSC.9

DR RSCB; RSCB0066

CC From: Royan Institute; Theran; Iran.

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_C415 ! FHC1-hiPSC1

OI CVCL_C416 ! FHC1-hiPSC2

OI CVCL_C417 ! FHC1-hiPSC3

OI CVCL_C418 ! FHC1-hiPSC4

OI CVCL_C419 ! FHC1-hiPSC5

OI CVCL_C420 ! FHC1-hiPSC6

OI CVCL_C421 ! FHC1-hiPSC7

OI CVCL_C422 ! FHC1-hiPSC8

SX Female

CA Induced pluripotent stem cell

ID FHCC-98

AC CVCL_L437

RX PubMed=15133854;

DI NCIt; C3099; Hepatocellular carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FHCR-1-2075/FH4

AC CVCL_K272

SY FH4

DR CLO; CLO_0003237

DR ATCC; HB-8775

RX Patent=US4876199;

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2199 ! Sp2/0-Ag14

CA Hybridoma

ID FHCR-1-2075/FH5

AC CVCL_K273

SY FH5

DR CLO; CLO_0003238

DR ATCC; HB-8770

RX Patent=US4876199;

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2199 ! Sp2/0-Ag14

CA Hybridoma

ID FHCR-1-2516/FH7

AC CVCL_K274

SY FH7

DR CLO; CLO_0003239

DR ATCC; HB-8861

RX Patent=US4851511;

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2199 ! Sp2/0-Ag14

CA Hybridoma

ID FHCR-1-2624/FH6/FHOT-1-3019

AC CVCL_K275

SY FH6

DR CLO; CLO_0003240

DR ATCC; HB-8873

RX Patent=US4904596;

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2199 ! Sp2/0-Ag14

CA Hybridoma

ID FHCR-1-2813/FDC-6

AC CVCL_K276

SY FDC-6

DR CLO; CLO_0003241

DR ATCC; HB-9018

RX Patent=US4894326;

OX NCBI_TaxID=10090; ! Mus musculus

CA Hybridoma

ID fHDF/TERT166

AC CVCL_GZ73

WW http://www.evercyte.com/fhdf-tert166.html

CC Transfected with: HGNC; 11730; TERT.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Telomerase immortalized cell line

ID FHDO-7

AC CVCL_H747

SY Fred Hutchinson Dog-7

RX PubMed=18065395;

RX PubMed=18632696;

OX NCBI_TaxID=9615; ! Canis lupus familiaris

SX Male

CA Embryonic stem cell

ID FHK-78

AC CVCL_X361

SY FHK78; Fetal Horse Kidney-78; EFK-78; Equine Fetal Kidney-78

RX CelloPub=CLPUB00148;

OX NCBI_TaxID=9796; ! Equus caballus

SX Sex undetermined

CA Undefined cell line type

ID FHK-Tcl3

AC CVCL_7214

SY Fetal Horse Kidney-Transformed clone 3

RX PubMed=17917390;

CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX NCBI_TaxID=9796; ! Equus caballus

CA Transformed cell line

ID FHK-Tcl3.1

AC CVCL_7193

SY Fetal Horse Kidney-Transformed clone 3.1

RX DOI=10.1294/jes.20.11;

RX PubMed=23594411;

CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX NCBI_TaxID=9796; ! Equus caballus

HI CVCL_7214 ! FHK-Tcl3

CA Transformed cell line

ID FHL124

AC CVCL_S908

SY FHL-124; FHL 124

RX CelloPub=CLPUB00039;

RX PubMed=11095618;

OX NCBI_TaxID=9606; ! Homo sapiens

CA Spontaneously immortalized cell line

ID FHM

AC CVCL_3820

SY Fat Head Minnow

DR CLO; CLO_0003242

DR CLDB; cl1320

DR CLDB; cl1321

DR CLDB; cl1322

DR CLDB; cl1323

DR ATCC; CCL-42

DR BCRC; 60351

DR CCLV; CCLV-RIE 0057

DR ECACC; 88102401

DR IZSLER; BS CL 45

DR KCB; KCB 89020YJ

RX DOI=10.3147/jsfp.28.27;

RX PubMed=5220177;

RX PubMed=5461163;

RX PubMed=19941903;

RX PubMed=23891577;

CC Group: Fish cell line.

OX NCBI_TaxID=90988; ! Pimephales promelas

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FHML2-6

AC CVCL_L022

SY Fat Head Minnow Liver 2-6

RX DOI=10.1007/s11626-009-9201-x;

CC Group: Fish cell line.

CC Doubling time: 2-3 days (DOI=10.1007/s11626-009-9201-x).

OX NCBI_TaxID=90988; ! Pimephales promelas

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FHMT-W1

AC CVCL_L018

SY FHMT; Fat Head Minnow Testis

RX CelloPub=CLPUB00325;

RX PubMed=21086187;

RX PubMed=25424833;

CC Group: Fish cell line.

OX NCBI_TaxID=90988; ! Pimephales promelas

SX Male

CA Spontaneously immortalized cell line

ID FHs 173We

AC CVCL_3308

SY FHs 173 WE

DR CLO; CLO_0003243

DR ATCC; HTB-158

DR BCRC; 60229

ST Source(s): ATCC

ST Amelogenin: X,Y

ST CSF1PO: 10,11

ST D13S317: 12

ST D16S539: 9,12

ST D5S818: 10,12

ST D7S820: 8,11

ST TH01: 7,8

ST TPOX: 8,9

ST vWA: 15,16

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_0661 ! Hs 173.Sp

OI CVCL_0662 ! Hs 173.We

SX Male

CA Finite cell line

ID FHs 738Bl

AC CVCL_T279

DR ATCC; HTB-160

CC Discontinued: ATCC; HTB-160; true.

ST Source(s): ATCC

ST Amelogenin: X,Y

ST CSF1PO: 10,11

ST D13S317: 8,11

ST D16S539: 9,11

ST D5S818: 11,13

ST D7S820: 8,12

ST TH01: 7,9.3

ST TPOX: 8

ST vWA: 16,18

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_3309 ! FHs 738Lu

OI CVCL_R767 ! Hs 738.Bl

OI CVCL_S035 ! Hs 738.Eye

OI CVCL_S314 ! Hs 738.K/Ad/Ts

OI CVCL_0879 ! Hs 738.Lu

OI CVCL_0880 ! Hs 738.St/Int

SX Male

CA Finite cell line

ID FHs 738Lu

AC CVCL_3309

DR CLO; CLO_0003244

DR ATCC; HTB-157

ST Source(s): ATCC

ST Amelogenin: X,Y

ST CSF1PO: 10,11

ST D13S317: 8,11

ST D16S539: 9,11

ST D5S818: 11,13

ST D7S820: 8,12

ST TH01: 7,9.3

ST TPOX: 8

ST vWA: 16,18

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_T279 ! FHs 738Bl

OI CVCL_R767 ! Hs 738.Bl

OI CVCL_S035 ! Hs 738.Eye

OI CVCL_S314 ! Hs 738.K/Ad/Ts

OI CVCL_0879 ! Hs 738.Lu

OI CVCL_0880 ! Hs 738.St/Int

SX Male

CA Finite cell line

ID FHs 74 Int

AC CVCL_2899

SY FHs74Int; FHs74 Int; 74Int

DR CLO; CLO_0003245

DR ATCC; CCL-241

DR BioSample; SAMN03471479

DR BioSample; SAMN03472360

DR JCRB; JCRB9076

DR IZSLER; BS CL 192

RX PubMed=176412;

RX PubMed=283258;

CC Characteristics: Can undergo 15 PDL.

CC Doubling time: 65 hours (with EGF), 168 hours (without EGF) (JCRB).

CC Caution: Could be identical to Hs 74.Int (CVCL_S089).

ST Source(s): ATCC; JCRB

ST Amelogenin: X

ST CSF1PO: 10,11

ST D13S317: 11,12

ST D16S539: 11,12

ST D5S818: 11,12

ST D7S820: 9,10

ST TH01: 7,9.3 (ATCC)

ST TH01: 7,9.3,11 (JCRB)

ST TPOX: 8

ST vWA: 16,18

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Finite cell line

ID FIB21

AC CVCL_8868

DR CLO; CLO_0003246

DR ATCC; HB-295

OX NCBI_TaxID=10090; ! Mus musculus

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_2199 ! Sp2/0-Ag14

CA Hybridoma

ID FIB504.64

AC CVCL_8869

DR CLO; CLO_0003247

DR ATCC; HB-293

OX NCBI_TaxID=10090; ! Mus musculus

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_2199 ! Sp2/0-Ag14

CA Hybridoma

ID FIGR

AC CVCL_K211

SY FiGR

DR CLO; CLO_0003357

DR ATCC; CRL-2173

RX PubMed=2019585;

CC Monoclonal antibody target: UniProtKB; P06536; Rat Nr3c1/Grl (also reacts with mouse but not with human).

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2155 ! P3/NS1/1-Ag4.1

CA Hybridoma

ID FIP293

AC CVCL_6902

DR CCRID; 3111C0001CCC000138

CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_0045 ! HEK293

SX Female

CA Transformed cell line

ID FiPS 5-7

AC CVCL_Y607

RX PubMed=20419109;

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_2769 ! CCD-1112Sk

SX Male

CA Induced pluripotent stem cell

ID FiPS 6-14

AC CVCL_Y608

RX PubMed=20419109;

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_2769 ! CCD-1112Sk

SX Male

CA Induced pluripotent stem cell

ID FiPS Ctrl1-mR5F-6

AC CVCL_9S18

WW http://www.isciii.es/ISCIII/es/contenidos/fd-el-instituto/fd-organizacion/fd-estructura-directiva/fd-subdireccion-general-investigacion-terapia-celular-medicina-regenerativa/fd-centros-unidades/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/pdf_2016/Documento_Deposito_FiPS_Ctrl1-mR5F-6.pdf

CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_9S19 ! FiPS Ctrl1-SV4F-7

SX Male

CA Induced pluripotent stem cell

ID FiPS Ctrl1-SV4F-7

AC CVCL_9S19

CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_9S18 ! FiPS Ctrl1-mR5F-6

SX Male

CA Induced pluripotent stem cell

ID FiPS Ctrl2-Ep6F-8

AC CVCL_9S20

CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_9S21 ! FiPS Ctrl2-mR5F-6

OI CVCL_9S22 ! FiPS Ctrl2-SV4F-1

SX Male

CA Induced pluripotent stem cell

ID FiPS Ctrl2-mR5F-6

AC CVCL_9S21

CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_9S20 ! FiPS Ctrl2-Ep6F-8

OI CVCL_9S22 ! FiPS Ctrl2-SV4F-1

SX Male

CA Induced pluripotent stem cell

ID FiPS Ctrl2-SV4F-1

AC CVCL_9S22

CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_9S20 ! FiPS Ctrl2-Ep6F-8

OI CVCL_9S21 ! FiPS Ctrl2-mR5F-6

SX Male

CA Induced pluripotent stem cell

ID FiPS-3F-1

AC CVCL_V191

SY ESi031-B

DR hPSCreg; ESi031-B

CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_9S07 ! FiPS-4F-7

OI CVCL_9S08 ! FiPS-4F-8

OI CVCL_C106 ! XFiPS-F44-3F-1

OI CVCL_C107 ! XFiPS-F44-3F-2

SX Male

CA Induced pluripotent stem cell

ID FiPS-4F-7

AC CVCL_9S07

SY ESi031-D

DR hPSCreg; ESi031-D

CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_V191 ! FiPS-3F-1

OI CVCL_9S08 ! FiPS-4F-8

OI CVCL_C106 ! XFiPS-F44-3F-1

OI CVCL_C107 ! XFiPS-F44-3F-2

SX Male

CA Induced pluripotent stem cell

ID FiPS-4F-8

AC CVCL_9S08

SY ESi031-C

DR GEO; GSM1012131

DR hPSCreg; ESi031-C

RX PubMed=23118351;

CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.

CC Omics: Transcriptome analysis.

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_V191 ! FiPS-3F-1

OI CVCL_9S07 ! FiPS-4F-7

OI CVCL_C106 ! XFiPS-F44-3F-1

OI CVCL_C107 ! XFiPS-F44-3F-2

SX Male

CA Induced pluripotent stem cell

ID FIS,VJ

AC CVCL_E663

SY FIS, VJ

DR dbMHC; 48859

DR ECACC; 94082259

DR IHW; IHW9159

DR IMGT/HLA; 11702

RX PubMed=8307784;

WW http://bioinformatics.hsanmartino.it/ecbr/cl159.html

CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Sex undetermined

CA Transformed cell line

ID Fitz-HSA

AC CVCL_1R34

SY FITZ-HSA; Fitz; DEN-HSA/Fitz

DR BioSample; SAMN03151633

DR GEO; GSM1974788

RX PubMed=17338158;

RX PubMed=21908323;

RX PubMed=22594682;

RX PubMed=27197945;

WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC Problematic cell line: Contaminated. Shown to be a DEN-HSA derivative (PubMed=21908323).

CC Part of: FACC canine tumor cell line panel.

CC Omics: Transcriptome analysis.

CC Breed/subspecies: Golden Retriever.

DI NCIt; C122783; Canine hemangiosarcoma

OX NCBI_TaxID=9615; ! Canis lupus familiaris

HI CVCL_1R33 ! DEN-HSA

SX Male

CA Cancer cell line

ID FJO

AC CVCL_E664

DR dbMHC; 48860

DR ECACC; 94071432

DR IHW; IHW9330

DR IMGT/HLA; 10582

WW http://bioinformatics.hsanmartino.it/ecbr/cl330.html

CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FK-91

AC CVCL_6C51

SY PC-91

RX Patent=RU2121501;

WW http://www.rccc.cytspb.rssi.ru/ecellbank/animal/afk-91.htm

WW http://worldwide.espacenet.com/publicationDetails/biblio?DB=worldwide.espacenet.com&II=2&ND=3&adjacent=true&locale=en_EP&FT=D&date=19981110&CC=RU&NR=2121501C1&KC=C1

OX NCBI_TaxID=9685; ! Felis catus

CA Spontaneously immortalized cell line

ID FKH-1

AC CVCL_2041

DR CLO; CLO_0050983

DR BioSample; SAMN01821625

DR BioSample; SAMN03473503

DR Cosmic; 975248

DR Cosmic; 1465949

DR Cosmic; 2306205

DR DSMZ; ACC-614

DR RCB; RCB1428

RX PubMed=9753053;

CC Doubling time: ~60-100 hours (DSMZ).

ST Source(s): DSMZ; RCB

ST Amelogenin: X,Y

ST CSF1PO: 11,12

ST D13S317: 8,10

ST D16S539: 10,11

ST D5S818: 12,13

ST D7S820: 12

ST TH01: 8,9

ST TPOX: 8,11

ST vWA: 17,18

DI NCIt; C9154; Adult acute myeloid leukemia

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FkMTp

AC CVCL_AE02

RX PubMed=26883919;

OX NCBI_TaxID=9685; ! Felis catus

SX Female

CA Cancer cell line

ID FKNp

AC CVCL_T989

RX PubMed=16397390;

CC Breed/subspecies: Persian.

OX NCBI_TaxID=9685; ! Felis catus

SX Female

CA Cancer cell line

ID FL

AC CVCL_1905

AS CVCL_2900

SY FL*

DR BTO; BTO:0003130

DR CLO; CLO_0003358

DR CLDB; cl1365

DR CLDB; cl1366

DR CLDB; cl1367

DR ATCC; CCL-62

DR BioSample; SAMN03151695

DR ECACC; 90111910

DR IZSLER; BS CL 46

DR JCRB; JCRB9016

DR TOKU-E; 1269

RX DOI=10.1007/978-1-4757-1647-4_13;

RX PubMed=1246601;

RX PubMed=13408317;

RX PubMed=20143388;

RX PubMed=23925245;

WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601, PubMed=20143388). Originally thought to originate from normal amnion.

CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

CC Omics: Genome sequenced (low read coverage).

CC Discontinued: JCRB; JCRB9016; true.

ST Source(s): ATCC; ECACC

ST Amelogenin: X

ST CSF1PO: 9,10

ST D13S317: 12,13.3 (ATCC)

ST D13S317: 12,14 (ECACC)

ST D16S539: 9,10

ST D5S818: 11,12

ST D7S820: 8,12

ST TH01: 7

ST TPOX: 8,12

ST vWA: 16,18

DI NCIt; C4029; Cervical adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_0030 ! HeLa

SX Female

CA Cancer cell line

ID FL 62891

AC CVCL_6390

SY FL62891

DR CLO; CLO_0003359

DR ATCC; CRL-11005

DR BioSample; SAMN03471327

RX Patent=US5621090;

RX Patent=US5912133;

CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

ST Source(s): ATCC

ST Amelogenin: X,Y

ST CSF1PO: 11,12

ST D13S317: 11,12

ST D16S539: 12,13

ST D5S818: 11

ST D7S820: 10,11

ST TH01: 7

ST TPOX: 8

ST vWA: 14,19

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FL-106

AC CVCL_2042

SY FL 106

DR DSMZ; ACC-620

CC Doubling time: ~2-3 days (DSMZ).

CC Transformant: ChEBI; CHEBI:34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).

CC Breed/subspecies: Wistar-AF/Han.

DI NCIt; C60416; Rat hepatocellular carcinoma

OX NCBI_TaxID=10116; ! Rattus norvegicus

SX Male

CA Cancer cell line

ID FL-18

AC CVCL_8093

SY FL18

DR BTO; BTO:0002518

DR Cosmic; 2396144

RX PubMed=1967982;

RX PubMed=2822175;

RX PubMed=3034807;

RX PubMed=3928551;

RX PubMed=8847894;

RX PubMed=12967475;

RX PubMed=14990977;

RX PubMed=15028022;

CC Omics: Transcriptome analysis.

DI NCIt; C3209; Follicular lymphoma

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_J353 ! FL-18-EB

SX Male

CA Cancer cell line

ID FL-18-EB

AC CVCL_J353

SY FL-18EB

RX PubMed=2822175;

RX PubMed=3034807;

RX PubMed=12967475;

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC Omics: Transcriptome analysis.

DI NCIt; C3209; Follicular lymphoma

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_8093 ! FL-18

SX Male

CA Transformed cell line

ID FL-218

AC CVCL_8094

SY FL218

DR BTO; BTO:0002519

RX PubMed=2180570;

RX PubMed=8847894;

RX PubMed=12967475;

RX PubMed=14990977;

RX PubMed=15028022;

CC Omics: Transcriptome analysis.

DI NCIt; C3209; Follicular lymphoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID FL-318

AC CVCL_8095

SY FL318

DR BTO; BTO:0002520

DR GEO; GSM380126

RX PubMed=2180570;

RX PubMed=8847894;

RX PubMed=12967475;

RX PubMed=14990977;

RX PubMed=19278952;

CC Omics: Array-based CGH.

CC Omics: CNV analysis.

CC Omics: miRNA expression profiling.

CC Omics: Transcriptome analysis.

DI NCIt; C3209; Follicular lymphoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FL-4

AC CVCL_M767

DR ATCC; CRL-10772

RX Patent=US5275813;

CC Discontinued: ATCC; CRL-10772; probable.

OX NCBI_TaxID=9685; ! Felis catus

HI CVCL_M765 ! FeT-1M

CA Spontaneously immortalized cell line

ID FL-418

AC CVCL_IU40

SY FL418

RX PubMed=12967475;

CC Omics: Transcriptome analysis.

DI NCIt; C3209; Follicular lymphoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FL-518

AC CVCL_IU41

SY FL518

RX PubMed=12967475;

RX PubMed=14990977;

CC Omics: Transcriptome analysis.

DI NCIt; C3209; Follicular lymphoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FL-6

AC CVCL_M768

DR ATCC; CRL-10773

RX Patent=US5275813;

CC Discontinued: ATCC; CRL-10773; probable.

OX NCBI_TaxID=9685; ! Felis catus

HI CVCL_M765 ! FeT-1M

CA Spontaneously immortalized cell line

ID FL-618

AC CVCL_IU42

SY FL618

RX PubMed=12967475;

CC Omics: Transcriptome analysis.

DI NCIt; C3209; Follicular lymphoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FL-64

AC CVCL_2043

SY FL 64

DR DSMZ; ACC-616

CC Doubling time: ~60-100 hours (DSMZ).

CC Transformant: ChEBI; CHEBI:34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).

CC Breed/subspecies: Wistar-AF/Han.

DI NCIt; C60416; Rat hepatocellular carcinoma

OX NCBI_TaxID=10116; ! Rattus norvegicus

SX Male

CA Cancer cell line

ID FL-718

AC CVCL_IU43

SY FL718

RX PubMed=12967475;

CC Omics: Transcriptome analysis.

DI NCIt; C3209; Follicular lymphoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FL-74

AC CVCL_Y090

SY FL74

RX PubMed=172437;

RX PubMed=5818677;

CC Doubling time: ~36 hours (PubMed=5818677).

CC Transformant: NCBI_TaxID; 11768; Feline leukemia virus.

DI NCIt; C132193; Feline lymphoma

OX NCBI_TaxID=9685; ! Felis catus

CA Cancer cell line

ID FL-74-UCD-1

AC CVCL_6391

SY FL74-UCD-1

DR CLO; CLO_0003360

DR ATCC; CRL-8012

DR BCRC; 60496

RX Patent=US4264587;

RX PubMed=18366545;

CC Characteristics: Produces large amounts of feline leukemia virus (FeLV).

CC Transformant: NCBI_TaxID; 11768; Feline leukemia virus.

DI NCIt; C132193; Feline lymphoma

OX NCBI_TaxID=9685; ! Felis catus

HI CVCL_Y090 ! FL-74

CA Cancer cell line

ID FL-818

AC CVCL_IU44

SY FL818

RX PubMed=12967475;

CC Omics: Transcriptome analysis.

DI NCIt; C3209; Follicular lymphoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FL-OH1

AC CVCL_S870

SY FLOH1

RX PubMed=12904596;

RX PubMed=23882450;

DI NCIt; C3749; Alveolar rhabdomyosarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FL-Y

AC CVCL_6C45

RX PubMed=17015706;

CC Characteristics: TNFA dependent.

CC Breed/subspecies: BALB/c.

OX NCBI_TaxID=10090; ! Mus musculus

CA Factor-dependent cell line

ID FL-YB

AC CVCL_6C46

DR RCB; RCB4452

RX PubMed=21911600;

CC Characteristics: TNFA dependent.

CC Transfected with: MGI; MGI:1344376; Tnfsf13b.

CC Transfected with: UniProtKB; P42212; GFP.

CC Breed/subspecies: BALB/c.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_6C45 ! FL-Y

CA Factor-dependent cell line

ID FL.1

AC CVCL_M051

DR ECACC; 92092319

RX PubMed=1834558;

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2199 ! Sp2/0-Ag14

CA Hybridoma

ID FL1

AC CVCL_M895

RX PubMed=15520187;

DI NCIt; C4912; Bladder carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_M892 ! T24T

SX Female

CA Cancer cell line

ID FL2

AC CVCL_M896

RX PubMed=15520187;

DI NCIt; C4912; Bladder carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_M895 ! FL1

SX Female

CA Cancer cell line

ID FL3

AC CVCL_M897

RX PubMed=15520187;

CC Part of: BLA-40 bladder carcinoma cell line panel.

DI NCIt; C4912; Bladder carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_M896 ! FL2

SX Female

CA Cancer cell line

ID FL5.12

AC CVCL_0262

SY FL5.12A; Fetal Liver clone 5.12

DR BTO; BTO:0003328

DR MCCL; MCC:0000153

DR Lonza; 259

RX PubMed=3933007;

RX PubMed=8358790;

RX PubMed=10200549;

WW http://www.cells-talk.com/index.php/page/copelibrary?key=FL5%2e12

WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/f/cell-lines-detail-468.html

CC Characteristics: IL3 dependent.

CC Breed/subspecies: BALB/c.

OX NCBI_TaxID=10090; ! Mus musculus

CA Factor-dependent cell line

ID FL5.12 Bax CL16

AC CVCL_HE70

SY FL5.12 Bax CL-16

RX PubMed=8358790;

RX PubMed=9863016;

CC Characteristics: IL3 dependent.

CC Transfected with: MGI; MGI:99702; Bax.

CC Breed/subspecies: BALB/c.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_0262 ! FL5.12

CA Factor-dependent cell line

ID FL653

AC CVCL_5A32

SY FL-653

CC Group: Hybridoma fusion partner cell line.

CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.

CC Breed/subspecies: BALB/c.

DI NCIt; C125417; Mouse plasma cell myeloma

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_4032 ! P3X63Ag8.653

SX Female

CA Cancer cell line

ID FL83B

AC CVCL_4691

SY FL-83B

DR BTO; BTO:0003327

DR CLO; CLO_0003361

DR ATCC; CRL-2390

DR BCRC; 60325

DR PRIDE; PXD001792

RX CelloPub=CLPUB00349;

RX PubMed=4572697;

RX PubMed=26280412;

CC Omics: Deep phosphoproteome analysis.

CC Breed/subspecies: C57BL/6J.

OX NCBI_TaxID=10090; ! Mus musculus

CA Spontaneously immortalized cell line

ID FLAM-76

AC CVCL_2901

SY Flam-76

DR Cosmic; 720784

DR Cosmic; 2081380

DR Cosmic; 2302405

DR Cosmic; 2367287

DR JCRB; JCRB1346

DR JCRB; NIHS0538

RX PubMed=1516003;

RX PubMed=8943038;

RX PubMed=9738977;

RX PubMed=10087940;

RX PubMed=10936422;

CC Characteristics: IL6 dependent.

CC Discontinued: JCRB; NIHS0538 ; true.

ST Source(s): JCRB

ST Amelogenin: X,Y

ST CSF1PO: 10,12

ST D13S317: 8,11

ST D16S539: 9

ST D5S818: 9,12

ST D7S820: 9,10

ST TH01: 6

ST TPOX: 8,11

ST vWA: 14,17

DI NCIt; C3242; Plasma cell myeloma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FLC 3Cl8

AC CVCL_W804

SY FLC-3CL-8; 3Cl8 FLC; FLC (clone 3Cl8); MRI 745 3CL8

RX PubMed=3106522;

RX PubMed=6179295;

CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).

CC Breed/subspecies: DBA/2.

DI NCIt; C21895; Mouse erythroid leukemia

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_3988 ! FLC clone 745

CA Cancer cell line

ID FLC clone 745

AC CVCL_3988

SY FLC clone 745A; 745-A; 745A; FLC 745 A; 745 A clone; Friend leukemic cell clone #745; MEL-745A; MEL 745A; MEL745A; MELC strain 745A; GM00086; GM0086; GM0086E; GM86 Clone 745A

DR BTO; BTO:0002885

DR CLO; CLO_0003538

DR CLO; CLO_0003363

DR CLO; CLO_0025155

DR CLDB; cl1370

DR CLDB; cl1506

DR Coriell; GM00086

RX PubMed=3106522;

CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).

CC Breed/subspecies: DBA/2.

DI NCIt; C21895; Mouse erythroid leukemia

OX NCBI_TaxID=10090; ! Mus musculus

OI CVCL_9R58 ! FSD1/F4

CA Cancer cell line

ID FLC clone 745 A 19

AC CVCL_W806

SY 745 A 19

RX PubMed=428460;

CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).

CC Breed/subspecies: DBA/2.

DI NCIt; C21895; Mouse erythroid leukemia

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_3988 ! FLC clone 745

CA Cancer cell line

ID FLC clone M2

AC CVCL_L877

SY Clone M2

DR CLO; CLO_0003364

DR CLDB; cl1371

RX PubMed=4136752;

CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).

CC Breed/subspecies: DBA/2.

DI NCIt; C21895; Mouse erythroid leukemia

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_4145 ! Clone 707

CA Cancer cell line

ID FLC-4

AC CVCL_D204

SY FLC4; Functional Liver Cell-4

DR Cosmic; 2321031

RX Patent=US5804441;

RX PubMed=17241388;

RX PubMed=21960466;

CC Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-5165.

CC Omics: Transcriptome analysis.

CC Caution: FLC-4 is often stated to be synonymous with JHH-4 (CVCL_2787), but the patent reference (Patent=US5804441) seems to indicate that FLC-4 is derived from JHH-4 and has a different karyotype.

DI NCIt; C3099; Hepatocellular carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_2787 ! JHH-4

SX Male

CA Cancer cell line

ID FLFMM-34

AC CVCL_0I20

RX PubMed=25639772;

CC Doubling time: 2-3 days (PubMed=25639772).

CC Derived from metastatic site: Lymph node.

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID FLG-R

AC CVCL_0I97

DR CCLV; CCLV-RIE 1093

CC Group: Bat cell line.

OX NCBI_TaxID=59452; ! Eptesicus serotinus

CA Finite cell line

ID FLK

AC CVCL_9T05

SY Fetal Lamb Kidney

DR IZSLER; BS CL 154

OX NCBI_TaxID=9940; ! Ovis aries

CA Spontaneously immortalized cell line

ID FLK-1

AC CVCL_M788

RX PubMed=11243383;

DI NCIt; C3209; Follicular lymphoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID FLK-BLV-044

AC CVCL_2044

DR CLO; CLO_0003365

DR CLDB; cl1372

DR DSMZ; ACC-153

CC Doubling time: ~50 hours (DSMZ).

OX NCBI_TaxID=9940; ! Ovis aries

CA Spontaneously immortalized cell line

ID FLK-N3

AC CVCL_N594

RX PubMed=21695582;

OX NCBI_TaxID=9940; ! Ovis aries

CA Spontaneously immortalized cell line

ID FLN-R

AC CVCL_0I53

DR CCLV; CCLV-RIE 1091

RX PubMed=19941903;

CC Group: Bat cell line.

OX NCBI_TaxID=59452; ! Eptesicus serotinus

CA Finite cell line

ID Flo Tel

AC CVCL_Y123

DR ATCC; CRL-1128

CC Discontinued: ATCC; CRL-1128; true.

DI NCIt; C34807; Marfan syndrome

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Finite cell line

ID FLO-1

AC CVCL_2045

SY Flo-1; FLO

DR BTO; BTO:0003641

DR BioSample; SAMN03473447

DR Cosmic; 1599339

DR Cosmic-CLP; 1503361

DR DSMZ; ACC-698

DR ECACC; 11012001

DR GDSC; 1503361

DR GEO; GSM1669793

RX PubMed=9407969;

RX PubMed=20075370;

RX PubMed=23795680;

RX PubMed=27397505;

CC Doubling time: ~40-50 hours (DSMZ).

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: DNA methylation analysis.

ST Source(s): Cosmic-CLP; DSMZ; ECACC

ST Amelogenin: X

ST CSF1PO: 11

ST D13S317: 11

ST D16S539: 12,13

ST D5S818: 12,14

ST D7S820: 8

ST TH01: 6

ST TPOX: 9,11

ST vWA: 16

DI NCIt; C4025; Esophageal adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID Flow1000

AC CVCL_5615

SY Flow 1000

WW http://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/summary.htm

CC From: Flow Laboratories (Rockville, MD, USA) which ceased operation.

OX NCBI_TaxID=9606; ! Homo sapiens

CA Finite cell line

ID Flow11000

AC CVCL_F663

SY Flow 11000; Flow-11000

WW http://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/summary.htm

CC From: Flow Laboratories (Rockville, MD, USA) which ceased operation.

OX NCBI_TaxID=9606; ! Homo sapiens

CA Finite cell line

ID Flow13000

AC CVCL_F664

SY Flow 13000

DR BioSample; SAMN03151849

RX PubMed=20143388;

WW http://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/summary.htm

WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC Problematic cell line: Contaminated. Shown to be a MRC-5 derivative (PubMed=20143388).

CC From: Flow Laboratories (Rockville, MD, USA) which ceased operation.

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_0440 ! MRC-5

SX Male

CA Finite cell line

ID Flow2000

AC CVCL_2902

SY Flow 2000; FLOW 2000; F2000

DR BioSample; SAMN03471057

DR ChEMBL-Cells; CHEMBL3307954

DR ChEMBL-Targets; CHEMBL612415

DR IFO; IFO50089

DR JCRB; JCRB0067

DR TKG; TKG 0196

WW http://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/summary.htm

CC From: Flow Laboratories (Rockville, MD, USA) which ceased operation.

CC Discontinued: JCRB; JCRB0067; true.

ST Source(s): JCRB

ST Amelogenin: X

ST CSF1PO: 10,11

ST D13S317: 12,13

ST D16S539: 11,13

ST D5S818: 11

ST D7S820: 9,12

ST TH01: 7,9.3

ST TPOX: 8,12

ST vWA: 15,18

OX NCBI_TaxID=9606; ! Homo sapiens

CA Finite cell line

ID Flow2002

AC CVCL_F661

SY FLOW 2002; Flow 2002; F2002

DR CLO; CLO_0003366

DR CLDB; cl1373

DR ChEMBL-Cells; CHEMBL3308387

DR ChEMBL-Targets; CHEMBL614727

CC From: Flow Laboratories (Rockville, MD, USA) which ceased operation.

OX NCBI_TaxID=9606; ! Homo sapiens

CA Finite cell line

ID Flow3000

AC CVCL_2903

SY Flow 3000

DR BioSample; SAMN03471058

DR JCRB; JCRB0068

WW http://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/summary.htm

CC From: Flow Laboratories (Rockville, MD, USA) which ceased operation.

ST Source(s): JCRB

ST Amelogenin: X

ST CSF1PO: 9,11

ST D13S317: 12

ST D16S539: 10,12

ST D5S818: 9,13

ST D7S820: 9,12

ST TH01: 8

ST TPOX: 8,11

ST vWA: 15,17

OX NCBI_TaxID=9606; ! Homo sapiens

CA Finite cell line

ID Flow4000

AC CVCL_5909

SY Flow 4000; Flow-4000; F4000

WW http://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/summary.htm

CC From: Flow Laboratories (Rockville, MD, USA) which ceased operation.

OX NCBI_TaxID=9606; ! Homo sapiens

CA Finite cell line

ID Flow5000

AC CVCL_5910

SY Flow 5000; Flow #5,000

DR BioSample; SAMN03151640

WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC Problematic cell line: Contaminated. Shown to be a Flow1000 derivative.

CC From: Flow Laboratories (Rockville, MD, USA) which ceased operation.

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_5615 ! Flow1000

CA Finite cell line

ID Flow6000

AC CVCL_F662

SY Flow 6000

DR CLO; CLO_0003367

DR CLDB; cl1375

DR BioSample; SAMN03151641

WW http://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/summary.htm

WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC Problematic cell line: Contaminated. Shown to be a Flow1000 derivative.

CC From: Flow Laboratories (Rockville, MD, USA) which ceased operation.

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_5615 ! Flow1000

CA Finite cell line

ID Flow7000

AC CVCL_2904

SY Flow 7000; F7000

DR CLO; CLO_0002985

DR CLDB; cl1196

DR BioSample; SAMN03151642

DR IFO; IFO50079

WW http://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/summary.htm

WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC Problematic cell line: Contaminated. Shown to be a Flow3000 derivative.

CC From: Flow Laboratories (Rockville, MD, USA) which ceased operation.

ST Source(s): JCRB

ST Amelogenin: X

ST CSF1PO: 9,11

ST D13S317: 12

ST D16S539: 10,12

ST D5S818: 9,13

ST D7S820: 9,12

ST TH01: 8

ST TPOX: 8,11

ST vWA: 15,17

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_2903 ! Flow3000

CA Finite cell line

ID Flp-In-293

AC CVCL_U421

SY Flp-In 293

WW http://www.thermofisher.com/order/catalog/product/R75007

WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/f/cell-lines-detail-217.html

CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_0045 ! HEK293

SX Female

CA Transformed cell line

ID Flp-In-3T3

AC CVCL_U422

SY Flp-In 3T3

WW http://www.thermofisher.com/order/catalog/product/R76107

CC Breed/subspecies: NIH Swiss.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_0594 ! NIH 3T3

SX Male

CA Transformed cell line

ID Flp-In-BHK

AC CVCL_U423

SY Flp-In BHK

WW http://www.thermofisher.com/order/catalog/product/R76007

OX NCBI_TaxID=10036; ! Mesocricetus auratus

HI CVCL_1915 ! BHK-21 clone 13

SX Male

CA Spontaneously immortalized cell line

ID Flp-In-CHO

AC CVCL_U424

SY Flp-In CHO

WW http://www.thermofisher.com/order/catalog/product/R75807

WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/f/cell-lines-detail-538.html

OX NCBI_TaxID=10029; ! Cricetulus griseus

HI CVCL_0213 ! CHO

SX Female

CA Spontaneously immortalized cell line

ID Flp-In-CV-1

AC CVCL_U425

SY Flp-In CV-1

WW http://www.thermofisher.com/order/catalog/product/R75207

WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/f/cell-lines-detail-539.html

CC Group: Non-human primate cell line.

CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX NCBI_TaxID=9534; ! Chlorocebus aethiops

HI CVCL_0229 ! CV-1

SX Male

CA Transformed cell line

ID Flp-In-Jurkat

AC CVCL_U426

SY Flp-In Jurkat

WW http://www.thermofisher.com/order/catalog/product/R76207

WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/f/cell-lines-detail-616.html

DI NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_0065 ! Jurkat

SX Male

CA Cancer cell line

ID Flp-In-T-REx-293

AC CVCL_U427

SY Flp-In T-REx-293; Flp-In T-Rex HEK293; Flp-In 293 T-Rex; HEK293FlpIN

DR ENCODE; ENCBS749QJL

DR GEO; GSM1009421

DR PRIDE; PXD002127

WW http://www.thermofisher.com/order/catalog/product/R78007

WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/f/cell-lines-detail-596.html

CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.

CC Omics: Deep RNAseq analysis.

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_D585 ! T-REx-293

SX Female

CA Transformed cell line

ID Flp293A

AC CVCL_U006

RX PubMed=16697259;

CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_0045 ! HEK293

SX Female

CA Transformed cell line

ID FLS11

AC CVCL_5502

DR TKG; TKG 0193

RX PubMed=2133543;

CC Breed/subspecies: C57BL/6J.

OX NCBI_TaxID=10090; ! Mus musculus

CA Stromal cell line

ID FLS3

AC CVCL_5503

DR IFO; IFO50377

DR TKG; TKG 0194

RX PubMed=2133543;

CC Breed/subspecies: C57BL/6J.

OX NCBI_TaxID=10090; ! Mus musculus

CA Stromal cell line

ID FLS4.1

AC CVCL_5629

RX PubMed=1346335;

WW http://www.cells-talk.com/index.php/page/copelibrary?key=FLS4.1

OX NCBI_TaxID=10090; ! Mus musculus

CA Stromal cell line

ID FLS5

AC CVCL_5504

DR IFO; IFO50378

DR TKG; TKG 0195

RX PubMed=2133543;

CC Breed/subspecies: C57BL/6J.

OX NCBI_TaxID=10090; ! Mus musculus

CA Stromal cell line

ID FLYA-JET

AC CVCL_EG37

RX PubMed=10488763;

CC Group: Retrovirus packaging cell line.

CC Transfected with: MGI; MGI:88117; Slc7a1.

DI NCIt; C3043; Fibrosarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_8870 ! FLYA13

SX Male

CA Cancer cell line

ID FLYA13

AC CVCL_8870

SY FLY-A13; FLY-AF-13

DR CLO; CLO_0003368

DR CLDB; cl1376

DR ECACC; 95091901

DR GEO; GSM827429

DR Ximbio; 151655

RX PubMed=7494248;

CC Group: Retrovirus packaging cell line.

CC Characteristics: Heterozygous for the IDH1 p.Arg132Cys mutation.

ST Source(s): ECACC

ST Amelogenin: X,Y

ST CSF1PO: 12

ST D13S317: 12,14

ST D16S539: 9,12

ST D5S818: 11,13

ST D7S820: 9,10

ST TH01: 6

ST TPOX: 8

ST vWA: 14,19

DI NCIt; C3043; Fibrosarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_0317 ! HT-1080

SX Male

CA Cancer cell line

ID FLYRD18

AC CVCL_8871

SY FLY-RD18; FLY-RDF-18

DR CLO; CLO_0003369

DR CLDB; cl1377

DR ECACC; 95091902

DR Ximbio; 151446

RX PubMed=7494248;

CC Group: Retrovirus packaging cell line.

CC Characteristics: Heterozygous for the IDH1 p.Arg132Cys mutation.

DI NCIt; C3043; Fibrosarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_0317 ! HT-1080

SX Male

CA Cancer cell line

ID FM-62

AC CVCL_9706

RX PubMed=1320624;

CC From: Van Valen F.; University of Munster; Germany.

DI NCIt; C4817; Ewing sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FM116

AC CVCL_4W88

DR Cosmic; 1047660

DR GEO; GSM156031

RX PubMed=17260012;

CC Omics: Array-based CGH.

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FM2

AC CVCL_C576

DR Cosmic; 851407

DR Cosmic; 874436

DR Cosmic; 1047661

DR GEO; GSM156026

RX PubMed=17260012;

CC Omics: Array-based CGH.

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FM28

AC CVCL_C583

SY FM-28; FM 28

DR Cosmic; 808545

DR Cosmic; 972279

DR Cosmic; 1047662

DR Cosmic; 2163766

DR ECACC; 13012412

DR ESTDAB; ESTDAB-006

DR GEO; GSM156041

RX PubMed=7656272;

RX PubMed=8968104;

RX PubMed=9288767;

RX PubMed=17260012;

CC Omics: Array-based CGH.

CC Derived from metastatic site: Not specified.

ST Source(s): ECACC; ESTDAB

ST Amelogenin: X,Y

ST CSF1PO: 13

ST D13S317: 12

ST D16S539: 11,13

ST D3S1358: 15

ST D5S818: 11,12

ST D7S820: 10,14

ST FGA: 22,24

ST TH01: 6

ST TPOX: 9.3 (ECACC)

ST TPOX: 8 (ESTDAB)

ST vWA: 16,17

DI NCIt; C3510; Cutaneous melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FM3

AC CVCL_2046

SY FM-3

DR Cosmic; 808544

DR Cosmic; 851400

DR Cosmic; 1047663

DR ECACC; 13012407

DR ESTDAB; ESTDAB-007

DR GEO; GSM156042

RX PubMed=7656272;

RX PubMed=7899823;

RX PubMed=8968104;

RX PubMed=17260012;

CC Omics: Array-based CGH.

CC Derived from metastatic site: Right inguinal lymph node.

ST Source(s): ECACC; ESTDAB

ST Amelogenin: X

ST CSF1PO: 11,13

ST D13S317: 12

ST D16S539: 12,13

ST D3S1358: 15,17

ST D5S818: 12

ST D7S820: 10

ST FGA: 23

ST TH01: 6,9.3

ST TPOX: 8,11

ST vWA: 15,16

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID FM3.13

AC CVCL_C578

SY FM-3.13

DR ECACC; 13012516

DR ESTDAB; ESTDAB-008

CC Derived from metastatic site: Right inguinal lymph node.

ST Source(s): ECACC; ESTDAB

ST Amelogenin: X

ST CSF1PO: 11,13

ST D13S317: 12

ST D16S539: 12,13

ST D3S1358: 15,17

ST D5S818: 12,13

ST D7S820: 10

ST FGA: 23

ST TH01: 6,9.3

ST TPOX: 8,11

ST vWA: 15,16

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_2046 ! FM3

SX Female

CA Cancer cell line

ID FM3.26

AC CVCL_C579

SY FM-3.26

DR ECACC; 13012554

DR ESTDAB; ESTDAB-009

CC Derived from metastatic site: Right inguinal lymph node.

ST Source(s): ECACC; ESTDAB

ST Amelogenin: X

ST CSF1PO: 11,13

ST D13S317: 12

ST D16S539: 12,13

ST D3S1358: 15,17

ST D5S818: 12

ST D7S820: 10

ST FGA: 23

ST TH01: 6,9.3

ST TPOX: 8,11

ST vWA: 15,16

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_2046 ! FM3

SX Female

CA Cancer cell line

ID FM3.29

AC CVCL_C580

SY FM-3.29; FM3-29; FM3-29-MEL

DR ECACC; 13012502

DR ESTDAB; ESTDAB-010

CC Derived from metastatic site: Right inguinal lymph node.

ST Source(s): ECACC; ESTDAB

ST Amelogenin: X

ST CSF1PO: 11,13

ST D13S317: 12

ST D16S539: 12,13

ST D3S1358: 15,17

ST D5S818: 12

ST D7S820: 10

ST FGA: 20,23

ST TH01: 6,9.3

ST TPOX: 8,11

ST vWA: 15,16

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_2046 ! FM3

SX Female

CA Cancer cell line

ID FM34

AC CVCL_X923

SY Formosan Monkey 34

RX PubMed=2579038;

CC Group: Non-human primate cell line.

CC Characteristics: IL2 dependent.

CC Transformant: NCBI_TaxID; 33747; Simian T-lymphotropic virus 1 (STLV-1).

OX NCBI_TaxID=78449; ! Macaca cyclopis

CA Transformed cell line

ID FM37

AC CVCL_C584

RX PubMed=7656272;

RX PubMed=9288767;

CC Derived from metastatic site: Not specified.

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FM39

AC CVCL_9673

DR Cosmic; 808542

DR Cosmic; 851417

DR Cosmic; 874438

RX PubMed=8968104;

RX PubMed=9288767;

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FM3A

AC CVCL_3869

DR BTO; BTO:0000472

DR CLO; CLO_0003370

DR CLO; CLO_0050963

DR CLDB; cl1378

DR ChEMBL-Cells; CHEMBL3307585

DR ChEMBL-Targets; CHEMBL614297

DR ECACC; 87100804

DR JCRB; JCRB0701

DR Lonza; 1054

DR RCB; RCB0086

DR TKG; TKG 0151

RX PubMed=5920633;

RX PubMed=5956504;

WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/f/cell-lines-detail-198.html

CC Breed/subspecies: C3H/He.

DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX NCBI_TaxID=10090; ! Mus musculus

SX Female

CA Cancer cell line

ID FM3A APRT~

AC CVCL_J368

DR JCRB; JCRB0703

RX PubMed=7105014;

CC Selected for resistance to: ChEBI; CHEBI:88290; 5-hydroxy-1H-imidazole-4-carboxamide (4-carbamoylimidazolium 5-olate; SM-108).

CC Breed/subspecies: C3H/He.

DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_D687 ! FM3A/F28-7

SX Female

CA Cancer cell line

ID FM3A FT-101

AC CVCL_J378

SY tsFT101

DR CLO; CLO_0050961

DR JCRB; JCRB0706

DR RCB; RCB0032

RX PubMed=2581712;

CC Characteristics: Cytokinesis is blocked at 39 Celsius.

CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

CC Breed/subspecies: C3H/He.

DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_3869 ! FM3A

SX Female

CA Cancer cell line

ID FM3A HPRT~

AC CVCL_J369

DR JCRB; JCRB0702

RX PubMed=7105014;

CC Selected for resistance to: ChEBI; CHEBI:38001; 2,6-diaminopurine (2,6-DAP).

CC Breed/subspecies: C3H/He.

DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_D687 ! FM3A/F28-7

SX Female

CA Cancer cell line

ID FM3A TK~

AC CVCL_J370

DR JCRB; JCRB0704

CC Breed/subspecies: C3H/He.

DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_3869 ! FM3A

SX Female

CA Cancer cell line

ID FM3A ts T244

AC CVCL_U141

DR CLO; CLO_0050962

DR RCB; RCB0034

CC Breed/subspecies: C3H/He.

DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_3869 ! FM3A

SX Female

CA Cancer cell line

ID FM3A/F28-7

AC CVCL_D687

SY F28-7

DR BTO; BTO:0001618

CC Breed/subspecies: C3H/He.

DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_3869 ! FM3A

SX Female

CA Cancer cell line

ID FM3A/R

AC CVCL_F975

DR TKG; TKG 0152

CC Breed/subspecies: C3H/He.

DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_3869 ! FM3A

SX Female

CA Cancer cell line

ID FM3Ats C1.T85

AC CVCL_4201

SY FM3A tscl.T85 Tsai; ts85

DR CLO; CLO_0003371

DR CLO; CLO_0050960

DR CLDB; cl1379

DR ECACC; 87111904

DR JCRB; JCRB0705

DR RCB; RCB0033

RX PubMed=6153988;

CC Breed/subspecies: C3H/He.

DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_3869 ! FM3A

SX Female

CA Cancer cell line

ID FM45

AC CVCL_9674

SY FM-45; FM 45

DR Cosmic; 808543

DR Cosmic; 851409

DR Cosmic; 972262

DR Cosmic; 1047664

DR Cosmic; 1132581

DR Cosmic; 2163767

DR ECACC; 13012410

DR ESTDAB; ESTDAB-011

DR GEO; GSM156047

RX PubMed=7656272;

RX PubMed=8968104;

RX PubMed=9288767;

RX PubMed=17260012;

CC Omics: Array-based CGH.

CC Derived from metastatic site: Not specified.

ST Source(s): ECACC; ESTDAB

ST Amelogenin: X

ST CSF1PO: 10,11

ST D13S317: 13

ST D16S539: 9,12

ST D3S1358: 15,16

ST D5S818: 9,10

ST D7S820: 9,11

ST FGA: 21,23

ST TH01: 9.3

ST TPOX: 9,11

ST vWA: 15,17

DI NCIt; C3510; Cutaneous melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FM48

AC CVCL_C587

DR Cosmic; 1047665

DR GEO; GSM156027

RX PubMed=8968104;

RX PubMed=9288767;

RX PubMed=17260012;

CC Omics: Array-based CGH.

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FM49

AC CVCL_9675

DR Cosmic; 808550

DR Cosmic; 851411

RX PubMed=9288767;

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FM516SV

AC CVCL_Z436

SY FM516SV3/3; FM-516-SV

DR BTO; BTO:0005456

RX PubMed=2543501;

CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FM55M1

AC CVCL_C589

SY FM-55-M1

DR Cosmic; 808538

DR Cosmic; 1006221

DR ECACC; 13012546

DR ESTDAB; ESTDAB-012

RX PubMed=7656272;

RX PubMed=8968104;

CC Derived from metastatic site: Subcutaneous.

ST Source(s): ECACC; ESTDAB

ST Amelogenin: X,Y

ST CSF1PO: 10,12

ST D13S317: 11

ST D16S539: 12,13

ST D3S1358: 14

ST D5S818: 10,11

ST D7S820: 8,10

ST FGA: 24

ST TH01: 5,7

ST TPOX: 9,11

ST vWA: 17,18

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_C590 ! FM55M2

OI CVCL_C591 ! FM55p

SX Male

CA Cancer cell line

ID FM55M2

AC CVCL_C590

SY FM-55-M2; FM 55 M2; FM55II

DR Cosmic; 808540

DR Cosmic; 972266

DR Cosmic; 1006225

DR Cosmic; 1047666

DR Cosmic; 2163768

DR ECACC; 13012559

DR ESTDAB; ESTDAB-013

DR GEO; GSM156043

RX PubMed=7656272;

RX PubMed=8968104;

RX PubMed=17260012;

CC Omics: Array-based CGH.

CC Derived from metastatic site: Subcutaneous.

ST Source(s): ECACC; ESTDAB

ST Amelogenin: X,Y

ST CSF1PO: 10,12

ST D13S317: 11

ST D16S539: 12,13

ST D3S1358: 14

ST D5S818: 10,11

ST D7S820: 8,10

ST FGA: 24

ST TH01: 5,7

ST TPOX: 9,11

ST vWA: 17,18

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_C589 ! FM55M1

OI CVCL_C591 ! FM55p

SX Male

CA Cancer cell line

ID FM55p

AC CVCL_C591

SY FM55P; FM-55-P; FM 55P

DR Cosmic; 808536

DR Cosmic; 972263

DR Cosmic; 1006223

DR ECACC; 13012417

DR ESTDAB; ESTDAB-014

RX PubMed=7656272;

RX PubMed=8968104;

ST Source(s): ECACC; ESTDAB

ST Amelogenin: X,Y

ST CSF1PO: 10,12

ST D13S317: 11

ST D16S539: 12,13

ST D3S1358: 14

ST D5S818: 10,11

ST D7S820: 8,10

ST FGA: 24

ST TH01: 5,7

ST TPOX: 9,11

ST vWA: 17,18

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_C589 ! FM55M1

OI CVCL_C590 ! FM55M2

SX Male

CA Cancer cell line

ID FM55p.R22.2

AC CVCL_C592

SY FM-55-p.R22.2

DR ECACC; 13012462

DR ESTDAB; ESTDAB-015

ST Source(s): ECACC; ESTDAB

ST Amelogenin: X,Y

ST CSF1PO: 10,12

ST D13S317: 11

ST D16S539: 12,13

ST D3S1358: 14

ST D5S818: 10,11

ST D7S820: 8,10

ST FGA: 24

ST TH01: 5,7

ST TPOX: 9,11

ST vWA: 17,18

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_C591 ! FM55p

SX Male

CA Cancer cell line

ID FM56

AC CVCL_C593

SY FM-56

DR Cosmic; 1047667

DR Cosmic; 2163769

DR ECACC; 13012427

DR ESTDAB; ESTDAB-016

DR GEO; GSM156039

RX PubMed=17260012;

CC Omics: Array-based CGH.

ST Source(s): ECACC; ESTDAB

ST Amelogenin: X

ST CSF1PO: 11,12

ST D13S317: 8,12

ST D16S539: 11,12

ST D3S1358: 15,18

ST D5S818: 11,12

ST D7S820: 10

ST FGA: 21,24

ST TH01: 6,7

ST TPOX: 8,9

ST vWA: 15,18

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FM57

AC CVCL_C594

SY FM-57

DR Cosmic; 808546

DR Cosmic; 874439

DR Cosmic; 1047668

DR Cosmic; 2163770

DR ECACC; 13012418

DR ESTDAB; ESTDAB-017

DR GEO; GSM156034

RX PubMed=8968104;

RX PubMed=17260012;

CC Omics: Array-based CGH.

ST Source(s): ECACC; ESTDAB

ST Amelogenin: X

ST CSF1PO: 11

ST D13S317: 12 (ECACC)

ST D13S317: 8,9 (ESTDAB)

ST D16S539: 11,12

ST D3S1358: 15,17

ST D5S818: 13 (ECACC)

ST D5S818: 12,13 (ESTDAB)

ST D7S820: 8,10

ST FGA: 22,23

ST TH01: 7,10

ST TPOX: 8,11

ST vWA: 16,17

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FM58

AC CVCL_C595

SY FM-58; FM 58

DR Cosmic; 808555

DR Cosmic; 874440

DR Cosmic; 972265

DR Cosmic; 1006229

DR Cosmic; 1047669

DR Cosmic; 2163771

DR ECACC; 13012414

DR ESTDAB; ESTDAB-018

DR GEO; GSM156046

RX PubMed=8968104;

RX PubMed=17260012;

CC Omics: Array-based CGH.

CC Derived from metastatic site: Skin.

ST Source(s): ECACC; ESTDAB

ST Amelogenin: X,Y

ST CSF1PO: 11

ST D13S317: 12

ST D16S539: 12

ST D3S1358: 16,17

ST D5S818: 11,12

ST D7S820: 10,11

ST FGA: 22

ST TH01: 6

ST TPOX: 8,10

ST vWA: 16

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FM59

AC CVCL_C596

RX PubMed=9288767;

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FM6

AC CVCL_C581

SY FM-6; FM 6

DR Cosmic; 808554

DR Cosmic; 874437

DR Cosmic; 972278

DR Cosmic; 1047670

DR Cosmic; 2163772

DR ECACC; 13012409

DR ESTDAB; ESTDAB-019

DR GEO; GSM156021

RX PubMed=7656272;

RX PubMed=8968104;

RX PubMed=9288767;

RX PubMed=17260012;

CC Omics: Array-based CGH.

CC Derived from metastatic site: Not specified.

ST Source(s): ECACC; ESTDAB

ST Amelogenin: X,Y

ST CSF1PO: 11

ST D13S317: 12

ST D16S539: 11,12

ST D3S1358: 14

ST D5S818: 9,13

ST D7S820: 9,10

ST FGA: 23,24

ST TH01: 9,9.3

ST TPOX: 11,12

ST vWA: 15,18

DI NCIt; C3510; Cutaneous melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FM60

AC CVCL_C597

DR Cosmic; 808551

DR Cosmic; 851442

DR Cosmic; 1006230

RX PubMed=8968104;

RX PubMed=9288767;

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FM62

AC CVCL_9676

DR Cosmic; 808548

DR Cosmic; 851419

DR Cosmic; 1047671

DR GEO; GSM156011

RX PubMed=8968104;

RX PubMed=9288767;

RX PubMed=17260012;

CC Omics: Array-based CGH.

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FM66

AC CVCL_C599

DR Cosmic; 808547

DR Cosmic; 1047672

DR GEO; GSM156028

RX PubMed=8968104;

RX PubMed=9288767;

RX PubMed=17260012;

CC Omics: Array-based CGH.

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FM69

AC CVCL_C600

DR Cosmic; 1047673

DR GEO; GSM156023

RX PubMed=9288767;

RX PubMed=17260012;

CC Omics: Array-based CGH.

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FM70

AC CVCL_C601

SY FM-70

DR Cosmic; 808553

DR Cosmic; 851408

DR Cosmic; 2163773

DR ECACC; 13012491

DR ESTDAB; ESTDAB-020

RX PubMed=8968104;

RX PubMed=9288767;

ST Source(s): ECACC; ESTDAB

ST Amelogenin: X

ST CSF1PO: 11

ST D13S317: 12,13

ST D16S539: 11

ST D3S1358: 14,18

ST D5S818: 11

ST D7S820: 10,11

ST FGA: 22,24

ST TH01: 9.3

ST TPOX: 8,11

ST vWA: 16

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID FM72

AC CVCL_C602

SY FM-72

DR Cosmic; 851401

DR Cosmic; 1047674

DR Cosmic; 2163774

DR ECACC; 13012415

DR ESTDAB; ESTDAB-021

DR GEO; GSM156040

RX PubMed=9288767;

RX PubMed=17260012;

CC Omics: Array-based CGH.

ST Source(s): ECACC; ESTDAB

ST Amelogenin: X

ST CSF1PO: 10,12

ST D13S317: 12

ST D16S539: 11

ST D3S1358: 15

ST D5S818: 12

ST D7S820: 12

ST FGA: 21,25

ST TH01: 6,7

ST TPOX: 8,11

ST vWA: 18

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FM74

AC CVCL_C603

SY FM-74

DR Cosmic; 808559

DR Cosmic; 1047675

DR ECACC; 13012422

DR ESTDAB; ESTDAB-022

DR GEO; GSM156015

RX PubMed=8968104;

RX PubMed=17260012;

CC Omics: Array-based CGH.

ST Source(s): ECACC; ESTDAB

ST Amelogenin: X,Y

ST CSF1PO: 11,12

ST D13S317: 8,9 (ECACC)

ST D13S317: 12 (ESTDAB)

ST D16S539: 12

ST D3S1358: 15,16

ST D5S818: 12,13 (ECACC)

ST D5S818: 13 (ESTDAB)

ST D7S820: 8,9 (ECACC)

ST D7S820: 8,10 (ESTDAB)

ST FGA: 20,21

ST TH01: 9.3

ST TPOX: 9,12

ST vWA: 16,17

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FM76

AC CVCL_9677

DR Cosmic; 808549

DR Cosmic; 1047676

DR GEO; GSM156037

RX PubMed=8968104;

RX PubMed=9288767;

RX PubMed=17260012;

CC Omics: Array-based CGH.

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_9678 ! FM81

SX Male

CA Cancer cell line

ID FM77

AC CVCL_C605

DR Cosmic; 808552

RX PubMed=8968104;

RX PubMed=9288767;

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FM78

AC CVCL_C606

SY FM-78

DR Cosmic; 1047677

DR Cosmic; 2163775

DR ECACC; 13012420

DR ESTDAB; ESTDAB-023

DR GEO; GSM156029

RX PubMed=9288767;

RX PubMed=17260012;

CC Omics: Array-based CGH.

ST Source(s): ECACC; ESTDAB

ST Amelogenin: X

ST CSF1PO: 10,11

ST D13S317: 8,11

ST D16S539: 12

ST D3S1358: 17

ST D5S818: 12

ST D7S820: 10

ST FGA: 22,24

ST TH01: 9,9.3

ST TPOX: 8,11

ST vWA: 15,16

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FM79

AC CVCL_C607

SY FM-79

DR Cosmic; 808556

DR Cosmic; 874441

DR Cosmic; 1047678

DR Cosmic; 1181766

DR Cosmic; 2163776

DR ECACC; 13012423

DR ESTDAB; ESTDAB-024

DR GEO; GSM156048

RX PubMed=8968104;

RX PubMed=9288767;

RX PubMed=17260012;

CC Omics: Array-based CGH.

ST Source(s): ECACC; ESTDAB

ST Amelogenin: X

ST CSF1PO: 10,12

ST D13S317: 11,12

ST D16S539: 12,13

ST D3S1358: 14,18

ST D5S818: 10,12

ST D7S820: 10,12

ST FGA: 23,24

ST TH01: 9

ST TPOX: 8

ST vWA: 16,17

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FM81

AC CVCL_9678

SY FM-81

DR Cosmic; 851415

DR Cosmic; 2163777

DR ECACC; 13012428

DR ESTDAB; ESTDAB-026

RX PubMed=9288767;

ST Source(s): ECACC; ESTDAB

ST Amelogenin: X,Y

ST CSF1PO: 13

ST D13S317: 11

ST D16S539: 11

ST D3S1358: 14

ST D5S818: 12,13

ST D7S820: 9

ST FGA: 20,26

ST TH01: 9.3

ST TPOX: 8

ST vWA: 17,18

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_9677 ! FM76

SX Male

CA Cancer cell line

ID FM82

AC CVCL_C609

SY FM-82

DR Cosmic; 851404

DR Cosmic; 1181749

DR Cosmic; 1047679

DR Cosmic; 2163778

DR ECACC; 13012426

DR ESTDAB; ESTDAB-027

DR GEO; GSM156030

RX PubMed=9288767;

RX PubMed=17260012;

CC Omics: Array-based CGH.

ST Source(s): ECACC; ESTDAB

ST Amelogenin: X

ST CSF1PO: 14

ST D13S317: 8 (ECACC)

ST D13S317: 8,10 (ESTDAB)

ST D16S539: 11,13

ST D3S1358: 18

ST D5S818: 12

ST D7S820: 11

ST FGA: 24,25

ST TH01: 6,8

ST TPOX: 8,11

ST vWA: 15,16

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID FM86

AC CVCL_C610

SY FM-86

DR Cosmic; 1047680

DR Cosmic; 2163779

DR ESTDAB; ESTDAB-028

DR GEO; GSM156035

RX PubMed=17260012;

CC Omics: Array-based CGH.

ST Source(s): ESTDAB

ST Amelogenin: X

ST CSF1PO: 11,12

ST D13S317: 11,12

ST D3S1358: 15,17

ST D5S818: 11

ST D7S820: 8,12

ST FGA: 20,21

ST TH01: 6

ST TPOX: 8,11

ST vWA: 15,17

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID FM87

AC CVCL_C611

DR Cosmic; 1132582

RX PubMed=9288767;

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FM88

AC CVCL_9679

SY FM-88

DR Cosmic; 851422

DR Cosmic; 874442

DR Cosmic; 1047681

DR Cosmic; 1181745

DR Cosmic; 1221591

DR Cosmic; 2163780

DR ECACC; 13012421

DR ESTDAB; ESTDAB-029

DR GEO; GSM156049

RX PubMed=9288767;

RX PubMed=17260012;

CC Omics: Array-based CGH.

CC Derived from metastatic site: Skin.

ST Source(s): ECACC; ESTDAB

ST Amelogenin: X,Y

ST CSF1PO: 11

ST D13S317: 10,12

ST D16S539: 9,13

ST D3S1358: 15,16

ST D5S818: 11

ST D7S820: 12

ST FGA: 21,23

ST TH01: 7,9

ST TPOX: 9,11

ST vWA: 16,19

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FM89

AC CVCL_C613

RX PubMed=9288767;

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FM9

AC CVCL_C582

SY FM-9

DR Cosmic; 808557

DR Cosmic; 874475

DR Cosmic; 1047682

DR Cosmic; 2163781

DR ECACC; 13012416

DR ESTDAB; ESTDAB-030

DR GEO; GSM156036

RX PubMed=7656272;

RX PubMed=8968104;

RX PubMed=9288767;

RX PubMed=17260012;

CC Omics: Array-based CGH.

CC Derived from metastatic site: Not specified.

ST Source(s): ECACC; ESTDAB

ST Amelogenin: X

ST CSF1PO: 10,13

ST D13S317: 11,12

ST D16S539: 8,11

ST D3S1358: 16

ST D5S818: 11,12

ST D7S820: 11

ST FGA: 22

ST TH01: 8

ST TPOX: 8,10

ST vWA: 15,19

DI NCIt; C3510; Cutaneous melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID FM91

AC CVCL_C614

DR Cosmic; 874443

RX PubMed=9288767;

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FM92

AC CVCL_C615

SY FM-92

DR Cosmic; 851402

DR Cosmic; 1006227

DR Cosmic; 1047683

DR Cosmic; 2163782

DR ECACC; 13012429

DR ESTDAB; ESTDAB-032

DR GEO; GSM156044

RX PubMed=17260012;

CC Omics: Array-based CGH.

ST Source(s): ECACC; ESTDAB

ST Amelogenin: X,Y

ST CSF1PO: 10,11

ST D13S317: 11,12

ST D16S539: 13,14

ST D3S1358: 15,18

ST D5S818: 11,12

ST D7S820: 10,11

ST FGA: 20

ST TH01: 8

ST TPOX: 8

ST vWA: 15,19

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FM93

AC CVCL_9680

DR Cosmic; 1047684

DR GEO; GSM156038

RX PubMed=9288767;

RX PubMed=17260012;

CC Omics: Array-based CGH.

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FM93/2

AC CVCL_C617

SY FM-93/2

DR Cosmic; 2163783

DR ECACC; 13012419

DR ESTDAB; ESTDAB-033

ST Source(s): ECACC; ESTDAB

ST Amelogenin: X

ST CSF1PO: 12,14

ST D13S317: 11

ST D16S539: 11,12

ST D3S1358: 18

ST D5S818: 11,12

ST D7S820: 9

ST FGA: 20

ST TH01: 9,9.3

ST TPOX: 9

ST vWA: 17,18 (ECACC)

ST vWA: 17 (ESTDAB)

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FM95

AC CVCL_C618

SY FM-95

DR Cosmic; 851403

DR Cosmic; 1047685

DR Cosmic; 2163784

DR ECACC; 13012425

DR ESTDAB; ESTDAB-034

DR GEO; GSM156012

RX PubMed=17260012;

CC Omics: Array-based CGH.

CC Discontinued: ESTDAB; ESTDAB-034; probable.

CC Derived from metastatic site: Skin.

ST Source(s): ECACC

ST Amelogenin: X,Y

ST CSF1PO: 10,11

ST D13S317: 9,10

ST D16S539: 9,13

ST D5S818: 12,13

ST D7S820: 8,11

ST TH01: 9.3

ST TPOX: 8

ST vWA: 15,18

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FM95-14

AC CVCL_EQ50

SY Fetal Myoblast 95-14

DR GEO; GSM86678

DR GEO; GSM86679

DR GEO; GSM86680

DR GEO; GSM86681

DR GEO; GSM86682

DR GEO; GSM86683

DR GEO; GSM86684

DR GEO; GSM86685

DR GEO; GSM86686

DR GEO; GSM86687

DR GEO; GSM86688

DR GEO; GSM86689

DR GEO; GSM86690

DR GEO; GSM86691

DR GEO; GSM86692

DR GEO; GSM86693

DR GEO; GSM86694

DR GEO; GSM86695

DR GEO; GSM86696

DR GEO; GSM86697

DR GEO; GSM86698

DR GEO; GSM86699

DR GEO; GSM86700

DR GEO; GSM86701

DR GEO; GSM86702

DR GEO; GSM86703

DR GEO; GSM86704

DR GEO; GSM86705

DR GEO; GSM86706

DR GEO; GSM86707

DR GEO; GSM86708

DR GEO; GSM86709

DR GEO; GSM86710

DR GEO; GSM86711

DR GEO; GSM86712

DR GEO; GSM86713

DR GEO; GSM86714

DR GEO; GSM86715

DR GEO; GSM86716

DR GEO; GSM86717

DR GEO; GSM86718

DR GEO; GSM86719

DR GEO; GSM86720

DR GEO; GSM86721

DR GEO; GSM86722

DR GEO; GSM86723

DR GEO; GSM86724

DR GEO; GSM86725

DR GEO; GSM86726

DR GEO; GSM86727

DR GEO; GSM86728

DR GEO; GSM86729

DR GEO; GSM86730

DR GEO; GSM86731

DR GEO; GSM86732

DR GEO; GSM86733

DR GEO; GSM86734

DR GEO; GSM86735

DR GEO; GSM86736

DR GEO; GSM86737

CC Omics: Transcriptome analysis.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Finite cell line

ID FMA3

AC CVCL_0264

SY FMA-3; FMA/3

DR MCCL; MCC:0000155

RX PubMed=134824;

RX PubMed=8547652;

CC Breed/subspecies: LAF1.

DI NCIt; C21632; Mouse mast cell neoplasm

OX NCBI_TaxID=10090; ! Mus musculus

CA Cancer cell line

ID FMB

AC CVCL_E665

DR dbMHC; 48861

DR ECACC; 94022529

DR IHW; IHW9233

DR IMGT/HLA; 10585

WW http://bioinformatics.hsanmartino.it/ecbr/cl233.html

CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC Discontinued: ECACC; 94022529; probable.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Sex undetermined

CA Transformed cell line

ID FMC-RB1

AC CVCL_S615

RX PubMed=2838158;

RX PubMed=2935245;

DI NCIt; C7541; Retinoblastoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FMCm

AC CVCL_T990

RX PubMed=16397390;

CC Derived from metastatic site: Lymph node.

CC Breed/subspecies: Japanese domestic.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_T991 ! FMCp1

OI CVCL_T992 ! FMCp2

SX Female

CA Cancer cell line

ID FMCp1

AC CVCL_T991

RX PubMed=16397390;

CC Breed/subspecies: Japanese domestic.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_T990 ! FMCm

OI CVCL_T992 ! FMCp2

SX Female

CA Cancer cell line

ID FMCp2

AC CVCL_T992

RX PubMed=16397390;

CC Breed/subspecies: Japanese domestic.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_T990 ! FMCm

OI CVCL_T991 ! FMCp1

SX Female

CA Cancer cell line

ID FME

AC CVCL_0B57

RX PubMed=7426299;

RX PubMed=7999427;

CC Derived from metastatic site: Inguinal lymph node.

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID FMN-R

AC CVCL_0I54

DR CCLV; CCLV-RIE 1102

RX PubMed=19941903;

OX NCBI_TaxID=47230; ! Microtus arvalis

CA Finite cell line

ID FMS

AC CVCL_9V01

SY FMSmel

RX PubMed=9331097;

RX PubMed=10395702;

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FMS-1

AC CVCL_IS33

RX PubMed=19921253;

CC Doubling time: ~38.5 hours (PubMed=19921253).

DI NCIt; C3798; Malignant peripheral nerve sheath tumor

DI NCIt; C3273; Neurofibromatosis type 1

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID FN-E

AC CVCL_0C09

RX PubMed=7736387;

DI NCIt; C5214; Breast adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID FNB6 hTERT

AC CVCL_F734

DR Ximbio; 151634

CC Transfected with: HGNC; 11730; TERT.

OX NCBI_TaxID=9606; ! Homo sapiens

CA Telomerase immortalized cell line

ID FNC-A6

AC CVCL_1D74

SY FNCA6

RX PubMed=7790915;

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Finite cell line

ID FNC-B4

AC CVCL_1D75

SY FNCB4

RX PubMed=7790915;

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Finite cell line

ID FNCB4-hTERT

AC CVCL_M960

SY FNC-B4-hTERT

RX CelloPub=CLPUB00248;

CC Transfected with: HGNC; 11730; TERT.

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_1D75 ! FNC-B4

SX Male

CA Telomerase immortalized cell line

ID FNNm

AC CVCL_T993

RX PubMed=16397390;

CC Derived from metastatic site: Pleural effusion.

CC Breed/subspecies: Persian.

OX NCBI_TaxID=9685; ! Felis catus

SX Female

CA Cancer cell line

ID FNS

AC CVCL_6392

DR CLO; CLO_0003376

DR ATCC; CRL-6170

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6170; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Sex undetermined

CA Undefined cell line type

ID FO [Human B-cell]

AC CVCL_E666

SY FORE-9334

DR dbMHC; 48863

DR IHW; IHW9334

DR IMGT/HLA; 10586

WW http://bioinformatics.hsanmartino.it/ecbr/cl334.html

CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Sex undetermined

CA Transformed cell line

ID FO [Mouse myeloma]

AC CVCL_6972

DR CLO; CLO_0003377

DR ATCC; CRL-1646

DR BCRC; 60040

DR CCRID; 3131C0001000800031

DR KCB; KCB 2014046YJ

RX PubMed=7009747;

WW http://www.addexbio.com/productdetail?pid=4886

CC Group: Hybridoma fusion partner cell line.

CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.

CC Breed/subspecies: BALB/c.

DI NCIt; C125417; Mouse plasma cell myeloma

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2199 ! Sp2/0-Ag14

SX Female

CA Cancer cell line

ID FO-4

AC CVCL_6393

DR CLO; CLO_0003378

DR ATCC; CRL-6171

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6171; true.

OX NCBI_TaxID=9685; ! Felis catus

SX Sex undetermined

CA Undefined cell line type

ID FO1-12

AC CVCL_GZ38

SY Fo1-12; FO-1 #12

DR ATCC; CRL-12177

DR TOKU-E; 3586

RX Patent=US6063375;

RX PubMed=10746551;

RX PubMed=10983636;

CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).

CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC Transformant: NCIt; C44386; Gamma radiation.

CC Discontinued: ATCC; CRL-12177; probable.

DI NCIt; C3802; Amelanotic melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_5619 ! MEL-CLS-1

SX Female

CA Cancer cell line

ID FOC1.K

AC CVCL_U959

SY FOc1K; FOC1

DR ATCC; CRL-6499

CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC Discontinued: ATCC; CRL-6499; true.

OX NCBI_TaxID=9986; ! Oryctolagus cuniculus

CA Finite cell line

ID FOCUS

AC CVCL_7955

SY Focus; Friendship Of China and United States

DR Cosmic; 873400

DR Cosmic; 948067

DR Cosmic; 979731

DR Cosmic; 2321034

RX PubMed=6086498;

RX PubMed=25574106;

CC Doubling time: 42-48 hours (PubMed=6086498).

CC Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).

DI NCIt; C3099; Hepatocellular carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FoLu

AC CVCL_3310

SY Folu; Fox lung

DR CLO; CLO_0003379

DR CLDB; cl1383

DR ATCC; CCL-168

DR ECACC; 90120501

DR IZSLER; BS CL 171

DR KCB; KCB 94021YJ

RX PubMed=7065527;

WW http://fluoview.magnet.fsu.edu/gallery/cells/folu/folucells.html

OX NCBI_TaxID=55040; ! Urocyon cinereoargenteus

SX Female

CA Finite cell line

ID FOM 71

AC CVCL_5751

SY FOM71

DR BTO; BTO:0004818

OX NCBI_TaxID=9606; ! Homo sapiens

CA Finite cell line

ID FOM 78

AC CVCL_5752

SY FOM78

DR BTO; BTO:0004819

OX NCBI_TaxID=9606; ! Homo sapiens

CA Finite cell line

ID FONm

AC CVCL_T994

RX PubMed=16397390;

CC Derived from metastatic site: Lymph node.

CC Breed/subspecies: Siamese.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_T995 ! FONp

SX Female

CA Cancer cell line

ID FONp

AC CVCL_T995

RX PubMed=16397390;

CC Breed/subspecies: Siamese.

OX NCBI_TaxID=9685; ! Felis catus

OI CVCL_T994 ! FONm

SX Female

CA Cancer cell line

ID FORE

AC CVCL_E667

SY FORE-9317; TER330

DR dbMHC; 48862

DR ECACC; 94050305

DR IHW; IHW9317

DR IMGT/HLA; 10587

WW http://bioinformatics.hsanmartino.it/ecbr/cl317.html

CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FOS_1077

AC CVCL_FA26

RX DOI=10.3390/vetsci3020009;

CC Breed/subspecies: Domestic shorthair.

OX NCBI_TaxID=9685; ! Felis catus

SX Female

CA Cancer cell line

ID FOS_1140

AC CVCL_FA27

RX DOI=10.3390/vetsci3020009;

CC Breed/subspecies: Domestic shorthair.

OX NCBI_TaxID=9685; ! Felis catus

SX Male

CA Cancer cell line

ID FOX-NY

AC CVCL_6971

SY Fox/NY

DR CLO; CLO_0003380

DR ATCC; CRL-1732

DR CCRID; 3111C0001CCC000065

CC Group: Hybridoma fusion partner cell line.

CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.

CC Breed/subspecies: BALB/c.

DI NCIt; C125417; Mouse plasma cell myeloma

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2155 ! P3/NS1/1-Ag4.1

SX Female

CA Cancer cell line

ID FPAF

AC CVCL_E668

SY FPF; FPA; GM03106

DR CLO; CLO_0013568

DR Coriell; GM03106

DR dbMHC; 48864

DR ECACC; 95051624

DR IHW; IHW9105

DR IMGT/HLA; 10588

WW http://bioinformatics.hsanmartino.it/ecbr/cl105.html

CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FPBH

AC CVCL_F123

RX PubMed=15192123;

CC From: Vetterlein M.; Institute of Tumour Biology and Cancer Research, University of Vienna; Vienna; Austria.

DI NCIt; C4817; Ewing sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FPC15JTO

AC CVCL_2905

DR JCRB; JCRB0319

ST Source(s): JCRB

ST Amelogenin: X

ST CSF1PO: 10

ST D13S317: 11

ST D16S539: 9,11

ST D5S818: 10,11

ST D7S820: 10,11

ST TH01: 7

ST TPOX: 8,11

ST vWA: 15,18

DI NCIt; C3339; Familial adenomatous polyposis

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Finite cell line

ID FPC5JTO

AC CVCL_2906

DR JCRB; JCRB0318

ST Source(s): JCRB

ST Amelogenin: X,Y

ST CSF1PO: 10,12

ST D13S317: 12

ST D16S539: 10,12

ST D5S818: 10,11

ST D7S820: 11,12

ST TH01: 7,9

ST TPOX: 8,11

ST vWA: 17,19

DI NCIt; C3339; Familial adenomatous polyposis

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Finite cell line

ID FPMI-CF-203

AC CVCL_Z469

SY FPMI-Cf-203; CF-203

RX CelloPub=CLPUB00186;

RX PubMed=8806500;

CC Group: Insect cell line.

OX NCBI_TaxID=7141; ! Choristoneura fumiferana

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FPMI-CF-50

AC CVCL_Z470

SY CF-50

RX DOI=10.1139/z85-337;

CC Group: Insect cell line.

OX NCBI_TaxID=7141; ! Choristoneura fumiferana

SX Female

CA Spontaneously immortalized cell line

ID FPMI-CF-60

AC CVCL_Z471

SY CF-60

RX DOI=10.1139/z85-337;

CC Group: Insect cell line.

OX NCBI_TaxID=7141; ! Choristoneura fumiferana

SX Female

CA Spontaneously immortalized cell line

ID FPMI-CF-70

AC CVCL_Z472

SY FPMI-Cf-70; CF-70

RX DOI=10.1016/0022-1910(94)00139-8;

RX DOI=10.1139/z85-337;

CC Group: Insect cell line.

OX NCBI_TaxID=7141; ! Choristoneura fumiferana

SX Female

CA Spontaneously immortalized cell line

ID FPMI-MS-12

AC CVCL_Z446

RX DOI=10.1385/0-89603-272-8:397;

CC Group: Insect cell line.

OX NCBI_TaxID=7130; ! Manduca sexta

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FPMI-MS-4

AC CVCL_Z448

RX DOI=10.1385/0-89603-272-8:397;

CC Group: Insect cell line.

OX NCBI_TaxID=7130; ! Manduca sexta

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FPMI-MS-5

AC CVCL_Z449

SY FPMI-Ms-5

RX DOI=10.1385/0-89603-272-8:397;

CC Group: Insect cell line.

OX NCBI_TaxID=7130; ! Manduca sexta

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FPMI-MS-7

AC CVCL_Z450

RX DOI=10.1385/0-89603-272-8:397;

CC Group: Insect cell line.

OX NCBI_TaxID=7130; ! Manduca sexta

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FPMI-NL-1

AC CVCL_GZ68

SY NL-1

RX CelloPub=CLPUB00187;

CC Group: Insect cell line.

OX NCBI_TaxID=441921; ! Neodiprion lecontei

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FPMI-NL-10

AC CVCL_Z491

SY NL-10

RX CelloPub=CLPUB00187;

RX DOI=10.1139/z85-337;

CC Group: Insect cell line.

OX NCBI_TaxID=441921; ! Neodiprion lecontei

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FPMI-NL-18

AC CVCL_Z492

SY NL-18

RX CelloPub=CLPUB00187;

RX DOI=10.1139/z85-337;

CC Group: Insect cell line.

OX NCBI_TaxID=441921; ! Neodiprion lecontei

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FPMI-NL-2

AC CVCL_Z493

SY NL-2

RX CelloPub=CLPUB00187;

RX DOI=10.1139/z85-337;

CC Group: Insect cell line.

OX NCBI_TaxID=441921; ! Neodiprion lecontei

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FPMI-NL-21

AC CVCL_Z494

SY NL-21

RX CelloPub=CLPUB00187;

RX DOI=10.1139/z85-337;

CC Group: Insect cell line.

OX NCBI_TaxID=441921; ! Neodiprion lecontei

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FPMI-NL-22

AC CVCL_Z495

SY NL-22

RX CelloPub=CLPUB00187;

RX DOI=10.1139/z85-337;

CC Group: Insect cell line.

OX NCBI_TaxID=441921; ! Neodiprion lecontei

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FPMI-NL-27

AC CVCL_GZ69

SY NL-27

RX CelloPub=CLPUB00187;

CC Group: Insect cell line.

OX NCBI_TaxID=441921; ! Neodiprion lecontei

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FPMI-NL-28

AC CVCL_Z496

SY NL-28

RX CelloPub=CLPUB00187;

RX DOI=10.1139/z85-337;

CC Group: Insect cell line.

OX NCBI_TaxID=441921; ! Neodiprion lecontei

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FPMI-NL-31

AC CVCL_GZ70

SY NL-31

RX CelloPub=CLPUB00187;

CC Group: Insect cell line.

OX NCBI_TaxID=441921; ! Neodiprion lecontei

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FPMI-NL-32

AC CVCL_Z497

RX DOI=10.1139/z85-337;

CC Group: Insect cell line.

OX NCBI_TaxID=441921; ! Neodiprion lecontei

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FPMI-NL-4

AC CVCL_Z498

SY NL-4

RX CelloPub=CLPUB00187;

RX DOI=10.1139/z85-337;

CC Group: Insect cell line.

OX NCBI_TaxID=441921; ! Neodiprion lecontei

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FPS-1

AC CVCL_M792

RX PubMed=17094458;

CC Characteristics: Has lost chromosome Y.

CC Doubling time: ~36.5 hours (PubMed=17094458).

DI NCIt; C4247; Unclassified pleomorphic sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FQ

AC CVCL_L984

DR BioSample; SAMN03151876

RX PubMed=68093;

RX PubMed=265539;

RX PubMed=7005696;

RX PubMed=7192801;

RX PubMed=12592342;

RX PubMed=20143388;

WW http://www.nytimes.com/1981/01/22/us/cells-in-disease-study-said-to-come-from-monkeys.html

WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC Group: Non-human primate cell line.

CC Problematic cell line: Misidentified. Originally thought to be of human origin but found to derive from OMK-210 from owl monkey (PubMed=7192801, PubMed=12592342, PubMed=20143388).

CC Anecdotal: Part of a set of 4 cell lines that were fraudulently stated to originate from Hodgkin's lymphoma (PubMed=265539).

OX NCBI_TaxID=9505; ! Aotus trivirgatus

HI CVCL_L983 ! OMK-210

SX Female

CA Undefined cell line type

ID FR

AC CVCL_4202

DR CLO; CLO_0003384

DR CLDB; cl1384

DR ATCC; CRL-1213

DR ECACC; 87020503

DR IZSLER; BS CL 195

WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/f/cell-lines-detail-504.html

CC Breed/subspecies: Sprague-Dawley.

OX NCBI_TaxID=10116; ! Rattus norvegicus

CA Finite cell line

ID FR-E

AC CVCL_0C10

DR NCBI_Iran; C564

RX PubMed=7736387;

RX PubMed=10100721;

CC Derived from metastatic site: Pericardial effusion.

DI NCIt; C4450; Large cell lung carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FR-M-101

AC CVCL_C544

DR Cosmic; 2163847

DR ESTDAB; ESTDAB-160

ST Source(s): ESTDAB

ST Amelogenin: X

ST CSF1PO: 11

ST D13S317: 11,12

ST D3S1358: 14,18

ST D5S818: 12

ST D7S820: 9,11

ST FGA: 22

ST TH01: 7

ST TPOX: 8,9

ST vWA: 16,19

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID FR-M-119

AC CVCL_C545

DR Cosmic; 2163848

DR ESTDAB; ESTDAB-161

ST Source(s): ESTDAB

ST Amelogenin: X,Y

ST CSF1PO: 11,12

ST D13S317: 11,13

ST D3S1358: 16,18

ST D5S818: 12

ST D7S820: 9,10

ST FGA: 22,25

ST TH01: 9.3

ST TPOX: 9,12

ST vWA: 17

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FR-M-134

AC CVCL_C546

DR ESTDAB; ESTDAB-162

ST Source(s): ESTDAB

ST Amelogenin: X

ST CSF1PO: 12,13

ST D13S317: 12

ST D3S1358: 16

ST D5S818: 10,12

ST D7S820: 12

ST FGA: 20,23

ST TH01: 6,8

ST TPOX: 8

ST vWA: 14,19

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID FR-M-170

AC CVCL_C547

DR Cosmic; 2163849

DR ESTDAB; ESTDAB-163

ST Source(s): ESTDAB

ST Amelogenin: X,Y

ST CSF1PO: 10

ST D13S317: 11,12

ST D3S1358: 16,18

ST D5S818: 13

ST D7S820: 9,12

ST FGA: 21,22

ST TH01: 6,9

ST TPOX: 8,11

ST vWA: 17

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FR-M-204

AC CVCL_C548

DR Cosmic; 2163850

DR ESTDAB; ESTDAB-164

ST Source(s): ESTDAB

ST Amelogenin: X

ST CSF1PO: 12

ST D13S317: 9,11

ST D3S1358: 14,16

ST D5S818: 12

ST D7S820: 11

ST FGA: 19,22

ST TH01: 7,9.3

ST TPOX: 8,10

ST vWA: 17

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID FR10B4

AC CVCL_CW50

DR NCBI_Iran; H165

CC Monoclonal antibody target: UniProtKB; P20273; Human CD22.

OX NCBI_TaxID=10090; ! Mus musculus

CA Hybridoma

ID FR4

AC CVCL_M505

SY FR-4

DR Cosmic; 720785

DR Cosmic; 2081381

DR Cosmic; 2367267

DR GEO; GSM143352

DR GEO; GSM290289

RX PubMed=1697013;

RX PubMed=10557056;

RX PubMed=10936422;

RX PubMed=11429052;

RX PubMed=12886255;

RX PubMed=17171682;

RX PubMed=18700954;

RX PubMed=19306352;

CC Omics: SNP array analysis.

CC Omics: Transcriptome analysis.

CC Derived from metastatic site: Ascites.

DI NCIt; C3242; Plasma cell myeloma

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_M504 ! AD3

SX Male

CA Cancer cell line

ID fR2

AC CVCL_2444

DR CLO; CLO_0003385

DR ECACC; 98031102

DR GEO; GSM827430

DR Ximbio; 153246

RX PubMed=6279290;

CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

ST Source(s): ECACC

ST Amelogenin: X

ST CSF1PO: 12,13

ST D13S317: 12

ST D16S539: 11,13

ST D5S818: 12,13

ST D7S820: 8,12

ST TH01: 9.3

ST TPOX: 8

ST vWA: 20

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_2445 ! fR5

SX Female

CA Transformed cell line

ID FR37-CMT

AC CVCL_CW16

RX PubMed=27140424;

CC Doubling time: 17 hours (PubMed=27140424).

DI NCIt; C124249; Canine mammary carcinoma

OX NCBI_TaxID=9615; ! Canis lupus familiaris

SX Female

CA Cancer cell line

ID FR3T3

AC CVCL_C691

SY FR-3T3; FR 3T3; Fisher rat 3T3

RX PubMed=201774;

RX PubMed=2535681;

RX PubMed=8455944;

CC Breed/subspecies: Fischer.

OX NCBI_TaxID=10116; ! Rattus norvegicus

CA Finite cell line

ID fR5

AC CVCL_2445

DR CLO; CLO_0003386

DR ECACC; 98031103

DR Ximbio; 153247

RX PubMed=6279290;

CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_2444 ! fR2

SX Female

CA Transformed cell line

ID FRAN4

AC CVCL_J149

DR CLO; CLO_0003387

DR ATCC; HB-10830

OX NCBI_TaxID=10090; ! Mus musculus

CA Hybridoma

ID Fravel

AC CVCL_M509

SY FRAVEL; Fr

RX PubMed=2537114;

RX PubMed=6804081;

RX PubMed=10087940;

RX PubMed=10936422;

DI NCIt; C3242; Plasma cell myeloma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FRE

AC CVCL_0B88

RX PubMed=3034934;

DI NCIt; C4917; Small cell lung carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FreeStyle 293-F

AC CVCL_D603

SY Freestyle 293; 293-F FreeStyle

DR BTO; BTO:0005267

WW http://www.thermofisher.com/order/catalog/product/R79007

WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/f/cell-lines-detail-421.html

CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_6642 ! HEK293-F

SX Female

CA Transformed cell line

ID FreeStyle CHO-S

AC CVCL_D604

WW http://www.thermofisher.com/order/catalog/product/R80007

OX NCBI_TaxID=10029; ! Cricetulus griseus

HI CVCL_7183 ! CHO-S

SX Female

CA Spontaneously immortalized cell line

ID FRFCB

AC CVCL_V373

DR IMGT/HLA; 14469

RX PubMed=16948657;

CC Part of: International Histocompatibility Workshop cell lines.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Sex undetermined

CA Transformed cell line

ID FRhK-4

AC CVCL_4522

SY FRHK-4; Frhk-4; FRhK4; Fetal Rhesus Kidney-4

DR CLO; CLO_0003388

DR CLDB; cl1385

DR ATCC; CRL-1688

DR BCRC; 60095

DR CCRID; 3131C0001000400018

DR CCRID; 3142C0001000000036

DR IZSLER; BS CL 115

RX PubMed=4633070;

CC Group: Non-human primate cell line.

OX NCBI_TaxID=9544; ! Macaca mulatta

OI CVCL_1E36 ! FRhL-4

SX Female

CA Spontaneously immortalized cell line

ID FRhK-4/R

AC CVCL_7223

SY Frhk-4/R; FRhK-4R

DR CLO; CLO_0003389

DR CLDB; cl1387

CC Group: Non-human primate cell line.

OX NCBI_TaxID=9544; ! Macaca mulatta

HI CVCL_4522 ! FRhK-4

SX Female

CA Spontaneously immortalized cell line

ID FRhL-4

AC CVCL_1E36

SY Fetal Rhesus Lung-4

RX PubMed=4203458;

RX PubMed=4633070;

CC Group: Non-human primate cell line.

OX NCBI_TaxID=9544; ! Macaca mulatta

OI CVCL_4522 ! FRhK-4

SX Female

CA Finite cell line

ID FRI

AC CVCL_J359

SY Fri; HCT-FRI

DR Cosmic; 711269

DR Cosmic; 887235

RX PubMed=3349466;

RX PubMed=7329817;

RX PubMed=9000147;

RX PubMed=9000572;

RX PubMed=11526487;

RX PubMed=24042735;

CC Microsatellite instability: Stable (MSS) (PubMed=9000147; PubMed=24042735).

CC Miscellaneous: STR profile mentioned but not shown in PubMed=24042735; obtained by personal communication of Lind G.E.

ST Source(s): PubMed=24042735

ST Amelogenin: X

ST CSF1PO: 10

ST D13S317: 11

ST D16S539: 12

ST D18S51: 13

ST D19S433: 12.2,14

ST D21S11: 27,29

ST D2S1338: 18

ST D3S1358: 15,17

ST D5S818: 12

ST D7S820: 9

ST D8S1179: 15,16

ST FGA: 20

ST TH01: 6,9.3

ST TPOX: 8,9

ST vWA: 18

DI NCIt; C4349; Colon adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FRI-AnCo-5B

AC CVCL_Z269

RX CelloPub=CLPUB00182;

CC Group: Insect cell line.

OX NCBI_TaxID=1069816; ! Anomala costata

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FRI-AnCu-35

AC CVCL_Z270

SY AnCu-35

RX PubMed=15117233;

CC Group: Insect cell line.

OX NCBI_TaxID=121601; ! Anomala cuprea

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FRI-MntH-520A

AC CVCL_Z369

RX CelloPub=CLPUB00163;

WW http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275039

CC Group: Insect cell line.

CC Doubling time: 6.93 days (CelloPub=CLPUB00163).

OX NCBI_TaxID=7098; ! Malacosoma neustria

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FRI-SpIm-1229

AC CVCL_Z133

DR CLO; CLO_0050005

DR NISES; SK0015

DR RCB; RCB0281

RX CelloPub=CLPUB00320;

RX DOI=10.1303/aez.23.488;

WW http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275021

CC Group: Insect cell line.

OX NCBI_TaxID=1578839; ! Lemyra imparilis

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FRIWT-8

AC CVCL_4908

SY WT-8; WT8

DR BTO; BTO:0003313

RX PubMed=1889088;

CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).

CC Transfected with: MGI; MGI:104878; Prkar1a.

CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC Breed/subspecies: AxC.

DI NCIt; C60416; Rat hepatocellular carcinoma

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_5124 ! FTO-2B

SX Male

CA Cancer cell line

ID FRM [Cat mammary tumor]

AC CVCL_T988

RX PubMed=9764406;

OX NCBI_TaxID=9685; ! Felis catus

SX Female

CA Cancer cell line

ID FRM [Human melanoma]

AC CVCL_M212

RX PubMed=12417263;

RX PubMed=19133143;

CC From: Zupi G.; Laboratory of Chemotherapy; Regina Elena Institute for Cancer Research; Rome; Italy.

DI NCIt; C3802; Amelanotic melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FRO

AC CVCL_6287

SY FRO81-2; Fro81-2; FRO 81-2

DR CGH-DB; 56-1

DR Cosmic; 685604

DR Cosmic; 849973

DR Cosmic; 918182

DR Cosmic; 931243

DR Cosmic; 990534

DR Cosmic; 1005457

DR Cosmic; 1094761

DR Cosmic; 1239981

DR Cosmic; 1699418

DR TOKU-E; 4067

RX PubMed=16924234;

RX PubMed=18713817;

ST Source(s): PubMed=18713817

ST Amelogenin: X,Y

ST D13S317: 9

ST D18S51: 12,15

ST D21S11: 28,30

ST D3S1358: 17

ST D5S818: 10,14

ST D7S820: 12,13

ST D8S1179: 13,14

ST FGA: 22

ST vWA: 16

DI NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID Frog-HSA

AC CVCL_0C97

SY FROG; Frog

RX PubMed=16797414;

RX PubMed=19461996;

WW https://www.kerafast.com/product/2265/canine-hemangiosarcoma-cell-line-frog

CC Doubling time: ~24 hours (Kerafast).

CC Breed/subspecies: Golden Retriever.

DI NCIt; C122783; Canine hemangiosarcoma

OX NCBI_TaxID=9615; ! Canis lupus familiaris

SX Female

CA Cancer cell line

ID FROv

AC CVCL_IS35

SY FROV; Fetalen Rinder Ovar

RX Patent=US5804430;

CC Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2051.

CC Breed/subspecies: Holstein Friesian.

OX NCBI_TaxID=9913; ! Bos taurus

SX Female

CA Spontaneously immortalized cell line

ID Frp/3

AC CVCL_W665

SY FrP3; Frp3

DR IZSLER; BS CL 169

RX PubMed=2997478;

CC Group: Non-human primate cell line.

OX NCBI_TaxID=9544; ! Macaca mulatta

HI CVCL_4522 ! FRhK-4

SX Female

CA Spontaneously immortalized cell line

ID FRSK

AC CVCL_5501

SY Fetal Rat Skin Keratinocytes

DR JCRB; JCRB0005

RX PubMed=894748;

RX PubMed=2172343;

RX PubMed=2428814;

CC Transformant: ChEBI; CHEBI:29865; Benzo[a]pyrene.

CC Breed/subspecies: Sprague-Dawley.

OX NCBI_TaxID=10116; ! Rattus norvegicus

CA Transformed cell line

ID FRSN

AC CVCL_6F51

RX PubMed=22567895;

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Adult stem cell

ID FRTK-1

AC CVCL_4W35

RX PubMed=16820901;

CC Doubling time: ~24 hours (PubMed=16820901).

DI NCIt; C8715; Rhabdoid tumor of the kidney

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FRTL

AC CVCL_5753

SY FRT-L; Fischer Rat Thyroid Low-serum

DR CLO; CLO_0003392

DR ATCC; CRL-1468

DR CLS; 500202/p2120_FRTL

DR TOKU-E; 1281

RX PubMed=1726925;

CC Breed/subspecies: Fischer.

OX NCBI_TaxID=10116; ! Rattus norvegicus

CA Finite cell line

ID FRTL-5

AC CVCL_0265

SY FRTL5; FRTL-5 Cl 2

DR BTO; BTO:0001875

DR CLO; CLO_0003396

DR MCCL; MCC:0000156

DR CLDB; cl1395

DR ATCC; CRL-8305

DR ChEMBL-Cells; CHEMBL3308088

DR ChEMBL-Targets; CHEMBL613879

DR CLS; 500407/p559_FRTL-5

DR ECACC; 91030711

RX Patent=US4608341;

RX PubMed=1726925;

RX PubMed=3670314;

RX PubMed=9709917;

CC Breed/subspecies: Fischer.

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_5753 ! FRTL

CA Spontaneously immortalized cell line

ID FRTL-Tc

AC CVCL_J436

RX PubMed=1968381;

CC Breed/subspecies: Fischer.

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_5753 ! FRTL

CA Spontaneously immortalized cell line

ID FS 6

AC CVCL_CW15

DR ATCC; CRL-3099

CC Breed/subspecies: BALB/c.

DI NCIt; C24017; Mouse fibrosarcoma

OX NCBI_TaxID=10090; ! Mus musculus

CA Cancer cell line

ID FS-1 [Human leukemia]

AC CVCL_2907

SY FS-A

DR BioSample; SAMN03472797

DR IFO; IFO50477

RX PubMed=8724543;

WW http://www.cells-talk.com/index.php/page/copelibrary?key=FS-1

ST Source(s): JCRB

ST Amelogenin: X,Y

ST CSF1PO: 12

ST D13S317: 8,11

ST D16S539: 11

ST D5S818: 12

ST D7S820: 10,12

ST TH01: 6,7

ST TPOX: 9,11

ST vWA: 16,18

DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FS-1 [Human maxillary sinus SCC]

AC CVCL_W511

RX PubMed=7591301;

DI NCIt; C6064; Maxillary sinus squamous cell carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FS-11

AC CVCL_C762

SY FS11

OX NCBI_TaxID=9606; ! Homo sapiens

CA Finite cell line

ID FS-133

AC CVCL_6965

RX PubMed=9658180;

OX NCBI_TaxID=9606; ! Homo sapiens

CA Finite cell line

ID FS-4

AC CVCL_0266

SY FS4

DR MCCL; MCC:0000157

OX NCBI_TaxID=9606; ! Homo sapiens

CA Finite cell line

ID FS-7

AC CVCL_C761

SY FS7

OX NCBI_TaxID=9606; ! Homo sapiens

CA Finite cell line

ID FS-Balb

AC CVCL_5754

DR CLS; 400272/p981_FS-Balb

CC Breed/subspecies: BALB/c.

DI NCIt; C24017; Mouse fibrosarcoma

OX NCBI_TaxID=10090; ! Mus musculus

CA Cancer cell line

ID FS-C3H

AC CVCL_5755

DR CLS; 400418/p554_FS-C3H

CC Breed/subspecies: C3H.

DI NCIt; C24017; Mouse fibrosarcoma

OX NCBI_TaxID=10090; ! Mus musculus

CA Cancer cell line

ID FS-C57BL

AC CVCL_5756

DR CLS; 400420/p2138_FS-C57BL

CC Breed/subspecies: C57BL/6.

DI NCIt; C24017; Mouse fibrosarcoma

OX NCBI_TaxID=10090; ! Mus musculus

SX Female

CA Cancer cell line

ID FS-M1

AC CVCL_AS90

RX PubMed=8083436;

DI NCIt; C3043; Fibrosarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FS-SC-1

AC CVCL_V014

RX PubMed=21527782;

OX NCBI_TaxID=9685; ! Felis catus

SX Male

CA Cancer cell line

ID FS-SC-2

AC CVCL_V015

RX PubMed=21527782;

OX NCBI_TaxID=9685; ! Felis catus

SX Male

CA Cancer cell line

ID FS-SC-3

AC CVCL_V016

RX PubMed=21527782;

OX NCBI_TaxID=9685; ! Felis catus

SX Male

CA Cancer cell line

ID FS-SC-4

AC CVCL_V017

RX PubMed=21527782;

OX NCBI_TaxID=9685; ! Felis catus

SX Male

CA Cancer cell line

ID FS-SC-5

AC CVCL_V018

RX PubMed=21527782;

OX NCBI_TaxID=9685; ! Felis catus

SX Female

CA Cancer cell line

ID FS/D1h

AC CVCL_U365

RX PubMed=12538636;

RX PubMed=15541569;

CC Breed/subspecies: Sprague-Dawley.

OX NCBI_TaxID=10116; ! Rattus norvegicus

SX Male

CA Spontaneously immortalized cell line

ID FS090

AC CVCL_D606

SY FS

RX PubMed=8689637;

RX PubMed=10632461;

RX PubMed=10906887;

RX PubMed=12168675;

DI NCIt; C2946; Chondrosarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FS6-14.13 Ag2.1

AC CVCL_M112

DR ECACC; 85082303

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_3896 ! BW5147

CA Hybridoma

ID FSCP-1

AC CVCL_M616

SY Fscp-1

RX PubMed=15547702;

DI NCIt; C2946; Chondrosarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FSD1/F4

AC CVCL_9R58

SY FSD1-F4; FSD-1-F4; FSD-1 clone F4; F4

RX PubMed=4507803;

RX PubMed=4514957;

CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).

CC Breed/subspecies: DBA/2.

DI NCIt; C21895; Mouse erythroid leukemia

OX NCBI_TaxID=10090; ! Mus musculus

OI CVCL_3988 ! FLC clone 745

CA Cancer cell line

ID FSHDCl17

AC CVCL_6B27

RX PubMed=22040608;

CC Transfected with: HGNC; 1773; CDK4.

CC Transfected with: HGNC; 11730; TERT.

DI NCIt; C84704; Facioscapulohumeral muscular dystrophy

OX NCBI_TaxID=9606; ! Homo sapiens

CA Telomerase immortalized cell line

ID FSHR-18

AC CVCL_E977

DR CLO; CLO_0003399

DR ATCC; CRL-2688

RX PubMed=8634264;

CC Monoclonal antibody target: UniProtKB; P23945; Human FSHR.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2199 ! Sp2/0-Ag14

CA Hybridoma

ID FSHR-323

AC CVCL_E978

DR CLO; CLO_0003400

DR ATCC; CRL-2689

RX PubMed=8634264;

CC Monoclonal antibody target: UniProtKB; P23945; Human FSHR.

CC Discontinued: ATCC; CRL-2689; true.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2199 ! Sp2/0-Ag14

CA Hybridoma

ID FSP

AC CVCL_R899

SY Flounder SPleen

RX PubMed=14710758;

CC Group: Fish cell line.

OX NCBI_TaxID=8255; ! Paralichthys olivaceus

SX Sex undetermined

CA Spontaneously immortalized cell line

ID Fsp 62891

AC CVCL_S457

DR ATCC; CRL-10935

DR BioSample; SAMN03471323

RX Patent=US5283354;

RX Patent=US5621090;

ST Source(s): ATCC

ST Amelogenin: X,Y

ST CSF1PO: 7,10,12,13

ST D13S317: 8,11,14

ST D16S539: 11,12,13

ST D5S818: 12

ST D7S820: 8,9,11,12

ST TH01: 6,7,8,9.3

ST TPOX: 8,9,11

ST vWA: 16,19

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Finite cell line

ID FSthy21

AC CVCL_C564

SY FSthy-21

DR JCRB; JCRB0719

CC Breed/subspecies: C3H/He.

DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_3869 ! FM3A

SX Female

CA Cancer cell line

ID FT

AC CVCL_4203

DR CLO; CLO_0003401

DR CLDB; cl1397

DR ATCC; CCL-41

DR ECACC; 90102525

RX PubMed=14169344;

CC Group: Amphibian cell line.

OX NCBI_TaxID=8400; ! Lithobates catesbeiana

SX Female

CA Spontaneously immortalized cell line

ID FT-1

AC CVCL_J508

RX PubMed=2822586;

RX PubMed=10976746;

RX PubMed=18366545;

DI NCIt; C132193; Feline lymphoma

OX NCBI_TaxID=9685; ! Felis catus

CA Cancer cell line

ID FT-1/ADM

AC CVCL_J509

RX PubMed=10976746;

CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

DI NCIt; C132193; Feline lymphoma

OX NCBI_TaxID=9685; ! Felis catus

HI CVCL_J508 ! FT-1

CA Cancer cell line

ID FT-2

AC CVCL_5123

SY FT-2 (TK-)

RX PubMed=6203516;

CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).

CC Breed/subspecies: AxC.

DI NCIt; C60416; Rat hepatocellular carcinoma

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_5125 ! Fu5-5

SX Male

CA Cancer cell line

ID FT210

AC CVCL_H224

RX PubMed=2208288;

CC Breed/subspecies: C3H/He.

DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_3869 ! FM3A

SX Female

CA Cancer cell line

ID FTC-133

AC CVCL_1219

SY FTC133

DR BTO; BTO:0001889

DR CLO; CLO_0003402

DR CLDB; cl1398

DR CLDB; cl1399

DR BioSample; SAMN03471027

DR CCLE; FTC133_THYROID

DR ChEMBL-Cells; CHEMBL3308732

DR ChEMBL-Targets; CHEMBL1075445

DR Cosmic; 906864

DR Cosmic; 928831

DR Cosmic; 1239976

DR Cosmic; 1280044

DR Cosmic; 1507371

DR Cosmic; 1533556

DR Cosmic; 1536124

DR Cosmic; 1889011

DR Cosmic; 2054103

DR Cosmic; 2319848

DR Cosmic-CLP; 906864

DR ECACC; 94060901

DR GDSC; 906864

DR GEO; GSM827308

DR GEO; GSM887012

DR GEO; GSM888081

DR GEO; GSM1669794

DR ICLC; HTL97015

RX PubMed=1384245;

RX PubMed=1726925;

RX PubMed=17804723;

RX PubMed=18713817;

RX PubMed=22460905;

RX PubMed=23162534;

RX PubMed=23833040;

RX PubMed=27397505;

CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: DNA methylation analysis.

CC Omics: SNP array analysis.

CC Omics: Transcriptome analysis.

CC Misspelling: 'FTC-113' in Cosmic 1889011.

ST Source(s): Cosmic-CLP; ECACC; PubMed=18713817; PubMed=25877200

ST Amelogenin: X

ST CSF1PO: 10

ST D13S317: 11

ST D16S539: 11

ST D18S51: 11,12

ST D19S433: 12,13

ST D21S11: 32.2

ST D2S1338: 20

ST D3S1358: 15

ST D5S818: 12

ST D7S820: 9,10 (Cosmic-CLP; ECACC; PubMed=18713817)

ST D7S820: 10 (PubMed=25877200)

ST D8S1179: 10

ST FGA: 21

ST Penta D: 12

ST Penta E: 13

ST TH01: 9.3 (Cosmic-CLP; ECACC)

ST TH01: 6.1,9.3 (PubMed=25877200)

ST TPOX: 9

ST vWA: 15,18

DI NCIt; C8054; Thyroid gland follicular carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_2446 ! FTC-236

OI CVCL_2447 ! FTC-238

SX Male

CA Cancer cell line

ID FTC-236

AC CVCL_2446

SY FTC236

DR BTO; BTO:0003875

DR Cosmic; 1239977

DR ECACC; 06030202

RX PubMed=1384245;

ST Source(s): ECACC

ST Amelogenin: X

ST CSF1PO: 10,11

ST D13S317: 11

ST D16S539: 11,12

ST D5S818: 11,12

ST D7S820: 9,10

ST TH01: 9.3

ST TPOX: 9

ST vWA: 15,18

DI NCIt; C8054; Thyroid gland follicular carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_1219 ! FTC-133

OI CVCL_2447 ! FTC-238

SX Male

CA Cancer cell line

ID FTC-238

AC CVCL_2447

SY FTC238

DR CLO; CLO_0003403

DR CLDB; cl1400

DR CLDB; cl1401

DR BioSample; SAMN03470981

DR CCLE; FTC238_THYROID

DR Cosmic; 1239978

DR ECACC; 94060902

DR GEO; GSM827316

DR ICLC; HTL96003

DR TOKU-E; 4078

RX PubMed=1384245;

WW http://www.addexbio.com/productdetail?pid=38

CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.

ST Source(s): ECACC; PubMed=25877200

ST Amelogenin: X

ST CSF1PO: 10,11

ST D13S317: 11

ST D16S539: 11,12

ST D18S51: 11,12

ST D19S433: 13

ST D21S11: 32.2

ST D2S1338: 20

ST D3S1358: 16

ST D5S818: 11,12

ST D7S820: 9,10

ST D8S1179: 10

ST FGA: 21

ST Penta D: 12

ST Penta E: 13

ST TH01: 9.3

ST TPOX: 9

ST vWA: 15,18

DI NCIt; C8054; Thyroid gland follicular carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_1219 ! FTC-133

OI CVCL_2446 ! FTC-236

SX Male

CA Cancer cell line

ID FTO-2B

AC CVCL_5124

SY FTO2B

DR BTO; BTO:0003234

RX PubMed=9745712;

WW http://www.ctsaip.org/details.cfm?id=6455

WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/f/cell-lines-detail-168.html

CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).

CC Breed/subspecies: AxC.

DI NCIt; C60416; Rat hepatocellular carcinoma

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_5123 ! FT-2

SX Male

CA Cancer cell line

ID FTRS-AbL81

AC CVCL_Z298

SY FTRS-AbL-81

RX CelloPub=CLPUB00170;

RX CelloPub=CLPUB00171;

CC Group: Insect cell line.

OX NCBI_TaxID=571296; ! Archips breviplicana

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FTRS-AfL

AC CVCL_Z296

RX CelloPub=CLPUB00170;

RX CelloPub=CLPUB00171;

CC Group: Insect cell line.

OX NCBI_TaxID=85585; ! Adoxophyes honmai

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FTRS-AoL1

AC CVCL_Z294

RX CelloPub=CLPUB00170;

RX CelloPub=CLPUB00171;

CC Group: Insect cell line.

OX NCBI_TaxID=480707; ! Adoxophyes orana

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FTRS-AoL2

AC CVCL_Z295

RX CelloPub=CLPUB00170;

RX CelloPub=CLPUB00171;

CC Group: Insect cell line.

OX NCBI_TaxID=480707; ! Adoxophyes orana

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FTRS-H1L1

AC CVCL_Z300

RX CelloPub=CLPUB00170;

RX CelloPub=CLPUB00171;

CC Group: Insect cell line.

OX NCBI_TaxID=928821; ! Choristoneura longicellana

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FTRS-H1L2

AC CVCL_Z301

RX CelloPub=CLPUB00170;

RX CelloPub=CLPUB00171;

CC Group: Insect cell line.

OX NCBI_TaxID=928821; ! Choristoneura longicellana

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FTRS-HmL45

AC CVCL_Z299

RX CelloPub=CLPUB00170;

RX CelloPub=CLPUB00171;

CC Group: Insect cell line.

OX NCBI_TaxID=410822; ! Homona magnanima

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FTRS-PhL

AC CVCL_Z297

RX CelloPub=CLPUB00170;

RX CelloPub=CLPUB00171;

CC Group: Insect cell line.

OX NCBI_TaxID=192191; ! Pandemis heparana

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FU-266

AC CVCL_J235

SY FU 266

RX PubMed=6316357;

CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).

DI NCIt; C3242; Plasma cell myeloma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_0566 ! U266B1

SX Male

CA Cancer cell line

ID FU-266 clone E1

AC CVCL_J236

SY FU-266 (E1)

RX PubMed=6316357;

CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).

DI NCIt; C3242; Plasma cell myeloma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_J235 ! FU-266

SX Male

CA Cancer cell line

ID FU-DDLS-1

AC CVCL_M815

SY FU-DD-LS1

DR Cosmic; 2307718

DR GEO; GSM529099

RX PubMed=12579306;

RX PubMed=22911243;

RX PubMed=24726063;

DI NCIt; C3704; Dedifferentiated liposarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FU-EPS-1

AC CVCL_E311

RX PubMed=16010416;

RX PubMed=19756736;

CC Doubling time: ~45 hours (PubMed=16010416).

DI NCIt; C3714; Epithelioid sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FU-GBC-1

AC CVCL_H703

SY Fukuoka University-Gall Bladder Carcinoma-1

RX PubMed=2680052;

RX PubMed=9502079;

CC Derived from metastatic site: Ascites.

DI NCIt; C3844; Gallbladder carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FU-GBC-2

AC CVCL_H704

SY Fukuoka University-Gall Bladder Carcinoma-2

RX PubMed=9211524;

CC Doubling time: 43 hours, at 20th passage (PubMed=9211524).

CC Derived from metastatic site: Ascites.

DI NCIt; C3844; Gallbladder carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID FU-MFH-1

AC CVCL_M816

SY Fukuoka University-Malignant Fibrous Histiocytoma-1

RX PubMed=12810255;

CC Doubling time: ~72 hours (PubMed=12810255).

DI NCIt; C4247; Unclassified pleomorphic sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID FU-MFH-2

AC CVCL_M817

SY Fukuoka University-Malignant Fibrous Histiocytoma-2

RX PubMed=21092322;

CC Doubling time: ~56 hours (PubMed=21092322).

DI NCIt; C4247; Unclassified pleomorphic sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FU-MMT-1

AC CVCL_U143

SY Fukuoka University-Malignant mixed Mullerian Tumor-1

RX PubMed=1312893;

CC Doubling time: 26 hours, at 5th passage (PubMed=1312893).

DI NCIt; C42700; Uterine carcinosarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID FU-MMT-2

AC CVCL_U144

SY Fukuoka University-Malignant mixed Mullerian Tumor-2

RX PubMed=1312893;

RX PubMed=8774655;

CC Doubling time: 30 hours, at 5th passage (PubMed=1312893).

DI NCIt; C42700; Uterine carcinosarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID FU-MMT-2-C1

AC CVCL_U145

RX PubMed=7683967;

DI NCIt; C42700; Uterine carcinosarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_U144 ! FU-MMT-2

SX Female

CA Cancer cell line

ID FU-MMT-2-S1

AC CVCL_U146

RX PubMed=7683967;

DI NCIt; C42700; Uterine carcinosarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_U144 ! FU-MMT-2

SX Female

CA Cancer cell line

ID FU-MMT-3

AC CVCL_U148

RX PubMed=9368662;

DI NCIt; C3359; Rhabdomyosarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID FU-NB-2006

AC CVCL_AQ51

SY FU-NB-06

WW http://www.christithomas.blogspot.ch/2006_12_01_archive.html

CC Anecdotal: Established from a sample taken just after the death of Christi Thomas who died in September 2006 aged 9. The cell line was named by Christi's father to show how angry (FU) he was against neuroblastoma (NB).

ST Source(s): COG

ST Amelogenin: X

ST CSF1PO: 10

ST D13S317: 11

ST D16S539: 11,13

ST D18S51: 11,16

ST D19S433: 13,15

ST D21S11: 29

ST D2S1338: 16,20

ST D3S1358: 15,16

ST D5S818: 11,12

ST D7S820: 12

ST D8S1179: 13,15

ST FGA: 21,23

ST TH01: 9

ST TPOX: 8

ST vWA: 17,18

DI NCIt; C3270; Neuroblastoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID FU-OV-1

AC CVCL_2047

SY FUOV1

DR CLO; CLO_0003406

DR BioSample; SAMN03471610

DR CCLE; FUOV1_OVARY

DR Cosmic; 1305328

DR Cosmic; 1995408

DR Cosmic-CLP; 1240129

DR DSMZ; ACC-444

DR GDSC; 1240129

DR GEO; GSM645842

DR GEO; GSM851917

DR GEO; GSM887014

DR GEO; GSM888083

DR GEO; GSM1669796

RX PubMed=10337661;

RX PubMed=22460905;

RX PubMed=22710073;

RX PubMed=23415752;

RX PubMed=23839242;

RX PubMed=25984343;

RX PubMed=27397505;

RX PubMed=28196595;

WW http://tcpaportal.org/mclp/

CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC Part of: MD Anderson Cell Lines Project.

CC Doubling time: 25 hours (in serum-free medium), 21 hours (in FBS-supplemented medium) (PubMed=10337661); 71 hours (PubMed=25984343); ~120 hours (DSMZ).

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: DNA methylation analysis.

CC Omics: Protein expression by reverse-phase protein arrays.

CC Omics: SNP array analysis.

CC Omics: Transcriptome analysis.

ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200

ST Amelogenin: X

ST CSF1PO: 10,12

ST D13S317: 8,10

ST D16S539: 12

ST D18S51: 14

ST D21S11: 30

ST D3S1358: 15

ST D5S818: 11,13

ST D7S820: 11

ST D8S1179: 11,12

ST FGA: 20

ST Penta D: 10,13

ST Penta E: 11

ST TH01: 6

ST TPOX: 8,9

ST vWA: 14,19

DI NCIt; C105555; High grade ovarian serous adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID FU-PNET-3

AC CVCL_IU17

RX PubMed=27613543;

CC Doubling time: 40.8 hours (PubMed=27613543).

DI NCIt; C3716; Primitive neuroectodermal tumor

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FU-PNET-4

AC CVCL_IU18

RX PubMed=27613543;

CC Doubling time: 45.6 hours (PubMed=27613543).

DI NCIt; C3716; Primitive neuroectodermal tumor

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID FU-RPNT-1

AC CVCL_4837

SY FU-PNET-1

DR CLO; CLO_0050891

DR BioSample; SAMN03473644

DR RCB; RCB1495

RX PubMed=9559290;

RX PubMed=27613543;

CC Doubling time: 45 hours (PubMed=9559290).

ST Source(s): RCB

ST Amelogenin: X,Y

ST CSF1PO: 10,11

ST D13S317: 9,12

ST D16S539: 11,12

ST D5S818: 11

ST D7S820: 10,12

ST TH01: 6,7

ST TPOX: 9,11

ST vWA: 15,18

DI NCIt; C3716; Primitive neuroectodermal tumor

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FU-RPNT-2

AC CVCL_4838

SY FU-PNET-2

DR CLO; CLO_0050901

DR BioSample; SAMN03472054

DR RCB; RCB1496

DR RCB; RCB2078

RX PubMed=9559290;

RX PubMed=20143388;

RX PubMed=27613543;

WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC Problematic cell line: Contaminated. Shown to be a FU-RPNT-1 derivative (PubMed=20143388).

CC Doubling time: 72 hours (PubMed=9559290).

CC Misspelling: 'FU-FRNT-2' in RCB RCB1496.

CC Discontinued: RCB; RCB1496; true.

ST Source(s): RCB

ST Amelogenin: X,Y

ST CSF1PO: 9,12

ST D13S317: 8,12

ST D16S539: 12,13

ST D5S818: 11,12

ST D7S820: 10,12

ST TH01: 9

ST TPOX: 8,9

ST vWA: 18

DI NCIt; C3716; Primitive neuroectodermal tumor

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_4837 ! FU-RPNT-1

SX Male

CA Cancer cell line

ID FU-SY-1

AC CVCL_N583

RX PubMed=12063544;

DI NCIt; C3400; Synovial sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID FU-UR-1

AC CVCL_6997

DR Cosmic; 1184243

RX PubMed=15138551;

DI NCIt; C27891; Renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID FU-UrC-1

AC CVCL_W469

RX PubMed=1888704;

DI NCIt; C8993; Ureter carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID FU0045

AC CVCL_8W38

DR ECACC; 96082706

CC Part of: ECACC chromosomal abnormality collection.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C84717; Fragile X syndrome

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FU0054

AC CVCL_8W39

DR ECACC; 98011408

CC Part of: ECACC chromosomal abnormality collection.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID Fu5-5

AC CVCL_5125

SY FU5-5; Fu 5-5

RX PubMed=4157008;

RX PubMed=6203516;

CC Breed/subspecies: AxC.

DI NCIt; C60416; Rat hepatocellular carcinoma

OX NCBI_TaxID=10116; ! Rattus norvegicus

HI CVCL_0285 ! H4-II-E-C3

SX Male

CA Cancer cell line

ID Fu97

AC CVCL_2908

SY FU97; FU-97

DR BTO; BTO:0005906

DR EFO; EFO_0002054

DR BioSample; SAMN03473260

DR CCLE; FU97_STOMACH

DR Cosmic; 1187271

DR Cosmic; 1995407

DR Cosmic-CLP; 1290806

DR GDSC; 1290806

DR GEO; GSM562400

DR GEO; GSM827164

DR GEO; GSM843502

DR GEO; GSM887013

DR GEO; GSM888082

DR GEO; GSM1237673

DR GEO; GSM1237698

DR GEO; GSM1669795

DR JCRB; JCRB1074

DR JCRB; NIHS0332

DR LINCS; 50013

RX PubMed=10614861;

RX PubMed=22460905;

RX PubMed=24807215;

RX PubMed=25485619;

RX PubMed=27397505;

RX PubMed=28196595;

WW http://tcpaportal.org/mclp/

CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC Part of: MD Anderson Cell Lines Project.

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: Deep RNAseq analysis.

CC Omics: DNA methylation analysis.

CC Omics: Protein expression by reverse-phase protein arrays.

CC Omics: SNP array analysis.

CC Omics: Transcriptome analysis.

CC Discontinued: JCRB; NIHS0332; true.

ST Source(s): Cosmic-CLP; JCRB; PubMed=25877200

ST Amelogenin: X

ST CSF1PO: 12

ST D13S317: 10,12

ST D16S539: 9,11

ST D18S51: 15

ST D21S11: 30

ST D3S1358: 16,17

ST D5S818: 10,12

ST D7S820: 11

ST D8S1179: 14,15

ST FGA: 19

ST Penta D: 14

ST Penta E: 15

ST TH01: 9

ST TPOX: 12

ST vWA: 17

DI NCIt; C4004; Gastric adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID FUA169

AC CVCL_D688

SY FUA 169

RX PubMed=7678417;

CC Breed/subspecies: C3H/He.

DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_D687 ! FM3A/F28-7

SX Female

CA Cancer cell line

ID Fufe-R

AC CVCL_0I55

SY Fufe

DR CCLV; CCLV-RIE 0322

RX PubMed=19941903;

OX NCBI_TaxID=9627; ! Vulpes vulpes

CA Spontaneously immortalized cell line

ID Fugu eye

AC CVCL_R807

SY Fre; Fugu rubripes eye

DR ATCC; CRL-2641

RX PubMed=9418286;

CC Group: Fish cell line.

OX NCBI_TaxID=31033; ! Takifugu rubripes

SX Sex undetermined

CA Spontaneously immortalized cell line

ID Fugu fry

AC CVCL_R808

SY Fnf; Fugu niphobles fry

DR ATCC; CRL-2642

RX PubMed=9418286;

CC Group: Fish cell line.

OX NCBI_TaxID=204815; ! Takifugu niphobles

SX Sex undetermined

CA Spontaneously immortalized cell line

ID FUHEN

AC CVCL_4U91

SY Frog-derived Unique HEmatopoietic Non-adherent

RX PubMed=26322253;

WW http://www.sc.niigata-u.ac.jp/biologyindex/sugimoto/saranifuhen.html

CC Group: Amphibian cell line.

CC Transformant: NCIt; C17262; X-Ray.

OX NCBI_TaxID=109175; ! Hyla japonica

SX Sex undetermined

CA Transformed cell line

ID FUHS-1

AC CVCL_L351

RX PubMed=1090262;

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID Fuji

AC CVCL_D880

SY FUJI

DR Cosmic; 1217474

DR Cosmic; 1319813

DR Cosmic; 2307726

DR GEO; GSM482568

RX PubMed=2171298;

RX PubMed=24726063;

DI NCIt; C3400; Synovial sarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID FUR,RE

AC CVCL_E669

SY FUR, RE

DR dbMHC; 48865

DR ECACC; 94082245

DR IHW; IHW9145

DR IMGT/HLA; 11688

RX PubMed=8307784;

WW http://bioinformatics.hsanmartino.it/ecbr/cl145.html

CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Sex undetermined

CA Transformed cell line

ID FVB-1

AC CVCL_F046

DR RCB; AES0045

DR RCB; RCB2194

CC Discontinued: RCB; RCB2194; true.

CC Breed/subspecies: FVB.

OX NCBI_TaxID=10090; ! Mus musculus

SX Male

CA Embryonic stem cell

ID FVB-2

AC CVCL_4E28

DR RCB; RCB2195

RX DOI=10.4051/ibc.2010.2.4.0014;

CC Caution: Not from strain FVB as originally assigned (DOI 10.4051/ibc.2010.2.4.0014).

CC Discontinued: RCB; RCB2195; true.

OX NCBI_TaxID=10090; ! Mus musculus

CA Embryonic stem cell

ID FVMUT-CFMG-1

AC CVCL_0A28

RX PubMed=23375365;

CC Doubling time: 25 hours (PubMed=23375365).

CC Omics: Proteome analysis by 2D-DE.

CC Breed/subspecies: Terrier.

DI NCIt; C124249; Canine mammary carcinoma

OX NCBI_TaxID=9615; ! Canis lupus familiaris

SX Female

CA Cancer cell line

ID Fvp^(r)B350

AC CVCL_U119

DR CLO; CLO_0050860

DR RCB; RCB0764

CC Selected for resistance to: ChEBI; CHEBI:4911; Etoposide (VP-16).

CC Breed/subspecies: C3H/He.

DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_3869 ! FM3A

SX Female

CA Cancer cell line

ID FVTCT.fl

AC CVCL_H732

DR CLO; CLO_0050774

DR RCB; RCB0571

CC Breed/subspecies: BALB/c.

DI NCIt; C21604; Mouse leukemia

OX NCBI_TaxID=10090; ! Mus musculus

SX Sex undetermined

CA Cancer cell line

ID FW11-10-3

AC CVCL_G119

SY FW 11.10.3; FW11.10.3; mAb 11.10

DR CLO; CLO_0003408

DR ATCC; HB-257

DR ECACC; 93070776

RX PubMed=7507492;

CC Monoclonal antibody target: UniProtKB; P16070; Human CD44.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2199 ! Sp2/0-Ag14

CA Hybridoma

ID FW11-24-17-36

AC CVCL_G120

SY FW 11.24.7.36; FW11.24.7.36; mAb 11.24

DR CLO; CLO_0003409

DR ATCC; HB-258

DR ECACC; 93070775

RX PubMed=7507492;

CC Monoclonal antibody target: UniProtKB; P16070; Human CD44.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2199 ! Sp2/0-Ag14

CA Hybridoma

ID FW11-9-2

AC CVCL_G121

SY FW 11.9.2.2; FW11.9.2.2; mAb 11.9

DR CLO; CLO_0003410

DR ATCC; HB-256

DR ECACC; 93070778

RX PubMed=7507492;

CC Monoclonal antibody target: UniProtKB; P16070; Human CD44.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2199 ! Sp2/0-Ag14

CA Hybridoma

ID FW14-14

AC CVCL_DB31

SY mAb 14-14

RX PubMed=7507492;

CC Monoclonal antibody target: UniProtKB; P23229; Human ITGA6/CD49f.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2199 ! Sp2/0-Ag14

CA Hybridoma

ID FW14-14-15

AC CVCL_DB32

DR ATCC; HB-259

CC Monoclonal antibody target: UniProtKB; P23229; Human ITGA6/CD49f.

CC Discontinued: ATCC; HB-259; true.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_DB31 ! FW14-14

CA Hybridoma

ID FW14-14-18

AC CVCL_L676

SY FW14.14.18

DR ECACC; 93100512

CC Monoclonal antibody target: UniProtKB; P23229; Human ITGA6/CD49f.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_DB31 ! FW14-14

CA Hybridoma

ID FW3-132.6

AC CVCL_AR46

SY FW3.132.6

DR ECACC; 93100514

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2199 ! Sp2/0-Ag14

CA Hybridoma

ID FW3-151

AC CVCL_AR47

SY FW3.151

DR ECACC; 93100515

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2199 ! Sp2/0-Ag14

CA Hybridoma

ID FW3-218-1

AC CVCL_G122

SY 218

DR CLO; CLO_0003411

DR ATCC; HB-261

RX PubMed=1372559;

CC Monoclonal antibody target: UniProtKB; W5Q5Y1; Sheep ITGA4/CD49d.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2199 ! Sp2/0-Ag14

CA Hybridoma

ID FW3-47

AC CVCL_L675

SY 47

DR ECACC; 91060559

RX PubMed=1372559;

CC Monoclonal antibody target: UniProtKB; B0FYY4; Sheep ITGB1/CD19.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2199 ! Sp2/0-Ag14

CA Hybridoma

ID FW4-101-1-1

AC CVCL_G123

SY FW 4.101; FW4/101

DR CLO; CLO_0003412

DR ATCC; HB-289

DR ECACC; 93070777

CC Monoclonal antibody target: UniProtKB; B0FYY4; Sheep ITGB1/CD19.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2199 ! Sp2/0-Ag14

CA Hybridoma

ID FY-3PN

AC CVCL_B138

DR ISCR; 765

RX PubMed=18611919;

WW http://grants.nih.gov/stem_cells/registry/not_approved.htm

CC From: Guangzhou Medical College; China.

CC Registration: NIH Human Embryonic Stem Cell Registry; not approved.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Embryonic stem cell

ID FY-hES-1

AC CVCL_9922

DR ISCR; 766

RX PubMed=18611919;

WW http://grants.nih.gov/stem_cells/registry/not_approved.htm

CC From: Guangzhou Medical College; China.

CC Registration: NIH Human Embryonic Stem Cell Registry; not approved.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Embryonic stem cell

ID FY-hES-10

AC CVCL_9929

SY GZHMCe003-A

DR hPSCreg; GZHMCe003-A

DR ISCR; 1461

RX PubMed=19376483;

RX PubMed=20657158;

CC From: Guangzhou Medical College; China.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Embryonic stem cell

ID FY-hES-11

AC CVCL_9930

SY GZHMCe004-A

DR hPSCreg; GZHMCe004-A

DR ISCR; 1462

RX PubMed=19376483;

RX PubMed=20657158;

CC From: Guangzhou Medical College; China.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Embryonic stem cell

ID FY-hES-12

AC CVCL_9931

DR ISCR; 1344

RX PubMed=20657158;

CC From: Guangzhou Medical College; China.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Embryonic stem cell

ID FY-hES-13

AC CVCL_9932

DR ISCR; 1345

RX PubMed=20657158;

CC From: Guangzhou Medical College; China.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Embryonic stem cell

ID FY-hES-14

AC CVCL_9933

DR ISCR; 1346

RX PubMed=20657158;

CC From: Guangzhou Medical College; China.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Embryonic stem cell

ID FY-hES-15

AC CVCL_9934

DR ISCR; 1347

RX PubMed=20657158;

CC From: Guangzhou Medical College; China.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Embryonic stem cell

ID FY-hES-16

AC CVCL_9935

DR ISCR; 1348

RX PubMed=20657158;

CC From: Guangzhou Medical College; China.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Embryonic stem cell

ID FY-hES-17

AC CVCL_9936

DR ISCR; 1349

RX PubMed=20657158;

CC From: Guangzhou Medical College; China.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Embryonic stem cell

ID FY-hES-18

AC CVCL_9937

DR ISCR; 1350

RX PubMed=20657158;

CC From: Guangzhou Medical College; China.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Embryonic stem cell

ID FY-hES-19

AC CVCL_9938

DR ISCR; 1351

RX PubMed=20657158;

CC From: Guangzhou Medical College; China.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Embryonic stem cell

ID FY-hES-20

AC CVCL_9939

DR ISCR; 1352

RX PubMed=20657158;

CC From: Guangzhou Medical College; China.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Embryonic stem cell

ID FY-hES-21

AC CVCL_9940

DR ISCR; 1353

RX PubMed=20657158;

CC From: Guangzhou Medical College; China.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Embryonic stem cell

ID FY-hES-22

AC CVCL_9941

DR ISCR; 1354

RX PubMed=20657158;

CC From: Guangzhou Medical College; China.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Embryonic stem cell

ID FY-hES-23

AC CVCL_9942

DR ISCR; 1355

RX PubMed=20657158;

CC From: Guangzhou Medical College; China.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Embryonic stem cell

ID FY-hES-24

AC CVCL_9943

DR ISCR; 1356

RX PubMed=20657158;

CC From: Guangzhou Medical College; China.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Embryonic stem cell

ID FY-hES-25

AC CVCL_9944

DR ISCR; 1357

RX PubMed=20657158;

CC From: Guangzhou Medical College; China.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Embryonic stem cell

ID FY-hES-27

AC CVCL_L646

DR ISCR; 1970

RX PubMed=22527897;

CC From: Guangzhou Medical College; China.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Embryonic stem cell

ID FY-hES-28

AC CVCL_L647

DR ISCR; 1971

RX PubMed=22527897;

CC From: Guangzhou Medical College; China.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Embryonic stem cell

ID FY-hES-29

AC CVCL_L648

DR ISCR; 1972

RX PubMed=22527897;

CC From: Guangzhou Medical College; China.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Embryonic stem cell

ID FY-hES-3

AC CVCL_9923

DR ISCR; 769

RX PubMed=18611919;

WW http://grants.nih.gov/stem_cells/registry/not_approved.htm

CC From: Guangzhou Medical College; China.

CC Registration: NIH Human Embryonic Stem Cell Registry; not approved.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Embryonic stem cell

ID FY-hES-30

AC CVCL_L649

DR ISCR; 1973

RX PubMed=22527897;

CC From: Guangzhou Medical College; China.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Embryonic stem cell

ID FY-hES-31

AC CVCL_L650

DR ISCR; 1974

RX PubMed=22527897;

CC From: Guangzhou Medical College; China.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Embryonic stem cell

ID FY-hES-32

AC CVCL_L651

DR ISCR; 1975

RX PubMed=22527897;

CC From: Guangzhou Medical College; China.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Embryonic stem cell

ID FY-hES-33

AC CVCL_L652

DR ISCR; 1976

RX PubMed=22527897;

CC From: Guangzhou Medical College; China.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Sex ambiguous

CA Embryonic stem cell

ID FY-hES-34

AC CVCL_L653

DR ISCR; 1977

RX PubMed=22527897;

CC From: Guangzhou Medical College; China.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Embryonic stem cell

ID FY-hES-35

AC CVCL_L654

DR ISCR; 1978

RX PubMed=22527897;

CC From: Guangzhou Medical College; China.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Embryonic stem cell

ID FY-hES-4

AC CVCL_9924

DR ISCR; 770

RX PubMed=18611919;

CC From: Guangzhou Medical College; China.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Embryonic stem cell

ID FY-hES-5

AC CVCL_9925

SY GZHMCe001-A

DR hPSCreg; GZHMCe001-A

DR ISCR; 771

RX PubMed=18611919;

RX PubMed=19376483;

WW http://grants.nih.gov/stem_cells/registry/not_approved.htm

CC From: Guangzhou Medical College; China.

CC Registration: NIH Human Embryonic Stem Cell Registry; not approved.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Embryonic stem cell

ID FY-hES-7

AC CVCL_9926

DR ISCR; 772

RX PubMed=18611919;

WW http://grants.nih.gov/stem_cells/registry/not_approved.htm

CC From: Guangzhou Medical College; China.

CC Registration: NIH Human Embryonic Stem Cell Registry; not approved.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Embryonic stem cell

ID FY-hES-8

AC CVCL_9927

DR ISCR; 773

RX PubMed=18611919;

WW http://grants.nih.gov/stem_cells/registry/not_approved.htm

CC From: Guangzhou Medical College; China.

CC Registration: NIH Human Embryonic Stem Cell Registry; not approved.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Embryonic stem cell

ID FY-hES-9

AC CVCL_9928

SY GZHMCe002-A

DR hPSCreg; GZHMCe002-A

DR ISCR; 1358

RX PubMed=19376483;

RX PubMed=20657158;

CC From: Guangzhou Medical College; China.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Embryonic stem cell

ID FY0028

AC CVCL_8W40

DR ECACC; 95090812

CC Part of: ECACC chromosomal abnormality collection.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FY0031

AC CVCL_8W41

DR ECACC; 95091118

CC Part of: ECACC chromosomal abnormality collection.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FY1181

AC CVCL_8W42

DR ECACC; 99080911

CC Part of: ECACC chromosomal abnormality collection.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FY1197

AC CVCL_8W43

DR ECACC; 00012901

CC Part of: ECACC chromosomal abnormality collection.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID FY1198

AC CVCL_8W44

DR ECACC; 00012902

CC Part of: ECACC chromosomal abnormality collection.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C2989; DiGeorge syndrome

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FY1199

AC CVCL_8W45

DR ECACC; 00012903

CC Part of: ECACC chromosomal abnormality collection.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Transformed cell line

ID FYMp

AC CVCL_T996

RX PubMed=16397390;

CC Breed/subspecies: Japanese domestic.

OX NCBI_TaxID=9685; ! Felis catus

SX Female

CA Cancer cell line

ID G

AC CVCL_GT44

RX PubMed=1634619;

RX PubMed=2431625;

DI NCIt; C129077; Canine mastocytoma

OX NCBI_TaxID=9615; ! Canis lupus familiaris

CA Cancer cell line

ID G-11

AC CVCL_U962

DR BioSample; SAMN03151696

RX PubMed=884688;

RX PubMed=1000504;

RX PubMed=1000505;

RX PubMed=1000506;

RX PubMed=6451928;

RX PubMed=20143388;

WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC Problematic cell line: Contaminated. Parent cell line (HBT-3) has been shown to be a HeLa derivative (PubMed=884688, PubMed=6451928, PubMed=20143388).

CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI NCIt; C4029; Cervical adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_D281 ! HBT-3

SX Female

CA Cancer cell line

ID G-1410

AC CVCL_F704

RX PubMed=21786362;

CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX NCBI_TaxID=9823; ! Sus scrofa

SX Female

CA Transformed cell line

ID G-201

AC CVCL_E078

SY G201

RX PubMed=7533171;

CC Knockout cell: Method=Gene trap; MGI; MGI:96610; Itgb1.

CC Breed/subspecies: 129S2/SvPas.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_4378 ! ES-D3

SX Male

CA Embryonic stem cell

ID G-292 clone A141B1

AC CVCL_2909

SY G 292 Clone A 141B1; G-292, clone A141B1; G-292; G292

DR BTO; BTO:0003877

DR CLO; CLO_0003428

DR CLDB; cl1406

DR ATCC; CRL-1423

DR BCRC; 60225

DR BioSample; SAMN03470921

DR CCLE; G292CLONEA141B1_BONE

DR ChEMBL-Cells; CHEMBL3307362

DR ChEMBL-Targets; CHEMBL614298

DR Cosmic; 931041

DR Cosmic; 931914

DR Cosmic; 1074401

DR Cosmic; 1733127

DR Cosmic-CLP; 1290807

DR ECACC; 90110522

DR GDSC; 1290807

DR GEO; GSM320832

DR GEO; GSM827342

DR GEO; GSM887015

DR GEO; GSM888084

DR GEO; GSM1669797

DR IFO; IFO50107

DR KCLB; 21423

DR NCBI_Iran; C116

RX PubMed=22460905;

RX PubMed=27397505;

RX PubMed=28196595;

WW http://tcpaportal.org/mclp/

CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC Part of: MD Anderson Cell Lines Project.

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: Protein expression by reverse-phase protein arrays.

CC Omics: DNA methylation analysis.

CC Omics: SNP array analysis.

CC Omics: Transcriptome analysis.

ST Source(s): ATCC; Cosmic-CLP; JCRB; KCLB; PubMed=25877200

ST Amelogenin: X

ST CSF1PO: 11,12

ST D13S317: 9,14

ST D16S539: 12

ST D18S51: 18

ST D19S433: 16.2

ST D21S11: 31

ST D2S1338: 17

ST D3S1358: 16,17

ST D5S818: 12,13

ST D7S820: 9

ST D8S1179: 15

ST FGA: 22

ST Penta D: 13

ST Penta E: 17

ST TH01: 6

ST TPOX: 8

ST vWA: 14

DI NCIt; C9145; Osteosarcoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID G-3-5

AC CVCL_C554

SY G3-5

DR CLO; CLO_0003431

DR ATCC; CRL-2252

DR CCRID; 3142C0001000000443

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2155 ! P3/NS1/1-Ag4.1

CA Hybridoma

ID G-361

AC CVCL_1220

SY G361; G361-mel; G361mel

DR BTO; BTO:0001584

DR CLO; CLO_0003433

DR CLO; CLO_0050698

DR EFO; EFO_0006394

DR CLDB; cl1407

DR CLDB; cl1408

DR CLDB; cl4941

DR ATCC; CRL-1424

DR BioSample; SAMN01821552

DR BioSample; SAMN01821727

DR BioSample; SAMN03471453

DR BioSample; SAMN03472419

DR CCLE; G361_SKIN

DR CGH-DB; 9315-4

DR ChEMBL-Cells; CHEMBL3307514

DR ChEMBL-Targets; CHEMBL614036

DR Cosmic; 687435

DR Cosmic; 874385

DR Cosmic; 905228

DR Cosmic; 906865

DR Cosmic; 928692

DR Cosmic; 933005

DR Cosmic; 1006557

DR Cosmic; 1007157

DR Cosmic; 1022275

DR Cosmic; 1155277

DR Cosmic; 1459650

DR Cosmic; 1995409

DR Cosmic; 2036701

DR Cosmic; 2159446

DR Cosmic-CLP; 906865

DR ECACC; 88030401

DR GDSC; 906865

DR GEO; GSM206469

DR GEO; GSM827495

DR GEO; GSM887016

DR GEO; GSM888085

DR GEO; GSM1374482

DR GEO; GSM1669798

DR ICLC; HTL99001

DR IFO; IFO50009

DR JCRB; JCRB9074

DR KCLB; 21424

DR Lonza; 987

DR RCB; RCB0991

RX PubMed=2174414;

RX PubMed=15467732;

RX PubMed=22460905;

RX PubMed=25485619;

RX PubMed=27397505;

RX PubMed=28196595;

WW http://tcpaportal.org/mclp/

CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC Part of: MD Anderson Cell Lines Project.

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: Deep RNAseq analysis.

CC Omics: DNA methylation analysis.

CC Omics: Protein expression by reverse-phase protein arrays.

CC Omics: SNP array analysis.

CC Omics: Transcriptome analysis.

ST Source(s): ATCC; Cosmic-CLP; ECACC; JCRB; KCLB; PubMed=25877200; RCB

ST Amelogenin: X

ST CSF1PO: 10

ST D13S317: 11

ST D16S539: 15

ST D18S51: 15,16

ST D21S11: 29,30

ST D3S1358: 16 (KCLB)

ST D3S1358: 11,16 (PubMed=25877200)

ST D5S818: 11

ST D7S820: 8,11

ST D8S1179: 12,13

ST FGA: 19,21

ST Penta D: 9,10,11

ST Penta E: 10,14

ST TH01: 7,9

ST TPOX: 8,10

ST vWA: 15,17

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID G-361/CMV-Luc

AC CVCL_4Y12

SY G361/CMV-Luc

DR JCRB; NIHS0705

CC Transfected with: UniProtKB; P08659; Firefly luciferase.

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_1220 ! G-361

SX Male

CA Cancer cell line

ID G-401

AC CVCL_0270

SY G401; G 401

DR BTO; BTO:0002586

DR CLO; CLO_0003434

DR EFO; EFO_0002179

DR MCCL; MCC:0000161

DR CLDB; cl1409

DR ATCC; CRL-1441

DR BioSample; SAMN03470969

DR BioSample; SAMN03472819

DR CCLE; G401_SOFT_TISSUE

DR CCRID; 3111C0001CCC000034

DR ChEMBL-Cells; CHEMBL3308394

DR ChEMBL-Targets; CHEMBL613509

DR Cosmic; 683682

DR Cosmic; 802044

DR Cosmic; 802245

DR Cosmic; 907299

DR Cosmic-CLP; 907299

DR ECACC; 87042204

DR ENCODE; ENCBS062JBT

DR ENCODE; ENCBS659PBH

DR GDSC; 907299

DR GEO; GSM827165

DR GEO; GSM887017

DR GEO; GSM888086

DR GEO; GSM1669799

DR GEO; GSM1676299

DR GEO; GSM1701634

DR IGRhCellID; G401

DR JCRB; JCRB9065

DR TOKU-E; 1303

RX PubMed=8382007;

RX PubMed=22460905;

RX PubMed=26351324;

RX PubMed=27397505;

WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/g/cell-lines-detail-286.html

CC Problematic cell line: Misidentified. Originally thought to be a Wilms tumor cell line but is a kidney rhabdoid tumor cell line (PubMed=8382007).

CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: DNA methylation analysis.

CC Omics: SNP array analysis.

CC Omics: Transcriptome analysis.

ST Source(s): ATCC; Cosmic-CLP; ECACC; JCRB; PubMed=25877200

ST Amelogenin: X,Y

ST CSF1PO: 11,13

ST D13S317: 9,14

ST D16S539: 12

ST D18S51: 14

ST D19S433: 13,14

ST D21S11: 31,32.2,33.2

ST D2S1338: 18,24

ST D3S1358: 16,18

ST D5S818: 13

ST D7S820: 11,14

ST D8S1179: 13,14

ST FGA: 24,27

ST Penta D: 10,11

ST Penta E: 7

ST TH01: 8,9.3 (ATCC; Cosmic-CLP; ECACC; JCRB)

ST TH01: 9.3 (PubMed=25877200)

ST TPOX: 8,11 (ATCC; Cosmic-CLP; ECACC; JCRB)

ST TPOX: 11 (PubMed=25877200)

ST vWA: 16

DI NCIt; C8715; Rhabdoid tumor of the kidney

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID G-401-Luc

AC CVCL_J252

SY G401-Luc

DR JCRB; JCRB1390

DR JCRB; NIHS0654

CC Transfected with: UniProtKB; P08659; Firefly luciferase.

CC Discontinued: JCRB; NIHS0654; true.

ST Source(s): JCRB

ST Amelogenin: X,Y

ST CSF1PO: 11,13

ST D13S317: 9,14

ST D16S539: 12

ST D5S818: 13

ST D7S820: 11,14

ST TH01: 8,9.3

ST TPOX: 8,11

ST vWA: 16

DI NCIt; C8715; Rhabdoid tumor of the kidney

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_0270 ! G-401

SX Male

CA Cancer cell line

ID G-402

AC CVCL_1221

SY G402

DR BTO; BTO:0000678

DR CLO; CLO_0003435

DR EFO; EFO_0002180

DR CLDB; cl1410

DR ATCC; CRL-1440

DR BioSample; SAMN03473165

DR CCLE; G402_SOFT_TISSUE

DR ChEMBL-Cells; CHEMBL3308733

DR ChEMBL-Targets; CHEMBL1075446

DR Cosmic; 687593

DR Cosmic; 907298

DR Cosmic-CLP; 907298

DR ECACC; 90112715

DR GDSC; 907298

DR GEO; GSM827166

DR GEO; GSM887018

DR GEO; GSM888087

DR GEO; GSM1669800

DR IGRhCellID; G402

DR IZSLER; BS TCL 212

DR JCRB; JCRB9070

DR KCLB; 21440

RX PubMed=22460905;

RX PubMed=25485619;

RX PubMed=27397505;

CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: Deep RNAseq analysis.

CC Omics: DNA methylation analysis.

CC Omics: SNP array analysis.

CC Omics: Transcriptome analysis.

ST Source(s): ATCC; Cosmic-CLP; ECACC; JCRB; PubMed=25877200

ST Amelogenin: X

ST CSF1PO: 10,13

ST D13S317: 9,12

ST D16S539: 11,13

ST D18S51: 12,16

ST D21S11: 30,31

ST D3S1358: 15,17

ST D5S818: 11,12

ST D7S820: 9,10

ST D8S1179: 14,15

ST FGA: 22,27

ST Penta D: 9,13

ST Penta E: 8,15

ST TH01: 7,9

ST TPOX: 10

ST vWA: 13,17

DI NCIt; C3486; Epithelioid cell type gastrointestinal stromal tumor

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID G-415

AC CVCL_8198

SY G415

DR CLO; CLO_0050017

DR BioSample; SAMN03471927

DR RCB; RCB2640

DR TKG; TKG 0642

RX PubMed=7429092;

RX PubMed=11713577;

CC Doubling time: 48 hours, at 30th passage (PubMed=7429092).

CC Derived from metastatic site: Ascites.

ST Source(s): RCB; TKG

ST Amelogenin: X

ST CSF1PO: 12

ST D13S317: 8,10

ST D16S539: 9,12 (RCB)

ST D16S539: 12 (TKG)

ST D5S818: 12

ST D7S820: 11,12

ST TH01: 7

ST TPOX: 11

ST vWA: 16 (RCB)

ST vWA: 15,16 (TKG)

DI NCIt; C3844; Gallbladder carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID G-7

AC CVCL_3821

SY G7

DR CLO; CLO_0003436

DR CLDB; cl1411

DR CLDB; cl5188

DR ATCC; CRL-1447

DR BCRC; 60236

DR ECACC; 90110520

DR IZSLER; BS TCL 133

RX PubMed=193191;

CC Breed/subspecies: Swiss Webster.

OX NCBI_TaxID=10090; ! Mus musculus

OI CVCL_3822 ! G-8

CA Spontaneously immortalized cell line

ID G-8

AC CVCL_3822

SY G.8; G8

DR CLO; CLO_0003416

DR CLO; CLO_0003437

DR CLDB; cl1412

DR CLDB; cl5189

DR ATCC; CRL-1456

DR BCRC; 60237

DR ECACC; 89050906

DR IZSLER; BS CL 130

DR NCBI_Iran; C141

RX PubMed=193191;

CC Breed/subspecies: Swiss Webster.

OX NCBI_TaxID=10090; ! Mus musculus

OI CVCL_3821 ! G-7

CA Spontaneously immortalized cell line

ID G-mel

AC CVCL_W798

SY G-MEL

DR Cosmic; 706101

DR Cosmic-CLP; 1240130

DR GDSC; 1240130

DR GEO; GSM1669811

RX PubMed=10766161;

RX PubMed=27397505;

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: DNA methylation analysis.

ST Source(s): Cosmic-CLP

ST Amelogenin: X,Y

ST CSF1PO: 12

ST D13S317: 10,11

ST D16S539: 9,13

ST D5S818: 11

ST D7S820: 8,11

ST TH01: 7,9.3

ST TPOX: 8,9

ST vWA: 16,18

DI NCIt; C3510; Cutaneous melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID G-Olig2

AC CVCL_9109

SY G-olig2; GFP-Olig2

DR CLO; CLO_0003549

DR ATCC; SCRC-1037

RX PubMed=12529550;

CC Transfected with: UniProtKB; P42212; GFP.

CC Breed/subspecies: 129X1/SvJ.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_6442 ! RW4

SX Male

CA Embryonic stem cell

ID g/G

AC CVCL_2048

SY G/G

DR CLO; CLO_0003417

DR CLDB; cl1426

DR DSMZ; ACC-224

RX PubMed=7687588;

CC Doubling time: ~35-50 hours (DSMZ).

CC Breed/subspecies: C3H/E1.

OX NCBI_TaxID=10090; ! Mus musculus

SX Female

CA Spontaneously immortalized cell line

ID G01-874

AC CVCL_Z988

RX CelloPub=CLPUB00206;

CC Group: Insect cell line.

OX NCBI_TaxID=192464; ! Phthorimaea operculella

SX Sex undetermined

CA Spontaneously immortalized cell line

ID G085

AC CVCL_E670

SY GO85

DR dbMHC; 48869

DR ECACC; 94050313

DR IHW; IHW9263

DR IMGT/HLA; 10596

WW http://bioinformatics.hsanmartino.it/ecbr/cl263.html

CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Transformed cell line

ID G088

AC CVCL_E671

SY GO88

DR dbMHC; 48866

DR ECACC; 94050314

DR IHW; IHW9264

DR IMGT/HLA; 10597

WW http://bioinformatics.hsanmartino.it/ecbr/cl264.html

CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC Discontinued: ECACC; 94050314; probable.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Sex undetermined

CA Transformed cell line

ID G1 [Carp]

AC CVCL_R842

RX CelloPub=CLPUB00022;

CC Group: Fish cell line.

OX NCBI_TaxID=7962; ! Cyprinus carpio

SX Sex undetermined

CA Spontaneously immortalized cell line

ID G1 [Drosophila]

AC CVCL_Z792

SY Gehring's line G; Gehring-1

DR DGRC; 16

RX DOI=10.1016/B978-012229460-0/50004-X;

WW http://flybase.org/reports/FBrf0205934.html

CC Group: Insect cell line.

OX NCBI_TaxID=7227; ! Drosophila melanogaster

SX Sex undetermined

CA Spontaneously immortalized cell line

ID G12

AC CVCL_H221

RX PubMed=10067924;

CC Doubling time: 2.3 days (PubMed=10067924).

DI NCIt; C3058; Glioblastoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID G144

AC CVCL_DG64

RX PubMed=19497285;

RX PubMed=23468990;

CC Group: Cancer stem cell line.

CC Omics: Array-based CGH.

CC Omics: DNA methylation analysis.

DI NCIt; C3058; Glioblastoma

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_DG65 ! G144ED

SX Male

CA Cancer cell line

ID G144ED

AC CVCL_DG65

RX PubMed=19497285;

CC Group: Cancer stem cell line.

DI NCIt; C3058; Glioblastoma

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_DG64 ! G144

SX Male

CA Cancer cell line

ID G14D

AC CVCL_5505

DR CLO; CLO_0003422

DR ATCC; CRL-2760

CC Group: Fish cell line.

OX NCBI_TaxID=7998; ! Ictalurus punctatus

SX Sex undetermined

CA Spontaneously immortalized cell line

ID G15.AO

AC CVCL_V192

SY G15_AO

RX PubMed=27345779;

CC From: Centro de Investigacion Medica Aplicada (CIMA); Pamplona; Spain.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Induced pluripotent stem cell

ID G15.D

AC CVCL_V193

SY G15_D

CC From: Centro de Investigacion Medica Aplicada (CIMA); Pamplona; Spain.

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Induced pluripotent stem cell

ID G166

AC CVCL_DG66

DR GEO; GSM1026858

RX PubMed=19497285;

RX PubMed=23468990;

CC Group: Cancer stem cell line.

CC Omics: Array-based CGH.

CC Omics: DNA methylation analysis.

DI NCIt; C3058; Glioblastoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID G16L1.1c8

AC CVCL_DC17

RX Patent=US5854010;

RX PubMed=8812265;

RX PubMed=18969542;

RX PubMed=21394221;

RX PubMed=26366531;

CC Biotechnology: Cell line developed for CALUX (Chemically Activated LUciferase eXpression) bioassay. CALUX is used for rapid screening of samples for the presence of dioxin/TCDD-like compounds and AhR agonists/antagonists.

CC Characteristics: Acts through the activation of a luciferase gene under the control of dioxin-response elements (DREs).

CC Transfected with: UniProtKB; P08659; Firefly luciferase.

OX NCBI_TaxID=10141; ! Cavia porcellus

HI CVCL_3463 ! GPC-16

SX Female

CA Cancer cell line

ID G16L7.5c1

AC CVCL_DC18

RX PubMed=26366531;

CC Characteristics: Acts through the activation of a luciferase gene under the control of dioxin-response elements (DREs).

CC Transfected with: UniProtKB; P08659; Firefly luciferase.

OX NCBI_TaxID=10141; ! Cavia porcellus

HI CVCL_3463 ! GPC-16

SX Female

CA Cancer cell line

ID G171

AC CVCL_K212

DR ATCC; HB-9254

RX Patent=US5059523;

OX NCBI_TaxID=10090; ! Mus musculus

CA Hybridoma

ID G174

AC CVCL_DG68

RX PubMed=19497285;

CC Group: Cancer stem cell line.

DI NCIt; C6959; Anaplastic oligoastrocytoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID G179

AC CVCL_DG69

DR GEO; GSM1026859

RX PubMed=19497285;

RX PubMed=23468990;

CC Group: Cancer stem cell line.

CC Omics: Array-based CGH.

CC Omics: DNA methylation analysis.

DI NCIt; C4325; Giant cell glioblastoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID G1B

AC CVCL_5506

DR CLO; CLO_0003423

DR ATCC; CRL-2536

DR BCRC; 60559

RX DOI=10.1139/f81-125;

RX Patent=US4219543;

CC Group: Fish cell line.

OX NCBI_TaxID=59899; ! Clarias batrachus

SX Sex undetermined

CA Spontaneously immortalized cell line

ID G1E

AC CVCL_D046

SY GATA-1(-) erythroid

DR EFO; EFO_0002034

DR ENCODE; ENCBS324ENC

DR ENCODE; ENCBS431QXW

DR ENCODE; ENCBS566SQH

DR ENCODE; ENCBS602TAQ

DR ENCODE; ENCBS807UWB

RX PubMed=9032291;

RX PubMed=12832487;

WW http://stokes.chop.edu/web/weiss/G1Ecells.html

WW http://genome.ucsc.edu/ENCODE/protocols/cell/mouse/G1E_Hardison_protocol.pdf

CC Part of: ENCODE project mouse cell lines.

OX NCBI_TaxID=10090; ! Mus musculus

SX Male

CA Embryonic stem cell

ID G1E-ER4

AC CVCL_D047

DR EFO; EFO_0002055

DR ENCODE; ENCBS158MXR

DR ENCODE; ENCBS214CAT

DR ENCODE; ENCBS325ENC

DR ENCODE; ENCBS326ENC

DR ENCODE; ENCBS327ENC

DR ENCODE; ENCBS328ENC

DR ENCODE; ENCBS329ENC

DR ENCODE; ENCBS330ENC

DR ENCODE; ENCBS529DMU

DR ENCODE; ENCBS840HQL

RX PubMed=12832487;

WW http://stokes.chop.edu/web/weiss/G1Ecells.html

WW http://genome.ucsc.edu/ENCODE/protocols/cell/mouse/G1E_Hardison_protocol.pdf

CC Part of: ENCODE project mouse cell lines.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_D046 ! G1E

SX Male

CA Embryonic stem cell

ID G1M2

AC CVCL_FG73

RX PubMed=1727655;

CC Derived from metastatic site: Left groin subcutaneous.

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_FG74 ! L1M1

SX Female

CA Cancer cell line

ID G1MF285D

AC CVCL_T774

DR CLO; CLO_0050281

DR RCB; RCB1652

RX PubMed=2324505;

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_3412 ! P3X63Ag8U.1

CA Hybridoma

ID G1SV1

AC CVCL_6630

RX PubMed=12096332;

RX PubMed=15541573;

CC Group: Non-human primate cell line.

CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX NCBI_TaxID=9483; ! Callithrix jacchus

SX Female

CA Transformed cell line

ID G2 [Drosophila]

AC CVCL_Z793

SY G 2; Gehring-2

DR CLO; CLO_0003414

DR EFO; EFO_0005746

DR CLDB; cl1404

DR DGRC; 4

RX PubMed=24985917;

WW http://flybase.org/reports/FBrf0205934.html

WW http://www.rccc.cytspb.rssi.ru/ecellbank/spinless/sg2.htm

CC Group: Insect cell line.

OX NCBI_TaxID=7227; ! Drosophila melanogaster

SX Sex undetermined

CA Spontaneously immortalized cell line

ID G2 [Human leukemia]

AC CVCL_R868

RX PubMed=1531243;

RX PubMed=7845014;

DI NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID G253

AC CVCL_K213

DR CLO; CLO_0003424

DR ATCC; HB-9207

DR ATCC; HB-9706

RX Patent=US5059523;

CC Discontinued: ATCC; HB-9207; probable.

OX NCBI_TaxID=10090; ! Mus musculus

CA Hybridoma

ID G26.4.1C3/86

AC CVCL_L515

SY RAT 1C3/86; RAT-1C3/86

DR CLO; CLO_0003426

DR ATCC; HB-9893

OX NCBI_TaxID=10090; ! Mus musculus

CA Hybridoma

ID G266

AC CVCL_4Z51

RX PubMed=21359817;

RX PubMed=22922019;

CC Group: Bird cell line.

CC Omics: Deep RNAseq analysis.

OX NCBI_TaxID=59729; ! Taeniopygia guttata

SX Male

CA Cancer cell line

ID G28-5

AC CVCL_L516

DR CLO; CLO_0003427

DR ATCC; HB-9110

DR NCBI_Iran; H150

RX Patent=US5182368;

CC Monoclonal antibody target: UniProtKB; P25942; Human CD40.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2155 ! P3/NS1/1-Ag4.1

CA Hybridoma

ID G2a.5

AC CVCL_K214

DR CLO; CLO_0003429

DR ATCC; HB-110

RX PubMed=6417068;

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2155 ! P3/NS1/1-Ag4.1

CA Hybridoma

ID G2b.2

AC CVCL_K215

DR CLO; CLO_0003430

DR ATCC; HB-109

RX PubMed=6417068;

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2155 ! P3/NS1/1-Ag4.1

CA Hybridoma

ID G3-3

AC CVCL_W456

RX PubMed=18395706;

CC Transfected with: UniProtKB; P42212; GFP.

CC Breed/subspecies: 129/Ola.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_C715 ! ZHBTc4

SX Male

CA Embryonic stem cell

ID G361/R

AC CVCL_IW13

RX PubMed=26365896;

CC Selected for resistance to: ChEBI; CHEBI:90295; PLX-4720.

DI NCIt; C3224; Melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_1220 ! G-361

SX Male

CA Cancer cell line

ID G3/F11

AC CVCL_0D18

DR BTO; BTO:0005631

RX PubMed=20423655;

RX PubMed=21466288;

OX NCBI_TaxID=10090; ! Mus musculus

CA Hybridoma

ID G3.32.2

AC CVCL_1Q46

RX PubMed=6686281;

RX PubMed=6951167;

CC Problematic cell line: Contaminated. Parent cell line (F-137) has been shown to be a Jiyoye derivative.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_1Q45 ! F-137

SX Male

CA Cancer cell line

ID G355

AC CVCL_GR56

RX PubMed=8392609;

OX NCBI_TaxID=9685; ! Felis catus

CA Finite cell line

ID G355-5

AC CVCL_5659

DR CLO; CLO_0003432

DR ATCC; CRL-2033

DR TOKU-E; 1301

RX PubMed=2983093;

RX PubMed=8392609;

OX NCBI_TaxID=9685; ! Felis catus

HI CVCL_GR56 ! G355

CA Finite cell line

ID G355-5/fOX40

AC CVCL_GR55

RX PubMed=18584886;

CC Transfected with: UniProtKB; Q75SV8; Cat TNFRSF4/CD134.

OX NCBI_TaxID=9685; ! Felis catus

HI CVCL_5659 ! G355-5

CA Finite cell line

ID G3S1

AC CVCL_5507

RX PubMed=19444860;

RX PubMed=20198326;

DI NCIt; C4872; Breast carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_5499 ! EM-G3

SX Female

CA Cancer cell line

ID G4

AC CVCL_E222

SY G4 ES

RX PubMed=17360545;

WW http://www.mmrrc.org/strains/Nagy/G4_info.pdf

CC Breed/subspecies: 129S6/SvEvTac x C57BL/6Ncr.

OX NCBI_TaxID=10090; ! Mus musculus

SX Male

CA Embryonic stem cell

ID G4-2

AC CVCL_E223

DR RCB; AES0150

RX PubMed=18395706;

CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC Breed/subspecies: 129/Ola.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_J647 ! EB3 [Mouse ESC]

SX Male

CA Embryonic stem cell

ID G401.6

AC CVCL_L269

DR EFO; EFO_0005703

DR ENCODE; ENCBS257AAA

RX PubMed=3031816;

WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/MRTG401.6_Crawford_protocol.pdf

CC Part of: ENCODE project common cell types; tier 3.

DI NCIt; C8715; Rhabdoid tumor of the kidney

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_0270 ! G-401

SX Male

CA Cancer cell line

ID G4b

AC CVCL_9W62

RX PubMed=11930168;

CC Transformant: Unknown product of UCHT1 (CVCL_9W35) conditioned media.

CC Breed/subspecies: C57BL/6 x Rb(16.17)32Lub/Rb(11.16)2H.

OX NCBI_TaxID=10090; ! Mus musculus

CA Transformed cell line

ID G5

AC CVCL_U450

RX PubMed=12514093;

CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC Breed/subspecies: BALB/c.

OX NCBI_TaxID=10090; ! Mus musculus

SX Male

CA Transformed cell line

ID G5B1

AC CVCL_U451

RX PubMed=12514093;

CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC Breed/subspecies: BALB/c.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_U450 ! G5

SX Male

CA Transformed cell line

ID G5B2

AC CVCL_U452

RX PubMed=12514093;

CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC Breed/subspecies: BALB/c.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_U450 ! G5

SX Male

CA Transformed cell line

ID G5B3

AC CVCL_U453

RX PubMed=12514093;

CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC Breed/subspecies: BALB/c.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_U450 ! G5

SX Male

CA Transformed cell line

ID G5F2

AC CVCL_U454

RX PubMed=12514093;

CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC Breed/subspecies: BALB/c.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_U450 ! G5

SX Male

CA Transformed cell line

ID G5G2

AC CVCL_U455

RX PubMed=12514093;

CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC Breed/subspecies: BALB/c.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_U450 ! G5

SX Male

CA Transformed cell line

ID G5T/VGH

AC CVCL_M731

SY G5T; G-5-T

DR BCRC; 60194

DR Cosmic; 1237540

RX PubMed=3858282;

ST Source(s): BCRC

ST Amelogenin: X,Y

ST CSF1PO: 10,12

ST D13S317: 8,11

ST D16S539: 9,11

ST D5S818: 10

ST D7S820: 10,11

ST TH01: 9

ST TPOX: 8

ST vWA: 14,20

DI NCIt; C3058; Glioblastoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID G603AD

AC CVCL_U090

RX PubMed=15573370;

DI NCIt; C45542; Lung pleomorphic carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID G603L

AC CVCL_U091

DR Cosmic; 1513407

RX PubMed=15573370;

RX PubMed=21498706;

DI NCIt; C45542; Lung pleomorphic carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID G8-1

AC CVCL_J424

CC Breed/subspecies: Swiss Webster.

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_3822 ! G-8

CA Spontaneously immortalized cell line

ID G821L

AC CVCL_U108

RX PubMed=16651449;

DI NCIt; C3512; Lung adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID G9T/VGH

AC CVCL_D276

SY G9T; G-9-T

DR BTO; BTO:0003880

DR Cosmic; 1237541

RX PubMed=3858282;

DI NCIt; C60781; Astrocytoma

OX NCBI_TaxID=9606; ! Homo sapiens

CA Cancer cell line

ID Ga Va

AC CVCL_3689

DR CLO; CLO_0003438

DR ATCC; CRL-1394

DI NCIt; C34568; Ehlers-Danlos syndrome

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Finite cell line

ID GA-10

AC CVCL_1222

SY GA10

DR CLO; CLO_0003439

DR EFO; EFO_0002181

DR ATCC; CRL-2392

DR BioSample; SAMN03473120

DR CCLE; GA10_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR Cosmic; 1303896

DR Cosmic-CLP; 1303896

DR GDSC; 1303896

DR GEO; GSM827343

DR GEO; GSM887019

DR GEO; GSM888088

DR GEO; GSM1669801

DR IGRhCellID; GA10

RX PubMed=11482875;

RX PubMed=22460905;

RX PubMed=25355872;

RX PubMed=25485619;

RX PubMed=27397505;

CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC Characteristics: EBV-negative.

CC Characteristics: Heterozygous for the TP53 p.Pro152Leu and p.Ile232Asn mutations.

CC Doubling time: ~24 hours (PubMed=11482875).

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: Deep RNAseq analysis.

CC Omics: DNA methylation analysis.

CC Omics: SNP array analysis.

CC Omics: Transcriptome analysis.

CC Omics: Virome analysis using RNAseq.

ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST Amelogenin: X,Y

ST CSF1PO: 10

ST D13S317: 11

ST D16S539: 11,12

ST D18S51: 14,18

ST D21S11: 28,30

ST D3S1358: 18

ST D5S818: 11

ST D7S820: 8,10

ST D8S1179: 11,13

ST FGA: 20,23

ST Penta D: 9,13

ST Penta E: 5,12

ST TH01: 9,9.3

ST TPOX: 8,11

ST vWA: 16,20

DI NCIt; C2912; Burkitt lymphoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID GA-10 clone 20

AC CVCL_1223

SY GA-10 (Clone 20); GA-10-Clone-20

DR CLO; CLO_0003440

DR ATCC; CRL-2394

DR Cosmic; 906866

CC Characteristics: EBV-negative.

CC Characteristics: Heterozygous for the TP53 p.Pro152Leu and p.Ile232Asn mutations.

ST Source(s): ATCC

ST Amelogenin: X,Y

ST CSF1PO: 10

ST D13S317: 11

ST D16S539: 11,12

ST D5S818: 11

ST D7S820: 8,10

ST TH01: 9,9.3

ST TPOX: 8,11

ST vWA: 16,20

DI NCIt; C2912; Burkitt lymphoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_1222 ! GA-10

SX Male

CA Cancer cell line

ID GA-10 clone 4

AC CVCL_1224

SY GA-10 (Clone 4); GA-10-Clone-4

DR CLO; CLO_0003441

DR ATCC; CRL-2393

DR Cosmic; 687841

DR Cosmic; 906867

DR GEO; GSM1669802

CC Characteristics: EBV-negative.

CC Characteristics: Heterozygous for the TP53 p.Pro152Leu and p.Ile232Asn mutations.

CC Omics: DNA methylation analysis.

ST Source(s): ATCC

ST Amelogenin: X,Y

ST CSF1PO: 10

ST D13S317: 11

ST D16S539: 11,12

ST D5S818: 11

ST D7S820: 8,10

ST TH01: 9,9.3

ST TPOX: 8,11

ST vWA: 16,20

DI NCIt; C2912; Burkitt lymphoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_1222 ! GA-10

SX Male

CA Cancer cell line

ID GA4

AC CVCL_J883

DR ECACC; 85062502

OX NCBI_TaxID=10090; ! Mus musculus

OX NCBI_TaxID=9940; ! Ovis aries

HI CVCL_2155 ! P3/NS1/1-Ag4.1

CA Hybrid cell line

ID GAC-1

AC CVCL_W470

RX PubMed=1467326;

DI NCIt; C4004; Gastric adenocarcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Male

CA Cancer cell line

ID GAD-1

AC CVCL_G124

DR CLO; CLO_0003447

DR ATCC; HB-184

DR ECACC; 92020601

RX PubMed=2430303;

CC Monoclonal antibody target: UniProtKB; P00368; Chicken GLUD1 (also reacts with other species).

OX NCBI_TaxID=10090; ! Mus musculus

HI CVCL_2199 ! Sp2/0-Ag14

CA Hybridoma

ID GAGI8381AN

AC CVCL_V374

DR IMGT/HLA; 14466

RX PubMed=16948657;

CC Part of: International Histocompatibility Workshop cell lines.

CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX NCBI_TaxID=9606; ! Homo sapiens

SX Sex undetermined

CA Transformed cell line

ID GAK

AC CVCL_1225

DR BioSample; SAMN03472868

DR CGH-DB; 9290-4

DR ChEMBL-Cells; CHEMBL3308154

DR ChEMBL-Targets; CHEMBL2366301

DR Cosmic; 905204

DR Cosmic; 910932

DR Cosmic; 1995410

DR Cosmic-CLP; 910932

DR GDSC; 910932

DR GEO; GSM1669803

DR IFO; IFO50321

DR JCRB; JCRB0180

RX PubMed=6431036;

RX PubMed=15467732;

RX PubMed=27397505;

CC Microsatellite instability: Stable (MSS) (Sanger).

CC Omics: Deep exome analysis.

CC Omics: DNA methylation analysis.

CC Derived from metastatic site: Inguinal lymph node.

ST Source(s): Cosmic-CLP; JCRB; PubMed=25877200

ST Amelogenin: X

ST CSF1PO: 10

ST D13S317: 9,13

ST D16S539: 12

ST D18S51: 13

ST D19S433: 14,15

ST D21S11: 29,30

ST D2S1338: 18,20

ST D3S1358: 16

ST D5S818: 10

ST D7S820: 11

ST D8S1179: 10,11

ST FGA: 24

ST Penta D: 9,11

ST Penta E: 9,10

ST TH01: 7

ST TPOX: 8,9

ST vWA: 15,18

DI NCIt; C40329; Vulvar melanoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID GAK14

AC CVCL_T052

SY Gata1 gene knockdown c-Kit+ leukemia-derived cell line 14

RX PubMed=23890289;

DI NCIt; C21604; Mouse leukemia

OX NCBI_TaxID=10090; ! Mus musculus

SX Female

CA Cancer cell line

ID GAKS

AC CVCL_5508

DR CLO; CLO_0051594

DR CLO; CLO_0051595

DR RCB; RCB0082

DR RCB; RCB1452

RX PubMed=18494573;

CC Group: Fish cell line.

OX NCBI_TaxID=7957; ! Carassius auratus

SX Sex undetermined

CA Spontaneously immortalized cell line

ID GAL-01

AC CVCL_M549

RX PubMed=16856916;

CC Characteristics: EBV-negative.

DI NCIt; C2912; Burkitt lymphoma

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_M550 ! GAL-02

SX Male

CA Cancer cell line

ID GAL-02

AC CVCL_M550

RX PubMed=16856916;

CC Characteristics: EBV-negative.

DI NCIt; C2912; Burkitt lymphoma

OX NCBI_TaxID=9606; ! Homo sapiens

OI CVCL_M549 ! GAL-01

SX Male

CA Cancer cell line

ID GaL23

AC CVCL_2T27

RX PubMed=9590507;

RX PubMed=9792049;

DI NCIt; C4450; Large cell lung carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Cancer cell line

ID GaL23LZ

AC CVCL_2T28

RX PubMed=9792049;

CC Transfected with: UniProtKB; P00722; E.coli lacZ.

DI NCIt; C4450; Large cell lung carcinoma

OX NCBI_TaxID=9606; ! Homo sapiens

HI CVCL_2T27 ! GaL23

SX Female

CA Cancer cell line

ID Gam Per

AC CVCL_3311

DR CLO; CLO_0003449

DR ATCC; CRL-1326

OX NCBI_TaxID=9606; ! Homo sapiens

SX Female

CA Finite cell line

在线咨询

您正在向 biovector.net 发送关于产品细胞株Cell Lines 16-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心的询问

留言

公告/新闻

IPsale®生物知识产权出售平台: 2024-06-27
BioVector NTCC Inc.产品分类中篇1: 2014-12-22
BioVector NTCC产品分类目录简介-上篇: 2014-12-22
BioVector NTCC典型培养物保藏中心简介: 2014-11-20
人源/鼠源cDNA基因ORF克隆/表达质粒现货-BioVector NTCC保藏中心: 2014-10-20
订购合同下载|汇款账户信息: 2014-06-08

*联系人
电话
E-mail

质粒载体:

细胞:

知识产权交易:

菌种:

订购Order:

蛋白/抗体:

商业授权:

基因库:

感受态:

VIRUS:

基因合成:

细胞株Cell Lines 16-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心

您正在向 biovector.net 发送关于产品 细胞株Cell Lines 16-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心 的询问

您正在向 biovector.net 发送关于产品细胞株Cell Lines 16-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心的询问